Wikipedia
bxrwiki
https://bxr.wikipedia.org/wiki/%D0%9D%D1%8E%D1%83%D1%80_%D1%85%D1%83%D1%83%D0%B4%D0%B0%D2%BB%D0%B0%D0%BD
MediaWiki 1.48.0-wmf.5
first-letter
Меди
Тусхай
Хэлэлсэхэ
Хэрэглэгшэ
Хэрэглэгшые хэлэлсэхэ
Википеэди
Википеэди тухай хэлэлсэхэ
Файл
Файл хэлэлсэхэ
MediaWiki
MediaWiki хэлэлсэхэ
Загбар
Загбар хэлэлсэхэ
Туһаламжа
Туһаламжа хэлэлсэл
Категори
Категори хэлэлсэхэ
TimedText
TimedText talk
Модуль
Обсуждение модуля
Event
Event talk
Хэрэглэгшые хэлэлсэхэ:Чёрный дрозд
3
3880
75161
16630
2026-11-19T17:47:38Z
S.Marchenko
18041
S.Marchenko ондоо тээшэнь шэлжүүлэгдээ хуудаһан [[Хэрэглэгшые хэлэлсэхэ:Mark Ekimov]]-һаа [[Хэрэглэгшые хэлэлсэхэ:Чёрный дрозд]] руу: Автоматическое переименование страницы при переименовании участника «[[Special:CentralAuth/Mark Ekimov|Mark Ekimov]]» в «[[Special:CentralAuth/Чёрный дрозд|Чёрный дрозд]]»
16630
wikitext
text/x-wiki
{| style="vertical-align:top; border:1px solid #abf5d5; background-color:#f1fcf5; padding: .5em .5em .2em .5em "
! style="border-bottom:1px solid #abf5d5; background-color:#d0f5e5; padding:0.2em 0.5em 0.2em 0.5em; font-weight:bold; font-size: 120%" | '''Hello {{PAGENAME}}, [[Wikipedia:welcome|welcome]] to [http://bxr.wikipedia.org/wiki/%D0%9D%D1%8E%D1%83%D1%80_%D1%85%D1%83%D1%83%D0%B4%D0%B0%D2%BB%D0%B0%D0%BD Buryat Wikipedia]!'''
|-
| style="border-bottom:1px solid #f1fcf5; padding:0.4em 1em 0.3em 1em; text-align: left; font-size:95%;" |
{| cellspacing="0" cellpadding="0" style="margin:.5em 0em 1em 0em; width:100%"
| style="width:50%; vertical-align:top; border:1px solid #AFA3BF; background-color:#faf5ff;" |
<div style="border-bottom:1px solid #AFA3BF; background-color:#ddcef2; padding:0.2em 1em 0.2em 1em; font-weight:bold">[[file:Crystal Clear app kedit.svg|right|48px|link=|Staring]] '''Starting'''</div>
<div style="border-bottom:1px solid #AFA3BF; padding:0.4em 1em 0.3em 1em">
* New users can view the [[Wikipedia:introduction|introduction]] first;
* You can welcome other Wikipedians in the [[Wikipedia:introductory page|introductory page]];
* Confused where to start to browse? Visit [[Wikipedia:random page|random page]];
* To try editing, please use the [[Wikipedia:sandbox|sandbox]];
* Write your profile on your profile page, so we can know you more;
* See also [[Wikipedia:Five pillars|Five pillars]] before continuing. This is the five rules on the Buryat Wikipedia.
</div>
<div style="border-bottom:1px solid #AFA3BF; background-color:#ddcef2; padding:0.2em 1em 0.2em 1em; font-weight:bold">[[file:Crystal Clear app utilities.png|right|48px|link=|Help]] '''Help'''</div>
<div style="padding:0.4em 1em 0.3em 1em">
* [[Help:Contents|Contents]] - you can find information about contributing to Wikipedia, before asking other users;
* [[Wikipedia:FAQ|FAQ]] - frequently asked questions about Wikipedia;
* [[Portal:Community |Community portal]] - activity information on Wikipedia.
</div>
| style="padding:0em 0.5em 0em 0.5em; background-color:#f1fcf5;"|
| style="width:50%%; vertical-align:top; border:1px solid #abd5f5; background-color:#f1f5fc;" |
<div style="border-bottom:1px solid #abd5f5; background-color:#d0e5f5; padding:0.2em 1em 0.2em 1em; font-weight:bold">[[file:Crystal Clear app kdmconfig.png|right|48px|link=|Tips]] '''Tips'''</div>
<div style="border-bottom:1px solid #abd5f5; padding:0.4em 1em 0.3em 1em">
* Always sign your question on any page or the [[Wikipedia:talk pages|talk pages]] by typing <nowiki>~~~~</nowiki> at the end of your sentence. It will automatically be converted into user name and date.
* Do not forget: [[Wikipedia:basic principles and guidelines|basic principles and guidelines]] of Wikipedia.
* Want to create or edit pages? First identify the [[Wikipedia:style|style]] of Wikipedia! Then look to [[Wikipedia:start a new page and edit a page|start a new page and edit a page]].
</div>
<div style="border-bottom:1px solid #abd5f5; background-color:#d0e5f5; padding:0.2em 1em 0.2em 1em; font-weight:bold">[[file:Crystal Clear action reload.png|right|48px|link=|Making mistake?]]'''Making mistake?'''</div>
<div style="solid #abd5f5; padding:0.4em 1em 0.3em 1em">
* [[Wikipedia:Do not be afraid|'''''Do not be afraid!''''']] You do not need to be afraid either when editing or creating new pages, adding or deleting a sentence.
|}
: '''Enjoy''', we wait your contribution on [http://bxr.wikipedia.org/wiki/%D0%9D%D1%8E%D1%83%D1%80_%D1%85%D1%83%D1%83%D0%B4%D0%B0%D2%BB%D0%B0%D0%BD Buryat Wikipedia]!
:'''This welcome message is written by:''' --[[User:Aris riyanto|Aris riyanto]] ([[User talk:Aris riyanto|talk]]) 11:13, 3 April 2012 (UTC)
|}
9ojtcfm969rc8gklh6ygk4jo8swevl5
Венесуэлэ
0
4650
75165
74187
2026-11-19T23:37:20Z
InternetArchiveBot
12366
Rescuing 2 sources and tagging 0 as dead. #IABot (v2.0.9.7)
75165
wikitext
text/x-wiki
{{Улас
|уугуул_нэрэ =<small>[[Испани хэл|исп.]] República Bolivariana de Venezuela</small>
|буряад_нэрэ =Боливарай Бүгэдэ Найрамдаха Венесуэлэ Улас
|богони_нэрэ =Венесуэлэ
|тугай_зураг =Flag of Venezuela.svg
|һүлдын_зураг =Coat of arms of Venezuela.svg
|уряа =
|дуулал = ''Gloria al Bravo Pueblo''<br/>Зоригтой арад түмэнэй алдар суу<br/><center>[[File:United States Navy Band - Gloria al Bravo Pueblo.ogg]]</center>
|үндэһэнэй_дуулал =[[Испани хэл|исп.]] Gloria al Bravo Pueblo<br />«Аймшиггүй ард түмний алдар цуу»
|газарай_зураг =VEN orthographic.svg
|map_size =100px
|ниислэл_хото =[[Файл:Coat of arms of Caracas.svg|20px]] [[Каракас]]
|хамагай_томо_хото =[[Файл:Coat of arms of Caracas.svg|20px]] [[Каракас]]
|албан_ёһоной_хэлэн =[[Испани хэл]]
|бүһэ_нютагай_хэлэн =
|үндэһэ_язгуур =испани индейшууд (33%), [[сагаан арһатан|сагаан]] (32%), хара сагаанай метис (21%), [[хара арһатан|хара]] (8%), [[индейшууд|улаан]] (4%), харюулаагүй (2%), [[ази]]ин (0%), бусад (0%)<ref>[http://www.infoamerica.org/primera/lb_2011.pdf Informe Latinobarómetro 2011], [[Latinobarómetro]] (p. 58).</ref>
|үндэһэ_язгуур_он =2011
| demonym =Венесуэлынхид
|засаглалай_хэлбэри =[[Бүгэдэ найрамдаха улас|Юрэнхылэгшын бүгэдэ найрамдаха засаг]]
|тэргүүнэй_класс1 = Юрэнхылэгшэ
|тэргүүнэй_нэрэ1 =[[Николас Мадуро]]
|тэргүүнэй_класс2 =Дэд юрэнхылэгшэ
|тэргүүнэй_нэрэ2 =Хорхе Арреаса
|тэргүүнэй_класс3 =
|тэргүүнэй_нэрэ3 =
|хууль_тогтоогч =
|дээдэ_танхим =
|доодо_танхим =
|түүхэн_утга =Бэе даанги ябадал
|тогтносон_үйл_явдал1 =[[Испани]]һаа
|түүхэн_огноо1 =[[1811]] оной [[7 һарын 5]]
|түүхэн_үйл1 =[[Ехэ Колумби]]һаа
|түүхэн_огноо2 =[[1830]] оной [[1 һарын 13]]
|түүхэн_үйл2 =Хүлеэн зүбшөөрэгдэһэн
|газар_нютаг_км2 =916,445
|нутгийн_талбайгаарх_эрэмбэ_дэс =33
|уһанай_процент = 0.32 %
|хүн_амай_тоосоо =
|хүн_ам_тооцоолсон_он =
|хүн_амын_тоогоор_эрэмбэ_дэс =
|хүн_амын_тооллого =27,150.095
|хүн_ам_тоолсон_он =2011
|хүн_амын_тооллого_эрэмбэ_тоологдсоноор =43
|хүн_амай_нягтрал_нэгжэ_км2 =30.2
|хүн_амын нягтрал_эрэмбэ_дэс =181
|ДНБ_ХАЧ =[[Америк доллар|$]]374.111 тэрбум<ref name=imf2>{{cite web|url=http://www.imf.org/external/pubs/ft/weo/2012/01/weodata/weorept.aspx?pr.x=32&pr.y=1&sy=2009&ey=2012&scsm=1&ssd=1&sort=country&ds=.&br=1&c=299&s=NGDPD%2CNGDPDPC%2CPPPGDP%2CPPPPC%2CLP&grp=0&a= |title=Venezuela|publisher=International Monetary Fund|accessdate=24 April 2012}}</ref>
|ДНБ_ХАЧ_он =2011
|ДНБ_ХАЧ_эрэмбэ =
|ДНБ_ХАЧ_Нэг_хүнд =$12,568<ref name=imf2/>
|ДНБ_ХАЧ_Нэг_хүнд_эрэмбэ =
|ДНБ_нэрлэсэн =$315.841 тэрбум<ref name=imf2/>
|ДНБ_нэрлэсэн_он =2011
|ДНБ_нэрлэһэн_эрэмбэ =
|ДНБ_нэрлэсэн_нэг_хүнд =$10,610<ref name=imf2/>
|ДНБ_нэрлэсэн_нэг_хүнд_эрэмбэ =
|ХТББИ =39<ref name="INE">{{cite web|url=http://www.ine.gov.ve/index.php?option=com_content&view=category&id=104&Itemid=45|title=Gini coefficient for the Bolivarian Republic of Venezuela|year=2011|publisher=Instituto Nacional de Estadística|accessdate=2014-12-07|archivedate=2012-07-27|archiveurl=https://web.archive.org/web/20120727181241/http://www.ine.gov.ve/index.php?option=com_content&view=category&id=104&Itemid=45}}</ref>
|Илтгэлцүүр_он =2010
|Илтгэлцүүр_ангилал =<span style="color:yellow;">дундажа</span>
|Илтгэлцүүр_эрэмбэ =
|ХХИ ={{increase}} 0.735
|ХХИ_он =2011
|ХХИ_ангилал =<span style="color:green;">һайн</span>
|ХХИ_эрэмбэ =73
|мүнгэн_тэмдэгтэ =Венесуэл боливар
|мүнгэн_тэмдэгтэ_код =VEF
|сагай_бүһэ =
| utc_offset = – 4
| зуны_цагийн_бүсийн_нэр =
| utc_offset_DST =
|хэв_огноо =
|аль_гарын_замын_хөдөлгөөн =
|интернет_домэйн =.ve
|телефоной_код =+58
|тэмдэглэл =
}}
'''Венесуэлэ''' ({{lang-es|Venezuela}}), албан ёһоор '''Боливарай Бүгэдэ Найрамдаха Венесуэлэ Улас''' ({{lang-es|República Bolivariana de Venezuela}}) гэжэ нэрэтэй [[Урда Америкэ|Урда Америкын]] хойто хэһэгтэ оршодог [[улас]]. Баруун зүгтэ [[Колумби]], зүүн зүгтэ [[Гайана]], урда зүгтэ [[Бразил]]тай хилэ залгажа зүүн хойто талаараа [[Карибын тэнгис]]тэ 2800 оршом километр ута далайн эрьетэй. Тус тэнгисэй хэд хэдэн жаахан аралые өөртөө харьяалдаг.
== Хүн зон ба эдэй засаг ==
Урда Америкын хойто хэһэгтэ 912.050 кв.км газар нютаг эзэлэн оршодог улас. 2003 оной үнэлгээр 24.654.694 хүн зонтой байһан ба мүн ондо хүн зоной жэлэй дундажа үсэлтэ 1.48 хуби боложо, 2050 ондо 37.106.394 болохо түлэбтэй ажа һэн. 27 хүндэ 1 кв.км газар нютаг ногдодог. Хүн зоной 87 хубинь хотодо, 13 хубинь хүдөө нютагта оршон һуудаг байна. Ниислэл Каракас хото 1.975.787 хүнтэй, хүн зоной 67 хубинь эрлиизүүд. 21 хубинь сагаан арһатан, 10 хубинь хара арһатан, дүнгэжэ 2 хубинь уугуул индейшууд ажа. Албанай хэлэниинь [[испани хэлэн|испани]]. [[Католик шажан]]тан. 2003 оной үнэлгээр дундажа наһалалта 73.8, нярайн эндэгдэл 1000 түрэлтэндэ 24 бүридхэгдэһэн байна. 2003 оной үнэлгээр хүн зоной 93.4 хубинь бэшэг үзэгтэй. [[Дотоодын ниитэ бүтээгдэхүүн]]эй 5.2 хубиие болбосоролой һалбарида зарсуулһан болоод албан ёһоной һургалта 7 жэл, нэгэ багшада 23 һурагша ногдожо байба. 1000 хүндэ 301 радио, 109 [[утаһан]], 189 [[телевизор]], 206 [[һонин]] хэблэл, 10.000 хүндэ 9.2 [[интернет]] оногдожо байһан байна. Венесуэлые 1498 ондо Колумби нээһэнэй дараа жэлынь Испани улас түримхэйлэн эзэлбэ. 1810 ондо Испаниин колонизацилгада эсэргүү бодолго гаража 1821 ондо тусгаар тогтонолоо олоһон байна. Венесуэлын засаг захиргаанай нэгэжэнь холбооной 20 можо, холбооной 1 тойрог, холбооной 2 бүһэ нютаг болон эзэмшэл газарһаа бүридэл болодог байна.
Түрын түрүүшын юрэнхылэгшые 6 жэлэй хугасаатай һунгаха ба тэрэ түрэ, засагай эрхые дабхар гүйсэдхэдэг, хуули тогтоохо байгуулгань 165 гэшүүнтэй 5 жэлээр һунгагдадаг Үндэһэнэй Ассамблей юм. Венесуэлын газарай хэбэлэй [[газарай тоһон]], [[хүнгэн сагаан]], [[байгаалиин хии]], [[түмэрэй хүдэр]] зэргэ баялигтай. Хүдэлмэри эрхэлэгшэ хүнэй тоо 2001 ондо 10.170.553 байһанай 11 хубинь хүдөө ажахын, 24 хубинь үйлэдбэрилэлэй, 65 хубинь үйлэшэлгээнэй һалбарида ажаллажа байһан ба ажалгүйдэл 14.9 хуби байгаа. 2000 оной уласай түһэбэй оролго 24.8 тэрбум, заралга 26.3 тэрбум доллар, 2001 ондо [[экспорт]] 25.3 тэрбум, [[импорт]] 16.4 тэрбум доллар, 2001 онд дотоодын ниитэ бүтээгдэхүүн 125 тэрбум долларта хүрэжэ нэгэ хүндэ 5.070 доллар ногдохо болоо. Дотоодын ниитэ бүтээгдэхүүнэй 50.4 хубиие үйлэдбэрилэлэй һалбари бай болгоһон байна. [[Зэбсэгтэ хүсэн]]эй бэе бүрилдэхүүн 2001 ондо 82.300 хүнтэй байһан ба тэрэндэ дотоодын ниитэ бүтээгдэхүүнэй 1.5 хубиие зарана. Мүнгэнэй нэгэжэнь боливар нэрэтэй.
== Засаг захиргаан ==
=== Венесуэлын можо уласууд ===
{| style="background:transparent;"
|- valign="top"
| <!--First column:-->
{| style="background:transparent;"
| || {{spaces|1}}'''Можо улас''' || {{smaller|'''Ниислэл'''}}
|-
| '''1''' ||{{spaces|1}}'''{{smaller|[[Амасонас (Венесуела)|Амасонас]]}}''' || {{smaller|[[Пуерто-Аякучо]]}} </tr>
| '''2''' || [[Файл:Flag of Anzoátegui State.svg|22x20px|Flag of Anzoátegui]]{{spaces|1}}'''{{smaller|[[Ансоатеги]]}}''' || {{smaller|[[Барселона (Венесуела)|Барселона]]}} </tr>
| '''3''' || [[Файл:Flag of Apure State.svg|22x20px|Flag of Apure]]{{spaces|1}}'''{{smaller|[[Апуре]]}}''' || {{smaller|[[Сан-Фернандо де Апуре]]}} </tr>
| '''4''' || [[Файл:Flag of Aragua State.svg|22x20px|Flag of Aragua]]{{spaces|1}}'''{{smaller|[[Арагуа]]}}''' || {{smaller|[[Маракай]]}} </tr>
| '''5''' || [[Файл:Flag of Barinas State.svg|22x20px|Flag of Barinas]]{{spaces|1}}'''{{smaller|[[Баринас (можо улас)|Баринас]]}}''' || {{smaller|[[Баринас]]}} </tr>
| '''6''' || [[Файл:Flag of Bolívar State.svg|22x20px|Flag of Bolívar]]{{spaces|1}}'''{{smaller|[[Боливар (можо улас)|Боливар]]}}''' || {{smaller|[[Сьюдад-Боливар]]}} </tr>
| '''7''' || [[Файл:Flag of Carabobo State.svg|22x20px|Flag of Carabobo]]{{spaces|1}}'''{{smaller|[[Карабобо]]}}''' || {{smaller|[[Валенси (Венесуела)|Валенси]]}} </tr>
| '''8''' || [[Файл:Flag of Cojedes State.svg|22x20px|Flag of Cojedes]]{{spaces|1}}'''{{smaller|[[Кохедес]]}}''' || {{smaller|[[Сан-Карлос (Кохедес)|Сан-Карлос]]}} </tr>
| '''9''' || [[Файл:Flag of Delta Amacuro State.svg|22x20px|Flag of Delta Amacuro]]{{spaces|1}}'''{{smaller|[[Дельта-Амакуро]]}}'''{{spaces|2}} || {{smaller|[[Тукупита]]}} </tr>
| '''10''' || [[Файл:Flag of Falcón State.svg|22x20px|Flag of Falcón]]{{spaces|1}}'''{{smaller|[[Фалькон (можо улас)|Фалькон]]}}''' || {{smaller|[[Санта-Ана-де-Коро]]}} </tr>
| '''11''' || [[Файл: Escudo de Guárico.svg|22x20px|Flag of Falcón]] {{spaces|1}}'''{{smaller|[[Гуарико]]}}''' || {{smaller|[[Сан-Хуан-де-лос-Моррос]]}}{{nbsp|6}} </tr>
| '''12''' || [[Файл:Flag of Lara State.svg|22x20px|Flag of Lara]]{{spaces|1}}'''{{smaller|[[Лара]]}}''' || {{smaller|[[Баркисимето]]}} </tr>
|}
| <!--Second column:-->
{| style="background:transparent;"
| || {{spaces|1}}'''Можо улас''' || {{smaller|'''Ниислэл'''}}
|-
| '''13''' || [[Файл:Flag of Mérida State.svg|22x20px|Flag of Mérida]]{{spaces|1}}'''{{smaller|[[Мерида (можо улас)|Мерида]]}}''' || {{smaller|[[Мерида (Венесуела)|Мерида]]}} </tr>
| '''14''' || [[Файл:Flag of Miranda State.svg|20px]]{{spaces|1}}'''{{smaller|[[Миранда (можо улас Венесуели)|Миранда]]}}''' || {{smaller|[[Лос-Текес]]}} </tr>
| '''15''' || [[Файл:Flag of Monagas State.png|22x20px|Flag of Monagas]]{{spaces|1}}'''{{smaller|[[Монагас]]}}''' || {{smaller|[[Матурин]]}} </tr>
| '''16''' || [[Файл:Flag of Nueva Esparta.svg|22x20px|Flag of Nueva Esparta]]{{spaces|1}}'''{{smaller|[[Нуева-Эспарта (Венесуела)|Нуева-Эспарта]]}}'''{{nbsp|2}} || {{smaller|[[Ла-Асунсьйон]]}} </tr>
| '''17''' || [[Файл:Flag of Portuguesa.svg|22x20px|Flag of Portuguesa]]{{spaces|1}}'''{{smaller|[[Португеса (Венесуела)|Португеса]]}}''' || {{smaller|[[Гуанаре]]}} </tr>
| '''18''' || [[Файл:Flag of Sucre State.svg|22x20px|Flag of Sucre]]{{spaces|1}}'''{{smaller|[[Сукре (можо улас)|Сукре]]}}''' || {{smaller|[[Кумана]]}} </tr>
| '''19''' || [[Файл:Flag of Táchira State.svg|22x20px|Flag of Táchira]]{{spaces|1}}'''{{smaller|[[Тачира]]}}''' || {{smaller|[[Сан-Кристобаль (Венесуела)|Сан-Кристобаль]]}}{{spaces|2}} </tr>
| '''20''' || [[Файл:Flag of Trujillo State.svg|22x20px|Flag of Trujillo]]{{spaces|1}}'''{{smaller|[[Трухильйо (можо улас Венесуели)|Трухильйо]]}}''' || {{smaller|[[Трухильйо (хото)|Трухильйо]]}} </tr>
| '''21''' || [[Файл:Flag of La Guaira State.svg|22x20px|Flag of Vargas]]{{spaces|1}}'''{{smaller|[[Варгас (можо улас)|Варгас]]}}''' || {{smaller|[[Ла-Гуайра]]}} </tr>
| '''22''' || [[Файл:Flag of Yaracuy State.svg|22x20px|Flag of Yaracuy]]{{spaces|1}}'''{{smaller|[[Яракуй]]}}''' || {{smaller|[[Сан-Фелипе]]}} </tr>
| '''23''' || [[Файл:Flag of Zulia State.svg|22x20px|Flag of Zulia]]{{spaces|1}}'''{{smaller|[[Сулия]]}}''' || {{smaller|[[Маракайбо (хото)|Маракайбо]]}} </tr>
|}
|}
== Зүүлтэ ==
{{зүүлтэ}}
== Холбооһон ==
{{commonscat|Venezuela}}
*{{sp icon}} [http://www.gobiernoenlinea.ve/ E-Government] {{Webarchive|url=https://web.archive.org/web/20010625100419/http://www.gobiernoenlinea.ve/ |date=2001-06-25 }}
*{{en icon}} [https://www.cia.gov/library/publications/world-leaders-1/world-leaders-v/venezuela.html Chief of State and Cabinet Members] {{Webarchive|url=https://web.archive.org/web/20130921055048/https://www.cia.gov/library/publications/world-leaders-1/world-leaders-v/venezuela.html |date=2013-09-21 }}
*{{en icon}} {{CIA World Factbook link|ve|Venezuela}}
*{{en icon}} [https://web.archive.org/web/20080607090601/http://ucblibraries.colorado.edu/govpubs/for/venezuela.htm Venezuela] at ''UCB Libraries GovPubs''
*{{en icon}} {{dmoz|Regional/South_America/Venezuela/}}
*{{en icon}} [http://lcweb2.loc.gov/frd/cs/vetoc.html Venezuela] from the [[Library of Congress Country Studies]] (1990)
*{{en icon}} [http://news.bbc.co.uk/2/hi/americas/country_profiles/1229345.stm Venezuela profile] from the [[BBC News]]
*{{sv icon}} {{osmrelation-inline|272644|bullet=no}}
*{{en icon}} [https://web.archive.org/web/20130116234858/http://www.cartografareilpresente.org/rubrique109.html?lang=en Maps on Venezuela – Cartographic features]
*{{en icon}} [http://www.ifs.du.edu/ifs/frm_CountryProfile.aspx?Country=VE Key Development Forecasts for Venezuela] from [[International Futures]]
*{{ar icon}} [http://www.immigrationtovenezuela.com.ve/index.php/2013-10-02-22-52-18/2013-10-02-22-58-18 Venezuela and Tourism] {{Webarchive|url=https://web.archive.org/web/20131218043924/http://www.immigrationtovenezuela.com.ve/index.php/2013-10-02-22-52-18/2013-10-02-22-58-18 |date=2013-12-18 }} from [[Sky Immigration]]
{{Урда Америкэ}}
{{1000 үгүүлэл}}
[[Категори:Урда Америкэ]]
a3siip9nwn88nltilttsybjkxs8prrp
Луи Пастер
0
7164
75167
72103
2026-11-20T00:06:01Z
InternetArchiveBot
12366
Rescuing 1 sources and tagging 0 as dead. #IABot (v2.0.9.7)
75167
wikitext
text/x-wiki
{{Алдартай хүн
|нэрэ = Луи Пастер
|уугуул_нэрэ = Louis Pasteur
|зураг = Louis Pasteur.jpg
|ажал_үйлэ = [[шэнжэлхэ ухаан|эрдэмтэн]] ([[микробиолог]], [[химик]], [[физик]])
|түрэһэн_үдэр =
|түрэһэн_газар = [[Доль, (Юра)]], [[Франци]]
|иргэн = [[File:Flag of France.svg|24px|link=Франци]] [[Франци]]
|наһа_бараһан_үдэр =
|наһа_бараһан_газар = [[Марн-ла-Кокет]] ([[О-де-Сен]]), [[Франци]]
|ажал_хэһэн_саг =
|нүхэр =
|һургалта =
|хүүгэд =
|шагнал =[[Файл:Legion Honneur GC ribbon.svg|50px|link=Хүндэтэй Легионой орден]] {{!}} [[Файл:Ordre du Merite agricole Chevalier ribbon.svg|50px|link=Хүдөө Ажахын Габьяагай Орден]] {{!}} [[Файл:Order of Saint Anna ribbon bar.svg|50px|link=Арюун Аннагай Орден]]
|гар = [[File:Louis Pasteur Signature.svg|100px]]
}}
'''Луи Пастер''' ({{lang-fr|Louis Pasteur}} [[1822 он]]ой [[12 һарын 27]]-ндо түрэжэ, [[1895 он]]ой [[9 һарын 28]]-нда наһа бараһан) [[Франци]]ин Доло хотодо түрэһэн Франциин [[хими|химик]], [[микробиологи|микробиолог]]. Тэрээр үбшэн үүһэгэхэ ушар шалтагаан, үбшэнһөө уридшалан һануулха талаар гайхамшагтай нээлтэ хэһэнээрээ хамагай ехэ алдаршаһан.
Тухайлбал тэрэ түрэхын халуунһаа болодог эхын эндэгдэлые бууруулжа, галзуу үбшэнэй эсэрэг анханай [[вакцина]] бии болгообо. Түүнэй туршалагай ажалууд үбшэные [[нян]] үүһэгэдэг гэхэ онолые баталһан. Луи Пастер мүн һүн, дараһанһаа үбшэлдэг ябадалые зогсоохо арга (арюутгаха пастеризациин арга) һэдэһэнээрээ олон ниитэдэ хамагай ехэ алдаршаһан. Тэрээр [[микробиологи]]ин һалбариие үндэһэлэгшэ гурбан эрдэмтэнэй нэгэ гэжэ тоосогдодог. Нүгөө хоёр [[Фердинанд Кон]], [[Роберт Кох]] хоёр юм. Пастер мүн химиин [[шэнжэлхэ ухаан]]ай һалбарида олон нээлэтэ хэһэнһээ хамагай алдартай зарим [[талаһата|талаһатын]] асимметриин молекул үндэһэлэлые гаргажа ерэһэн ябадал юм. Түүнэй согсос [[Парис]] дахи [[Пастериин хүрээлэн]]гэй доор тусгай бунханда байрладаг.<ref>{{cite web|url=http://books.google.com/books?id=u8FUAAAAMAAJ&lpg=PA31&ots=HEB87YS4Kj&dq=pasteur%20tomb%20mosaic&pg=PA31#v=onepage&q=pasteur%20tomb%20mosaic&f=false |title=VM/SAC, Veterinary medicine & small ... - Google Books |publisher=Books.google.com |date=2007-12-29 |accessdate=2009-10-07}}</ref>
== Зүүлтэ ==
{{зүүлтэ}}
== Холбооһон ==
{{commonscat|Louis Pasteur}}
* [http://www.pasteur.fr/english.html The Institut Pasteur] - Foundation Dedicated to the prevention and treatment of diseases through biological research, education and public health activities
* [http://www.pasteurfoundation.org The Pasteur Foundation] - A US nonprofit organization dedicated to promoting the mission of the [[Institut Pasteur]] in Paris. Full archive of newsletters available online containing examples of US Tributes to Louis Pasteur.
* [http://biotech.law.lsu.edu/cphl/history/articles/pasteur.htm Pasteur's Papers on the Germ Theory]
* [http://www.pasteurbrewing.com Pasteur's Work on Beer Brewing]
* [https://web.archive.org/web/20080407182558/http://php.pasteur.net/index.php?newlang=english The Pasteur Galaxy]
* [http://www-personal.umich.edu/~jbourj/money5.htm Louis Pasteur featured on the 5 French Franc banknote from 1966.] {{Webarchive|url=https://web.archive.org/web/20090416151301/http://www-personal.umich.edu/~jbourj/money5.htm |date=2009-04-16 }}
* [http://www.fordham.edu/halsall/mod/1878pasteur-germ.html Germ Theory and Its Applications to Medicine and Surgery, 1878] {{Webarchive|url=https://web.archive.org/web/20140915135641/http://www.fordham.edu/halsall/mod/1878pasteur-germ.html |date=2014-09-15 }}
* [http://www.life.com/Life/millennium/events/06.html LIFE magazine's top 100 events of the millennium: Germ theory of disease and Pasteur] {{Webarchive|url=https://web.archive.org/web/20080131215721/http://www.life.com/Life/millennium/events/06.html |date=2008-01-31 }}
* [http://www.accessexcellence.org/RC/AB/BC/Louis_Pasteur.html Louis Pasteur (1822-1895)] profile, AccessExcellence.org
The complete work of Pasteur, BNF (Bibliothèque nationale de France)
* {{PDF|[http://gallica.bnf.fr/ark:/12148/bpt6k7356c Pasteur Œuvre tome 1 – Dissymétrie moléculaire]}}
* {{PDF|[http://gallica.bnf.fr/ark:/12148/bpt6k7357p Pasteur Œuvre tome 2 – Fermentations et générations dites spontanées]}}
* [http://math-doc.ujf-grenoble.fr/RBSM/cr-gallica.html ''Comptes rendus de l’Académie des sciences''] Articles published by Pasteur
{{DEFAULTSORT:Луи Пастер}}
{{1000 үгүүлэл}}
[[Категори:Биологууд]]
[[Категори:Химикууд]]
[[Категори:Микробиологууд]]
[[Категори:Эмшэд]]
2pnkm21i6rbk2ssmyyox8334q86kp1q
Хорхой шумуул
0
7499
75168
74999
2026-11-20T00:43:42Z
InternetArchiveBot
12366
Rescuing 1 sources and tagging 0 as dead. #IABot (v2.0.9.7)
75168
wikitext
text/x-wiki
{{Таксон
| color = pink
| name = Хорхой шумуул (Insecta)
| regnum = [[Амитан]] (''Animalia'')
| phylum = [[Үетэ хүлтэн]] (''Anthropoda'')
| classis = '''Хорхой шумуул (''Insecta'')'''
| classis_authority = [[Карл Линней]], 1758
| image = Insects collage.jpg
| image_width = 250px
| image_caption = Мүнөөнэй болон усадхагдаһан хорхой шумуул (''Insecta'')
| rang =
| latin = Insecta
| author = ([[Linnaeus]], [[1758]])
| subdivision_ranks = Дэд анги:
| subdivision =
* '''[[Жэгүүргүй шумуул]]''' (Apterygota) и
* '''[[Жэгүүртэй шумуул]]''' (Pterygota)
'''гү, али:'''
* '''[[Далда үргэтэн]]''' (Entognatha) и
* '''[[Сэхэ үргэтэн]]''' (Amyocerata)
** '''[[Шэрхэг һүүлтэн]]''' (Triplura) и
** '''[[Жэгүүртэй шумуул]]''' (Pterygota)
| wikispecies = Insecta
| commons = Category:Insecta
| itis = 99208
| ncbi = 50557
| eol = 344
}}
'''Хорхой шумуул''' ({{lang-la|Insecta}}) — трахейн һубагай туһаламжатайгаар амисхалдаг, гурбан хос хүлтэй [[Үетэ хүлтэн|үетэ хүлтэнэй хүрээнэй]] хамагай томо анги болоод сая гаран зүйл [[амитан|амитад]] тэмдэглэгдээд байгаа болобош 1,5 сая оршом зүйл байхань зайлшагүй гэжэ эрдэмтэд үзэжэ байгаа. [[Дэлхэй]]н амитанай зүйлэй бүридэлэй талаһаа үлүү хубиие шумуул эзэлхэ<ref name="Chapman">{{cite book |author=Chapman, A. D. |year=2006 |title=Numbers of living species in Australia and the World |pages=60pp |Publisher=Canberra: [[Australian Biological Resources Study]] |id=ISBN 978-0-642-56850-2 |url=http://www.deh.gov.au/biodiversity/abrs/publications/other/species-numbers/index.html}} {{Webarchive|url=http://webarchive.loc.gov/all/20090609110928/http://www.deh.gov.au/biodiversity/abrs/publications/other/species-numbers/index.html |date=2009-06-09 }}</ref><ref>[http://www.globalchange.umich.edu/globalchange2/current/lectures/biodiversity/biodiversity.html Threats to Global Biodiversity] {{Webarchive|url=https://web.archive.org/web/20150220154543/http://www.globalchange.umich.edu/globalchange2/current/lectures/biodiversity/biodiversity.html |date=2015-02-20 }} (Accessed December 2007</ref> болоод нээгдээгүй 30 саяһаа үлүү зүйл шумуул байгаа гэжэ тоосодог байна<ref>Erwin, T.L. (1982) Tropical forests: their richness in Coleoptera and other arthropod species. Coleopt. Bull. 36, 74-5</ref>.
Бэе гүйсэһэн шумуулай хэмжээ 0.139 [[метр|мм]]- 55.5 [[метр|см]]<ref name="walker">Walker, T.J., ed. 2001. University of Florida Book of Insect Records, 2001. [http://ufbir.ifas.ufl.edu/] {{Webarchive|url=https://web.archive.org/web/20081216161323/http://ufbir.ifas.ufl.edu/ |date=2008-12-16 }}</ref>, хүндэ хүнгэниинь 70 [[кг|грамм]] хүрэнэ<ref name="walker"/>. Хорхой шумуул амидаралай олон янза бүриин нүхэсэлдэ амидарха шадабариие хүгжэлэй ябасада олоһон ушарһаа тэдэнэй бэеын бүтэсэ, эрхэтэнүүдэй гүйсэдхэхэ үүргэ маша олон янза боложо һэн. Хорхой шумуул онсолог бол ниидэхэ шадабаритай болоһон ябадал юм. Маша олон зүйлэй шумуул байгаали дээрэ ехэ хэмжээгээр тохёолдохо ушар байгаалиин [[биоценоз]]до угаа ехэ үүргые гүйсэдхэнэ. Тэрэшэлэн олон зүйлэй шумуул [[хүдөө ажахы]]да хорон хүнөөл ушаруулха, [[ургамал]]ай тооһон хүртээхэ, хүн ба амитанай бэедэ паразитлан амидарха, үбшэн тарааха зэргэ практикын холбогдолоор маша ехэ юм.
[[Монгол Улас|Монгол орондо]] 13,000 гаран зүйлэй шумуул мэдэгдээд байна.
== Бэеын бүтэсэ, физиологи ==
Бэе гүйсэһэн шумуулай ехэ бэе толгой, сээжэ, хэбэл гэһэн тодоор 3 хэһэгтэ хубаагдана. Толгой акрон ба 4 сегментһээ, сээжэ ямагта 3, хэбэлэй 11 сегментһээ бүтэнэ.
=== Толгойн хэһэг ===
[[Файл:Evolution insect mouthparts coloured.svg|мини|left|300px|Хорхой шумуулай аманай аппаратай янза бүри: А — мэрэхэ, В — долёохо-мэрэхэ, С — һорохо. a — һахал; c — нюдэн; lb — лябиум; lr — лабрум; md — мандибула; mx — максилла]]
Толгой [[хитин]] капсулаар бүрхэгдэһэн байха ба хүзүүнэй нэгэ үеһөө сээжэтэйгээ хүдэлгөөнтэйгээр холбогдоһон байна. Толгойн доодо талада гү, али үмэнэ үзүүртэ аманай һүба оршоно. Толгойн хоёр хажуугаар 2 том зүймэл нюдэн байрлаха ба тэдэгээрэй хоорондо бишыхан хэд хэдэн энгэй нюдэн байна. Нюдэнэй оршомһоо хос һахал гараха болоод үнэрлэхэ ба хүрэлсэхэ эрхэтэнэй үүргэ гүйсэтгэнэ. Һахал олон үеһөө тогтоно. Һахалай хэлбэри олон янза: утаһалга, булсуута, хюрөө маягай, үдэлгэ, һам маягай, тахир гэхэ мэтэ. Энэнь шумуулые танижа мэдэхэд шухала үүргые гүйсэдхэдэг. Һахалай толгойтой ниилһэн үеые һахалай һуури гэнэ. Шумуулай һахалые толгойн 1-р үеын мүсэ гэжэ үзэдэг. Толгойн 2-р сегмент мүсэгүй, дээдэ урал боложо хубирһан байна. Харин бусад гурбан үеһөө толгойн дээдэ хэһэгтэ байрлаха аманай эрхэтэн үүдэжэ бии болоно. Гэбэшье толгойн сегментүүд өөр хоорондоо нягта ниилсэн байха тула илгагдадаггүй. Харин духа, зулай, хасар, дагжа гэһэн хэһэгүүдиинь заадаһаар илгагдана.
Шумуулай аманай аппаратай бүтэсэ олон янза байдагынь хоол тэжээлые абажа хэрэглэхэ үйлэ ажаллагаанһаа шалтагаална. эртын шумуулнууд ургамал ба амитанай гаралтай органик хатуу зүйлһээр хоололжо байһаниинь тэдэгээрые мэрэхэ, буталхад зохилдожо аманай мэрэхэ эрхэтэнтэй боложо һэн. Иинхүү мэрэгжэ аманай эрхэтэниие хамагай энгэй бүтэсэтэй, эртэ үедэ үүдхэһэн гэжэ үзэдэг. Шингэн тэжээлээр хоололхо (амитанай шуһан һорохо, ургамалай бал, [[шүүһэн|шүүһые]] һорохо, органик шингэнээр хоололхо зэргэ) болоһониинь аманай аппаратай өөр зохилдолгоое нүхэсэлдүүлжэ һэн.
Шулуун далитанууд, [[жоом]] (тархаан), [[сохо]]нуудай аманай эрхэтэн мэрэхэ хэлбэриин аппарат юм. Ехэнхи шумуулай абгалдайн (жээшэнь: [[эрбээхэй]]н хүрэнсэр) аманай эрхэтэн олон хүлтэнэй аманай эрхэтэнэй адлигаар мэрэхэд зохилдоһон байдаг. Мэдрэхэ хэлбэриин аманай аппаратай бүтэсые абажа үзэбэл: дээдэ талаһаа хос бэшэ дээдэ уралаар бүрхэгдэнэ. Дээдэ уралай дооро хүсэрхэг балсантай, хитинжэһэн хос дээдэ угаажа (мандибула) оршоно.
Дээдэ угаажын дотор тала хүсэрхэг шүдэлигдэһэн байхань эдеэн тэжээлэй зүйлые буталжа жэжэглэхэ, үмлэхэ үүргэтэй. Дээдэ угаажын доро хос доодо угаажа (максилла) доодо талаһаа доодо уралаар халхагдан байрлана. Мандибула толгойн 2-р үеын мүсэ юм. Максилла толгойн 2 ба 3-р үеын мүсэнүүд болоно. Мандибула максилланууд үенүүдһээ тогтоһон байхань ябаха хүлһөө анха үүдэжэ гараһан болохые гэршэлнэ. Доодо үрүү 2 үеһөө тогтохо бүшөөд тэрэнэй дээрэ 3 һалаа унжалга байхань дотоодо, гадаада һэртэн ба тэмтэрүүл гэжэ нэрэлнэ.
Доодо урал 2 үеһөө бүтэхэ ба тэрэнэй дээрэ 3 һалаа унжалга байхань доодо уралай дотоодо, гадаада унжалга ба доодо уралай тэмтэрүүл гэжэ нэрэлэгдэнэ.
[[Файл:Phlebotomus pappatasi bloodmeal finished.jpg|мини|300px|[[Хүн]]эй [[шуһан|шуһые]] һородог [[боргооһон]]]]
Аманай хүндын оёор дотогшо нугларжа хитинжэлэгдэһэн хэлэн гү, али гипофаринксые үүдхэһэн байхань аманай аппаратда хамаарагдана. Шумуулай аманай эрхэтэнэй өөр нэгэ хэлбэри бол хазажа һорохо аппарат юм. Ехэнхи [[һарьһан далитад]] ([[зүгы]], хүхэтэрүү, хэдгэнэ) хазажа һороход зохилдоһон аманай эрхэтэнтэй боложо һэн. Үүндэ: дээдэ урал ба дээдэ угаажань мэрэхэ аппаратай дээдэ урал, угаажатай түһөөтэй байна. Харин доодо угаажа утаһажа хатхуур хэлбэритэй болоһон байха ба доодо урал һунажа хобил бүхы хушуу боложо хубиржэ һэн. Хушуунай хобил дотор доодо угаажа оршоно. Энэ байдал хоололхо онсолигһоо боложо һэн. Мандибула, [[сэсэг]]эй тооһоной хатуу хэһэгые бутлаха болбол амитанай арһые хазаха үүргэ гүйсэдхэхэд доодо угаажые үүдхэһэн хушуу сэсэгэй [[бал]] гү, али [[амитан]]ай [[шуһан|шуһые]] һорохо үүргэ гүйсэдхэнэ.
[[Мухар бошхи]]ин, [[боргооһон]]ой аманай эрхэтэн хатхажа һорохо хэлбэриин аппарат юм. Үүндэ: аманай эрхэтэнэй бүхы хэһэгүүд һунаһан байна. Дээдэ, доодо угаажууд һунажа хушуу үүдхэнэ. Дээдэ, доодо угаажууд ута хатхуур болоһон байна. Иинхүү амитанай [[арһан|арһые]] соо хатхажа шуһан һорожо хоололход зохилдожо.
[[Эрбээхэй]]н аманай эрхэтэн ута хушуу хэлбэриие оложо зүбхэн һорохо аппарат боложо хубирбэ. Дээдэ урал үлэгдэл имагтал хосоржо дээдэ угаажанууд юрэдөө үгы боложо доодо угаажань һунажа уян налархай, тайбан байдалдаа мушгиран байрлаха онсологтой хушуу болоһон байна. Доодо урал маша жэжэгхэн, түүн дээрэ 3 үе бүхы богони тэмтэрүүл оршоно. Иинхүү эрбээхэй гагсахүү доодо угаажаараа сэсэгэй балые һорон абажа хоололно. Хос далитанһаа ехэнхи илаанай аманай эрхэтэн долоожо һорохо аппарат болоһон байна. Илаанда дээдэ, доодо угаажа байхагүй харин доодо угаажын тэмтэрүүл бии. Доодо урал һунажа, хобил бүхы хушуу болоно. Хушуунай хобил дээрэһээ дээдэ урал бүтээжэ, нэгэн хоолой гуурһые үүдхэнэ. Хушуунай (доодо уралай) һалбан бүхы дэлбэнгээр түгэсжэ шүүхэ аппарат болоһон байна. Иинхүү шэнгэн тэжээл хошуунай үзүүрээр долоогдон шүүгдэжэ хошуунай һүбээр һорогдохо болоно.
Хорхой шумуулай аманай эрхэтэнэй бүтэсэ, ангилал зүйн ехэхэн ажа холбогдолтой юм. Ехэнхи хорхой шумуулай аманай эрхэтэнүүд (угаажууд) толгойн хэһэгтэ тодоор тодо байрлаһан байна. Тиимэ хорхой шумуулнууд ил угаажатанай һалбари ангида (Ectognatha) багтана. Сөөнхи хорхой шумуулай аманай эрхэтэнүүд тусгай бүрхөөл дотор байрлажа зүбхэн үзүүрынь гадагша орёын харагдана. Тиимэ хорхой шумуулые нюуса угаажатанай һалбари ангида (Entognatha) хамааруулна.
=== Cээжын бүтэсэ ===
[[Файл:Motion of Insectwing.gif|right|250px|thumb|Хорхой шумуулай далиин энгэй хүдэлгөөниие харуулһан хүндэлэн огтололой зураг <br /> '''a''' дали <br /> '''b''' холбооһон <br />
'''c''' хүндэлэн балсан <br />
'''d''' тууша балсан.]]
Хорхой шумуулай сээжын хэһэг гурбан сегментһээ тогтохо тула үмэнэдэ, дунда, хойто сээжэ гэжэ нэрэлдэг. Сээжын гурбан сегмент тус бүриһээ хос хүлнүүд гараһан байна. Хос хүл бүхэн үенүүдһээ тогтоһон байна. Үүндэ: аарсаг, тойго, шаантаг, шилбэ, һарбуу болоно. Хорхой шумуулай хүл ябаха үүргэ гүйсэдхэхэ болобош амидаралай онсолигһоо боложо олон янзын хэлбэритэй байдаг. Ехэнхи хорхой шумуулай хүл гүйхэд зохилдожо нарыхан, урта байдаг. Гэтэл сарсаа, дэбхэргэ, голио зэргэ хорхой шумуулай хойто хүлын шаантаг, шилбэ нарыхан ута боложо үдэржэ дэбхэрхэд зохилдоһон байна. «Хүн хорхойн» хүл, илангаяа урда хүл малтахад зохилдожо богонихон, малтуур маягтай болоһон байха ба хитинжэлэгдэһэн шүдэлгүүдтэй байдаг. Уһажа сохын хойто хүл уһанда сэлхэд зохилдожо һарбуунай үенүүд үзүүр өөрөө нарысажа гадана талаараа үһээр хушигдаһан байна. Хорхой шумуулай үбэрмэсэ онсолог бол нисэхэд зохилдоһон ябадал мүн. Хорхой шумуулай дали ниидэхэ үүргэ гүйсэдхэхэ болоод сээжын 2 ба 3 сегмент хүдэлгөөнтэйгөөр холбогдоһон байна. Ехэнхи хорхой шумуулнууд хоёр хос далитай байдаг.
Хорхой шумуулай дали эхилэн үүдэхдээ бэеын ханын арһан гадагша сүлхын хоёр дабхар нимгэн илтэһэн маягтай боложо тэдэгээр илтэһэнэй забһараар хүнды үүдэнэ. Тэрэ хүнды бол бэеын хүндын үргэлжэлэл юм. Далиин хүндыдэ шуһан, транхейн гуурһан далиин нимгэн элтэһээр нэбтэ харагдаха тула түүниие шудал гэжэ нэрэлнэ. Далиин шудал тууша ба хүндылэн байдаг. Далиин угһаа гараһан тууша шудалуудые урда захаһаа эхилэн косталь, субкосталь, радиаль, медиаль, кубиталь, аналь ба югаль шудалнууд гэжэ нэрэлнэ.
Далинь бүтэсэ, байдалаараа хатуу, һарьһалиг, арһалиг ба эбэрлиг байдаг. Мүн далинь хайраһаар хушигдаһан байжа болоно. Иимэдэ шумуулые далиин бүтэсэ байдалаариинь хатуу далитан, хахад хатуу далитан, һарьһан далитан, хайрһан далитан, торон далитан, хос далитан гэжэ нэрэлдэг. Хатуу далитанай (сохын) үмэнэдэ далинь хатуу, эбэрлиг (далинь ниидэхэд ямаршье үүргэ гүйсэдхэхгүй, харин бэеые нюруун талаһаа хамгаалха үүргэтэй.
Дээдэ далиин дооро (сээжын III үеһөө гараһан) һарьһалиг бүтэсэтэй нимгэн дали оршоно. Энэниие жэнхэни дали гэхэ ба ниидэхэ гол үүргэ гүйсэдхэнэ.
Хахад хатуу далитанай (бясаа) үмэнэдэ далиин угай хэһэг хатуу, эбэрлиг байхад үзүүрэй хэһэгиинь нимгэн һарьһархаг, шудалтай байдаг. Энэ ушарһаа иимэ далиие хахад хатуу дали гэжэ нэрэлжэ һэн.
[[Эрбээхэй]]н далинууд хайраһаар хушагдаһан тула хайраһан далитан гэдэг.
Зарим хорхой шумуул үбүрмүһэн далигүй байдаг. Жээшэнь: анханай далигүй хорхой шумуулнууд — Artherygota юм. Харин бөөһэ, нохой бөөһэ зэргэ хорхой шумуул паразит амидаралһаа боложо далигүй болоһон байна.
Хорхой шумуулай сээжын хэһэгтэ далинуудай хүдэлгөөниие нүхэсэлдүүлэгшэ хүшэрхэг балсанууд оршоно.
=== Хэбэлэй хэһэг ===
Хорхой шумуулай хэбэлэй сегментһээ тогтоно. Сегментэй тоо зүйл бүридэ харилсан адлигүй байха болобош 10-һаа хэтэрхэгүй. Харин дээдэ хэлбэринүүдтэ 4-5 байна. Хэбэлэй сегментүүдтэ мүсэ байхагүй, хатуу хитин бүрхөөлээр хушагдаһан байха болобош хоёр үеын заадһаа уян налархай бүтэсэтэй. Хэбэлэй үенүүд сээжын үенүүдэй адлигаар нюруу, өөхэ хажуу хэһэгүүдһээ тогтоно. Зарим шумуулай хэбэлэй түгэсхэлдэ мүсын үлэгдэл эрхэтэн болохо гадуур эрхэтэн сөөнгүй тохёолдоно. Тухайлбал: үндэгэ булагша ([[сарсаа]], [[голёо]], [[шонхор зүгы]]), церки ([[сарсаа]], [[жоом]]), грифельки ([[жоом]], [[голёо]]) зэргые нэрэлжэ болоно.
=== Арһан бүреэһэн ===
[[Файл:Bombyx mori Cocon 02.jpg|мини|left|[[Торгон]]ой хооройн гэр]]
Хорхой шумуулай ехэ бэе арһаар бүрхэгдэнэ. Арһан [[эпидерма|эпидермын]] [[эс]]эй дабхарга гү, али [[гиподерма]], кутикулэһээс бүрэлдэн тогтоно. Кутикула бол гиподермын эсэй илгаруулалтын бүтээгдэхүүн мүн. Кутикула химиин найрлагаараа харилсан адлигүй 3 дабхаргаһаа бүридэн тогтоно. Кутикулын доодо дабхаргань үетэһэн, уян налархай байна. Энэ дабхаргын дээрэ оршохо хоёрдогшо (дунда) дабхарга босоо үетэй, хатуу бата бэхэ шэнжэ шанартай. Кутикулын хамагай дээдэ гурбадагша дабхарга маша нимгэн, хальсаг, тоһолиг бүтэсэтэй тула бэеын шиигые гадагжа, уһые дотогшо багаар нэбтэрүүлнэ. Кутикулын дабхаргын гадаргуу тэгшэ ба эрмэгтэһэн, түбыһэн, хобилтоһон, хонхойһон, сэглэгдэһэн гэхэ мэтын хэлбэреэр гүдэгэр юмуу хотхор байжа болоно. Хорхой шумуулай арһан бүреэһэнэй гадаргууд үе хайрса байдаг. Эдэгээрынь гиподермын эсүүдэй томорһоной үрэ дүндэ үүдэжэ бии болоно.
Хорхой шумуулай үнгэ зүһэ кутикула ба гиподермын дабхаргада оршох будагша бодос пегментһээ хамаарна. Гялалзаһан үнгэ тэрэнэй туяань кутикулын бүтэсэһээ боложо гэрэлые хугалха ба сасаруулха шадабаритай шууд холбоотой. Арһан бүреэһэндэ арһанай гиподермын дүрсэ хубирһан эснүүд болохо булшархайнууд хамаарагдана.
Булшархайнууд нэгэ ба олон эсһээ тогтоно. Нэгэ эстэй булшархай гиподермын эснүүдэй хоорондо оршоно. Олон эстэй булшархай ууталаг гү, али хоолой хэлбэреэр бэеын хүндыдэ оршожо илгаруулха һубагай туһаламжатайгаар арһанай гадаргууда нээгдэнэ. Хорхой шумуул тоһые илгаруулха тоһоной булшархай, үнэртэ бодосые илгаруулагша үнэртэ булшархай, хорто булшархай байхаһаа гадана зарим хорхой шумуулай абгалдайда миндаһан илгаруулагша булшархай байна. Түүгээр миндаһан гэрые (кокон) хэнэ.
Хорхой шумуултай химиин аргаар тэмсэлые ябуулхад арһан бүреэһэнэй бүтэсын онсолигые харгалзаха хэрэгтэй.
Тоһоной булшархайн илгаруулалтаар бүрхэгдэһэн гү, али битүү үһээр хушагдаһан хорхой шумуултай бэедэ шэнгэн хоруудай нилзалта муу байдаг тула тэдэгээрые хэрэглэхэнь һайн үрэ дүн үгэдэггүй. Хорхой шумуулай арһан нилээд бодосые нэбтэрүүлдэг болобошье хорые нэбтэрүүлхэ шанарынь харилсан адлигүй болоод кутикулын дабхаргын химиин найрлага болон бүтэсэһээ хамаарагдана. Гадаада үйлэшэлгээнэй зарим хорые хэрэглэхэдээ тэдэгээр хоро хорхой шумуулай арһаар хэрхэн нэбтэрдэг болохые уридшалан мэдэхэ ябадал шухала.
=== Балсан ===
Хорхой шумуулай балсангай эд агшах шадабаритай нарин ута [[эс]]нүүдһээ тогтоно. Багса балсангуудай тоо маша олон 1,5-2 мянгада хүрэнэ. Хорхой шумуулай балсанг араг яһанай гү, али хүдэлгөөнэй, дотоодо эрхэтэнүүдэй балсан гэжэ ангилан үзэдэг. Хүдэлгөөнэй балсангууд ехэ бэе тэрэнэй дагууруудай арһанай дотоодо хананда бэхлэгдэнэ. Досоодо эрхэтэнэй балсан, [[зүрхэн]]эй ханые үүдхэхэ ба [[гэдэһэн]] болон бусад эрхэтэнүүдэй тогтосондо оролсожо, тэдэгээрэй хүдэлгөөн, үйлэ ажаллалгые нүхэсэлдүүлнэ.
Хорхой шумуулай бэеын бараг бүхы балсан (гистологиин бүтэсээр) хүндэлэн шудалта балсангууд юм.
=== Хоол болбосоруулха системэ ===
Хорхой шумуулай хоол болбосоруулха системэ аманай һүбээр эхилжэ, хойто һүбээр түгэсһэн, хоолой хэлбэритэй [[гэдэһэн]]эй системэ юм. Гэдэһэн үмэнэдэ, дунда, хойто гэжэ 3 хэһэгһээ тогтоно. Гэдэһэнэй үмэнэдэ ба хойто хэһэг дотор таладаа кутикулээр хушагдаһан, тэжээл зүбхэн гэдэһэнэй дунда хэһэгээр шэмэгдэнэ. Хорхой шумуулай гэдэһэнэй үмнэдэ хэһэгые шүлһэнэй булшархай бүхы аманай хүнды, багалзуур, улаан хоолой, гүеэ (улаан хоолойн бүдүүрһэн хэһэг) гэжэ ангилна. Гүеэнь хоол тэжээлые түрэ агуулха үүргэтэй. Хатуу тэжээлээр хоололдог хорхой шумуулай гүеэнэй арад балсанта ходоод оршохо ба эндэ тэжээл жэжэглэгдэнэ.
Дунда гэдэһэнэй дотоодо хана олон һалбари нугашааһатай байха ба гэдэһэнһээ мухар унжалгууд һалбарилан гараһаниинь шүүһэ илгарха, хоол болбосоруулха гадаргууе ехэдхэхэ үүргэтэй юм. Дунда гэдэһэнэй ханын эснүүд тэжээл болбосоруулха фермент илгаруулна. Энэхүү ферментын туһаламжатайгаар хоол тэжээл бүримүһэн задаржа болбосорно. Хоолые задалха ферментын үйлэшэлгээ хоол тэжээлэй найрлагһаа боложо хорхой шумуул бүхэндэ харилсан адлигүй байна. Шуһан һорогшад тэжээлэй найрлага уураг ехэтэй тула уургые задалха фермент илгаруулна.
[[Эрбээхэй]]н тэжээлэй (сэсэгэй балын) найрлаганда һахар элбэг ушар зүбхэн һахарые задалха фермент илгаруулха жэшээтэй юм.
Тэжээлэй задаралаар үүдэжэ, гэдэһэнэй ханаар шэмэгдэһэн бүтээгдэхүүн эс, эдүүдтэ шуһаар хүргэгдэжэ түүнһээ шэнээр [[нүүрһэнуһан]], өөх тос, уураг бүрэлдэнэ. Болбосорогдоогүй зүйл хойто гэдэһэндэ шэлжэжэ, шулуун гэдэһэндэ хуримталагдан аажамаар хойто һүбээр гадагшалха болоно. Хорхой шумуулай тэжээл олон янза, гол түлэб [[ургамал]], [[амитан]]ай гаралтай тэжээлээр хоололно.
=== Илгаруулха системэ ===
[[Файл:Fire ants02.jpg|мини|left|[[Шоргоолзон]] — һайн [[тархи]]тай ниигэмдэ амидаралтай шумуул]]
Хорхой шумуулай илгаруулха эрхэтэниинь үндэһэндээ ''мальпигиин һудалууд'' юм. Эдэгээрынь дунда ба хойто гэдэһэнэй заае дээрэ нээгдэһэн нимгэн ханатай (2-200 хүрэтэрхи) һудалнууд болоно. Мальпигын үзүүрнүүд бэеын хүндын шуһанда хүбэжэ байна.
Уурагай задаралай бүтээгдэхүүн болохо [[шээһэнэй хүшэл]] шуһанһаа мальпигиин һудалай ханаар шэнгээгдэжэ, уламаар хойто гэдэһэндэ орожл үтгэнэй хамта гадагшална. Мальпигиин һудалуудһаа гадана өөхэн бэе илгаруулха үүргэ гүйсэдхэнэ. Задаралай бүтээгдэхүүн [[шээһэнэй хүшэл]] өөхэн бэеын энсүүдтэ хуримталагдана. Мүн хорхой шумуулай шуһанда [[амёбо]] маягай эснүүд ба [[нефроцит]] гэдэг бүлэг эснүүд байдагиинь зайлуулха үүргэ гүйсэдхэнэ. Нефроцитууд задаралай бүтээгдэхүүниие жиүээлбэл карбиниие шэнгээжэ абана. Харин амёбо маягай эснүүд талһатуудые барижа абадаг. Хорхой шумуулай бэедэ оршохо өөхэн бэеын эдүүд һиирэг болоод трахейн гуурһаар дүүрһэн байна.
Өөхэн бэе зайлуулха эрхэтэнэй үүрэг гүйсэдхэхэһээ гадана хоол тэжээлэй бодосой дарасые хадгална. Тэрээр дарасын ашаар хорхой шумуул удаан хугасаагаар үлэн байжа шадана.
Зарим хорхой шумуулай өөхэн бэе гэрэлтэхэ эрхэтэн болодог. Хорхой шумуулай гэрэлтэхэ процесс [[Мэдэрэлэй системэ|мэдэрэлэй системын]] зохисуулалтаар гүйсэдхэгдэнэ.
=== Мэдэрэлэй системэ ===
[[Файл:Insects nervous system-RUS.png|мини|Шумуулай мэдэрэлэй системын зураг]]
Хорхой шумуулай [[мэдэрэлэй системэ]] бусад [[үетэ хүлтэн]]эй мэдэрэлэй системын адли хэбэлэй нервнэ гэнжэлһэн хэлбэритэй байха болобош хүгжэлэй дээдэ түбшэндэ хүрэһэн байна. [[Түб мэдэрэлэй системэ]]нь [[тархи]] болон хэбэлэй нервын гэнжэлһэн зангилаануудһаа тогтоно. Тархинь үмэнэдэ-протоцеребрум, дунда-дейтоцеребрум, хойто-тритоцеребрум гэһэн 3 хэһэгһээ бүтэнэ. Тархи гитологиин маша нарин бүтэсэтэй болоод тэрэнэй хэһэг тус бүри нервнэ шэрхэг бүхы хэд хэдэн зангилаануудһаа тогтоно. [[Тархи]]ин задалан илгаха шухала түбынь протоцеребрумда оршохо «мөөгэн хэлбэриин бэе» болоно. Энэ ушар ниигэмжэ амидаралтай хорхой шумуулай ([[шоргоолзон]], [[балта зүгы]], [[термит]]) тархинай энэ хэһэг һайн хүгжэһэн байна.
Хэбэлэй мэдэрэлэй гэнжэлһэн зангилаань багалзуурай доодо зангилаа (түүнһээ гараһан нервүүд 3 хос хүл өөд ошоһон байна) сээжын 3 томо зангилаа ба хэбэлэй зангилаануудһаа тогтоно. Хэбэлэй зангилаанай тоо харилсан адлигүй. Бүрэн тохёолдолдо (жоом, хун хорхой, сохонуудай хүбрэлэй хүгжэлэй эхин үедэ) 11 шэрхэг байна. Ехэнхи хорхой шумуулай хэбэлэй гэнжэлһэн зангилаанай тоо гол түлэб 8 байха болобош хүгжэнгүй шабжуудта түүнһээшье сөөнэ байна. Зарим хорхой шумуул сээжэ ба хэбэлэй нервын зангилаанууд ниилэжэ зүбхэн сээжын зангилаае үүдхэһэн байха тула хэбэлэй хэһэгтэ, зангилаагүй нервүүд оршоно. Хорхой шумуул тархиһаа симпатик нервүүд гараһан байхань дотоодо эрхэтэнүүд, балсангуудай үйлэ ажаллалгые ударидан зохисуулна. Симпатик нервын системын үйлэ ажалалгаа түб нервын системэтэй холбоотой. Нервын түбүүд бэеэ дааһан шэнжэтэй өөр хоорондоо холбоотой байна. Багалзуурын дээрэхи нервын зангилаа (тархи) нервын системын бүхы үйлэ ажалалгые зохисуулна.
Үабжиин дотоодо эрхэтэнэй үйлэ ажаллагаанда гормоной шэнгэнэй зохисуулалта шухала үүргэ гүйсэдхэхэ ба түүниие нервын системэ ударидаха тула нерв-шингэнэй зохисуулалта гэжэ нэрэлдэг.
=== Мэдэрхэ эрхэтэн ===
Хорхой шумуулай мэдэрэлэй эрхэтэнүүд нилээд нарин, һайн хүгжэлые олоһон олон хэлбэритэй. Энэнь хорхой шумуулай бэеын бүтэсэ үндэр түвшэндэ байгаагаар тайлбарилагдана. Хорхой шумуул гадаада оршонһоо янза бүриин сошоролые хүлеэн абаха, хүрэлсэхэ, амталха, сонсохо, хараха эрхэтэнүүдтэй. Мэдэрхэ эрхэтэнүүдэй морфологи, үйлэ ажалалгаанай үндэһэн нэгэжэнь сенсиллнүүд юм.
Сенсилл бүхэн нэгэ гү, али хэд хэдэн мэдэрхэ эсһээ тогтоно. Тэрхүү мэдрхэ эс бүриһээ сэжүүр гаража нервын шэрхэгүүдтэй холбогдожо мэдрэлэй заха хизгаарай ба түб системэдэ хүрэнэ. Хамагай энгын сенсилл бол гаданай механика сошоролые хүлеэн абаха сенсилл мүн. Сошоролые хүлеэн абаха сенсиллынь арһанай кутикулада хүдэлгөөнтэй холбогдоһон үһэн, үргэһэнүүд болоно. Тэдэгээр үһэн, үргэсүүд бүхы бэеын илангаяа һахал, тэмтэрүүл, хүл, хэбэлэй гадаргуу дээрэ байрлажа гадаад сошоролые мэдэрнэ. Үнэрые хүлеэн абаха сенсиллүүдиинь угаажын тэмтэрүүлнүүд ба һахалай гадаргуу дээрэ оршохо болоод энэнь үһэн бүхы арһанай олон тооной дүрсэ хубирһан эснүүд болоно. Эдэгээр үһын эснүүдтэй түбһөө ерэһэн нервүүд холбогдожо үнэрэй һэрлиие хүлеэн абана.
Хорхой шумуулай үнэрлэхэ эрхэтэн хоол тэжээлые олохо, дайһанһаа зугтаха, бэе бэеһээ хайжа олоход шухала үүргэ гүйсэдхэдэг. Орооной үедэ эрэгшэниинь эмэгшэнээ үнэрээр олоно. Эмэгшэн хорхой шумуул үнэртэ бодос аттрактаниие илгаруулдаг. Энэхүү бодосой үшүүхэн хэмжээ (агаарай 1 см³ дахи 1000-най хэһэг) эрэгшэниие сошоруулна.
Амтые хүлеэн абаха үһэн бүхы сенсиллнүүд аманай эрхэтэнэй дагуурнууд ба һарбуунай доодо талада оршоно. Эдэгээр сенсиллнүүд үнэрлэхэ сенсиллэй адли бүтэсэтэй. Хорхой шумуулуудай гашуун, шорбог, шэхэрлиг шанарые илгабарлана. Амталха эрхэтэн һайн хүгжэһэн байна.
=== Сонсохо эрхэтэн ===
Нилээд шумуулуудай [[һээр нюруутан]] амитадай сонсохо эрхэтэнэй зарим талаар аналог тусхай эрхэтэнтэй байха ба тэдэгээрынь сонсохо эрхэтэнэй үүргэ гүйсэдхэнэ. Үүндэ: сарсаанай хэбэлэй 1-р үеын хажууда нимгэн һарьһаар бүрихэмэл дугарие нүхэ оршоно. Энэхүү нүхэнь дотогшоо хүндытэй байха болоод уула хүндыдэ нервын түгэсхэлэтэй (үзүүртэй) холбогдоһон мэдрэлэй эс бүхы унжалгууд һалбарилаһан байна. Тэрэнь агаарай долгиниие мэдэрнэ.
Голёоной үмэнэдэ шэлбэн дээрэ дотогшо ороһон хүндытэй хобил хэлбэриин сонсохо эрхэтэн оршоно. Тэрхүү хүндын кутикулын нимгэн халисанда нервын түгэсхэлүүдтэй (үзүүрүүдтэй) холбогдоһон мэдэрхэ эснүүд бэхлэгдэнэ. Тэдэгээр эснүүд агаарай долгиниие хүлеэн абана. Өөрөөһөө дуу гаргадаг шумуулнууд сонсоголын эрхэтэнтэй байна. Дууе эрэгшэн, эмэгшэниинь бэе бэеһээ эрэжэ олохо ба айлгаха, бэеэ хамгаалхын тулада гаргана. Юрынь шумуулнууд маша үргэн диапазонтой, юрын дуунһаа (8-10 гц) хэтэ нам дуу (45000 гц) хүрэтэлхи шэмээг хүлеэн абадаг. Сонсоголой эрхэтэн бүхы шумуулнууд дуу гаргаха шадбаритай. Нэгэн тохёолдолдо далинай хооронын үрэлтээр дуу гаргаха (голёолог таршаа) нүгөө тохёолдолдо гуя, далинай шудалтай хабирһанаар дуу гарана (сарсаа). Энэ мэтэшэлэн дуу гаргаха олон хэлбэри байдаг.
=== Хараха эрхэтэн ===
Шумуулуудай хараха эрхэтэн нюдэн ниилмэл (зүймэл) ба энгын бүтэсэтэй. Ниилмэл нюдэниинь олон жэжэг нюдэһээ (омматидаһаа) бүтэнэ. Ниилмэл нюдэнэй омматидын тоо шэрхэг харилсан адлигүй байхань шумуулуудай биологиин онсологһоо шалтагаална. Ниилмэл нюдэнэй гадаргуунь жэжэг нюдэн (омматид) тус бүриин гадаада хэһэг болохо олон тооной дугариг гү, али зургаан талта сархяагһаа тогтоно.
Омматид тус бүриин оптикын аппарат эбэрлэг тунгалаг хэһэг болохо хрусталиин конус, гэрэлэй туяае нэбтэрүүлхэ ба хугалха аппарат рабдум, гэрэлэй туяае хүлеэн абаха торлог гэһэн 3 хэһэгһээ тогтоно. Тархинһаа ерэхэ хараанай нервын түгэсхэл (үзүүр) гэрэлэй туяае хүлеэн абаха торлогой эснүүдтэй холбогдоно. Омматид (нюдэн) тус бүри туяае үл сасаруулагша пегментэй эснүүдээр бүхы талаараа хүрээлэгдэһэн байна. Иимэдэ 1 омматидта тусһан туяа нүгөө хажуугай омматидта тусхагүй. Гэтэл зарим шумуулуудай омматид тус бүри пегментэй эсээр бүхы талаараа хүрээлэгдээгүй, зүбхэн хрусталиин конусын хажууда пегментэй эснүүд оршоно. Иимэдэ 1 омматидта тусһан гэрэлэй туяа нүгөө хажуугай омматидай торлогто тусна. Иинхүү пегментэй эснүүдэй байршилһаа боложо шумуулуудай хараа өөр өөр байдаг тул үдэрэй ба һүниин хараатай шумуулнууд гэжэ илгабаралан үзэдэг. Шумуулуудай нюдэн зүбхэн ойрын хараатай байха ба хүдэлжэ байгаа юумэниие һайн харадаг. Шумуулуудай ниилмэл нюдэнэй омматид тус бүри юумэниие хэһэглэжэ харахаар харагдажа байгаа бэенүүд зүйгдэн нэгэн хэлбэриие олохо тула шумуулуудай (ниилмэл нюдэнэй) хараае зүймэл хараа гэжэ нэрэлнэ. Шумуулуудай ниилмэл нюдэн гэрэлэй богони туяае һайн мэдэрнэ. Гэтэл хүн [[ультра ягаан туяа]]е мэдэрхэгүй. Бэе гүйсэһэн шумуулуудта ниилмэл нюдэнһээ гадана энгын нюдэн байна. Ехэбшэлэн 2-3 тооной энгын нюдэн ниилмэл нюдэнэй хоорондо (толгойн хэһэгтэ) оршоно. Энгын нюдэн хараанай эрхэтэн болохо болоод гэрэлэй хүсые тодорхойлхо шадабаритай. Бүрэн хубиралтатай шумуулуудай абгалдайнууд зүбхэн энгын нюдэтэй. Энгын нюдэн толгойн хажуугаар 1-8 хос байна. Абгалдайн энгын нюдэнэй бүтэсэ бэе гүйсэһэн шумуулуудай энгын нюдэнэй бүтэсэһээ өөр байна.
=== Амисхалай эрхтэн ===
Шумуулуудай бэеээр нэбтэрэн һүлжэлдэһэн [[амисхал]]ай [[трахей]]н системэ бол амисхалые эрхэтэн юм. Трахей сээжэ ба хэбэлэй хоёр хажуугаар оршохо амисхалай һүбүүд гү, али амисхалууруудһаа һалбарилна. Амисхалай һүбые (амисхалуурые) стигма гэжэ нэрлэнэ. Трахейн эхинэй хэһэгтэ бүдүүн трахей байха болоод тэдэшээриинь сааша һалбарилан нариджа олон тооной маша жэжэг хялгасалаг трахеолуудые үүдхэжэ ябасаар бэеын эд эснүүдэй дотор нэбтэрэн орожо түгэснэ. Амисхалай томо трахейнууд өөр хоорондоо тууша ба хүндэлэн жэжэг трахейгаар холбогдоно. Амисхалай трахей хүбрэлиин эктодермын дабхарһаа үүдэхэ тула дотоодо ханань кутикулээр бүрхэгдэнэ. Бэеын хоёр хажуугай трахей тус бүриин үзүүртэ амисхалай һүбын (стигмын) ойролсоо хааха аппарат байна. Хааха аппарат бол амисхалай һүбые тойроһон хүшүүргэй системэ юм. Хүшүүрэг, балсангай үйлэшэлгээгээр ойротон, амисхалай һүбын амасрые шахажа, тэрэнэй дотоодо хүндые хаана.
Шумуулуудай оршоной агаарай тохиромжогүй нүхэсэл юмуу хорто хиитэй тулгарбал амисхалай аппарат (стигма) хаагдажа түрэ зууршье атугай амисхал зогсонги байдалда ороно. Гэбэшье түүниие шумуул тэһэбэрилжэ шадана. Тэрэшлэн амисхалай һүбиин дотор ханаар маша олон үе хилгаһууд байхань агаарай бохирдолтые (тооһые) шүүхэ үүргэ гүйсэдхэнэ.
Трахей дотор таладаа ороомог хэлбэриин кутикулээр хушагдаһан байна. Амисхалай трахейн иимэ ороомог бүтэсэ, түүниие юманда дарагдан хабшагдажа хаагдахаһаа хамгаална. Иимэ тохёолдолдо ороомог трахейн дотуур хии сүлөөтэй урдаха болоно. Зарим хорхой шумуул (сарсаа, илаа) трахейн зарим хэһэгтэ амисхалай уута үүдэхэ болоод тэрэнь запас хиие хадгалхад зохилдоһон байхын зэргэсээ ниһэлтын үедэ бэеын хубиин жинг багадхаха үүргэ гүйсэдхэнэ. Хэбэлэй балсангуудай агшалтаар бэеын багтаамжа багадхажа амисхал гадагшалха ба балсангай һулралтаар бэеын багтаамжа ехэдхэжэ амисхал абана.
[[Хүшэлтүрэгшэ]] хии трахейн системэ өөд орохо ба [[нүүрһэнхүшэлэй хии]] илгаран гараха процесс амисхалай һүбүүдээр [[диффузи]]ин замаар ябагдана. Амисхалай хүдэлгөөнэй тоо минутада 4-200 хүрэтэр гүйсэдхэгдэхэ болобошье шумуулуудай хүдэлгөөнэй үедэ ехэднэ.
Шумуул бодосой солилсооной процессын үрэ дүндэ бараг бэеын жингын хүниихэтэй адли хэмжээнэй дулааниие илгаруулабжа шумуулуудай бэеын хэмжээ бага, кутикулын бүрхөөлээр дулаан нэбтэржэ гэрлые сасруулха талбай харисангуй ехэ тула дулааниие түргэн алдадаг. Энэ ушарһаа шумуулуудай бэеын дулаан хүйтэниинь гадаада оршоной дулаан хүйтэнтэй шууд порпорциналь байна. Харин наринай элжэ гү, али болбол хүдэлөөнэй үедэ балсангай үйлэ ажалалгаа ехэдхэһэнһээ боложо бэеын температура 10-аар нэмэгдэнэ. Уһанай шумуул абгалдай трахейн системэ бэтүү, өөрөөр хэлэбэл амисхалай һүбэ (стигма) байхагүй. Иимэ тохёолдолдо тэдэгээрэй хиин солилсоо трахейлиг заламгай ашаар ябагдана. Тэдэгээрэй бэеын хоёр хажуу гү, али түгэсхэлдэ маша нимгэн ханатай элтэһэн маягай трахейлиг заламгай оршоно. Трахейлиг заламгай маша нарин трахеолуудаар баялаг байна. Түүгээр хиин солилсоо нүхэсэлдэнэ.
== Зүүлтэ ==
{{зүүлтэ}}
== Ном зохёол ==
* Davidson, E. (ed.) 1981. Pathogenesis of Invertebrate Micorobial Diseases. Allanheld, Osmun & Co. Publishers, Inc., Totowa, New Jersey, USA. 562 pages.
* Davidson, E. 2006. ''Big Fleas Have Little Fleas: How Discoveries of Invertebrate Diseases Are Advancing Modern Science'' University of Arizona Press, Tucson, 208 pages, ISBN 0-8165-2544-7
* Davidson, RH and William F. Lyon. 1979 ''Insect Pests of Farm, Garden, and Orchard.'' John Wiley & Sons., New York. 596 pages, ISBN 0-471-86314-9.
* {{cite book|author=[[David Grimaldi|Grimaldi, D.]] and [[Michael S. Engel|Engel, M.S.]] |title=Evolution of the Insects|year=2005|publisher=[[Cambridge University Press]]|id=ISBN 0-521-82149-5}}
* Reimer, N.J., J.W. Beardsley, and G. C. Jahn 1990. Pest ants in the Hawaiian Islands. In R. Vander Meer, K. Jaffe, and A. Cedena [eds.], «Applied Myrmecology: a world perspective.» Westview Press, Oxford, 40-50.
* Triplehorn, Charles A. and Norman F. Johnson (2005-05-19). Borror and DeLong’s Introduction to the Study of Insects, 7th edition, Thomas Brooks/Cole. ISBN 0-03-096835-6. — a classic textbook in North America
* {{cite book|author=[[David Grimaldi|Grimaldi, D.]] and [[Michael S. Engel|Engel, M.S.]] |title=Evolution of the Insects|year=2005|publisher=[[Cambridge University Press]]|id=ISBN 0-521-82149-5}} — an up to date review of the evolutionary history of the insects
* {{cite book|author=[[Alex Rasnitsyn|Rasnitsyn, A.P.]] and Quicke, D.L.J.|title=History of Insects|year=2002|publisher=[[Kluwer Academic Publishers]]|id=ISBN 1-4020-0026-X}} — detail coverage of various aspects of the evolutionary history of the insects
* {{cite book|author= Biewener, Andrew A.|title=Animal Locomotion|url= https://archive.org/details/animallocomotion0000biew|year=2003|publisher=Oxford University Press|id=ISBN 0-19-850022-X}}
* {{cite book|author=Merritt, RW, KW Cummins, and MB Berg|title=An Introduction To The Aquatic Insects Of North America|year=2007|publisher=Kendall Hunt Publishing Company|id=ISBN 0-7575-4128-3}}
== Холбооһон ==
* [http://tolweb.org/tree?group=Insecta&contgroup=Hexapoda Tree of Life Project] — Insecta
* [http://www.entomology.umn.edu/cues/4015/morpology/ Insect Morphology] {{Webarchive|url=https://web.archive.org/web/20110303060627/http://www.entomology.umn.edu/cues/4015/morpology/ |date=2011-03-03 }} Illustrated and extensively linked overview of insect external and internal anatomy
* [http://www.urbanext.uiuc.edu/insects Let’s Talk About Insects] Let’s Talk About Insects is designed to help students ages 9–11 years of age gain an appreciation of insects; learn how insects grow and develop (metamorphosis), and learn the importance of insects in our environment. (Also in [http://www.urbanext.uiuc.edu/insects_sp Spanish] {{Webarchive|url=https://web.archive.org/web/20090125005934/http://www.urbanext.uiuc.edu/insects_sp/ |date=2009-01-25 }})
* [http://www.ub.es/dpep/meganeura/meganeura.htm Meganeura] {{Webarchive|url=https://web.archive.org/web/20061114232025/http://www.ub.es/dpep/meganeura/meganeura.htm |date=2006-11-14 }} Website about insect evolution and fossil record.
* [https://web.archive.org/web/20131030152528/http://fossilinsects.net/index.htm IPS] Website of the International Palaeoentomological Society.
* [http://ufbir.ifas.ufl.edu/ UF Book of Insect Records] {{Webarchive|url=https://web.archive.org/web/20081216161323/http://ufbir.ifas.ufl.edu/ |date=2008-12-16 }}, documenting «insect champions» in different categories
* [http://www.life.uiuc.edu/delcomyn/RSInsectWalking.html/ Insect Walking] {{Webarchive|url=https://web.archive.org/web/20090425062004/http://www.life.uiuc.edu/delcomyn/RSInsectWalking.html |date=2009-04-25 }} Fred Delcomyn, Research into Insect Locomotion at the University of Illinois
* [http://www.berkeley.edu/news/media/releases/2002/09/rfull/locomotion.html/ Press Release 2002 on research into polypodal locomotion] {{Webarchive|url=https://web.archive.org/web/20130522124425/http://berkeley.edu/news/media/releases/2002/09/rfull/locomotion.html |date=2013-05-22 }}
* [http://www.insectclopedia.com/ Insectclopedia] Insect research portal
* [http://www.food-insects.com/ Insects as Food] {{Webarchive|url=https://web.archive.org/web/20030311131121/http://www.food-insects.com/book7_31/Chapter%2025%20Other%20Countries%20in%20SE%20Asia.htm |date=2003-03-11 }} by Gene DeFoliart. Information about insects as a food resource.
* [http://www.ndsu.edu/entomology/topics/culture.htm Insects and human culture] {{Webarchive|url=https://web.archive.org/web/20090615160306/http://www.ndsu.edu/entomology/topics/culture.htm |date=2009-06-15 }} Entertaining U.S.A. site
* [http://www.insectstore.com Information on keeping, breeding and rearing] {{Webarchive|url=https://web.archive.org/web/20180703064118/http://www.insectstore.com/ |date=2018-07-03 }} insects and invertebrates.
* [http://www.ars.usda.gov/pandp/docs.htm?docid=10919 Bug Bytes] A reference library of digitized insect sounds.
* [http://www.insects.org/index.html INSECTS .org] Insect appreciation.
* [http://www.nzzfolio.ch/www/d80bd71b-b264-4db4-afd0-277884b93470/showarticle/d217322c-e20e-4870-84c4-ec8839e4ee02.aspx The Unexpected Apocalypse]. Entomologist May Berenbaum about a world without insects.
* [http://news.bbc.co.uk/1/hi/world/americas/4808342.stm Pentagon plans cyber-insect army]
* [http://www.antiquebooks.net/readpage.html#insects Introduction to the Natural History and Classification of Insects in a Series of Familiar Letters with Engravings, Priscilla Wakefield, 1816] {{Webarchive|url=https://web.archive.org/web/20060708063248/http://www.antiquebooks.net/readpage.html#insects |date=2006-07-08 }} A free to read book courtesy the Carnegie Museum of Natural History Library
* [http://www.earthlife.net/insects/anatomy.html Earthlife Web] {{Webarchive|url=https://web.archive.org/web/20081103053511/http://www.earthlife.net/insects/anatomy.html |date=2008-11-03 }} — Insect Morphology and Anatomy
* [http://creatures.ifas.ufl.edu/ Featured Creatures] {{Webarchive|url=https://web.archive.org/web/20090122084113/http://creatures.ifas.ufl.edu/ |date=2009-01-22 }} — the good, the bad and the pretty — hundreds of species and groups
* [http://woodypest.ifas.ufl.edu/ WoodyBug] {{Webarchive|url=https://web.archive.org/web/20090118005749/http://woodypest.ifas.ufl.edu/ |date=2009-01-18 }} — you plant 'em, they eat 'em — S.E. U.S. woody ornamental pests and beneficials
* [http://vector.ifas.ufl.edu/ Public Health Pest Control] {{Webarchive|url=https://web.archive.org/web/20090118005556/http://vector.ifas.ufl.edu/ |date=2009-01-18 }} — the EPA national manual on public health arthropods
=== Зурагууд ===
* [http://bugguide.net/ BugGuide] Photographs, life history information, and identification of North American arthropods, especially insects
* [http://www.livescience.com/insects/ LiveScience: Insects] Insect information and User-submitted Insect pictures
* [http://www.me.esalq.usp.br/index_i.php ESALQ Entomological Museum] A collection of 6000+ insect pictures (jpeg format). Brazilian collection (ESALQ/USP).
* [http://www.cirrusimage.com/ North American Insects] A library of 4,000+ reference quality large format insect pictures. Creative Commons licensed
* [http://www.floridanaturepictures.com/insects/insects.html Pictures of Florida insects]
* [http://www.insectimages.org/ InsectImages.org] A archive or 24,000+ high resolution insect photographs. Free for Non-profit Educational Uses.
{{1000 үгүүлэл}}
[[Категори:Хорхой шумуул| ]]
[[Категори:Амитад]]
36crn85vy4om3hqjo7ro5za440to6gs
COVID-19
0
12127
75163
70693
2026-11-19T23:20:14Z
InternetArchiveBot
12366
Rescuing 1 sources and tagging 0 as dead. #IABot (v2.0.9.7)
75163
wikitext
text/x-wiki
{{Үбшэн |
| 01-КОД = U07.1
| 01-НЭРЭ = COVID-19, Вирус баталагдаһан
| 02-КОД = U07.2
| 02-НЭРЭ = COVID-19, Вирус баталагдаһангүй
}}
'''COVID-19''' ({{lang-en|'''CO'''rona'''VI'''rus '''D'''isease 20'''19'''}} тобшолһон нэрэ — ''{{comment|2019 оной коронавирусай халдабари}}''<ref name="Мосгорздрав">{{Cite web |title=Департамент здравоохранения города Москвы. Медицинская реабилитация детей, перенесших COVID19 в режиме дистанционного дневного стационара с использованием цифровых технологий |url=https://mosgorzdrav.ru/ru-RU/science/default/download/745.html |accessdate=2021-06-21 |archivedate=2021-05-02 |archiveurl=https://web.archive.org/web/20210502124317/https://mosgorzdrav.ru/ru-RU/science/default/download/745.html }}</ref>), түрүүн '''2019-nCoV коронавирусай халдабари'''<ref name="temporary name">{{Cite web|url=http://www.euro.who.int/en/health-topics/health-emergencies/novel-coronavirus-2019-ncov_old|title=Novel coronavirus (2019-nCoV)|website=WHO/Europe|date=2020-03-09|publisher=[[WHO|World Health Organization]]|lang=en|accessdate=2020-03-09|archiveurl=https://web.archive.org/web/20200418084252/http://www.euro.who.int/en/health-topics/health-emergencies/novel-coronavirus-2019-ncov_old|archivedate=2020-04-18|deadlink=no}}</ref><ref name=":29" /> (тахалай эхиндэ саг зуурын нэрэшэл<ref>[https://www.bbc.com/russian/news-51388243 Коронавирусу дадут имя. Почему лучше не ошибиться при его выборе] // Статья от 05.02.2020 г. Русская служба BBC. Джасмин Тэйлор-Колман.</ref>) — гээшэ [[SARS-CoV-2]] гэжэ [[коронавирусууд|коронавирусһаа]] ушаруулагдаһан магад хүндэ хурса амисхал замай [[халдабарита үбшэн]]{{sfn|Beeching, Fletcher, Fowler|2020|loc=Definition}}.
Энэ болбол аюултай<ref name=":29">{{Cite web|title=Коронавирусная инфекция 2019-nCoV внесена в перечень опасных заболеваний|url=https://www.rosminzdrav.ru/news/2020/02/02/13258-koronavirusnaya-infektsiya-2019-ncov-vnesena-v-perechen-opasnyh-zabolevaniy|author=|website=[[Министерство здравоохранения Российской Федерации]]|websiteurl=|date=2020-02-02|accessdate=|lang=ru|archiveurl=|archivedate=|doi=|isbn=|issn=|ref=}}</ref>,
хүнгэнөөршье, хүндөөршье<ref>{{Cite web| url=https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected |title=Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected |date=2020-01-28}}</ref> урдадаг хурса амисхал замай халдабарита үбшэн<ref name=":9">{{Статья|ссылка=https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30374-3/abstract|автор=David L. Heymann, Nahoko Shindo|заглавие=COVID-19: what is next for public health?|год=2020|язык=en|издание=[[The Lancet]]|тип=|месяц=02|число=13|том=|выпуск=|номер=|страницы=|issn=0140-6736, 1474-547X|doi=10.1016/S0140-6736(20)30374-3|издательство=[[Elsevier]]|nodot=1}}</ref><ref name=":7">{{Cite web|url=https://static-0.rosminzdrav.ru/system/attachments/attaches/000/049/629/original/Временные_МР_COVID-19_03.03.2020_%28версия_3%29_6-6.pdf?1583255386|title=Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)|author=|website=Минздрав России|subtitle=Временные методические рекомендации|date=2020-03-03|publisher=Министерство здравоохранения Российской Федерации|lang=ru|archiveurl=https://web.archive.org/web/20211225055437/https://static-0.rosminzdrav.ru/system/attachments/attaches/000/049/629/original/%D0%92%D1%80%D0%B5%D0%BC%D0%B5%D0%BD%D0%BD%D1%8B%D0%B5_%D0%9C%D0%A0_COVID-19_03.03.2020_%28%D0%B2%D0%B5%D1%80%D1%81%D0%B8%D1%8F_3%29_6-6.pdf?1583255386|archivedate=2021-12-25|accessdate=2022-03-24}}</ref>. Вирус шууд гү, али бэеын дархалалай харюу урбалаар янза бүриин эрхтэндэ халдабарилха шадабаритай байдаг <ref name=":72">{{Статья|ссылка=https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009037|автор=Wim Trypsteen, Jolien Van Cleemput, Willem van Snippenberg, Sarah Gerlo, Linos Vandekerckhove|заглавие=On the whereabouts of SARS-CoV-2 in the human body: A systematic review|год=2020|язык=en|издание=PLOS Pathogens|месяц=10|число=30|том=16|выпуск=10|страницы=e1009037|issn=1553-7374|doi=10.1371/journal.ppat.1009037}}</ref>. Энэ үбшэнэй эгээн ходо hэдэрэлгэ хадаа [[хурса амисхал замай дистресс-хомсодол]]ые ба һүүлдэ [[хурса амисхалай дутагдал]]ые ушаруулдаг [[вирусай пневмони]] болоод, энэниие анагаахын түлөө [[хүшэлтүрэгшын терапи]] ба амисхалай дэмжэлгэ хэрэгтэй<ref name=":2">{{публикация|статья|язык=ru|ссылка=https://journal.pulmonology.ru/pulm/article/view/1315|заглавие=Практические рекомендации по кислородотерапии и респираторной поддержке пациентов с COVID-19 на дореанимационном этапе|автор=С. Н. Авдеев|автор2=Н. А. Царева|автор3=З. М. Мержоева|автор4=Н. В. Трушенко|автор5=А. И. Ярошецкий|издание=Пульмонология|год=2020|том=30|номер=2|месяц=06|число=02|страницы=151—163|issn=2541-9617}}</ref>. Ондоо hэдэрэлгэнүүдэй дунда баһал [[олон эрхэтэнэй дутагдал]], септическэ сошорол ба венозно [[тромбоэмболи]]<ref>{{Cite web|lang=en|url=https://bestpractice.bmj.com/topics/ru-ru/3000201|title=Коронавирусная болезнь 2019 (COVID-19) - Симптомы, диагностика и лечение {{!}} BMJ Best Practice|website=BMJ Best Practices|date=2020-12-21|publisher=BMJ Publishing Group Limited|archiveurl=https://web.archive.org/web/20210119034243/https://bestpractice.bmj.com/topics/ru-ru/3000201|archivedate=2021-01-19|accessdate=2021-01-17}}</ref>. Үбшэнэй эгээн үргэнөөр дэлгэрэнги [[шэнжэ тэмдэг]] хадаа халуурха, эсэhэнээ мэдэхэ ба хуурайгаар [[ханяадан|ханяадаха]]<ref name=":20">{{Cite web|url=https://www.who.int/ru/emergencies/diseases/novel-coronavirus-2019/advice-for-public/q-a-coronaviruses|title=Вопросы и ответы о COVID-19|publisher=[[Всемирная организация здравоохранения]]|lang=ru|accessdate=2020-08-10|deadlink=no}}</ref>. Шухаг тохёолдолдо үхибүүдые хадалбарилаа һаа, [[Хүүгэдэй олонсистемын хабдаhан хомсодол|хабдаhан хомсодол]] ушаруулха магадгүй<ref name=":54">{{Cite web|lang=en|url=https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19|title=Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19|publisher=[[World Health Organization]]|accessdate=2020-05-18}}</ref>. Мүн баһа [[постковид хомсодол]] гэһэн удаан болзорой hэдэрэлгэ ушаруулха магадгүй<ref name=":76">{{Статья|ссылка=https://www.nature.com/articles/s41591-020-01202-8|автор=Petter Brodin|заглавие=Immune determinants of COVID-19 disease presentation and severity|год=2021|язык=en|издание=Nature Medicine|месяц=01|том=27|выпуск=1|страницы=28–33|issn=1546-170X|doi=10.1038/s41591-020-01202-8}}</ref>.
== Зүүлтэ ==
{{зүүлтэ}}
[[Категори:Халдабарита үбшэн]]
j814egkjb63e8sy6pd1mkov59lrlqgw
COVID-19-дэ эсэргүү вакцинын зүбшөөрэлэй жагсаалта
0
12578
75164
75049
2026-11-19T23:20:33Z
InternetArchiveBot
12366
Rescuing 1 sources and tagging 0 as dead. #IABot (v2.0.9.7)
75164
wikitext
text/x-wiki
National [[regulation of therapeutic goods|regulatory authorities]] have granted emergency use authorizations for thirty-four [[COVID-19 vaccine]]s.
Nine vaccines have been approved for emergency or full use by at least one [[List of stringent regulatory authorities|stringent regulatory authority]] recognized by the [[World Health Organization]] (WHO): [[Pfizer–BioNTech COVID-19 vaccine|Pfizer–BioNTech]], [[Oxford–AstraZeneca COVID-19 vaccine|Oxford–AstraZeneca]], [[Sinopharm BIBP COVID-19 vaccine|Sinopharm BIBP]], [[Moderna COVID-19 vaccine|Moderna]], [[Janssen COVID-19 vaccine|Janssen]], [[CoronaVac]], [[Covaxin]], [[Novavax COVID-19 vaccine|Novavax]] and [[Convidecia]]. Five others are under assessment by the WHO: [[Sputnik V COVID-19 vaccine|Sputnik V]], [[Sinopharm WIBP COVID-19 vaccine|Sinopharm WIBP]], [[Sanofi–GSK COVID-19 vaccine|Sanofi–GSK]] and [[SCB-2019]].<ref name="WHO status">{{#invoke:Cite web||title=Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process|url=https://extranet.who.int/pqweb/key-resources/documents/status-covid-19-vaccines-within-who-eulpq-evaluation-process|publisher=[[World Health Organization]] (WHO)}}</ref>
Specific versions of six vaccines have been authorized by the [[European Medicines Agency]] (EMA): [[Pfizer–BioNTech COVID-19 vaccine|Pfizer–BioNTech]], [[Janssen COVID-19 vaccine|Janssen]], [[Novavax COVID-19 vaccine|Novavax]], [[Moderna COVID-19 vaccine|Moderna]], [[Oxford–AstraZeneca COVID-19 vaccine|Oxford–AstraZeneca]], and [[Valneva COVID-19 vaccine|Valneva]].<ref>{{cite web |title=COVID-19 vaccines: authorised |url=https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-authorised |website=[[European Medicines Agency]] (EMA)}}</ref> Specific versions of another three vaccines are under evaluation by the EMA: [[Sputnik V COVID-19 vaccine|Sputnik V]], [[CoronaVac]], and [[Sanofi–GSK COVID-19 vaccine|Sanofi–GSK]].<ref name="ema.europa.eu">{{cite web |title=COVID-19 vaccines: under evaluation |url=https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-under-evaluation |website=[[European Medicines Agency]] (EMA)}}</ref>
Note that in some countries, vaccines may be authorized solely for travel purposes. They may not be approved for the general population. For example, the [[CoronaVac]], [[Covishield]], [[Sinopharm BIBP COVID-19 vaccine|BBIBP-CorV]] and [[Covaxin]] vaccines are not part of Australia's [[COVID-19 vaccination in Australia|national vacciation program]], however, they are recognised for the purpose of travel to Australia.<ref>{{cite web |title=International COVID-19 vaccines recognised by Australia |url=https://www.tga.gov.au/international-covid-19-vaccines-recognised-australia |website=Therapeutic Goods Administration |publisher=Australian Government Department of Health |access-date=12 January 2022 |accessdate=25 December 2021 |archivedate=7 February 2022 |archiveurl=https://web.archive.org/web/20220207080016/https://www.tga.gov.au/international-covid-19-vaccines-recognised-australia }}</ref><ref>{{cite web |title=COVID-19 and the border - Vaccinated travellers |url=https://covid19.homeaffairs.gov.au/vaccinated-travellers#toc-0 |website=Department of Home Affairs |publisher=Australian Government Department of Home Affairs |access-date=12 January 2022 |accessdate=6 July 2022 |archivedate=14 March 2022 |archiveurl=https://web.archive.org/web/20220314092238/https://covid19.homeaffairs.gov.au/vaccinated-travellers#toc-0 }}</ref><ref>{{cite web |url=https://www.smartraveller.gov.au/COVID-19/COVID-19-vaccinations#TGA-approved |website=Smartraveller |publisher=Australian Government Department of Foreign Affairs and Trade |access-date=12 January 2022|title=COVID-19 vaccinations }}</ref>
{{Horizontal TOC}}
== Overview maps ==
{| class=center
|
<gallery mode="nolines" widths="400" heights="300">
File:COVID-19 RNA and DNA vaccines authorization map.svg|<div style="text-align:left">[[RNA vaccine]]s and [[DNA vaccine]]s{{Legend|#800080|[[Pfizer–BioNTech COVID-19 vaccine|Pfizer–BioNTech]]}}{{Legend|#008800|[[Moderna COVID-19 vaccine|Moderna]]}}{{Legend|#008CFF|[[ZyCoV-D]]}}</div>
File:COVID-19 adenovirus vaccines authorization map.svg|<div style="text-align:left">[[Viral vector vaccine|Adenovirus vector vaccines]]{{Legend|#000088|[[Oxford–AstraZeneca COVID-19 vaccine|Oxford–AstraZeneca]]}}{{Legend|#008800|[[Janssen COVID-19 vaccine|Janssen]]}}{{Legend|#880000|[[Sputnik V COVID-19 vaccine|Sputnik V]]}}{{Legend|#FF008C|[[Sputnik Light]]}}{{Legend|#888800|[[Convidecia]]}}</div>
</gallery>
<gallery mode="nolines" widths="400" heights="300">
File:COVID-19 inactivated vaccines authorization map.svg|<div style="text-align:left">[[Inactivated vaccine|Inactivated virus vaccines]]{{Legend|#008888|[[Sinopharm BIBP COVID-19 vaccine|Sinopharm BIBP]]}}{{Legend|#888800|[[CoronaVac]]}}{{Legend|#FF008C|[[Valneva COVID-19 vaccine|Valneva]]}}{{Legend|#800080|[[Covaxin]]}}{{Legend|#FF8C00|[[Sinopharm WIBP COVID-19 vaccine|Sinopharm WIBP]]}}{{Legend|#666666|Others}}</div>
File:COVID-19 subunit and VLP vaccines authorization map.svg|<div style="text-align:left">[[Subunit vaccine]]s{{Legend|#FF8C00|[[Novavax COVID-19 vaccine|Novavax]]}}{{Legend|#008CFF|[[Abdala (vaccine)|Abdala]]}}{{Legend|#008888|[[EpiVacCorona]]}}{{Legend|#8C00FF|[[ZF2001|Zifivax]]}}{{Legend|#8CFF00|[[Soberana 02]]}}{{Legend|#666666|Others}}</div>
</gallery>
|}
== Oxford–AstraZeneca ==
<section begin="oxfordauthmap"/>
{{infobox
| image = {{Graph:Map|scale=65|defaultValue=gainsboro
|AD=dodgerblue|AE=dodgerblue|AF=dodgerblue|AG=dodgerblue|AI=dodgerblue|AL=dodgerblue|AM=dodgerblue|AO=dodgerblue|AR=dodgerblue|AT=dodgerblue|AU=blueviolet|AW=dodgerblue|AZ=dodgerblue
|BA=limegreen|BB=dodgerblue|BD=dodgerblue|BE=dodgerblue|BF=dodgerblue|BG=dodgerblue|BH=dodgerblue|BJ=dodgerblue|BM=dodgerblue|BN=limegreen|BO=dodgerblue|BQ=dodgerblue|BR=blueviolet|BS=dodgerblue|BT=dodgerblue|BW=dodgerblue|BZ=dodgerblue
|CA=blueviolet|CD=dodgerblue|CF=dodgerblue|CG=dodgerblue|CH=turquoise|CI=dodgerblue|CK=dodgerblue|CL=dodgerblue|CM=dodgerblue|CO=dodgerblue|CR=dodgerblue|CV=dodgerblue|CW=dodgerblue|CY=dodgerblue|CZ=dodgerblue
|DE=dodgerblue|DJ=dodgerblue|DK=dodgerblue|DM=dodgerblue|DO=dodgerblue|DZ=dodgerblue
|EC=dodgerblue|EE=dodgerblue|EG=dodgerblue|ES=dodgerblue|ET=dodgerblue
|FI=darkred|FJ=dodgerblue|FK=dodgerblue|FM=dodgerblue|FR=dodgerblue
|GB=dodgerblue|GD=dodgerblue|GE=dodgerblue|GG=dodgerblue|GH=dodgerblue|GL=dodgerblue|GM=dodgerblue|GN=dodgerblue|GP=dodgerblue|GR=dodgerblue|GT=dodgerblue|GW=dodgerblue|GY=dodgerblue
|HK=turquoise|HN=dodgerblue|HR=dodgerblue|HT=dodgerblue|HU=dodgerblue
|ID=dodgerblue|IE=dodgerblue|IM=dodgerblue|IN=blueviolet|IQ=dodgerblue|IR=dodgerblue|IS=dodgerblue|IT=dodgerblue
|JE=dodgerblue|JP=dodgerblue|JM=dodgerblue|JO=dodgerblue
|KE=dodgerblue|KG=dodgerblue|KH=dodgerblue|KI=dodgerblue|KM=dodgerblue|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue
|LA=dodgerblue|LB=dodgerblue|LC=dodgerblue|LI=dodgerblue|LK=dodgerblue|LR=dodgerblue|LS=dodgerblue|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=dodgerblue
|MA=dodgerblue|MC=limegreen|MD=dodgerblue|ME=dodgerblue|MG=dodgerblue|MH=limegreen|MK=dodgerblue|ML=dodgerblue|MM=dodgerblue|MN=dodgerblue|MR=dodgerblue|MS=dodgerblue|MT=dodgerblue|MU=dodgerblue|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=dodgerblue
|NA=dodgerblue|NE=dodgerblue|NG=dodgerblue|NI=dodgerblue|NL=dodgerblue|NO=darkred|NP=dodgerblue|NR=limegreen|NZ=dodgerblue
|OM=dodgerblue
|PA=dodgerblue|PE=dodgerblue|PF=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PL=dodgerblue|PN=dodgerblue|PS=dodgerblue|PT=dodgerblue|PY=dodgerblue
|QA=dodgerblue
|RO=dodgerblue|RS=dodgerblue|RW=dodgerblue
|SA=dodgerblue|SB=dodgerblue|SC=dodgerblue|SD=dodgerblue|SE=dodgerblue|SG=dodgerblue|SH=dodgerblue|SI=dodgerblue|SK=darkred|SL=dodgerblue|SN=dodgerblue|SO=dodgerblue|SR=dodgerblue|SS=dodgerblue|ST=dodgerblue|SV=dodgerblue|SX=dodgerblue|SY=dodgerblue|SZ=dodgerblue
|TD=limegreen|TG=dodgerblue|TH=dodgerblue|TJ=dodgerblue|TL=dodgerblue|TM=dodgerblue|TN=dodgerblue|TO=dodgerblue|TR=turquoise|TT=dodgerblue|TV=dodgerblue|TW=dodgerblue
|UA=dodgerblue|UG=dodgerblue|US=turquoise|UY=dodgerblue|UZ=dodgerblue
|VC=dodgerblue|VE=limegreen|VG=dodgerblue|VN=dodgerblue|VU=dodgerblue
|WF=dodgerblue|WS=limegreen
|XK=dodgerblue
|YE=dodgerblue
|ZA=darkred|ZM=dodgerblue|ZW=dodgerblue
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|limegreen|Eligible [[COVAX]] recipient}}
{{leftlegend|darkred|Usage stopped}}
}}
<section end="oxfordauthmap"/>
The [[Oxford–AstraZeneca COVID-19 vaccine]], sold under the brand names Vaxzevria<ref name="Vaxzevria EPAR">{{cite web | title=Vaxzevria (previously COVID-19 Vaccine AstraZeneca) EPAR | publisher=[[European Medicines Agency]] (EMA) | url=https://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria-previously-covid-19-vaccine-astrazeneca }}</ref> and Covishield,<ref>{{cite news|date=4 March 2021|title=Covishield and Covaxin: What we know about India's Covid-19 vaccines|work=BBC News|url=https://www.bbc.com/news/world-asia-india-55748124|access-date=8 March 2021|archive-date=7 March 2021|archive-url=https://web.archive.org/web/20210307222320/https://www.bbc.com/news/world-asia-india-55748124|url-status=live}}</ref> is a [[viral vector vaccine]]<ref name="NCT044008383">{{#invoke:Cite web||date=26 May 2020|title=Investigating a Vaccine Against COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04400838|url-status=live|archive-url=https://web.archive.org/web/20201011084750/https://clinicaltrials.gov/ct2/show/NCT04400838/|archive-date=11 October 2020|access-date=14 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04400838}}</ref> produced by the British [[University of Oxford]], British-Swedish company [[AstraZeneca]], and the [[Coalition for Epidemic Preparedness Innovations|Coalition for Epidemic Preparedness Innovations<wbr />]].<ref name="NCT044008383"/><ref name="EudraCT-2020-001228-322">{{#invoke:Cite web||date=21 April 2020|title=A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19|url=https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB|url-status=live|archive-url=https://web.archive.org/web/20201005201654/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB|archive-date=5 October 2020|access-date=3 August 2020|website=EU Clinical Trials Register|publisher=European Union|id=[[EudraCT]] 2020-001228-32}}</ref><ref name="ISRCTN899514242">{{cite journal|last1=O'Reilly|first1=Peter|date=26 May 2020|title=A Phase III study to investigate a vaccine against COVID-19|doi=10.1186/ISRCTN89951424|id=ISRCTN89951424|doi-access=free|website=ISRCTN|name-list-style=vanc}}</ref> Finland, Denmark and Norway suspended the use of the Oxford–AstraZeneca vaccine due to a small number of reports of a rare blood clot disorder.<ref>{{cite web |title=THL temporarily suspends the use of the AstraZeneca COVID-19 vaccine - Press release - THL |url=https://thl.fi/en/web/thlfi-en/-/thl-temporarily-suspends-the-use-of-the-astrazeneca-covid-19-vaccine |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=5 December 2021 }}{{Dead link|date=March 2025 |bot=InternetArchiveBot |fix-attempted=yes }}</ref><ref>{{cite web | title=Denmark continues its vaccine rollout without the COVID-19 vaccine from AstraZeneca | website=Danish Health Authority | date=14 April 2021 | url=https://www.sst.dk/en/english/news/2021/denmark-continues-its-vaccine-rollout-without-the-covid-19-vaccine-from-astrazeneca | access-date=31 July 2021 | quote=That is why it is important to emphasise that it is still an approved vaccine. | accessdate=6 October 2021 | archivedate=31 July 2021 | archiveurl=https://web.archive.org/web/20210731185815/https://www.sst.dk/en/english/news/2021/denmark-continues-its-vaccine-rollout-without-the-covid-19-vaccine-from-astrazeneca }}</ref><ref>{{cite news |last1=Peltier |first1=Elian |title=Denmark says it's permanently stopping use of the AstraZeneca vaccine. |url=https://www.nytimes.com/2021/04/14/world/europe/denmark-astrazeneca-vaccine.html |work=The New York Times |date=14 April 2021}}</ref><ref>{{#invoke:Cite web||last=omsorgsdepartementet|first=Helse-og|date=12 May 2021|title=AstraZeneca-vaksinen tas ut av koronavaksinasjons-programmet|url=https://www.regjeringen.no/no/aktuelt/astrazeneca-vaksinen-tas-ut-av-koronavaksinasjonsprogrammet/id2849494/|access-date=12 May 2021|website=Regjeringen.no|language=no}}</ref> Slovakia suspended its use after the death of a predisposed recipient.<ref>{{cite news |title=Slovakia suspends use of AstraZeneca COVID-19 vaccine as a recipient dies |url=https://www.reuters.com/business/healthcare-pharmaceuticals/slovakia-halting-use-astrazeneca-covid-vaccine-first-doses-2021-05-11/ |access-date=23 June 2021 |date=11 May 2021 |work=Reuters |location=Prague}}</ref> South Africa suspended its use because a small trial found only minimal protection against mild to moderate disease from the locally predominant [[SARS-CoV-2 Beta variant|Beta variant]].<ref>{{cite news |title=South Africa sells AstraZeneca COVID-19 vaccines to other African countries |url=https://www.reuters.com/article/us-health-coronavirus-safrica-vaccine-idUSKBN2BD0K4 |access-date=23 June 2021 |work=Reuters |date=21 March 2021 |location=Johannesburg}}</ref> Japan approved the vaccine for emergency use in May 2021, but did not plan to use them immediately because of rare cases of a blood clotting disorder reported overseas.<ref>{{cite news | title = Japan to donate millions more AstraZeneca vaccine doses across Asia | date = 25 June 2021 | url = https://english.kyodonews.net/news/2021/06/082ff96b4bdb-japan-to-donate-millions-more-astrazeneca-vaccines-across-asia.html | work = Kyodo News }}</ref> Later, Japan started to use the vaccine for people aged 40 or over to mitigate the surge of the [[SARS-CoV-2 Delta variant|Delta variant]] in August.<ref>{{cite web|date=4 August 2021|title=Japan to give COVID-19 emergency areas AstraZeneca vaccine|url=https://www.japantimes.co.jp/news/2021/08/04/national/japan-give-covid-19-emergency-areas-astrazeneca-vaccine/|access-date=28 August 2021|website=The Japan Times|accessdate=6 October 2021|archivedate=28 August 2021|archiveurl=https://web.archive.org/web/20210828022422/https://www.japantimes.co.jp/news/2021/08/04/national/japan-give-covid-19-emergency-areas-astrazeneca-vaccine/}}</ref> Finland ceased use of the vaccine as the last batch expired on 30 November 2021. Until then it was only offered for those aged 65 or more due to extremely rare coagulation disorders among younger recipients of the vaccine. After this Finland will not procure more of the vaccine.<ref name="thl.fi">{{cite web |title=Suspension of AstraZeneca COVID-19 vaccines for those under the age of 65 extended – THL evaluating how it affects the vaccination programme - Press release - THL |url=https://thl.fi/en/web/thlfi-en/-/suspension-of-astrazeneca-covid-19-vaccines-for-those-under-the-age-of-65-extended-thl-evaluating-how-it-affects-the-vaccination-programme |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=5 December 2021 |accessdate=25 December 2021 |archivedate=5 December 2021 |archiveurl=https://web.archive.org/web/20211205163524/https://thl.fi/en/web/thlfi-en/-/suspension-of-astrazeneca-covid-19-vaccines-for-those-under-the-age-of-65-extended-thl-evaluating-how-it-affects-the-vaccination-programme }}</ref><ref name="Use of AstraZeneca coronavirus vacc">{{cite web |title=Use of AstraZeneca coronavirus vaccine to end in Finland in November - News - THL |url=https://thl.fi/en/web/thlfi-en/-/use-of-astrazeneca-coronavirus-vaccine-to-end-in-finland-in-november |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=5 December 2021 |accessdate=25 December 2021 |archivedate=5 December 2021 |archiveurl=https://web.archive.org/web/20211205155743/https://thl.fi/en/web/thlfi-en/-/use-of-astrazeneca-coronavirus-vaccine-to-end-in-finland-in-november }}</ref><ref name="Adenovirus vaccines: FAQ - THL">{{cite web |title=Adenovirus vaccines: FAQ - THL |url=https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/vaccines-and-coronavirus/adenovirus-vaccines-faq |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=3 December 2021 |accessdate=25 December 2021 |archivedate=3 December 2021 |archiveurl=https://web.archive.org/web/20211203222207/https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/vaccines-and-coronavirus/adenovirus-vaccines-faq }}</ref><ref name="Getting vaccinated against COVID-19">{{cite web |title=Getting vaccinated against COVID-19: how, why and when? - THL |url=https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/vaccines-and-coronavirus/getting-vaccinated-against-covid-19-how-why-and-when- |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=3 December 2021 |accessdate=25 December 2021 |archivedate=14 March 2022 |archiveurl=https://web.archive.org/web/20220314032806/https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/vaccines-and-coronavirus/getting-vaccinated-against-covid-19-how-why-and-when- }}</ref> The AstraZeneca vaccine is the most widely accepted internationally,<ref>{{cite news|date=23 July 2021|title=Which covid-19 vaccine is the most widely accepted for international travel?|url=https://www.economist.com/graphic-detail/2021/07/20/which-covid-19-vaccine-is-the-most-widely-accepted-for-international-travel|access-date=11 June 2022|newspaper=The Economist}}</ref> and the most popular in terms of total inoculated worldwide, over 1.3 billion.<ref>{{cite web|date=21 October 2021|title=India celebrates 1 billion COVID-19 vaccine doses with song and dance|url=https://www.reuters.com/world/india/india-celebrates-1-bln-covid-19-vaccine-doses-with-song-film-2021-10-21/|access-date=11 June 2022|website=REUTERS}}</ref><ref>{{cite web|date=29 July 2021|title=Oxford vaccine reaches one billion doses released|url=https://www.ox.ac.uk/news/2021-07-29-oxford-vaccine-reaches-one-billion-doses-released|access-date=11 June 2022|website=University of Oxford}}</ref><ref>{{cite web|date=16 November 2021|title=Two billion doses of AstraZeneca's COVID-19 vaccine supplied to countries across the world less than 12 months after first approval|url=https://www.astrazeneca.com/media-centre/press-releases/2021/two-billion-doses-of-astrazenecas-covid-19-vaccine-supplied-to-countries-across-the-world-less-than-12-months-after-first-approval.html|access-date=11 June 2022|website=AstraZeneca}}</ref><ref>{{cite web|date=8 June 2022|title=Vaxzevria COVID-19 Vaccine (AstraZeneca)|url=https://www.precisionvaccinations.com/vaccines/vaxzevria-covid-19-vaccine-astrazeneca|access-date=11 June 2022|website=precisionvaccinations.com|accessdate=6 July 2022|archivedate=26 June 2022|archiveurl=https://web.archive.org/web/20220626080401/https://www.precisionvaccinations.com/vaccines/vaxzevria-covid-19-vaccine-astrazeneca}}</ref> The AstraZeneca vaccine is administered in more countries than any other vaccine.<ref name="covid.cdc.gov">{{cite web|date=9 June 2022|title=Where are Vaccines (Company and Brand) Administered Globally?|url=https://covid.cdc.gov/covid-data-tracker/#global-vaccinations|access-date=13 June 2022|website=CDC Covid Data Tracker|archiveurl=https://web.archive.org/web/20210125031037/https://covid.cdc.gov/covid-data-tracker/#global-vaccinations|archivedate=25 January 2021|accessdate=7 July 2021}}</ref>
;Full (<section begin="Oxford–AstraZeneca_FN"/>5<section end="Oxford–AstraZeneca_FN"/>)
# Australia<ref>{{cite news|date=16 February 2021|title=AstraZeneca coronavirus vaccine approved for use in Australia by TGA|newspaper=[[ABC News (Australia)|ABC News]] (Australia)|url=https://www.abc.net.au/news/2021-02-16/coronavirus-astrazeneca-vaccine-approved-for-use-in-australia/13115784|access-date=16 February 2021}}</ref><ref>{{#invoke:Cite web||date=16 February 2021|title=TGA provisionally approves AstraZeneca's COVID-19 vaccine|url=https://www.tga.gov.au/media-release/tga-provisionally-approves-astrazenecas-covid-19-vaccine|access-date=16 February 2021|publisher=[[Therapeutic Goods Administration]] (TGA)}}</ref>
# Brazil<ref>{{cite news|date=12 March 2021|title=Brazil grants full approval to Oxford vaccine, orders Sputnik|publisher=[[France 24]]|agency=[[Agence France-Presse]]|location=Brasilia|url=https://www.france24.com/en/live-news/20210312-brazil-grants-full-approval-to-oxford-vaccine-orders-sputnik|access-date=13 March 2021}}</ref>
# Canada<ref>{{cite web | title=Regulatory Decision Summary - Vaxzevria | website=[[Health Canada]] | url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detail.html?linkID=RDS00889 | access-date=26 November 2021}}</ref>
# India<ref name=":1">{{Cite news|last1=Sharma|first1=Milan|last2=Mordani|first2=Sneha|date=27 January 2022|title=Covaxin, Covishield granted market approval in India but conditions apply|work=[[India Today]]|url=https://www.indiatoday.in/coronavirus-outbreak/vaccine-updates/story/covaxin-covishield-granted-regular-market-approval-india-1905218-2022-01-27|access-date=29 January 2022}}</ref>
# Israel<ref name="covid.cdc.gov"/><ref>{{cite web|date=18 October 2021|title=Israel to offer AstraZeneca vaccines starting Thursday|url=https://www.timesofisrael.com/israel-to-offer-astrazeneca-vaccines-starting-thursday/|access-date=13 June 2022|website=The Times of Israel}}</ref><ref>{{cite web|date=31 May 2022|title=Vaccines "Three vaccines have been approved for use in Israel for protection from coronavirus, by Pfizer, Moderna and AstraZeneca."|url=https://corona.health.gov.il/en/vaccine-for-covid/fully-vaccinated/|access-date=13 June 2022|website=Vaccines - Corona Traffic Light Model (Ramzor) Website}}</ref>
{{-}}
;Emergency (<section begin="Oxford–AstraZeneca_EN" />170<section end="Oxford–AstraZeneca_EN" />)
<div style="margin-top: 0.3em; column-width: 15em;">
# Afghanistan<ref>{{cite news|last=Sediqi|first=Abdul Qadir|date=7 February 2021|title=First doses of COVID-19 vaccine arrive in Afghanistan from India|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-afghanistan-vaccine-idUSKBN2A707M|access-date=24 February 2021}}</ref><ref>{{#invoke:Cite web||title=India donates 500,000 COVID vaccines to Afghanistan|url=https://www.aljazeera.com/news/2021/2/8/afghanistan-gets-first-doses-of-covid-19-vaccine-from-india|access-date=24 February 2021|publisher=Al Jazeera}}</ref>
# Albania<ref name=":0" />
# Algeria<ref>{{#invoke:Cite web||last=Kreo|title=البلاد الوطني / وزارة الصناعات الصيدلانية ترخص باستعمال لقاح "أسترا زينيكا -أوكسفورد " المضاد لكورونا|url=http://elbilad.net/article/detail?id=113247|access-date=1 April 2021|website=elbilad.net|language=AR}}</ref>
# Andorra<ref name="Andorra vaccines" />
# Angola<ref>{{#invoke:Cite web||last=AfricaNews|date=3 March 2021|time=CET13:13:37+01:00|title=Angola begins Covid immunization fight with COVAX vaccines|url=https://www.africanews.com/2021/03/03/angola-begins-covid-immunization-fight-with-covax-vaccines/|access-date=14 April 2021|website=Africanews}}</ref>
# Argentina<ref>{{cite news|date=30 December 2020|title=Argentine regulator approves AstraZeneca/Oxford COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-argentina-astrazen/argentine-regulator-approves-astrazeneca-oxford-covid-19-vaccine-astrazeneca-idUSKBN29421P|access-date=30 December 2020|publisher=Reuters}}</ref>
# Armenia<ref>{{cite web |title=Armenia Scraps Restrictions For AstraZeneca Vaccine |url=https://www.azatutyun.am/a/31226006.html |website=«Ազատ Եվրոպա/Ազատություն» ռադիոկայան |language=hy}}</ref>
# Azerbaijan<ref name="cdctracker"/>
# Bahrain<ref>{{#invoke:Cite web||date=25 January 2021|title=Bahrain approves Oxford/AstraZeneca coronavirus vaccine produced in India|url=http://saudigazette.com.sa/article/602862|access-date=30 January 2021|website=Saudigazette}}</ref>
# Bangladesh<ref>{{#invoke:Cite web||title=Oxford University-Astrazeneca vaccine: Bangladesh okays it for emergency use|url=https://www.thedailystar.net/frontpage/news/oxford-university-astrazeneca-vaccine-bangladesh-okays-it-emergency-use-2022381|access-date=6 January 2021|website=[[The Daily Star (Bangladesh)|The Daily Star]]|date=4 January 2021}}</ref><ref>{{#invoke:Cite web||title=Bangladesh approves Oxford-AstraZeneca COVID-19 vaccine|url=https://www.aa.com.tr/en/asia-pacific/bangladesh-approves-oxford-astrazeneca-covid-19-vaccine/2099147|access-date=6 January 2021|website=aa.com.tr}}</ref>
# Benin<ref name="cdctracker"/>
# Bhutan<ref>{{#invoke:Cite web||title=Bhutan receives 400,000 doses of COVID-19 vaccine from India |url=http://www.xinhuanet.com/english/asiapacific/2021-03/22/c_139827645.htm|access-date=1 April 2021|publisher=Xinhuanet}}</ref><ref>{{#invoke:Cite web||title=Bhutan begins biggest vaccination drive against COVID-19|url=https://www.channelnewsasia.com/news/asia/bhutan-begins-biggest-covid-19-vaccination-drive-astrazeneca-14504644|access-date=1 April 2021|website=CNA}}</ref>
# Bolivia<ref name="cdctracker"/>
# Bosnia and Herzegovina<ref name=":3" />
# Botswana<ref>{{#invoke:Cite web||title=Botswana starts COVID-19 vaccine rollout |url=http://www.xinhuanet.com/english/2021-03/26/c_139838942.htm|access-date=1 April 2021|publisher=Xinhuanet}}</ref>
# Brunei<ref name="auto"/>
# Burkina Faso<ref name="whotracker"/>
# Cambodia<ref name="cdctracker"/>
# Cameroon<ref name="cdctracker"/>
# Cape Verde<ref>{{#invoke:Cite web||title=COVID-19 vaccines sent by COVAX arrive in Cabo Verde |url=https://reliefweb.int/report/cabo-verde/covid-19-vaccines-sent-covax-arrive-cabo-verde|access-date=17 April 2021|website=ReliefWeb}}</ref>
# Central African Republic<ref name="whotracker"/>
# Chile<ref>{{#invoke:Cite web||title=Instituto de Salud Pública de Chile|url=https://www.ispch.cl/noticia/isp-aprueba-la-tercera-vacuna-para-combatir-covid-19/|access-date=1 April 2021|language=es}}</ref>
# Colombia<ref>{{cite news|title=Colombia approves emergency use of AstraZeneca coronavirus vaccine |url=https://www.reuters.com/article/us-health-coronavirus-colombia-idUSKBN2AO01A|publisher=Reuters|access-date=22 March 2021|location=Bogotá|date=23 February 2021}}</ref>
# Comoros<ref name="cdctracker"/>
# Congo-Brazzaville<ref name="cdctracker"/>
# Congo-Kinshasa<ref>{{#invoke:Cite web||title=More than 1.7 million COVID-19 vaccines arrive in the Democratic Republic of Congo|url=https://www.unicef.org/press-releases/more-17-million-covid-19-vaccines-arrive-democratic-republic-congo|access-date=25 April 2021|website=www.unicef.org}}</ref>
# Costa Rica<ref>{{cite web |title=Costa Rica approves use of AstraZeneca's COVID-19 vaccine |url=https://qcostarica.com/costa-rica-approves-use-of-astrazenecas-covid-19-vaccine/ |website=Q COSTA RICA |date=9 April 2021}}</ref>
# Djibouti<ref name="cdctracker"/>
# Dominican Republic<ref>{{cite news|date=31 December 2020|title=La República Dominicana aprueba la vacuna de AstraZeneca contra la covid-19|language=es|work=Agencia EFE|url=https://www.efe.com/efe/america/sociedad/la-republica-dominicana-aprueba-vacuna-de-astrazeneca-contra-covid-19/20000013-4431079}}</ref>
# East Timor<ref>{{#invoke:Cite web||date=1 April 2021|title=First vaccines for East Timor arrive in Dili on Monday – LUSA|url=https://covid19.gov.tl/en/first-vaccines-for-east-timor-arrive-in-dili-on-monday-lusa/|url-status=live|archive-url=https://web.archive.org/web/20210402144040/https://covid19.gov.tl/en/first-vaccines-for-east-timor-arrive-in-dili-on-monday-lusa/|archive-date=2 April 2021|website=COVID-19 Timor-Leste Dashboard}}</ref>
# Ecuador<ref>{{cite news|date=24 January 2021|title=Ecuador approves use of AstraZeneca vaccine for COVID-19|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-ecuador-astrazeneca-idUSL1N2JZ0HC|access-date=30 January 2021}}</ref>
# Egypt<ref name="Gulf News"/>
# El Salvador<ref>{{cite news|date=30 December 2020|title=El Salvador greenlights AstraZeneca, Oxford University COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-el-salvador-vaccin/el-salvador-greenlights-astrazeneca-oxford-university-covid-19-vaccine-idINKBN2942HQ}}</ref>
# Eswatini<ref>{{#invoke:Cite web||title=Eswatini launches nationwide COVID-19 vaccination campaign|url=https://www.afro.who.int/news/eswatini-launches-nationwide-covid-19-vaccination-campaign|access-date=1 April 2021|publisher=[[World Health Organization]] (WHO) }}</ref>
# Ethiopia<ref>{{#invoke:Cite web||title=Ethiopia begins COVID-19 vaccine rollout|url=https://www.aa.com.tr/en/africa/ethiopia-begins-covid-19-vaccine-rollout/2174904|access-date=19 March 2021|website=aa.com.tr}}</ref><ref>{{#invoke:Cite web||title=Ethiopia introduces COVID-19 vaccine in a national launching ceremony|url=https://www.afro.who.int/news/ethiopia-introduces-covid-19-vaccine-national-launching-ceremony|access-date=19 March 2021|website=[[World Health Organization]] (WHO)}}</ref><ref>{{cite news|date=9 February 2021|title=Ethiopia says it has secured 9 million doses of COVID-19 vaccines till April|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-ethiopia-idUSKBN2A916S|access-date=19 March 2021}}</ref>
# Fiji<ref name="cdctracker"/>
# Gambia<ref>{{#invoke:Cite web||title=The Arrival of COVAX vaccines Raises Hope in The Gambia|url=https://www.afro.who.int/news/arrival-covax-vaccines-raises-hope-gambia|access-date=19 March 2021|website=[[World Health Organization]] (WHO)}}</ref>
# Georgia<ref>{{#invoke:Cite web||title=Georgia to receive first doses of COVID-19 vaccine in early March instead of February|url=https://agenda.ge/en/news/2021/477|access-date=22 March 2021|website=Agenda.ge}}</ref>
# Ghana<ref>{{#invoke:Cite web||title=Welcome to Ghana Food And Drug Authority |url=http://fdaghana.gov.gh/news-media.php?page=78|access-date=1 April 2021|website=fdaghana.gov.gh}}</ref>
# Guatemala<ref name="auto3"/>
# Guinea-Bissau<ref>{{cite web |title=Today, 28,800 doses of COVID-19 vaccine arrive in Bissau |url=https://www.unicef.org/guineabissau/press-releases/today-28800-doses-covid-19-vaccine-arrive-bissau |website=www.unicef.org}}</ref>
# Guinea<ref name="whotracker"/>
# Honduras<ref name="cdctracker"/>
# Indonesia<ref>{{#invoke:Cite web||title=BPOM Terbitkan Izin Penggunaan Darurat Vaksin Covid-19 AstraZeneca|url=https://nasional.kompas.com/read/2021/03/09/12124611/bpom-terbitkan-izin-penggunaan-darurat-vaksin-covid-19-astrazeneca|access-date=10 February 2021|website=Kompas}}</ref>
# Iran<ref>{{cite web |date=17 February 2021|title=Iran issues permit for emergency use for three other COVID-19 vaccines: Official|url=https://en.irna.ir/news/84233593/Iran-issues-permit-for-emergency-use-for-three-other-COVID-19|access-date=1 April 2021|website=IRNA English}}</ref>
# Iraq<ref name="bignewsnetwork.com">{{#invoke:Cite web||title=Iraq approves Sinopharm, AstraZeneca vaccines|url=https://www.bignewsnetwork.com/news/267583081/iraq-approves-sinopharm-astrazeneca-vaccines|access-date=30 January 2021|website=Big News Network}}</ref>
# Ivory Coast<ref>{{cite news|date=1 March 2021|title=Covax: Ivory Coast and Ghana begin mass Covid vaccination rollouts|work=BBC News|url=https://www.bbc.com/news/world-africa-56239136|access-date=19 March 2021}}</ref>
# Japan<ref name="jp">{{cite news | title=Japan Approves Moderna, AstraZeneca Coronavirus Vaccines | website=Bloomberg | date=20 May 2021 | url=https://www.bloomberg.com/news/articles/2021-05-20/japan-approves-moderna-astra-covid-shots-report-says | access-date=2 July 2021}}</ref>
# Jordan<ref>{{#invoke:Cite web||title=COVAX roll-out - Jordan|url=https://www.gavi.org/covax-vaccine-roll-out/jordan|access-date=14 May 2021|website=www.gavi.org}}</ref>
# Kenya<ref>{{#invoke:Cite web||title=Kenya Receives 1M Vaccine Doses, Will Distribute to Health Workers First |url=https://www.voanews.com/covid-19-pandemic/kenya-receives-1m-vaccine-doses-will-distribute-health-workers-first|access-date=19 March 2021|publisher=Voice of America}}</ref>
# Kiribati<ref name="whotracker"/>
# Kosovo<ref>{{#invoke:Cite web||date=29 March 2021|title=Kosovo receives first COVID-19 vaccines through Covax scheme|url=https://www.euronews.com/2021/03/29/kosovo-receives-first-covid-19-vaccines-through-covax-programme|access-date=14 April 2021|website=euronews}}</ref><ref>{{#invoke:Cite web||title=Kosovo PM Becomes Nation's First Person To Receive COVID-19 Vaccine|url=https://www.rferl.org/a/kosovo-covid-vaccines-immunization-last-europe-astrazeneca-covax/31174048.html|access-date=14 April 2021|website=RadioFreeEurope/RadioLiberty}}</ref>
# Kuwait<ref>{{#invoke:Cite web||last=Godinho|first=Varun|date=31 January 2021|title=Kuwait authorises emergency use of Oxford-AstraZeneca Covid-19 vaccine|url=https://gulfbusiness.com/kuwait-authorises-emergency-use-of-oxford-astrazeneca-covid-19-vaccine/|access-date=1 April 2021|website=Gulf Business}}</ref>
# Kyrgyzstan<ref name="whotracker"/>
# Laos<ref name="whotracker"/>
# Lebanon<ref>{{#invoke:Cite web||title=Lebanon Received 33600 Doses of The AstraZeneca Vaccine as First Batch|url=https://www.moph.gov.lb/en/Drugs/index/0/48177/page:3/sort:Drug.brand_name/direction:ASC|website=Ministry of Public Health of Lebanon}}</ref>
# Lesotho<ref>{{#invoke:Cite web||title=Lesotho receives 1st batch of COVID-19 vaccines|url=https://www.aa.com.tr/en/africa/lesotho-receives-1st-batch-of-covid-19-vaccines/2164388|access-date=19 March 2021|website=aa.com.tr}}</ref>
# Liberia<ref>{{#invoke:Cite web||title=96,000 Doses of COVID-19 Vaccine Arrives in Liberia|url=https://www.afro.who.int/news/96000-doses-covid-19-vaccine-arrives-liberia|access-date=11 April 2021|publisher=[[World Health Organization]] (WHO)}}</ref>
# Libya<ref name="auto4">{{#invoke:Cite web||title=Libya kicks off delayed COVID-19 vaccination drive|url=https://www.aljazeera.com/news/2021/4/10/libya-launches-covid-19-vaccination-drive-after-delays|access-date=25 April 2021|website=Al Jazeera}}</ref><ref name="auto5">{{#invoke:Cite web||title=57,600 COVID-19 vaccine doses received today in Tripoli, Libya|url=https://reliefweb.int/report/libya/57600-covid-19-vaccine-doses-received-today-tripoli|access-date=25 April 2021|website=ReliefWeb}}</ref>
# Madagascar<ref name="cdctracker"/>
# Malawi<ref>{{#invoke:Cite web||title=Malawi to receive COVID-19 vaccines in late February – Xinhua |url=http://www.xinhuanet.com/english/2021-02/02/c_139716241.htm|access-date=19 March 2021|publisher=Xinhuanet}}</ref><ref>{{#invoke:Cite web||title=Malawi Sticks to AstraZeneca Despite Concerns Over Efficacy |url=https://www.voanews.com/covid-19-pandemic/malawi-sticks-astrazeneca-despite-concerns-over-efficacy|access-date=19 March 2021|publisher=Voice of America}}</ref>
# Malaysia<ref name="MYS approves">{{cite news|last1=Sipalan|first1=Joseph|last2=Donovan|first2=Kirsten|date=3 March 2021|title=Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use|agency=Reuters|url=https://www.msn.com/en-au/lifestyle/wellbeing/malaysia-approves-sinovac-astrazeneca-covid-19-vaccines-for-use/ar-BB1e9q01|access-date=7 March 2021}}</ref>
# Maldives<ref>{{#invoke:Cite web||title=Maldives starts training healthcare workers on COVID-19 vaccine distribution – Xinhua |url=http://www.xinhuanet.com/english/2021-01/23/c_139691718.htm|access-date=19 February 2021|publisher=Xinhuanet}}</ref>
# Mali<ref>{{#invoke:Cite web||last=AfricaNews|date=6 March 2021 |title=Mali receives first batch of COVID-19 vaccines|url=https://www.africanews.com/2021/03/06/mali-receives-first-batch-of-covid-19-vaccines/|access-date=1 April 2021|website=Africanews}}</ref>
# Mauritania<ref name="whotracker"/>
# Mauritius<ref>{{#invoke:Cite web||last=AfricaNews|date=26 January 2021|title=Mauritius begins vaccinating frontline health workers against covid-19|url=https://www.africanews.com/2021/01/26/mauritius-begins-vaccinating-frontline-health-workers-against-covid-19/|access-date=24 February 2021|website=Africanews}}</ref>
# Mexico<ref>{{cite news|date=5 January 2021|title=Mexico approves AstraZeneca COVID-19 vaccine, minister says|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-mexico-vaccine-idUSKBN29A04O|access-date=14 January 2021}}</ref>
# Micronesia<ref name="whotracker"/>
# Moldova<ref name=":2" />
# Mongolia<ref name="news.mn">{{#invoke:Cite web||date=11 January 2021|title=Mongolia approved three Covid-19 vaccines |url=https://news.mn/en/795048/|access-date=1 April 2021|website=News.MN}}</ref>
# Montenegro<ref name="cdctracker"/>
# Morocco<ref>{{Cite news|date=7 January 2021|title=Morocco approves AstraZeneca/Oxford COVID-19 vaccine – Minister|publisher=Reuters|url=https://www.reuters.com/article/uk-health-coronavirus-morocco-idUSKBN29C0QA|access-date=22 March 2021}}</ref>
# Mozambique<ref name="cdctracker"/>
# Myanmar<ref>{{cite news|date=27 January 2021|title=Myanmar launches nationwide COVID-19 vaccination program|website=Xinhua News|url=http://www.xinhuanet.com/english/2021-01/27/c_139700809.htm|accessdate=7 July 2021|archivedate=27 January 2021|archiveurl=https://web.archive.org/web/20210127163302/http://www.xinhuanet.com/english/2021-01/27/c_139700809.htm}}</ref>
# Namibia<ref name="mhss.gov.na">{{cite web|url=https://mhss.gov.na/documents/119527/775250/SKM_36721030413220.pdf/7a4534bb-022f-46e4-9113-571432290194|title=Importation of COVID-19 Vaccines into Namibia for Public Use and Guidance on Administration of Vaccines by Private Health Care Providers|date=31 March 2021|website=Republic of Namibia Ministry of Health and Social Services|others=Public Notice No.: 05/032021|accessdate=7 July 2021|archivedate=22 April 2021|archiveurl=https://web.archive.org/web/20210422075829/https://mhss.gov.na/documents/119527/775250/SKM_36721030413220.pdf/7a4534bb-022f-46e4-9113-571432290194}}</ref>
# Nauru<ref name=Reliefweb>{{#invoke:Cite web||title=Samoa receives 24,000 doses of COVID-19 vaccines through the COVAX facility - Samoa|url=https://reliefweb.int/report/samoa/samoa-receives-24000-doses-covid-19-vaccines-through-covax-facility|access-date=7 June 2021|website=ReliefWeb}}</ref>
# Nepal<ref>{{cite news|date=15 January 2021|title=Nepal approves AstraZeneca COVID vaccine for emergency use – government statement|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-nepal/nepal-approves-astrazeneca-covid-vaccine-for-emergency-use-government-statement-idUSKBN29K140}}</ref>
# New Zealand<ref name="whotracker"/>
# Nicaragua<ref name="cdctracker"/>
# Niger<ref name="cdctracker"/>
# Nigeria<ref>{{cite news|title=Wetin we sabi about NAFDAC approval of Oxford AstraZeneca vaccine use for Nigeria|publisher=BBC News Pidgin|url=https://www.bbc.com/pidgin/media-56084858|access-date=24 February 2021}}</ref>
# North Macedonia<ref>{{cite web |title=Сѐ за вакцините |url=https://kovid19vakcinacija.mk/za-vakcinite/ |website=Официјална веб-страница за вакцинација против КОВИД19 |language=mk-MK |accessdate=2021-07-07 |archivedate=2021-05-03 |archiveurl=https://web.archive.org/web/20210503232352/https://kovid19vakcinacija.mk/za-vakcinite/ }}</ref>
# Oman<ref name="cdctracker"/>
# Pakistan<ref>{{cite news|date=16 January 2021|title=Pakistan approves AstraZeneca COVID-19 vaccine for emergency use|url=https://www.reuters.com/article/us-health-coronavirus-pakistan-astrazene/pakistan-approves-astrazeneca-covid-19-vaccine-for-emergency-use-idUKKBN29L0DO}}</ref>
# Palestine<ref name="cdctracker"/>
# Panama<ref name="cdctracker"/>
# Papua New Guinea<ref>{{#invoke:Cite web||date=30 March 2021|title=PNG prime minister first to be vaccinated with Australian-supplied doses 'to show it's safe'|url=http://www.theguardian.com/world/2021/mar/30/png-prime-minister-first-to-be-vaccinated-with-australian-supplied-doses-to-show-its-safe|access-date=1 April 2021|website=The Guardian}}</ref><ref>{{#invoke:Cite web||date=17 March 2021|title=Australia gives Covid-19 vaccine doses to hard-hit Papua New Guinea|url=https://www.france24.com/en/asia-pacific/20210317-australia-gives-covid-19-vaccine-doses-to-hard-hit-papua-new-guinea|access-date=1 April 2021|publisher=France 24}}</ref>
# Paraguay<ref name="whotracker"/>
# Peru<ref>{{cite web |title=DIGEMID |url=http://www.digemid.minsa.gob.pe/main.asp?Seccion=1065 |website=www.digemid.minsa.gob.pe |language=es |access-date=2 May 2021 |archive-date=7 May 2021 |archive-url=https://web.archive.org/web/20210507204150/http://www.digemid.minsa.gob.pe/main.asp?Seccion=1065 |url-status=dead |accessdate=7 July 2021 |archivedate=7 May 2021 |archiveurl=https://web.archive.org/web/20210507204150/http://www.digemid.minsa.gob.pe/main.asp?Seccion=1065 }}</ref>
# Philippines<ref>{{cite news|date=28 January 2021|title=Philippine regulator approves emergency use of AstraZeneca vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-philippines-vaccin-idUSKBN29X0CY|access-date=28 January 2021}}</ref>
# Qatar<ref name="whotracker"/>
# Rwanda<ref>{{#invoke:Cite web||title=Rwanda receives COVID-19 Vaccines through COVAX|url=https://www.afro.who.int/news/rwanda-receives-covid-19-vaccines-through-covax|access-date=19 March 2021|website=[[World Health Organization]] (WHO)}}</ref>
# Samoa<ref name=Reliefweb />
# São Tomé and Príncipe<ref name="cdctracker"/>
# Saudi Arabia<ref name="gulfnews.com" />
# Senegal<ref name="whotracker"/>
# Serbia<ref>{{cite news|date=21 February 2021|title=Serbia receives first shipment of AstraZeneca COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-serbia-vaccines-idUSL1N2KR03M|access-date=19 March 2021}}</ref>
# Seychelles<ref>{{Cite news|last=Bhattacherjee|first=Kallol|date=22 January 2021|title=Coronavirus {{!}} Myanmar, Mauritius, Seychelles receive Covishield vaccine|work=The Hindu|url=https://www.thehindu.com/news/national/coronavirus-myanmar-mauritius-seychelles-receive-covishield-vaccine/article33638057.ece|access-date=1 April 2021}}</ref>
# Sierra Leone<ref>{{#invoke:Cite web||title=COVID-19 vaccines shipped by COVAX arrive in Sierra Leone|url=https://www.afro.who.int/news/covid-19-vaccines-shipped-covax-arrive-sierra-leone|access-date=19 March 2021|website=[[World Health Organization]] (WHO)}}</ref>
# Singapore<ref name="channelnewsasia.com">{{#invoke:Cite web||title=Those who opt for Sinovac, other vaccines under WHO emergency list to be considered fully vaccinated |url=https://www.channelnewsasia.com/singapore/sinovac-vaccine-covid19-sinopharm-astrazeneca-fully-vaccinated-2096576 |access-date=6 August 2021 |work=CNA |date=6 August 2021}}</ref> ''(restricted)''
# Solomon Islands<ref name="cdctracker"/>
# Somalia<ref>{{#invoke:Cite web||title=Somalia Receives Its First Batch of COVID-19 Vaccines |url=https://www.voanews.com/covid-19-pandemic/somalia-receives-its-first-batch-covid-19-vaccines|access-date=1 April 2021|publisher=Voice of America}}</ref>
# South Korea<ref>{{cite news|last1=Kim|first1=Han-joo|date=10 February 2021|title=S. Korea approves AstraZeneca's COVID-19 vaccine for all adults|publisher=Yonhap News |url=https://en.yna.co.kr/view/AEN20210210006351320|access-date=10 February 2021}}</ref><ref>{{cite news|last1=Maresca|first1=Thomas|date=10 February 2021|title=South Korea approves AstraZeneca COVID-19 vaccine|publisher=United Press International|url=https://www.upi.com/Top_News/World-News/2021/02/10/South-Korea-approves-AstraZeneca-COVID-19-vaccine/4231612945438/|access-date=10 February 2021}}</ref>
# South Sudan<ref>{{#invoke:Cite web||title=COVID-19 vaccination kicks-off in South Sudan|url=https://www.afro.who.int/news/covid-19-vaccination-kicks-south-sudan|access-date=14 April 2021|publisher=[[World Health Organization]] (WHO)}}</ref>
# Sri Lanka<ref>{{#invoke:Cite web||date=22 January 2021|title=Sri Lanka approves vaccine amid warnings of virus spread|url=https://apnews.com/article/sri-lanka-coronavirus-pandemic-340488c48ab372050825e70e057dd294|access-date=22 January 2021|publisher=Associated Press}}</ref>
# Sudan<ref>{{#invoke:Cite web||title=COVID-19 vaccination in Sudan|url=https://www.unicef.org/sudan/stories/covid-19-vaccination-sudan|access-date=19 March 2021|website=[[UNICEF]]}}</ref><ref>{{#invoke:Cite web||title=Sudan receives first delivery of COVID-19 vaccines with over 800,000 doses|url=https://www.unicef.org/press-releases/sudan-receives-first-delivery-covid-19-vaccines-over-800000-doses|access-date=19 March 2021|website=[[UNICEF]]}}</ref>
# Syria<ref name="whotracker"/>
# Taiwan<ref>{{cite news|date=20 February 2021|title=Taiwan grants emergency authorisation for AstraZeneca COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-taiwan-idUSKBN2AK05R|access-date=13 March 2021|publisher=Reuters}}</ref>
# Tajikistan<ref>{{#invoke:Cite web||title=Tajikistan becomes first country in Central Asia to receive COVID-19 vaccine through COVAX Facility|url=https://www.unicef.org/tajikistan/press-releases/tajikistan-becomes-first-country-central-asia-receive-covid-19-vaccine-through-0|access-date=14 April 2021|website=unicef.org}}</ref>
# Thailand<ref>{{#invoke:Cite web||date=23 January 2021|title=Thai Food and Drug registers COVID-19 vaccine developed by AstraZeneca|url=https://www.pattayamail.com/thailandnews/thai-food-and-drug-registers-covid-19-vaccine-developed-by-astrazeneca-341186|website=Pattaya Mail}}</ref>
# Togo<ref>{{#invoke:Cite web||last=First|first=Togo|title=Covid-19: First vaccination campaign to soon begin|url=https://www.togofirst.com/en/health/1602-7300-covid-19-first-vaccination-campaign-to-soon-begin|access-date=19 March 2021|website=togofirst}}</ref>
# Tonga<ref>{{#invoke:Cite web||title=Over 500 people given first COVID-19 vaccine shot in Tonga – Xinhua |url=http://www.xinhuanet.com/english/asiapacific/2021-04/16/c_139885080.htm|access-date=25 April 2021|website=xinhuanet}}</ref><ref>{{#invoke:Cite web||date=16 April 2021|title=Tonga's Princess takes the lead on Covid-19 vaccination|url=https://www.rnz.co.nz/international/pacific-news/440580/tonga-s-princess-takes-the-lead-on-covid-19-vaccination|access-date=25 April 2021|website=RNZ}}</ref><ref>{{#invoke:Cite web||title=Kingdom of Tonga receives 24,000 doses of COVID-19 vaccines through the COVAX facility|url=https://www.who.int/westernpacific/about/how-we-work/pacific-support/news/detail/31-03-2021-kingdom-of-tonga-receives-24-000-doses-of-covid-19-vaccines-through-the-covax-facility|access-date=25 April 2021|publisher=[[World Health Organization]] (WHO)}}</ref>
# Tunisia<ref name="whotracker"/>
# Turkmenistan<ref name="whotracker">{{cite web |title=WHO Coronavirus (COVID-19) Dashboard |url=https://covid19.who.int/ |publisher=[[World Health Organization]] (WHO) }}</ref>
# Tuvalu<ref name="Reliefweb"/>
# Uganda<ref>{{#invoke:Cite web||last=AfricaNews|date=10 March 2021|title=Uganda starts COVID-19 vaccinations|url=https://www.africanews.com/2021/03/10/uganda-starts-covid-19-vaccinations/|access-date=19 March 2021|website=Africanews}}</ref>
# Ukraine<ref>{{#invoke:Cite web||title=COVID-19: AstraZeneca vaccine certified for use in Ukraine|url=https://covid.unian.info/covid-19-astrazeneca-vaccine-certified-for-use-in-ukraine-11330906.html|access-date=10 March 2021|website=covid.unian.info}}</ref>
# United Arab Emirates<ref name="cdctracker"/>
# United Kingdom<ref>{{#invoke:Cite web||date=30 December 2020|title=Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca|access-date=4 January 2021|website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA)}}</ref><ref>{{cite press release|title=Oxford University/AstraZeneca vaccine authorised by UK medicines regulator|url=https://www.gov.uk/government/news/oxford-universityastrazeneca-vaccine-authorised-by-uk-medicines-regulator|publisher=Department of Health and Social Care|access-date=30 December 2020|date=30 December 2020}}</ref><ref>{{#invoke:Cite web||date=30 December 2020|title=Conditions of Authorisation for COVID-19 Vaccine AstraZeneca|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/conditions-of-authorisation-for-covid-19-vaccine-astrazeneca|access-date=4 January 2021|website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA)}}</ref>
# Uruguay<ref name="cdctracker"/>
# Uzbekistan<ref name="cdctracker"/>
# Vanuatu<ref name="whotracker"/>
# Vietnam<ref>{{#invoke:Cite web||title=Vietnam approves AstraZeneca COVID-19 vaccine, cuts short Communist Party congress|url=https://www.channelnewsasia.com/news/asia/vietnam-approves-astrazeneca-vaccine-reports-34-new-covid-19-14074712|access-date=5 February 2021|website=CNA}}</ref>
# Yemen<ref>{{#invoke:Cite web||title=Yemen receives 360,000 COVID-19 vaccine doses through the COVAX Facility|url=https://www.unicef.org/press-releases/yemen-receives-360000-covid-19-vaccine-doses-through-covax-facility|access-date=7 June 2021|website=www.unicef.org}}</ref>
# Zambia<ref name=":5">{{Cite news|date=25 March 2021|title=Zambia sets out plans to vaccinate all people over 18 against COVID-19|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-zambia-vaccine-idUSKBN2BH2NS|access-date=17 April 2021}}</ref><ref name=":6">{{#invoke:Cite web||title=Zambia launches the COVID-19 vaccination|url=https://reliefweb.int/report/zambia/zambia-launches-covid-19-vaccination|access-date=17 April 2021|website=ReliefWeb}}</ref><ref name=":8">{{#invoke:Cite web||title=Zambia gets 1st 228,000 vaccine doses from COVAX|url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/zambia-gets-1st-228-000-vaccine-doses-from-covax/2206521|access-date=17 April 2021|website=aa.com.tr}}</ref>
# Zimbabwe<ref name="whotracker"/>
'''{{nowrap|[[European Medicines Agency|EMA]] countries}}'''<ref name="Vaxzevria EPAR" /><ref name="EU Marketing authorisation" /><ref>{{cite web | title=Vaxzevria | website=Union Register of medicinal products | url=https://ec.europa.eu/health/documents/community-register/html/h1529.htm | access-date=26 November 2021}}</ref>
# Austria
# Belgium
# Bulgaria
# Croatia
# Cyprus
# Czech Republic
# Denmark
# Estonia
# Finland
# France
# Germany
# Greece
# Hungary
# Iceland
# Ireland
# Italy
# Latvia
# Liechtenstein
# Lithuania
# Luxembourg
# Malta
# Netherlands
# Norway
# Poland
# Portugal
# Romania
# Slovakia
# Slovenia
# Spain
# Sweden
'''{{nowrap|[[Caribbean Public Health Agency|CARPHA]] countries}}'''<ref name="carpha-oxford">{{cite web |title=CARPHA Issues its First Emergency Use Recommendation for a COVID-19 Vaccine |url=https://www.carpha.org/More/Media/Articles/ArticleID/435/CARPHA-Issues-its-First-Emergency-Use-Recommendation-for-a-COVID-19-Vaccine |website=Caribbean Public Health Agency}}</ref>
# Antigua and Barbuda
# Bahamas
# Barbados
# Belize
# Dominica
# Grenada
# Guyana
# Haiti
# Jamaica
# Saint Kitts and Nevis
# Saint Lucia
# Saint Vincent and the Grenadines
# Suriname<ref>{{cite news|date=23 February 2021|title=Suriname begins coronavirus vaccination campaign with donated doses|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-suriname-vaccine-idUSKBN2AN2AT|access-date=28 February 2021}}</ref>
# Trinidad and Tobago
<!-- not counted -->'''[[List of ISO 3166-1 codes|Non-country entities]]'''
* Anguilla{{efn|name=carphance|via CARPHA authorization<ref name="carpha-oxford"/>}}
* Aruba{{efn|name=carphance}}
* British Virgin Islands{{efn|name=carphance}}
* Bermuda{{efn|name=carphance}}
* Caribbean Netherlands{{efn|name=carphance}}
* Cayman Islands{{efn|name=carphance}}
* Curaçao{{efn|name=carphance}}
* Cook Islands<ref name="cdctracker"/>
* Falkland Islands<ref name="cdctracker"/>
* French Polynesia<ref name="cdctracker"/>
* Greenland<ref name="NYT vaccine tracker"/>
* Guadeloupe<ref name="whotracker"/>
* Guernsey<ref name="cdctracker"/>
* Isle of Man<ref name="cdctracker"/>
* Jersey<ref name="cdctracker"/>
* Montserrat{{efn|name=carphance}}
* Northern Cyprus<ref name=":4">{{#invoke:Cite web||last=Psyllides|first=George|title=Coronavirus: 10,000 vaccines handed over to north |url=https://cyprus-mail.com/2021/03/31/coronavirus-10000-vaccines-handed-over-to-north/|access-date=17 April 2021|website=cyprus-mail.com/}}</ref>
* Pitcairn<ref name="whotracker"/>
* Saint Helena, Ascension and Tristan da Cunha<ref name="whotracker"/>
* Sint Maarten{{efn|name=carphance}}
* Turks and Caicos Islands{{efn|name=carphance}}
* Wallis and Futuna<ref name="cdctracker"/>
* ''[[World Health Organization]]''<ref name="WHO status" /><ref>{{#invoke:Cite web||title=Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca|url=https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-AZD1222-2021.1|access-date=27 February 2021|publisher=[[World Health Organization]] (WHO)}}</ref><ref>{{cite news|title=AstraZeneca/Oxford Covid-19 Vaccine Gets Emergency Approval From WHO|website=Forbes|url=https://www.forbes.com/sites/alisondurkee/2021/02/15/astrazeneca-oxford-covid-19-vaccine-gets-emergency-approval-from-who/|access-date=16 February 2021}}</ref><ref>{{cite web | title=WHO Recommendation AstraZeneca/SKBio - COVID-19 Vaccine (ChAdOx1-S [recombinant]) | website=[[World Health Organization]] (WHO) | date=15 February 2021 | url=https://extranet.who.int/pqweb/vaccines/covid-19-vaccine-chadox1-s-recombinant | access-date=8 May 2021 | accessdate=7 July 2021 | archivedate=4 July 2021 | archiveurl=https://web.archive.org/web/20210704174442/https://extranet.who.int/pqweb/vaccines/covid-19-vaccine-chadox1-s-recombinant }}</ref><ref>{{cite web | title=WHO recommendation Serum Institute of India Pvt Ltd - COVID-19 Vaccine (ChAdOx1-S [recombinant]) - Covishield | website=[[World Health Organization]] (WHO) | date=15 February 2021 | url=https://extranet.who.int/pqweb/vaccines/covid-19-vaccine-chadox1-s-recombinant-covishield | access-date=8 May 2021 | accessdate=7 July 2021 | archivedate=6 July 2021 | archiveurl=https://web.archive.org/web/20210706125046/https://extranet.who.int/pqweb/vaccines/covid-19-vaccine-chadox1-s-recombinant-covishield }}</ref>
;Travel-only
* Hong Kong<ref name="HK">{{cite web |title=List of COVID-19 Vaccines Recognised for Specified Purposes |url=https://www.coronavirus.gov.hk/pdf/list_of_recognised_covid19_vaccines.pdf |publisher=Hong Kong Department of Health |access-date=24 November 2021}}</ref>
* Switzerland<ref>{{cite web|last=FOPH|first=Federal Office of Public Health|title=Coronavirus: Entering Switzerland|url=https://www.bag.admin.ch/bag/en/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/empfehlungen-fuer-reisende/quarantaene-einreisende.html|access-date=19 November 2021|website=www.bag.admin.ch|accessdate=25 December 2021|archivedate=24 July 2020|archiveurl=https://web.archive.org/web/20200724080307/https://www.bag.admin.ch/bag/en/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/empfehlungen-fuer-reisende/quarantaene-einreisende.html}}</ref>
* Turkey<ref name="visasturkey.com">{{cite web|date=10 April 2019|title=Vaccinations for Turkey: Do I need an Approved COVID Vaccine?|url=https://www.easyturkeyvisa.com/news/vaccinations-for-turkey|access-date=24 November 2021|website=Turkey Visa}}{{Dead link|date=December 2023 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>
* United States<ref>{{cite web|date=11 February 2020|title=COVID-19 and Your Health|url=https://www.cdc.gov/coronavirus/2019-ncov/travelers/proof-of-vaccination.html|access-date=17 November 2021|website=U.S. [[Centers for Disease Control and Prevention]] (CDC)}}</ref>
</div>
== Pfizer–BioNTech ==
<section begin="pfizerauthmap"/>
{{infobox|image={{Graph:Map|scale=65|defaultValue=gainsboro
|AD=dodgerblue|AE=dodgerblue|AF=dodgerblue|AG=dodgerblue|AI=dodgerblue|AL=dodgerblue|AM=dodgerblue|AO=limegreen|AR=dodgerblue|AS=dodgerblue|AT=dodgerblue|AU=blueviolet|AW=dodgerblue|AZ=dodgerblue
|BA=dodgerblue|BB=dodgerblue|BD=dodgerblue|BE=dodgerblue|BF=limegreen|BG=dodgerblue|BH=dodgerblue|BJ=dodgerblue|BM=dodgerblue|BN=limegreen|BO=dodgerblue|BQ=dodgerblue|BR=blueviolet|BS=dodgerblue|BT=dodgerblue|BW=dodgerblue|BZ=dodgerblue
|CA=blueviolet|CD=dodgerblue|CF=limegreen|CG=limegreen|CH=blueviolet|CI=dodgerblue|CK=dodgerblue|CL=dodgerblue|CM=dodgerblue|CO=dodgerblue|CR=dodgerblue|CV=dodgerblue|CW=dodgerblue|CY=dodgerblue|CZ=dodgerblue
|DE=dodgerblue|DJ=dodgerblue|DK=dodgerblue|DM=dodgerblue|DO=dodgerblue|DZ=dodgerblue
|EC=dodgerblue|EE=dodgerblue|EG=dodgerblue|ES=dodgerblue|ET=limegreen
|FI=dodgerblue|FJ=limegreen|FM=blueviolet|FO=dodgerblue|FR=dodgerblue
|GA=dodgerblue|GB=dodgerblue|GD=dodgerblue|GE=dodgerblue|GH=dodgerblue|GI=dodgerblue|GL=dodgerblue|GM=limegreen|GN=dodgerblue|GP=dodgerblue|GR=dodgerblue|GT=dodgerblue|GU=dodgerblue|GY=dodgerblue
|HK=dodgerblue|HN=dodgerblue|HR=dodgerblue|HT=dodgerblue|HU=dodgerblue
|ID=dodgerblue|IE=dodgerblue
|IL=dodgerblue|IM=dodgerblue|IN=limegreen|IQ=dodgerblue|IR=limegreen|IS=dodgerblue|IT=dodgerblue
|JE=dodgerblue|JM=dodgerblue|JO=dodgerblue|JP=dodgerblue
|KE=dodgerblue|KG=dodgerblue|KH=limegreen|KI=limegreen|KM=limegreen|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue|KZ=dodgerblue
|LA=dodgerblue|LB=limegreen|LC=dodgerblue|LI=dodgerblue|LK=dodgerblue|LR=limegreen|LS=limegreen|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=dodgerblue
|MA=dodgerblue|MC=dodgerblue|MD=dodgerblue|ME=dodgerblue|MH=blueviolet|MK=dodgerblue|ML=limegreen|MM=limegreen|MN=dodgerblue|MO=dodgerblue|MP=dodgerblue|MQ=dodgerblue|MR=limegreen|MS=dodgerblue|MT=dodgerblue|MU=limegreen|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=limegreen
|NA=dodgerblue|NC=dodgerblue|NE=limegreen|NG=dodgerblue|NI=dodgerblue|NL=dodgerblue|NO=dodgerblue|NP=dodgerblue|NR=limegreen|NU=dodgerblue|NZ=blueviolet
|OM=dodgerblue
|PA=dodgerblue|PE=dodgerblue|PF=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PL=dodgerblue|PR=dodgerblue|PS=dodgerblue|PT=dodgerblue|PW=blueviolet|PY=dodgerblue
|QA=dodgerblue
|RO=dodgerblue|RS=dodgerblue|RW=dodgerblue
|SA=blueviolet|SB=limegreen|SD=dodgerblue|SE=dodgerblue|SG=dodgerblue|SI=dodgerblue|SK=dodgerblue|SL=limegreen|SM=dodgerblue|SN=limegreen|SO=limegreen|SR=dodgerblue|SS=limegreen|ST=limegreen|SV=dodgerblue|SX=dodgerblue|SY=limegreen|SZ=dodgerblue
|TC=dodgerblue|TD=limegreen|TG=limegreen|TH=dodgerblue|TJ=dodgerblue|TK=dodgerblue|TL=dodgerblue|TN=dodgerblue|TO=dodgerblue|TR=dodgerblue|TT=dodgerblue|TV=limegreen|TW=dodgerblue|TZ=dodgerblue
|UA=dodgerblue|UG=dodgerblue|US=blueviolet|UY=dodgerblue|UZ=dodgerblue
|VA=dodgerblue|VC=dodgerblue|VE=limegreen|VG=dodgerblue|VN=dodgerblue|VU=limegreen
|WS=limegreen
|XK=dodgerblue
|YE=limegreen
|ZA=dodgerblue|ZM=dodgerblue|ZW=limegreen
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|limegreen|Eligible [[COVAX]] recipient}}
}}
<section end="pfizerauthmap"/>
The [[Pfizer–BioNTech COVID-19 vaccine]], sold under the brand name Comirnaty,<ref name="Comirnaty EPAR">{{#invoke:Cite web||title=Comirnaty EPAR|url=https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty|access-date=23 December 2020|publisher=[[European Medicines Agency]] (EMA)}}</ref> is an [[mRNA vaccine]]<ref name="hcreg">{{#invoke:Cite web||date=9 December 2020|title=Regulatory Decision Summary – Pfizer-BioNTech COVID-19 Vaccine|url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00730|access-date=9 December 2020|publisher=Health Canada, Government of Canada}}</ref> produced by the German company [[BioNTech]] and the American company [[Pfizer]].<ref name="hcreg"/><ref name="NCT04368728">{{#invoke:Cite web||date=30 April 2020|title=Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults|url=https://clinicaltrials.gov/ct2/show/NCT04368728|url-status=live|archive-url=https://web.archive.org/web/20201011084828/https://clinicaltrials.gov/ct2/show/NCT04368728/|archive-date=11 October 2020|access-date=14 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04368728}}</ref><ref name="EudraCT-2020-001038-36">{{#invoke:Cite web||date=14 April 2020|title=A Multi-site Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of four Prophylactic SARS-CoV-2 RNA Vaccines Against COVID-19 Using Different Dosing Regimens in Healthy Adults|url=https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE|url-status=live|archive-url=https://web.archive.org/web/20200422111024/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE|archive-date=22 April 2020|access-date=22 April 2020|website=EU Clinical Trials Register|publisher=European Union|id=[[EudraCT]] 2020-001038-36}}</ref> In Hong Kong, Macau, and Taiwan, Comirnaty is distributed by [[Fosun Pharma]].<ref>{{#invoke:Cite web||title=BioNTech and China partner, not Pfizer, to produce HK shots|url=https://www.thestandard.com.hk/section-news/section/11/225661/BioNTech-and-China-partner,-not-Pfizer,-to-produce-HK-shots|website=The Standard}}</ref><ref>{{#invoke:Cite web||title=Pfizer and BioNTech's overlooked third partner will distribute the vaccine in China – and it's facing some resistance |url=https://fortune.com/2021/01/09/covid-vaccine-china-fosun-pfizer-biontech/|access-date=18 April 2021}}</ref><ref>{{Cite news|last=Burger|first=Ludwig|date=16 March 2020|title=BioNTech in China alliance with Fosun over potential coronavirus vaccine|work=Reuters|url=https://www.reuters.com/article/us-biontech-fosunpharma-vaccine-collabor-idUKKBN2130O5|access-date=18 April 2021}}</ref><ref>{{Cite news|date=25 November 2020|title=BioNTech, Fosun start Phase II trial of COVID-19 vaccine in China|work=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-biontech-fosunphar-idUSKBN2850ZZ|access-date=18 April 2021}}</ref><ref name="RTHK 20210711" /><ref name="BioNTech PR 20210712" />
;Full (<section begin="Pfizer-BioNTech_FN"/>10<section end="Pfizer-BioNTech_FN"/>)
# Australia<ref>{{#invoke:Cite web||title=Comirnaty|url=https://www.tga.gov.au/apm-summary/comirnaty|date=25 January 2021|access-date=25 January 2021|publisher=[[Therapeutic Goods Administration]] (TGA)}}</ref><ref>{{cite report | url=https://www.tga.gov.au/sites/default/files/auspar-bnt162b2-mrna-210125.pdf | title=Australian Public Assessment Report for BNT162b2 (mRNA) | publisher=[[Therapeutic Goods Administration]] (TGA) | access-date=25 January 2021 | archive-date=26 January 2021 | archive-url=https://web.archive.org/web/20210126144716/https://www.tga.gov.au/sites/default/files/auspar-bnt162b2-mrna-210125.pdf | url-status=dead }}</ref>
# Brazil<ref name="Brazil approves full vaccine">{{#invoke:Cite web||url=https://g1.globo.com/bemestar/vacina/noticia/2021/02/23/anvisa-concede-registro-definitivo-a-vacina-da-pfizer.ghtml|title=Vacina da Pfizer é a 1ª a obter registro definitivo no Brasil|publisher=G1|date=23 February 2021|access-date=23 February 2021|language=pt-br}}</ref>
# Canada<ref>{{cite web|date=23 August 2021|title=U.S. gives Pfizer COVID-19 vaccine full approval - CityNews Toronto|url=https://toronto.citynews.ca/2021/08/23/us-pfizer-covid-19-vaccine-full-approval/|access-date=23 August 2021|website=CityNews Toronto}}</ref><ref>{{cite news|author1=The Associated Press|date=23 August 2021|title=U.S. regulators give full approval of Pfizer-BioNTech's COVID-19 vaccine|url=https://www.cbc.ca/news/health/us-pfizer-fda-approval-1.6149959|access-date=23 August 2021|website=CBC News}}</ref><ref name=":13">{{Cite news|last=Osman|first=Laura|date=16 September 2021|title=Goodbye Pfizer, hello Comirnaty: Top COVID-19 vaccines given brand names in Canada|work=CBC News|url=https://www.cbc.ca/news/health/vaccine-name-change-canada-1.6178484|access-date=16 September 2021}}</ref>
# Marshall Islands{{efn|name=CFA}}{{efn|name=useua|Full approval only for those aged 16+. EUA still applies for recipients aged 5-15.}}
# Micronesia{{efn|name=CFA}}{{efn|name=useua}}
# New Zealand<ref>{{#invoke:Cite web||date=3 February 2021|title=Robust assessment ahead of Medsafe approval of vaccine|url=https://www.health.govt.nz/news-media/media-releases/robust-assessment-ahead-medsafe-approval-vaccine|access-date=6 February 2021|work=Ministry of Health}}</ref>
# Palau{{efn|name=CFA|via United States authorization through [[Compact of Free Association]]<ref>{{cite press release | title=Interior Applauds Inclusion of Insular Areas through Operation Warp Speed to Receive COVID-19 Vaccines | publisher=[[United States Department of the Interior]] (DOI) | date=12 December 2020 | url=https://www.doi.gov/oia/press/interior-applauds-inclusion-insular-areas-through-operation-warp-speed-receive-covid-19 | access-date=13 January 2021}} {{PD-notice}}</ref><ref>{{cite news|url=https://www.hawaiipublicradio.org/post/asia-minute-palau-administers-vaccines-keep-country-free-covid#stream/0|publisher=[[Hawaii Public Radio]]|title=Asia Minute: Palau Administers Vaccines to Keep Country Free of COVID|first=Bill|last=Dorman|date=6 January 2021|access-date=13 January 2021|name-list-style=vanc}}</ref>}}{{efn|name=useua}}
# Saudi Arabia<ref>{{#invoke:Cite web||date=10 December 2020|title=Coronavirus: Saudi Arabia approves Pfizer COVID-19 vaccine for use|url=https://english.alarabiya.net/en/coronavirus/2020/12/10/Coronavirus-Saudi-Arabia-approves-Pfizer-COVID-19-vaccine-for-use|access-date=10 December 2020|website=Al Arabiya English}}</ref><ref name="NYT vaccine tracker">{{cite news|last1=Zimmer|first1=Carl|last2=Corum|first2=Jonathan|last3=Wee|first3=Sui-Lee|title=Coronavirus Vaccine Tracker|work=[[The New York Times]]|url=https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html|name-list-style=vanc}}</ref>
# Switzerland<ref name="Swiss authorization">{{cite press release|title=Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland|url=https://www.bag.admin.ch/bag/en/home/das-bag/aktuell/medienmitteilungen.msg-id-81761.html|publisher=[[Swissmedic|Swiss Agency for Therapeutic Products (Swissmedic)]]|date=19 December 2020|access-date=19 December 2020}}</ref><ref>{{#invoke:Cite web||title=Comirnaty Product information|url=https://www.swissmedicinfo.ch/ShowText.aspx?textType=FI&lang=DE&authNr=68225|access-date=31 January 2021|language=DE|trans-quote=Due to incomplete clinical data at the time of the assessment of the authorization application, the Comirnaty medicinal product is authorized for a limited period (Art. 9a Medicinal Products Act).}}</ref>
# United States{{efn|name=useua}}<ref>{{cite press release|title=FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine|publisher=U.S. [[Food and Drug Administration]] (FDA)|date=11 December 2020|url=https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19|access-date=11 December 2020}} {{PD-notice}}</ref><ref name="Pfizer-BioNTech COVID-19 Vaccine EUA fact sheet">{{#invoke:Cite web||date=25 February 2021|title=Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers|url=https://www.fda.gov/media/144413/download|access-date=25 February 2021|publisher=Pfizer|format=PDF}}</ref><ref name="FDA PR 20210823">{{Cite press release |title=FDA Approves First COVID-19 Vaccine |date=23 August 2021 |publisher=U.S. [[Food and Drug Administration]] (FDA) |url=https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine |access-date=23 August 2021 |archive-url=https://web.archive.org/web/20210823143040/https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine |archive-date=23 August 2021 |url-status=live}}</ref>
{{-}}
;Emergency (<section begin="Pfizer-BioNTech_EN"/>140<section end="Pfizer-BioNTech_EN"/>)
<div style="margin-top: 0.3em; column-width: 15em;">
# Afghanistan<ref name="cdctracker"/>
# Albania<ref>{{#invoke:Cite web||title=Albania to start COVID-19 immunisation with Pfizer vaccine in January – report|url=https://seenews.com/news/albania-to-start-covid-19-immunisation-with-pfizer-vaccine-in-jan-report-726470|website=Seenews}}</ref>
# Algeria<ref>{{cite web|date=5 May 2021|title=Canada allows Pfizer COVID-19 vaccine for children aged 12-15|url=https://www.reuters.com/world/americas/canada-authorizes-pfizer-covid-19-vaccine-children-aged-12-15-2021-05-05/|access-date=19 August 2021|website=Reuters}}</ref>
# Andorra<ref>{{#invoke:Cite web||title=Andorra COVID-19|url=https://www.govern.ad/covid19_newsletter/en/|access-date=19 February 2021|website=govern.ad}}</ref>
# Argentina<ref>{{cite news|title=Coronavirus en la Argentina: La ANMAT aprobo el uso de emergencia de la vacuna Pfizer|url=https://www.lanacion.com.ar/sociedad/coronavirus-argentina-anmat-aprobo-uso-emergencia-vacuna-nid2548852|access-date=23 December 2020|website=La Nación|language=es}}</ref>
# Armenia<ref>{{#invoke:Cite web||date=30 June 2021|title=Dashboard: Vaccinating Eurasia- June|url=https://eurasianet.org/dashboard-vaccinating-eurasia-june|access-date=4 August 2021|website=[[Eurasianet]]}}</ref>
# Azerbaijan<ref name="whotracker"/>
# Bahrain<ref>{{#invoke:Cite web||title=Bahrain becomes second country to approve Pfizer COVID-19 vaccine|url=https://www.aljazeera.com/news/2020/12/4/bahrain-becomes-second-country-to-approve-pfizer-covid-19-vaccine|access-date=5 December 2020|publisher=[[Al Jazeera]]}}</ref><ref>{{cite web | title=The Pfizer-BioNTech COVID-19 Vaccine Was Granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) & Bahrain National Health Regulatory Authority (NHRA) | website=cvdvaccine | url=https://www.cvdvaccine-bh.com/ | access-date=18 April 2021 | accessdate=7 July 2021 | archivedate=21 April 2021 | archiveurl=https://web.archive.org/web/20210421145401/https://www.cvdvaccine-bh.com/ }}</ref>
# Bangladesh<ref>{{#invoke:Cite web||title=Bangladesh approves Pfizer Covid-19 vaccine for emergency use|date=27 May 2021|url=https://www.dhakatribune.com/bangladesh/2021/05/27/bangladesh-approves-pfizer-covid-19-vaccine-for-emergency-use|access-date=27 May 2021|publisher=[[Dhaka Tribune]]}}</ref>
# Benin<ref name="whotracker"/>
# Bhutan<ref name="whotracker"/>
# Bolivia<ref name="cdctracker"/>
# Bosnia and Herzegovina<ref name=":3">{{#invoke:Cite web||title=Pfizer/BioNTech COVID-19 vaccines shipped by COVAX arrive in Bosnia and Herzegovina|url=https://bosniaherzegovina.un.org/en/123137-pfizerbiontech-covid-19-vaccines-shipped-covax-arrive-bosnia-and-herzegovina|access-date=14 April 2021|publisher=United Nations}}</ref>
# Botswana<ref>{{Cite news|title=Botswana expects to welcome multiple COVID-19 vaccines|url=http://www.xinhuanet.com/english/africa/2021-02/27/c_139771113.htm|access-date=1 April 2021|publisher=Xinhuanet|accessdate=7 July 2021|archivedate=27 February 2021|archiveurl=https://web.archive.org/web/20210227224341/http://www.xinhuanet.com/english/africa/2021-02/27/c_139771113.htm}}</ref>
# Brunei<ref name="auto">{{#invoke:Cite web||title=COVID-19: Brunei to begin mass vaccination on April 3 |url=https://thescoop.co/2021/04/02/covid-19-brunei-to-begin-mass-vaccination-on-april-3/|access-date=6 April 2021|website=TheScoop|date=2 April 2021}}</ref>
# Cameroon<ref name="whotracker"/>
# Cape Verde<ref name="cdctracker"/>
# Chile<ref name="chile">{{#invoke:Cite web||date=17 December 2020|title=Chile approves Pfizer-BioNTech Covid-19 vaccine for emergency use|url=https://www.straitstimes.com/world/chile-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use|access-date=17 December 2020|website=The Straits Times}}</ref>
# Colombia<ref>{{cite news|date=6 January 2021|title=Colombia regulator approves Pfizer-BioNTech vaccine for emergency use|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-colombia-vaccine/colombia-regulator-approves-pfizer-biontech-vaccine-for-emergency-use-idINL1N2JH00P/|access-date=6 January 2021}}</ref>
# Congo-Kinshasa<ref name="DRC">{{cite web|date=2021-12-07|title=Covid-19 en RDC: des officiers et agents de la Police se font vacciner après échanges avec le ministre de la Santé|url=https://actualite.cd/2021/12/07/covid-19-en-rdc-des-officiers-et-agents-de-la-police-se-font-vacciner-apres-echanges|access-date=2022-01-12|website=Actualite.cd|language=fr}}</ref>
# Costa Rica<ref name="costa">{{#invoke:Cite web||date=16 December 2020|title=Costa Rica authorizes Pfizer-BioNTech coronavirus vaccine|url=https://ticotimes.net/2020/12/16/costa-rica-authorizes-pfizer-biontech-coronavirus-vaccine|access-date=16 December 2020|website=The Tico Times}}</ref>
# Djibouti<ref name="whotracker"/>
# Dominican Republic<ref>[https://covid-19pharmacovigilance.paho.org/pfizer-biontech Pfizer-BioNTech COVID-19 vaccine] {{Webarchive|url=https://web.archive.org/web/20211006044525/https://covid-19pharmacovigilance.paho.org/pfizer-biontech |date=2021-10-06 }}. Pan American Health Organization.</ref>
# East Timor<ref name="whotracker"/>
# Ecuador<ref name="ecuador">{{#invoke:Cite web||title=Arcsa autoriza ingreso al país de vacuna Pfizer-BioNTech para el Covid-19 – Agencia Nacional de Regulación, Control y Vigilancia Sanitaria|url=https://www.controlsanitario.gob.ec/arcsa-autoriza-ingreso-al-pais-de-vacuna-pfizer-biontech-para-el-covid-19/|access-date=17 December 2020|language=es}}</ref>
# Egypt<ref name="whotracker"/>
# El Salvador<ref name="cdctracker"/><ref>{{#invoke:Cite web||last=McGwin|first=Kevin|date=30 December 2020|title=Greenland to begin new year with COVID vaccinations|url=https://www.arctictoday.com/greenland-to-begin-new-year-with-covid-vaccinations/|access-date=21 March 2021|website=ArcticToday}}</ref>
# Eswatini<ref name="whotracker"/>
#Fiji<ref>{{cite web|title=Vaccine FAQs – MINISTRY OF HEALTH & MEDICAL SERVICES| date=24 March 2021 |url=https://www.health.gov.fj/covid-vaccine/vaccine-faqs/|access-date=2022-01-06|language=en-US}}</ref>
# Gabon<ref name="whotracker"/>
# Georgia<ref name="whotracker"/>
# Ghana<ref>{{cite web|title=Ghana approves two more COVID-19 vaccines - Xinhua | English.news.cn|url=http://www.xinhuanet.com/english/africa/2021-07/29/c_1310092883.htm|access-date=30 November 2021|website=xinhuanet|accessdate=25 December 2021|archivedate=30 November 2021|archiveurl=https://web.archive.org/web/20211130221511/http://www.xinhuanet.com/english/africa/2021-07/29/c_1310092883.htm}}</ref>
# Guatemala<ref name="auto3">{{cite web |title=COVID-19 Information |url=https://gt.usembassy.gov/alert-covid-19-2/ |website=U.S. Embassy in Guatemala |date=25 February 2020 |accessdate=7 July 2021 |archivedate=7 May 2021 |archiveurl=https://web.archive.org/web/20210507124017/https://gt.usembassy.gov/alert-covid-19-2/ }}</ref>
# Guinea<ref name="whotracker"/>
# Honduras<ref name="whotracker"/>
# Indonesia<ref>{{cite news|url=https://www.cnnindonesia.com/nasional/20210715145336-20-668159/bpom-terbitkan-izin-penggunaan-darurat-vaksin-covid-19-pfizer|title=BPOM Terbitkan Izin Penggunaan Darurat Vaksin COVID-19 Pfizer|work=CNN Indonesia|date=15 July 2021|access-date=15 July 2021|language=id}}</ref>
# Iraq<ref>{{#invoke:Cite web||title=Iraq grants emergency approval for Pfizer COVID-19 vaccine|url=https://www.msn.com/en-ae/news/other/iraq-grants-emergency-approval-for-pfizer-covid-19-vaccine/ar-BB1cgvD6|access-date=27 December 2020|publisher=MSN}}</ref>
# Israel<ref>{{#invoke:Cite web||title=Israeli Health Minister 'pleased' as FDA approves Pfizer COVID-19 vaccine|url=https://www.jpost.com/breaking-news/fda-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use-nyt-651871|access-date=28 December 2020|website=The Jerusalem Post}}</ref>
# Ivory Coast<ref name="whotracker"/>
# Japan<ref name="jp" /><ref>{{cite news|date=14 February 2021|title=Japan approves Pfizer's COVID-19 vaccine, 1st for domestic use|work=[[Nikkei Asia]]|url=https://asia.nikkei.com/Spotlight/Coronavirus/Japan-approves-Pfizer-s-COVID-19-vaccine-1st-for-domestic-use|access-date=14 February 2021|name-list-style=vanc|accessdate=7 July 2021|archivedate=18 March 2021|archiveurl=https://web.archive.org/web/20210318232113/https://asia.nikkei.com/Spotlight/Coronavirus/Japan-approves-Pfizer-s-COVID-19-vaccine-1st-for-domestic-use}}</ref><ref>{{#invoke:Cite web||last=Tsukimori|first=Osamu|date=15 February 2021|title=Japan gives OK to Pfizer coronavirus vaccine, with rollout to begin this week|url=https://www.japantimes.co.jp/news/2021/02/15/national/science-health/pfizer-vaccine-approval-japan/|access-date=1 April 2021|website=The Japan Times}}</ref>
# Jordan<ref>{{#invoke:Cite web||date=15 December 2020|title=Jordan approves Pfizer-BioNTech Covid vaccine|url=https://www.france24.com/en/live-news/20201215-jordan-approves-pfizer-biontech-covid-vaccine|access-date=15 December 2020|publisher=France 24}}</ref>
# Kazakhstan<ref name="whotracker"/>
# Kenya<ref name="auto13">{{#invoke:Cite news||date=2 August 2021|title=Kenya Approves J&J, Pfizer Covid-19 Vaccines as Cases Surge|work=Bloomberg.com|url=https://www.bloomberg.com/news/articles/2021-08-02/kenya-approves-j-j-pfizer-covid-19-vaccines-as-cases-surge|access-date=24 September 2021}}</ref>
# Kosovo<ref name="whotracker"/>
# Kuwait<ref>{{#invoke:Cite web||date=13 December 2020|title=Kuwait authorizes emergency use of Pfizer-BioNTech COVID-19 vaccine|url=https://arab.news/427j9|access-date=15 December 2020|website=Arab News}}</ref>
# Kyrgyzstan<ref name="whotracker"/>
# Laos<ref name="whotracker"/>
# Lebanon<ref>{{#invoke:Cite web||date=14 February 2021|title=Lebanon starts Covid-19 vaccination campaign|url=https://www.france24.com/en/middle-east/20210214-lebanon-starts-covid-19-vaccination-campaign|access-date=16 March 2021|publisher=France 24}}</ref>
# Libya<ref name="cdctracker"/>
# Malawi<ref name="auto7">{{cite web|title=Malawi Ministry of Health on Facebook|url=https://www.facebook.com/login/?next=https%253A%252F%252Fwww.facebook.com%252Fmalawimoh%252Fposts%252F4098884300167054|access-date=14 September 2021|website=Facebook}}</ref>
# Malaysia<ref>{{cite news|last=Lim|first=Ida|date=8 January 2021|title=Khairy: Malaysia can use Pfizer's Covid-19 vaccine now as conditional registration granted|work=[[The Malay Mail]]|url=https://www.msn.com/en-my/news/national/khairy-malaysia-can-use-pfizer-e2-80-99s-covid-19-vaccine-now-as-conditional-registration-granted/ar-BB1czVUU|access-date=8 January 2021|name-list-style=vanc}}</ref>
# Maldives<ref>{{#invoke:Cite web||date=15 March 2021|title=Sinopharm & Pfizer approved for use in Maldives|url=https://timesofaddu.com/2021/03/15/breaking-sinopharm-pfizer-approved-for-use-in-maldives/|access-date=1 April 2021|website=The Times of Addu}}</ref>
# Mexico<ref>{{cite news|date=12 December 2020|title=Mexico Approves Pfizer Vaccine for Emergency Use as Covid Surges|publisher=Bloomberg|url=https://www.bloomberg.com/news/articles/2020-12-12/mexico-approves-pfizer-vaccine-for-emergency-use-as-covid-surges|access-date=12 December 2020}}</ref><ref>{{cite news|date=12 December 2020|title=Mexico authorizes emergency use of Pfizer-BioNTech coronavirus vaccine|website=The Economic Times|url=https://economictimes.indiatimes.com/news/international/world-news/mexico-authorizes-emergency-use-of-pfizer-biontech-coronavirus-vaccine/articleshow/79696221.cms|access-date=14 January 2021}}</ref>
# Moldova<ref name=":2">{{cite news|last=Foundation|first=Thomson Reuters|title=Moldova approves Russia's Sputnik V vaccine as political row simmers|url=https://news.trust.org/item/20210227162136-o0jx5/|access-date=1 April 2021|website=news.trust.org|accessdate=7 July 2021|archivedate=3 April 2021|archiveurl=https://web.archive.org/web/20210403221351/https://news.trust.org/item/20210227162136-o0jx5/}}</ref>
# Monaco<ref>{{#invoke:Cite web||title=First Vaccines Arrive in Monaco – COVID-19 vaccination campaign begins tomorrow / Actualités / Coronavirus (Covid-19) / Policy & Practice / Portail du Gouvernement – Monaco|url=https://en.gouv.mc/Policy-Practice/Coronavirus-Covid-19/Actualites/FIRST-VACCINES-ARRIVE-IN-MONACO-COVID-19-vaccination-campaign-begins-tomorrow|access-date=19 February 2021|website=en.gouv.mc}}</ref>
# Mongolia<ref>{{#invoke:Cite web||title=Mongolia will receive 300,000 doses of COVID-19 vaccine developed by China|url=https://akipress.com/news:654794:Mongolia_will_receive_300,000_doses_of_COVID-19_vaccine_developed_by_China/|access-date=19 March 2021|website=AKIpress News Agency}}</ref>
# Montenegro<ref name="whotracker"/>
# Morocco<ref name="whotracker"/>
# Namibia<ref name="whotracker"/>
# Nepal<ref>{{cite web|date=14 November 2021|title=People to get Pfizer vaccine from today|url=https://thehimalayantimes.com/nepal/people-to-get-pfizer-vaccine-from-today|access-date=28 December 2021|website=himalayantimes}}</ref>
# Nicaragua<ref name="whotracker"/>
# Nigeria<ref>{{#invoke:Cite web||date=30 April 2021|title=NAFDAC approves Pfizer Biotech Vaccine for emergency use authorisation|url=https://editor.guardian.ng/news/nafdac-approves-pfizer-biotech-vaccine-for-emergency-use-authorisation/|access-date=21 July 2021|website=The Guardian Nigeria News - Nigeria and World News}}</ref>
# North Macedonia<ref>{{#invoke:Cite web||title=North Macedonia Kicks Off COVID-19 Vaccinations As Serbia Looks To Highlight Regional Efforts|url=https://www.rferl.org/a/north-macedonia-kicks-off-covid-19-vaccinations/31108206.html|access-date=19 February 2021|website=RadioFreeEurope/RadioLiberty}}</ref>
# Oman<ref name="oman">{{cite news|date=15 December 2020|title=Oman issues licence to import Pfizer BioNTech Covid vaccine – TV|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-oman-vaccine-int-idUSKBN28P1RA|access-date=16 December 2020}}</ref>
# Pakistan<ref>{{cite web |title=DRAP gives emergency approval for Pfizer's coronavirus vaccine |url=https://www.geo.tv/latest/352816-drap-gives-emergency-approval-for-pfizers-coronavirus-vaccine |website=www.geo.tv }}</ref>
# Palestine<ref name="cdctracker"/>
# Panama<ref name="panama">{{#invoke:Cite web||title=Panama approves Pfizer's COVID-19 vaccine – health ministry|url=https://finance.yahoo.com/news/panama-approves-pfizers-covid-19-010942802.html|access-date=16 December 2020|publisher=Yahoo! Finance}}</ref>
# Papua New Guinea<ref>{{#invoke:Cite web||date=12 August 2021|title=Vaccination is not compulsory, Prime Minister tells Parliament|url=https://covid19.info.gov.pg/vaccination-is-not-compulsory-prime-minister-tells-parliament/|access-date=24 September 2021|website=PNG | COVID 19}}</ref>
# Paraguay<ref>{{#invoke:Cite web||title=DNVS otorga registro sanitario de emergencia a Pfizer - MSPBS Py|url=https://www.mspbs.gov.py/portal/23306/dnvs-otorga-registro-sanitario-de-emergencia-a-pfizer.html}}</ref><ref>{{#invoke:Cite web||title=Pfizer: la nueva vacuna que compró Paraguay. MSPBS Paraguay|url=https://www.mspbs.gov.py/portal/23192/pfizer-la-nueva-vacuna-que-compro-paraguay.html}}</ref>
# Peru<ref>{{#invoke:Cite web||title=Peru regulators approve Pfizer vaccine against COVID-19: filing|url=https://news.yahoo.com/peru-regulators-approve-pfizer-vaccine-173719455.html|access-date=31 March 2021|publisher=Yahoo! News}}</ref>
# Philippines<ref>{{#invoke:cite news||date=14 January 2021|title=PH authorizes Pfizer's COVID-19 vaccine for emergency use|publisher=CNN Philippines|url=https://cnnphilippines.com/news/2021/1/14/Pfizer-COVID-19-vaccine-Philippines-FDA-emergency-use-EUA.html|access-date=14 January 2021}}</ref>
# Qatar<ref>{{#invoke:cite news||title=Qatar, Oman to receive Pfizer-BioNTech COVID-19 vaccine this week|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-qatar/qatar-oman-to-receive-pfizer-biontech-covid-19-vaccine-this-week-idUSKBN28U0VE|access-date=24 December 2020}}</ref>
# Rwanda<ref name="cdctracker"/>
# San Marino<ref name="cdctracker"/>
# Serbia<ref>{{#invoke:cite news||date=21 December 2020|title=Serbia leads region in expecting COVID-19 vaccines within days|work=BalkanInsight|url=https://balkaninsight.com/2020/12/21/serbia-leads-region-in-expecting-covid-19-vaccines-within-days/|access-date=26 December 2020}}</ref><ref>{{cite news|date=22 December 2020|title=First shipment of Pfizer-BioNTech vaccine arrives in Serbia|work=Serbian government website|url=https://www.srbija.gov.rs/vest/en/165409/first-shipment-of-pfizer-biontech-vaccine-arrives-in-serbia.php|access-date=26 December 2020}}</ref>
# Singapore<ref>{{#invoke:Cite web||date=14 December 2020|title=Singapore approves use of Pfizer's COVID-19 vaccine|url=https://apnews.com/article/science-singapore-coronavirus-pandemic-lee-hsien-loong-coronavirus-vaccine-5bf8461b9d2d32ec08d56fcf5958317a|access-date=15 December 2020|publisher=Associated Press}}</ref>
# South Africa<ref>{{#invoke:Cite web||title=South Africa approves Pfizer Covid-19 vaccine for emergency use|url=https://businesstech.co.za/news/trending/476360/south-africa-approves-pfizer-covid-19-vaccine-for-emergency-use/|access-date=18 March 2021}}</ref><ref>{{#invoke:Cite web||title=Pfizer-BioNTec approved for emergency use in SA: here is what you need to know about the vaccine|url=https://www.timeslive.co.za/news/south-africa/2021-03-18-pfizer-biontec-approved-for-emergency-use-in-sa-here-is-what-you-need-to-know-about-the-vaccine/|access-date=19 March 2021|website=TimesLIVE}}</ref>
# South Korea<ref>{{cite news|last1=Lee|first1=Kyung-eun|date=27 February 2021|title=S. Korea begins rolling out Pfizer vaccines on second day of national vaccination program|work=Arirang News|url=https://www.arirang.com/news/News_View.asp?nseq=273056|access-date=28 February 2021|accessdate=7 July 2021|archivedate=10 March 2021|archiveurl=https://web.archive.org/web/20210310013846/https://www.arirang.com/news/News_View.asp?nseq=273056}}</ref><ref>{{cite news|last1=Kim|first1=Han-joo|date=5 March 2021|title=S. Korea approves Pfizer's COVID-19 vaccine amid immunization push|publisher=Yonhap News |url=https://en.yna.co.kr/view/AEN20210305001500320|access-date=5 March 2021}}</ref>
# Sri Lanka<ref>{{cite web |title=Sri Lanka approves Pfizer COVID vaccine for emergency use |url=https://www.reuters.com/business/healthcare-pharmaceuticals/sri-lanka-approves-pfizer-covid-vaccine-emergency-use-2021-05-08/ |website=Reuters |date=8 May 2021}}</ref>
# Sudan<ref name="cdctracker"/>
# Taiwan<ref name="RTHK 20210711">{{cite web | last=Kemp | first=Robert | title=Fosun says it has struck deal to send Taiwan vaccines | website=RTHK | date=11 July 2021 | url=https://news.rthk.hk/rthk/en/component/k2/1600277-20210711.htm? | access-date=11 July 2021}}</ref><ref name="BioNTech PR 20210712">{{cite press release | title=10 Million Doses of mRNA-based COVID-19 Vaccine to be supplied to Taiwan Region | website=BioNTech | date=12 July 2021 | url=https://investors.biontech.de/news-releases/news-release-details/10-million-doses-mrna-based-covid-19-vaccine-be-supplied-taiwan | access-date=18 July 2021}}</ref>
# Tajikistan<ref name="whotracker"/>
# Tanzania<ref name="whotracker"/>
# Thailand<ref>{{cite news | title = Thailand approves Pfizer-Biontech vaccine for emergency use | date = 24 June 2021 | url = https://www.reuters.com/world/asia-pacific/thailand-approves-pfizer-biontech-vaccine-emergency-use-2021-06-24/ | work = Reuters }}</ref>
# Tonga<ref name="whotracker"/>
# Tunisia<ref name="NYT vaccine tracker" />
# Turkey<ref>{{cite web |author=Gözde Bayar |date=18 March 2021 |url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkey-to-receive-45m-doses-of-pfizer-vaccine-this-month/2179702 |title=Turkey to receive 4.5M doses of Pfizer vaccine this month |publisher=Anadolu Agency}}</ref>
# Uganda<ref name="whotracker"/>
# Ukraine<ref>{{#invoke:Cite web||title=Наказ МОЗ України від 22.02.2021 № 308 "Про державну реєстрацію лікарського засобу (медичного імунобіологічного препарату) для екстреного медичного застосування"|url=https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-22022021--308-pro-derzhavnu-reestraciju-likarskogo-zasobu-medichnogo-imunobiologichnogo-preparatu-dlja-ekstrenogo-medichnogo-zastosuvannja|access-date=19 March 2021|website=moz.gov.ua}}</ref>
# United Arab Emirates<ref>{{#invoke:Cite web||date=23 December 2020|title=Dubai approves the Pfizer-BioNTech vaccine which will be free of charge|url=https://emirateswoman.com/dubai-approves-the-pfizer-biontech-vaccine-for-free/|access-date=28 December 2020|website=Emirates Woman}}</ref>
# United Kingdom<ref name="ukgov12-2">{{#invoke:Cite web||date=2 December 2020|title=UK medicines regulator gives approval for first UK COVID-19 vaccine|url=https://www.gov.uk/government/news/uk-medicines-regulator-gives-approval-for-first-uk-covid-19-vaccine|access-date=2 December 2020|publisher=Medicines and Healthcare Products Regulatory Agency, Government of the UK}}</ref><ref name="MHRA 2020-12-08">{{#invoke:Cite web||date=8 December 2020|title=Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine|url=https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-healthcare-professionals-on-pfizerbiontech-covid-19-vaccine|access-date=13 December 2020|website=Medicines & Healthcare products Regulatory Agency (MHRA)}}</ref><ref>{{#invoke:Cite web||date=3 December 2020|title=Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine|url=https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/conditions-of-authorisation-for-pfizerbiontech-covid-19-vaccine|access-date=13 December 2020|website=Medicines & Healthcare products Regulatory Agency (MHRA)}}</ref>
# Uruguay<ref>{{cite web |title=Uruguay acquired Pfizer and Sinovac vaccines; details will be announced Saturday |url=https://en.mercopress.com/2021/01/23/uruguay-acquired-pfizer-and-sinovac-vaccines-details-will-be-announced-saturday |website=MercoPress }}</ref>
# Uzbekistan<ref>{{cite web|date=12 September 2021|title=U.S. Donates Over 1.2 million COVID-19 Pfizer Vaccines to Uzbekistan|url=https://uz.usembassy.gov/u-s-donates-over-1-2-million-covid-19-pfizer-vaccines-to-uzbekistan/|access-date=4 October 2021|website=<nowiki>[[U.S. Embassy in Uzbekistan</nowiki>}} {{Dead link|date=September 2026 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>
# Vatican City<ref>{{cite news|last=McElwee|first=Joshua J.|date=11 December 2020|title=Vatican to offer coronavirus vaccine to residents and staff in early 2021|publisher=[[National Catholic Reporter]]|url=https://www.ncronline.org/news/coronavirus/vatican-offer-coronavirus-vaccine-residents-and-staff-early-2021|access-date=9 February 2021}}</ref><ref>{{cite press release|url=https://www.vaticannews.va/it/vaticano/news/2020-12/in-vaticano-parte-il-piano-vaccinale-anticovid.html|title=In Vaticano parte il piano vaccinale anticovid|date=11 December 2020|access-date=9 February 2021|first=Massimiliano|last=Menichetti|website=vatican.va}}</ref>
# Vietnam<ref>{{Cite news|last=Le|first=Nga|date=12 June 2021|title=Vietnam approves Pfizer Covid vaccine for emergency use|work=[[VnExpress]]|url=https://e.vnexpress.net/news/news/vietnam-approves-pfizer-covid-vaccine-for-emergency-use-4293267.html}}</ref>
# Zambia<ref name="TrackVax">{{cite web|title=COVID19 Vaccine Tracker|url=https://covid19.trackvaccines.org/|access-date=2022-01-12|website=covid19.trackvaccines.org|archiveurl=https://web.archive.org/web/20220703051331/https://covid19.trackvaccines.org/|archivedate=2022-07-03|accessdate=2022-07-06}}</ref>
'''{{nowrap|[[European Medicines Agency|EMA]] countries}}'''<ref name="Comirnaty EPAR" /><ref name="EU Marketing authorisation" /><ref>{{cite web | title=Comirnaty | website=Union Register of medicinal products | date=21 December 2020 | url=https://ec.europa.eu/health/documents/community-register/html/h1528.htm | access-date=26 November 2021}}</ref>
# Austria
# Belgium
# Bulgaria
# Croatia
# Cyprus
# Czech Republic
# Denmark
# Estonia
# Finland
# France
# Germany
# Greece
# Hungary
# Iceland
# Ireland
# Italy
# Latvia
# Liechtenstein
# Lithuania
# Luxembourg
# Malta
# Netherlands
# Norway
# Poland
# Portugal
# Romania
# Slovakia
# Slovenia
# Spain
# Sweden
'''{{nowrap|[[Caribbean Public Health Agency|CARPHA]] countries}}'''<ref name="carpha-pfizer">{{cite web | title=Caribbean Public Health Agency > Who We Are > Member States | website=The Caribbean Public Health Agency (CARPHA) | url=https://www.carpha.org/Who-We-Are/Member-States | access-date=7 April 2021}}</ref><ref>{{#invoke:Cite web||date=6 January 2021|title=Pfizer vaccine approved for region but Health Ministry wants more info|url=https://newsday.co.tt/2021/01/06/pfizer-vaccine-approved-for-region-but-health-ministry-wants-more-info/|access-date=24 February 2021|website=Trinidad and Tobago Newsday}}</ref>
# Antigua and Barbuda
# Bahamas
# Barbados
# Belize
# Dominica
# Grenada
# Guyana
# Haiti
# Jamaica
# Saint Kitts and Nevis
# Saint Lucia
# Saint Vincent and the Grenadines
# Suriname
# Trinidad and Tobago
<!-- not counted --><br />
'''[[List of ISO 3166-1 codes|Non-country entities]]'''
* American Samoa<ref name="whotracker"/>
* Anguilla{{efn|name=carphance}}
* Aruba{{efn|name=carphance}}
* Bermuda{{efn|name=carphance}}
* British Virgin Islands{{efn|name=carphance}}
* Caribbean Netherlands{{efn|name=carphance}}
* Cayman Islands{{efn|name=carphance}}
* Cook Islands<ref name="whotracker"/>
* Curaçao{{efn|name=carphance}}
* Faroe Islands<ref>{{#invoke:Cite web||last=Nielsdóttir|first=Alda|date=30 December 2020|title=First Covid-19 vaccines administered in the Faroe Islands|url=https://local.fo/first-covid-19-vaccines-administered-in-the-faroe-islands/|access-date=29 March 2021|website=Local.fo}}</ref>
* French Polynesia<ref name="whotracker"/>
* Gibraltar<ref name="cdctracker"/>
* Greenland<ref>{{#invoke:Cite web||last1=Sevunts|first1=Levon|last2=International|first2=Radio Canada|date=4 January 2021|title=Greenland launches COVID-19 vaccination campaign|url=https://www.rcinet.ca/eye-on-the-arctic/2021/01/04/greenland-launches-covid-19-vaccination-campaign-1/|access-date=21 March 2021|website=Eye on the Arctic}}</ref>
* Guadeloupe<ref name="whotracker"/>
* Guam<ref name="whotracker"/>
* Guernsey<ref name="cdctracker"/>
* Hong Kong<ref>{{#invoke:Cite web||date=25 January 2021|title=Use of vaccine approved|url=https://www.news.gov.hk/eng/2021/01/20210125/20210125_175428_123.html|access-date=15 February 2021|publisher=Government of Hong Kong}}</ref>
* Isle of Man<ref name="cdctracker"/>
* Jersey<ref name="cdctracker"/>
* Macau<ref>{{#invoke:cite web||title=Local BioNTech vaccination to resume on April 5 |url=https://www.macaubusiness.com/local-biontech-vaccination-to-resume-on-april-5/ |website=macaubusiness.com |access-date=15 April 2021}}</ref>
* Martinique<ref name="whotracker"/>
* Montserrat{{efn|name=carphance}}
* New Caledonia<ref name="cdctracker"/>
* Niue<ref name="whotracker"/>
* Northern Cyprus<ref name=":4" />
* Northern Mariana Islands<ref name="whotracker"/>
* Puerto Rico<ref name="whotracker"/>
* Sint Maarten{{efn|name=carphance}}
* Tokelau<ref name="whotracker"/>
* Turks and Caicos Islands{{efn|name=carphance}}
* ''[[World Health Organization]]''<ref name="WHO status"/><ref>{{cite press release|title=WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access|website=[[World Health Organization]] (WHO)|url=https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access|date=31 December 2020|access-date=6 January 2021}}</ref><ref>{{cite web | title=WHO recommendation Tozinameran – COVID-19 mRNA vaccine (nucleoside modified) – Comirnaty | website=[[World Health Organization]] (WHO) | date=31 December 2020 | url=https://extranet.who.int/pqweb/vaccines/who-recommendation-covid-19-mrna-vaccine-nucleoside-modified-comirnaty | access-date=8 May 2021 | accessdate=7 July 2021 | archivedate=9 May 2021 | archiveurl=https://web.archive.org/web/20210509155424/https://extranet.who.int/pqweb/vaccines/who-recommendation-covid-19-mrna-vaccine-nucleoside-modified-comirnaty }}</ref>
</div>
== Janssen ==
<section begin="janssenauthmap"/>
{{infobox|image={{Graph:Map|scale=65|defaultValue=gainsboro
|AD=dodgerblue|AF=dodgerblue|AG=dodgerblue|AI=dodgerblue|AL=limegreen|AM=limegreen|AO=limegreen|AR=dodgerblue|AS=dodgerblue|AT=dodgerblue|AU=lightpink|AW=dodgerblue|AZ=limegreen
|BA=limegreen|BB=dodgerblue|BD=dodgerblue|BE=dodgerblue|BF=dodgerblue|BG=dodgerblue|BH=dodgerblue|BJ=dodgerblue|BM=dodgerblue|BN=dodgerblue|BO=dodgerblue|BR=dodgerblue|BS=dodgerblue|BT=limegreen|BW=dodgerblue|BZ=dodgerblue
|CA=blueviolet|CD=dodgerblue|CF=dodgerblue|CG=limegreen|CH=blueviolet|CI=dodgerblue|CL=dodgerblue|CM=dodgerblue|CO=dodgerblue|CR=limegreen|CV=limegreen|CW=dodgerblue|CY=dodgerblue|CZ=dodgerblue
|DE=dodgerblue|DJ=dodgerblue|DK=darkred|DM=dodgerblue|DO=limegreen|DZ=limegreen
|EC=limegreen|EE=dodgerblue|EG=dodgerblue|ES=dodgerblue|ET=dodgerblue
|FI=dodgerblue|FJ=limegreen|FM=dodgerblue|FO=dodgerblue|FR=dodgerblue
|GA=dodgerblue|GB=dodgerblue|GD=dodgerblue|GE=limegreen|GH=dodgerblue|GL=dodgerblue|GM=limegreen|GN=dodgerblue|GR=dodgerblue|GT=limegreen|GU=dodgerblue|GY=dodgerblue
|HK=turquoise|HN=dodgerblue|HR=dodgerblue|HT=dodgerblue|HU=dodgerblue
|ID=dodgerblue|IE=dodgerblue|IN=dodgerblue|IQ=limegreen|IR=dodgerblue|IS=dodgerblue|IT=dodgerblue
|JM=dodgerblue|JO=dodgerblue
|KE=dodgerblue|KG=limegreen|KH=dodgerblue|KI=limegreen|KM=limegreen|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue
|LA=dodgerblue|LB=limegreen|LC=dodgerblue|LI=dodgerblue|LK=limegreen|LR=dodgerblue|LS=dodgerblue|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=dodgerblue
|MA=dodgerblue|MC=limegreen|MD=dodgerblue|ME=limegreen|MG=dodgerblue|MH=dodgerblue|MK=limegreen|ML=dodgerblue|MM=limegreen|MN=limegreen|MP=dodgerblue|MR=dodgerblue|MS=dodgerblue|MT=dodgerblue|MU=limegreen|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=dodgerblue
|NA=dodgerblue|NC=dodgerblue|NE=limegreen|NG=dodgerblue|NI=dodgerblue|NL=dodgerblue|NO=darkred|NP=dodgerblue|NR=limegreen|NZ=dodgerblue
|OM=limegreen
|PA=limegreen|PE=dodgerblue|PF=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=limegreen|PL=dodgerblue|PR=dodgerblue|PS=dodgerblue|PT=dodgerblue|PW=dodgerblue|PY=limegreen
|QA=dodgerblue
|RO=dodgerblue|RS=limegreen|RW=dodgerblue
|SA=dodgerblue|SB=limegreen|SD=dodgerblue|SE=dodgerblue|SG=limegreen|SI=darkred|SK=dodgerblue|SL=limegreen|SN=dodgerblue|SO=dodgerblue|SR=dodgerblue|SS=dodgerblue|ST=limegreen|SV=limegreen|SX=dodgerblue|SY=dodgerblue|SZ=dodgerblue
|TC=dodgerblue|TD=limegreen|TH=dodgerblue|TG=limegreen|TJ=limegreen|TL=limegreen|TN=dodgerblue|TO=limegreen|TR=turquoise|TT=dodgerblue|TV=limegreen|TW=dodgerblue|TZ=dodgerblue
|UA=dodgerblue|UG=dodgerblue|US=dodgerblue|UY=limegreen|UZ=limegreen
|VC=dodgerblue|VE=limegreen|VG=dodgerblue|VN=dodgerblue|VU=limegreen
|WS=limegreen
|XK=limegreen
|YE=dodgerblue
|ZA=dodgerblue|ZM=dodgerblue|ZW=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|lightpink|Full authorization, not used}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|limegreen|Eligible [[COVAX]] recipient}}
{{leftlegend|darkred|Usage stopped}}
}}
<section end="janssenauthmap"/>
The [[Janssen COVID-19 vaccine]]<ref>{{cite web | title=Janssen COVID-19 Emergency Use Authorization (EUA) Official Website | website=Janssen | date=28 February 2021 | url=https://www.janssencovid19vaccine.com/hcp.html | access-date=28 February 2021}}</ref> is a [[viral vector vaccine]]<ref>{{cite techreport|type=Briefing|date=26 February 2021|title=Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19|publisher=U.S. [[Food and Drug Administration]] (FDA)|url=https://www.fda.gov/media/146217/download|page=6|access-date=6 March 2021|quote=The vaccine, known as Ad26.COV2.S, is a replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a stabilized variant of the SARS-CoV-2 S protein.}}</ref> produced by [[Janssen Pharmaceutica]] (a subsidiary of [[Johnson & Johnson]]) and [[Beth Israel Deaconess Medical Center]].<ref name=":22">{{#invoke:Cite web||date=4 August 2020|title=A Study of Ad26.COV2.S in Adults|url=https://clinicaltrials.gov/ct2/show/NCT04436276|url-status=live|archive-url=https://web.archive.org/web/20200916063346/https://clinicaltrials.gov/ct2/show/NCT04436276|archive-date=16 September 2020|access-date=23 August 2020|website=[[ClinicalTrials.gov]]}}</ref><ref name=":32">{{#invoke:Cite web||title=A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants|url=https://clinicaltrials.gov/ct2/show/NCT04505722|url-status=live|archive-url=https://web.archive.org/web/20200926145744/https://clinicaltrials.gov/ct2/show/NCT04505722|archive-date=26 September 2020|website=[[ClinicalTrials.gov]]|publisher=US National Library of Medicine}}</ref> It is also known as Johnson & Johnson COVID-19 Vaccine and as COVID-19 Vaccine Janssen.<ref name="COVID-19 Vaccine Janssen EPAR">{{#invoke:Cite web||date=5 March 2021|title=COVID-19 Vaccine Janssen EPAR|url=https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-janssen|access-date=16 March 2021|publisher=[[European Medicines Agency]] (EMA)}}</ref> Three countries, Denmark, Finland, and Norway, discontinued the use of the Janssen vaccine in favor of other available vaccines due to a possible link between the vaccine and a rare blood clot disorder.<ref>{{cite web |title=The Danish COVID-19 vaccine rollout continues without the COVID-19 vaccine from Johnson & Johnson |url=https://www.sst.dk/en/english/news/2021/the-danish-covid-19-vaccine-rollout-continues-without-the-covid-19-vaccine-from-johnson-johnson |website=www.sst.dk |accessdate=2021-07-07 |archivedate=2021-07-01 |archiveurl=https://web.archive.org/web/20210701225047/https://www.sst.dk/en/english/news/2021/the-danish-covid-19-vaccine-rollout-continues-without-the-covid-19-vaccine-from-johnson-johnson }}</ref><ref name="thl.fi"/><ref>{{cite web |title=Decision on using the Johnson & Johnson coronavirus vaccine in Finland to come after European Medicines Agency issues recommendations - News - THL |url=https://thl.fi/en/web/thlfi-en/-/decision-on-using-the-johnson-johnson-coronavirus-vaccine-in-finland-to-come-after-european-medicines-agency-issues-recommendations |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=5 December 2021 |accessdate=25 December 2021 |archivedate=5 December 2021 |archiveurl=https://web.archive.org/web/20211205171139/https://thl.fi/en/web/thlfi-en/-/decision-on-using-the-johnson-johnson-coronavirus-vaccine-in-finland-to-come-after-european-medicines-agency-issues-recommendations }}</ref> The use of the Janssen adenovirus vector vaccine began in Finland in October 2021. It is only offered for those aged 65 and over because of a very rare risk of thrombosis in younger age groups.<ref name="Use of AstraZeneca coronavirus vacc"/><ref name="Getting vaccinated against COVID-19"/><ref name="Adenovirus vaccines: FAQ - THL"/>
;Full (<section begin="Janssen_FN"/>3<section end="Janssen_FN"/>)
# Australia (not used)<ref>{{cite web | title=COVID-19 Vaccine Janssen | website=Therapeutic Goods Administration | date=25 June 2021 | url=https://www.tga.gov.au/apm-summary/covid-19-vaccine-janssen | access-date=26 June 2021 | accessdate=7 July 2021 | archivedate=28 August 2021 | archiveurl=https://web.archive.org/web/20210828190300/https://www.tga.gov.au/apm-summary/covid-19-vaccine-janssen }}</ref><ref>{{#invoke:Cite web||date=25 June 2021|title=TGA grants third provisional approval to COVID-19 vaccine: Janssen|url=https://www.tga.gov.au/media-release/tga-grants-third-provisional-approval-covid-19-vaccine-janssen|access-date=28 June 2021|website=[[Therapeutic Goods Administration]] (TGA)}}</ref>
# Canada<ref>{{cite web | title=Janssen (Johnson & Johnson) COVID-19 vaccine | website=[[Health Canada]] | date=5 March 2021 | url=https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/janssen.html | access-date=24 November 2021}}</ref><ref>{{cite web | title=Regulatory Decision Summary - Janssen COVID-19 Vaccine | website=[[Health Canada]] | url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detail.html?linkID=RDS00890 | access-date=24 November 2021}}</ref>
# Switzerland<ref>{{cite news|agency=Keystone-SDA/Reuters/sb|title=Johnson & Johnson Covid vaccine approved for use in Switzerland|url=https://www.swissinfo.ch/eng/johnson---johnson-covid-vaccine-approved-for-use-in-switzerland/46469458|access-date=1 April 2021|website=SWI swissinfo.ch}}</ref><ref>{{cite news | title=Swissmedic regulator approves Johnson & Johnson COVID-19 vaccine | publisher=Reuters | date=22 March 2021 | url=https://www.reuters.com/article/health-coronavirus-swiss-johnsonjohnson-idUSZ8N2K8003 | access-date=3 April 2021}}</ref>
{{-}}
;Emergency (<section begin="Janssen_EN"/>126<section end="Janssen_EN"/>)
<div style="margin-top: 0.3em; column-width: 15em;">
# Afghanistan<ref name="whotracker"/>
# Andorra<ref name="Andorra vaccines">{{cite news|title=Informació en relació amb la vacunació contra la COVID-19|publisher=Govern d'Andorra|url=https://www.govern.ad/vacunacio/faqs/FAQS_Vacunacio_COVID19.pdf|access-date=14 March 2021 | language=ca }}</ref>
# Argentina<ref>{{cite web|last=de 2021|first=6 de Octubre|title=COVID-19: la ANMAT aprobó el uso de emergencia de la vacuna de Johnson & Johnson|url=https://www.infobae.com/salud/2021/10/06/covid-19-la-anmat-aprobo-el-uso-de-emergencia-de-la-vacuna-de-janssen/|access-date=6 October 2021|website=infobae|language=es-ES}}</ref>
# Bahamas<ref>{{cite web|title=Farmacovigilancia de vacunas para COVID-19 - Janssen|url=https://covid-19pharmacovigilance.paho.org/|access-date=9 October 2021|website=Farmacovigilancia de vacunas para COVID-19|accessdate=6 October 2021|archivedate=6 October 2021|archiveurl=https://web.archive.org/web/20211006044523/https://covid-19pharmacovigilance.paho.org/}}</ref>
# Bahrain<ref>{{cite news | title=Bahrain first to approve Johnson & Johnson COVID-19 vaccine for emergency use | publisher=Reuters | date=25 February 2021 | url=https://www.reuters.com/article/health-coronavirus-bahrain-idUSS8N2I4021 | access-date=25 February 2021}}</ref><ref>{{cite news | title=Bahrain becomes 1st nation to grant J&J shot emergency use | website=ABC News (United States) | date=25 February 2021 | url=https://abcnews.go.com/International/wireStory/bahrain-1st-nation-grant-jj-shot-emergency-76112143 | access-date=25 February 2021}}</ref>
# Bangladesh<ref>{{cite news | title=Bangladesh approves Johnson & Johnson's Covid-19 vaccine for emergency use| publisher=Dhaka Tribune | date=15 June 2021| url=https://www.dhakatribune.com/bangladesh/2021/06/15/johnson-johnson-s-covid-19-vaccine-approved-for-emergency-use | access-date=15 June 2021}}</ref><ref>{{cite news |url=https://www.thedailystar.net/coronavirus-deadly-new-threat/news/single-dose-covid-19-vaccine-janssen-gets-emergency-use-authorization-bangladesh-2111557| title=Single-dose Covid-19 vaccine Janssen gets emergency use authorization in Bangladesh| website=[[The Daily Star (Bangladesh)|The Daily Star]]| date=15 June 2021|access-date=15 June 2021}}</ref>
# Benin<ref name="whotracker"/>
# Bolivia<ref name="whotracker" />
# Botswana<ref>{{cite web |title=COVID-19 Vaccines Approved by BoMRA |url=https://www.bomra.co.bw/index.php/news-updates/177-covid-19-vaccines-approved-by-bomra |website=www.bomra.co.bw |accessdate=2021-07-07 |archivedate=2021-06-13 |archiveurl=https://web.archive.org/web/20210613171202/https://www.bomra.co.bw/index.php/news-updates/177-covid-19-vaccines-approved-by-bomra }}</ref>
# Brazil<ref>{{cite news |date=31 March 2021 |title=Brazil health regulator approves emergency use of Johnson & Johnson COVID-19 vaccine |url=https://www.reuters.com/article/health-coronavirus-brazil-janssen/brazil-health-regulator-approves-emergency-use-of-johnson-johnson-covid-19-vaccine-idUSL1N2LT2PS |publisher=Reuters |location=Rio de Janeiro |access-date=1 April 2021}}</ref>
# Brunei<ref name="whotracker"/>
# Burkina Faso<ref name="whotracker"/>
# Cambodia<ref name="whotracker"/>
# Cameroon<ref name="whotracker"/>
# Central African Republic<ref name="TrackVax"/>
# Chile<ref>{{cite web|title=Chile authorizes emergency use of Johnson & Johnson's Janssen vaccine through COVAX|url=https://www.ispch.cl/noticia/isp-valida-uso-de-emergencia-de-la-vacuna-janssen-de-johnson-johnson-a-traves-de-mecanismo-covax/|publisher=Public Health Institute, [[Ministry of Health (Chile)|Ministry of Health of Chile]]|date=10 June 2021|accessdate=7 July 2021|archivedate=12 June 2021|archiveurl=https://web.archive.org/web/20210612004858/https://www.ispch.cl/noticia/isp-valida-uso-de-emergencia-de-la-vacuna-janssen-de-johnson-johnson-a-traves-de-mecanismo-covax/}}</ref>
# Colombia<ref>{{cite news|last=Acosta|first=Luis Jaime|location=Bogotá|title=Colombia grants emergency use for J&J coronavirus vaccine |url=https://www.reuters.com/article/health-coronavirus-colombia/colombia-grants-emergency-use-for-jj-coronavirus-vaccine-idUSL1N2LO01O |access-date=25 March 2021 |publisher=Reuters |date=25 March 2021}}</ref>
# Congo-Kinshasa<ref name="DRC"/>
# Djibouti<ref name="whotracker"/>
# Egypt<ref name="whotracker"/>
# Eswatini<ref name="whotracker"/>
# Ethiopia<ref name="whotracker"/>
# Gabon<ref name="TrackVax"/>
# Ghana<ref>{{#invoke:cite web ||title=Johnson & Johnson COVID-19 vaccine to be available in Ghana by August |url=https://www.graphic.com.gh/news/general-news/johnson-johnson-covid-19-vaccine-to-be-available-in-ghana-by-august.html |website=Graphic Online}}</ref>
# Guinea<ref name="whotracker"/>
# Honduras<ref name="cdctracker"/>
# India<ref>{{#invoke:Cite web||date=7 August 2021|title=India approves J&J COVID-19 vaccine for emergency use|url=https://www.reuters.com/world/india/india-approves-jj-covid-19-vaccine-emergency-use-2021-08-07/|access-date=7 August 2021|website=Reuters}}</ref>
# Indonesia<ref name="auto6">{{cite web|last=|first=|date=7 September 2021|title=BPOM Terbitkan Izin Penggunaan Darurat Vaksin Covid-19 Produksi Johnson & Johnson dan Cansino|url=https://nasional.kompas.com/read/2021/09/07/18330171/bpom-terbitkan-izin-penggunaan-darurat-vaksin-covid-19-produksi-johnson|access-date=7 September 2021|website=KOMPAS.com|language=id}}</ref>
# Iran<ref name="TrackVax"/>
# Ivory Coast<ref name="whotracker"/>
# Jordan<ref name="whotracker"/>
# Kenya<ref name="auto13"/>
# Kuwait<ref>{{cite web |title=Kuwait authorises emergency use of Johnson & Johnson vaccine |url=https://www.kuna.net.kw/ArticleDetails.aspx?id=2980741&language=en |publisher=Kuwait News Agency (KUNA) |date=8 June 2021}}</ref>
# Laos<ref name="whotracker"/>
# Lesotho<ref name="whotracker"/>
# Liberia<ref name="TrackVax"/>
# Libya<ref name="cdctracker"/>
# Madagascar<ref name="whotracker"/>
# Malawi<ref name="whotracker"/>
# Malaysia<ref>{{cite news|date=15 June 2021|title=Malaysia grants conditional approval for CanSino, J&J COVID-19 vaccines|url= https://www.reuters.com/business/healthcare-pharmaceuticals/malaysia-grants-conditional-approval-cansino-jj-covid-19-vaccines-2021-06-15/|work=[[Reuters]]|access-date= 15 June 2021}}</ref>
# Maldives<ref>{{cite web |title=Approval to use of Covid-19 vaccine Janssen |url=http://health.gov.mv/Uploads/Downloads//Informations/Informations(381).pdf |publisher=Maldives Food and Drug Authority |date=6 June 2021 |accessdate=7 July 2021 |archivedate=11 June 2021 |archiveurl=https://web.archive.org/web/20210611230415/http://health.gov.mv/Uploads/Downloads//Informations/Informations(381).pdf }}</ref>
# Mali<ref name="TrackVax"/>
# Marshall Islands{{efn|name=CFA}}
# Mauritania<ref name="TrackVax"/>
# Mexico<ref>{{cite web |title= El Comité de Moléculas Nuevas de COFEPRIS informa sobre los resultados de votación para la vacuna COVID-19 (Ad26.COV2-S [Recombinante]) |url=https://www.gob.mx/cofepris/articulos/el-comite-de-moleculas-nuevas-de-cofepris-informa-sobre-los-resultados-de-votacion-para-la-vacuna-covid-19-ad26-cov2-s-recombinante |website=www.gob.mx/cofepris |language=es}}</ref><ref>{{cite web |title= COFEPRIS emite autorización para uso de emergencia a vacuna contra COVID-19 Ad26.COV2.S de Janssen (Johnson & Johnson) |url=https://www.gob.mx/cofepris/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-a-vacuna-contra-covid-19-ad26-cov2-s-de-janssen-johnson-johnson |website=www.gob.mx/cofepris |language=es}}</ref>
# Micronesia{{efn|name=CFA}}
# Moldova<ref name="msmps.gov.md"/>
# Morocco<ref name="whotracker"/>
# Mozambique<ref name="whotracker"/>
# Namibia<ref name="whotracker"/>
# Nepal<ref>{{#invoke:Cite web||title=1.5 million doses of J&J vaccine arrive in Nepal|url=https://kathmandupost.com/health/2021/07/12/1-5-million-doses-of-j-j-vaccine-arrive-in-nepal|access-date=12 July 2021|website=kathmandupost}}</ref>
# New Zealand<ref name="whotracker"/>
# Nicaragua<ref name="whotracker"/>
# Nigeria<ref>{{#invoke:Cite web||date=20 April 2021|title=905m COVID-19 shots administered worldwide – Report|url=https://www.premiumtimesng.com/health/456360-905m-covid-19-shots-administered-worldwide-report.html|access-date=7 June 2021}}</ref>
# Palau{{efn|name=CFA}}
# Palestine<ref name="whotracker"/>
# Papua New Guinea<ref name="whotracker"/>
# Peru<ref>{{#invoke:Cite web||date=9 July 2021|title=Peru authorizes use of Johnson & Johnson COVID-19 vaccine|url=https://andina.pe/ingles/noticia-peru-authorizes-use-of-johnson-johnson-covid19-vaccine-852510.aspx|access-date=3 August 2021|website=[[ATV (Peruvian TV channel)|Andina]]}}</ref>
# Philippines<ref>{{#invoke:Cite web||url=https://cnnphilippines.com/news/2021/4/19/covaxin-janssen-emergency-use-authorization.html|title=Covaxin, Janssen approved for emergency use in PH |work=CNN Philippines|date=19 April 2021}}</ref>
# Qatar<ref name="whotracker"/>
# Rwanda<ref name="whotracker"/>
# Saudi Arabia<ref name="whotracker"/>
# Senegal<ref name="whotracker"/>
# Singapore<ref name="channelnewsasia.com"/> ''(restricted)''
# Somalia<ref name="whotracker"/>
# South Africa<ref>{{cite news|url=https://www.bbc.com/news/world-africa-55675806|title=Coronavirus: South Africa rolls out vaccination programme|date=17 February 2021|access-date=19 February 2021|work=BBC News}}</ref>
# South Korea<ref>{{cite news |last1=Lardieri |first1=Alexa |title=South Korea Approves Johnson & Johnson Vaccine |url=https://www.usnews.com/news/health-news/articles/2021-04-07/south-korea-grants-conditional-approval-to-johnson-johnson-coronavirus-vaccine |access-date=8 April 2021 |work=U.S. News & World Report |date=7 April 2021}}</ref>
# South Sudan<ref name="whotracker"/>
# Sudan<ref name="whotracker"/>
# Syria<ref name="whotracker"/>
# Taiwan (not used)<ref>{{Cite news|date=10 June 2021|title=嬌生疫苗通過我緊急使用授權 BNT僅「有條件通過」|publisher=The Liberty Times|url=https://news.ltn.com.tw/news/life/breakingnews/3565594}}</ref>
# Tanzania<ref name="whotracker"/>
# Thailand<ref>{{Cite news|date=25 March 2021|title=Thailand approves Johnson & Johnson's COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-thailand-idUSKBN2BH1L7|access-date=1 April 2021}}</ref>
# Tunisia<ref>{{cite news |title=Tunisia approve Johnson & Johnson COVID-19 vaccine |url=https://www.reuters.com/article/uk-health-coronavirus-tunisia/tunisia-approve-johnson-johnson-covid-19-vaccine-idUSKBN2BV1SQ |website=Reuters |date=8 April 2021}}</ref>
# Uganda<ref name="whotracker"/>
# Ukraine<ref name="whotracker"/>
# United Kingdom<ref>{{cite news |title=Janssen single-dose Covid vaccine approved by UK |url=https://www.bbc.com/news/health-57283837 |publisher=BBC News |date=28 May 2021}}</ref>
# United States<ref name="FDA PR 20210227">{{cite press release | title=FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine | publisher=U.S. [[Food and Drug Administration]] (FDA) | date=27 February 2021 | url=https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-third-covid-19-vaccine | access-date=27 February 2021}}</ref><ref name="FDA EUA">{{cite web|url=https://www.fda.gov/media/146303/download|title=Janssen COVID-19 Vaccine EUA Letter of Authorization 06102021|date=10 June 2021|website=U.S. Food & Drug Administration}}</ref>
# Vietnam<ref name=ldo1507>{{Cite news|date=15 July 2021|title=Việt Nam phê duyệt khẩn cấp vaccine COVID-19 của Johnson & Johnson|work=Lao Động|url=https://laodong.vn/y-te/viet-nam-phe-duyet-khan-cap-vaccine-covid-19-cua-johnson--johnson-930853.ldo}}</ref><ref name=vnp1507>{{Cite news|date=15 July 2021|title=Bộ Y tế phê duyệt vaccine phòng COVID-19 Janssen của Johnson & Johnson|work=Vietnam+|url=https://www.vietnamplus.vn/bo-y-te-phe-duyet-vaccine-phong-covid19-janssen-cua-johnson-johnson/726931.vnp}}</ref>
# Yemen<ref name="whotracker"/>
# Zambia<ref name=":5" /><ref name=":6" /><ref name=":8" />
# Zimbabwe<ref>{{#invoke:Cite web||date=28 July 2021|title=Zimbabwe approves J&J COVID-19 vaccine for emergency use|url=https://www.reuters.com/business/healthcare-pharmaceuticals/zimbabwe-approves-jj-covid-19-vaccine-emergency-use-2021-07-28/|access-date=23 August 2021|website=Reuters}}</ref>
'''{{nowrap|[[European Medicines Agency|EMA]] countries}}'''<ref name="COVID-19 Vaccine Janssen EPAR" /><ref name="EU Marketing authorisation">{{#invoke:Cite web||title=Marketing authorisation|url=https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation|access-date=23 March 2021|publisher=[[European Medicines Agency]] (EMA)}}</ref><ref>{{cite web | title=COVID-19 Vaccine Janssen | website=Union Register of medicinal products | url=https://ec.europa.eu/health/documents/community-register/html/h1525.htm | access-date=26 November 2021}}</ref>
# Austria
# Belgium
# Bulgaria
# Croatia
# Cyprus
# Czech Republic
# Denmark
# Estonia
# Finland
# France
# Germany
# Greece
# Hungary
# Iceland
# Ireland
# Italy
# Latvia
# Liechtenstein
# Lithuania
# Luxembourg
# Malta
# Netherlands
# Norway
# Poland
# Portugal
# Romania
# Slovakia
# Slovenia
# Spain
# Sweden
'''{{nowrap|[[Caribbean Public Health Agency|CARPHA]] countries}}'''<ref name="COVID-19 Vaccine Information">{{cite web |title=COVID-19 Vaccine Information |url=https://www.carpha.org/What-We-Do/Public-Health/Novel-Coronavirus/COVID-19-Vaccine-Information |website=www.carpha.org}}</ref>
# Antigua and Barbuda
# Bahamas
# Barbados
# Belize
# Dominica
# Grenada
# Guyana
# Haiti
# Jamaica
# Saint Kitts and Nevis
# Saint Lucia
# Saint Vincent and the Grenadines<ref name="auto2"/>
# Suriname
# Trinidad and Tobago
<!-- not counted -->
<!-- not counted --><br />
'''Non-country entities'''
* American Samoa<ref name="whotracker"/>
* Anguilla{{efn|name=carphance}}
* Aruba{{efn|name=carphance}}
* Bermuda{{efn|name=carphance}}
* British Virgin Islands{{efn|name=carphance}}
* Caribbean Netherlands{{efn|name=carphance}}
* Cayman Islands{{efn|name=carphance}}
* Curaçao{{efn|name=carphance}}
* French Polynesia<ref name="whotracker"/>
* Greenland<ref name="NYT vaccine tracker" />
* Guam<ref name="whotracker"/>
* Montserrat{{efn|name=carphance}}
* New Caledonia<ref name="whotracker"/>
* Northern Cyprus<ref>{{cite web|title=Aşı Türleri - K.K.T.C. Sağlık Bakanlığı - Aşı Bilgi Sistemi|url=https://asi.saglik.gov.ct.tr/content/vaccine-types|access-date=19 November 2021|website=asi.saglik.gov.ct.tr|accessdate=25 December 2021|archivedate=19 November 2021|archiveurl=https://web.archive.org/web/20211119085117/https://asi.saglik.gov.ct.tr/content/vaccine-types}}</ref>
* Northern Mariana Islands<ref name="whotracker"/>
* Puerto Rico<ref name="whotracker"/>
* Sint Maarten{{efn|name=carphance}}
* Turks and Caicos Islands{{efn|name=carphance}}
* ''Africa Regulatory Taskforce''<ref>{{#invoke:Cite web||title=UPDATE: Statement to Member States regarding thromboembolic events after vaccination with Janssen COVID-19 vaccine (Johnson & Johnson)|url=https://africacdc.org/news-item/update-statement-to-member-states-regarding-thromboembolic-events-after-vaccination-with-janssen-covid-19-vaccine-johnson-johnson/|access-date=7 June 2021|website=Africa CDC}}</ref>
* ''[[World Health Organization]]''<ref>{{cite news |title=WHO approves J&J's COVID-19 vaccine for emergency listing |url=https://www.channelnewsasia.com/news/world/covid-19-who-approves-johnson-jj-vaccine-emergency-listing-14394654 |access-date=13 March 2021 |publisher=Channel NewsAsia |date=13 March 2021 |accessdate=7 July 2021 |archivedate=18 March 2021 |archiveurl=https://web.archive.org/web/20210318014950/https://www.channelnewsasia.com/news/world/covid-19-who-approves-johnson-jj-vaccine-emergency-listing-14394654 }}</ref><ref>{{cite web | title=WHO recommendation Janssen–Cilag International NV (Belgium) COVID-19 Vaccine (Ad26.COV2-S [recombinant]) | website=[[World Health Organization]] (WHO) | date=12 March 2021 | url=https://extranet.who.int/pqweb/vaccines/who-recommendation-janssen-cilag-international-nv-belgium-covid-19-vaccine-ad26cov2-s | access-date=8 May 2021 | accessdate=7 July 2021 | archivedate=8 May 2021 | archiveurl=https://web.archive.org/web/20210508195419/https://extranet.who.int/pqweb/vaccines/who-recommendation-janssen-cilag-international-nv-belgium-covid-19-vaccine-ad26cov2-s }}</ref>
;Travel-only
* Hong Kong<ref name="HK"/>
* Turkey<ref name="visasturkey.com"/>
</div>
== Moderna ==
<section begin="modernaauthmap" />
{{infobox|image={{Graph:Map|scale=65|defaultValue=gainsboro
|AD=dodgerblue|AE=dodgerblue|AF=limegreen|AG=dodgerblue|AI=dodgerblue|AL=limegreen|AM=dodgerblue|AO=limegreen|AR=dodgerblue|AS=dodgerblue|AU=blueviolet|AT=dodgerblue|AW=dodgerblue|AZ=limegreen
|BA=limegreen|BB=dodgerblue|BD=dodgerblue|BE=dodgerblue|BF=limegreen|BG=dodgerblue|BH=dodgerblue|BJ=limegreen|BM=dodgerblue|BN=dodgerblue|BO=limegreen|BQ=dodgerblue|BR=dodgerblue|BS=dodgerblue|BT=dodgerblue|BW=dodgerblue|BZ=dodgerblue
|CA=blueviolet|CD=dodgerblue|CF=limegreen|CG=dodgerblue|CH=blueviolet|CI=limegreen|CL=dodgerblue|CM=limegreen|CO=dodgerblue|CR=limegreen|CV=dodgerblue|CW=dodgerblue|CY=dodgerblue|CZ=dodgerblue
|DE=dodgerblue|DJ=limegreen|DK=dodgerblue|DM=dodgerblue|DO=limegreen|DZ=limegreen
|EC=limegreen|EE=dodgerblue|EG=dodgerblue|ES=dodgerblue|ET=limegreen
|FI=dodgerblue|FJ=dodgerblue|FM=dodgerblue|FO=dodgerblue|FR=dodgerblue
|GB=blueviolet|GD=dodgerblue|GE=limegreen|GF=dodgerblue|GH=dodgerblue|GL=dodgerblue|GM=limegreen|GN=limegreen|GP=dodgerblue|GR=dodgerblue|GT=dodgerblue|GU=dodgerblue|GY=dodgerblue
|HK=turquoise|HN=dodgerblue|HR=dodgerblue|HT=dodgerblue|HU=dodgerblue
|ID=dodgerblue|IE=dodgerblue|IL=dodgerblue|IM=dodgerblue|IN=dodgerblue|IQ=limegreen|IR=limegreen|IS=dodgerblue|IT=dodgerblue
|JE=dodgerblue|JP=dodgerblue|JM=dodgerblue|JO=dodgerblue
|KE=dodgerblue|KG=dodgerblue|KH=limegreen|KI=limegreen|KM=limegreen|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue
|LA=limegreen|LB=limegreen|LC=dodgerblue|LK=dodgerblue|LR=limegreen|LS=limegreen|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=dodgerblue
|MA=limegreen|MC=limegreen|MD=dodgerblue|ME=limegreen|MH=dodgerblue|MK=limegreen|ML=limegreen|MM=limegreen|MN=dodgerblue|MP=dodgerblue|MR=limegreen|MS=dodgerblue|MT=dodgerblue|MU=limegreen|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=limegreen
|NA=limegreen|NE=limegreen|NG=dodgerblue|NI=limegreen|NL=dodgerblue|NO=dodgerblue|NP=dodgerblue|NR=limegreen|NZ=turquoise
|OM=limegreen
|PA=limegreen|PE=dodgerblue|PG=limegreen|PH=dodgerblue|PK=dodgerblue|PL=dodgerblue|PR=dodgerblue|PS=dodgerblue|PT=dodgerblue|PW=dodgerblue|PY=dodgerblue
|QA=dodgerblue
|RO=dodgerblue|RS=dodgerblue|RW=dodgerblue
|SA=dodgerblue|SB=limegreen|SD=limegreen|SE=dodgerblue|SG=dodgerblue|SI=dodgerblue|SK=dodgerblue|SL=limegreen|SN=limegreen|SO=limegreen|SR=dodgerblue|SS=limegreen|ST=limegreen|SV=dodgerblue|SX=dodgerblue|SY=limegreen|SZ=limegreen
|TC=dodgerblue|TD=limegreen|TG=limegreen|TH=dodgerblue|TJ=dodgerblue|TL=limegreen|TN=|TR=turquoise |TO=limegreen|TT=dodgerblue|TV=limegreen|TW=dodgerblue
|UA=dodgerblue|UG=dodgerblue|US=blueviolet|UY=limegreen|UZ=dodgerblue
|VC=dodgerblue|VE=limegreen|VG=dodgerblue|VU=limegreen|VN=dodgerblue
|WF=dodgerblue|WS=limegreen
|XK=limegreen
|YE=limegreen
|ZA=limegreen|ZM=limegreen|ZW=limegreen
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|limegreen|Eligible [[COVAX]] recipient}}
}}
<section end="modernaauthmap" />
The [[Moderna COVID-19 vaccine]], also known as Spikevax,<ref name="COVID-19 Vaccine Moderna EPAR" /> is an [[RNA vaccine|mRNA vaccine]]<ref name="NCT04283461">{{#invoke:Cite web||date=16 March 2020|title=Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)|url=https://clinicaltrials.gov/ct2/show/NCT04283461|access-date=5 March 2021|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04283461}}</ref> produced by the American company [[Moderna]], the U.S. [[National Institute of Allergy and Infectious Diseases]], the U.S. [[Biomedical Advanced Research and Development Authority]], and the [[Coalition for Epidemic Preparedness Innovations]].<ref name="NCT044704272">{{#invoke:Cite web||date=14 July 2020|title=A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04470427|url-status=live|archive-url=https://web.archive.org/web/20201011084833/https://clinicaltrials.gov/ct2/show/NCT04470427/|archive-date=11 October 2020|access-date=27 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04470427}}</ref><ref name="palca2">{{cite news|last1=Palca|first1=Joe|date=27 July 2020|title=COVID-19 vaccine candidate heads to widespread testing in U.S.|publisher=NPR|url=https://www.npr.org/sections/coronavirus-live-updates/2020/07/27/895672859/us-vaccine-candidate-heads-to-widespread-testing-in-people|url-status=live|access-date=27 July 2020|archive-url=https://web.archive.org/web/20201011084836/https://www.npr.org/sections/coronavirus-live-updates/2020/07/27/895672859/us-vaccine-candidate-heads-to-widespread-testing-in-people/|archive-date=11 October 2020|name-list-style=vanc}}</ref> The Moderna vaccine is not offered for men under 30 years of age in Finland as a precaution to reduce a very rare risk of myocarditis.<ref>{{cite web |title=THL issues instructions that men under 30 years of age should only be offered the Comirnaty coronavirus vaccine - Press release - THL |url=https://thl.fi/en/web/thlfi-en/-/thl-issues-instructions-that-men-under-30-years-of-age-should-only-be-offered-the-comirnaty-coronavirus-vaccine |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=5 December 2021 |accessdate=25 December 2021 |archivedate=5 December 2021 |archiveurl=https://web.archive.org/web/20211205160943/https://thl.fi/en/web/thlfi-en/-/thl-issues-instructions-that-men-under-30-years-of-age-should-only-be-offered-the-comirnaty-coronavirus-vaccine }}</ref><ref name="Getting vaccinated against COVID-19"/>
;Full (<section begin="Moderna_FN" />5<section end="Moderna_FN" />)
# Australia<ref>{{#invoke:Cite web||date=9 August 2021|title=TGA provisionally approves Moderna’s COVID-19 vaccine|url=https://www.tga.gov.au/media-release/tga-provisionally-approves-modernas-covid-19-vaccine-0|website=Therapeutic Goods Administration}}</ref>
# Canada<ref name="hc-moderna12-23">{{cite web|date=23 December 2020|title=Regulatory Decision Summary – Moderna COVID-19 Vaccine|url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00736|access-date=23 December 2020|publisher=Health Canada, Government of Canada}}</ref><ref name="hcapps">{{#invoke:Cite web||date=9 December 2020|title=Drug and vaccine authorizations for COVID-19: List of applications received|url=https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/applications.html|access-date=9 December 2020|publisher=Health Canada, Government of Canada}}</ref><ref name=":13" />
# Switzerland<ref>{{cite press release|title=Swissmedic grants authorisation for the COVID-19 vaccine from Moderna |url=https://www.swissmedic.ch/swissmedic/en/home/news/coronavirus-covid-19/zulassung-covid-19-impfstoff-moderna.html |publisher=[[Swissmedic|Swiss Agency for Therapeutic Products (Swissmedic)]] |date=12 January 2020 |access-date=12 January 2020}}</ref>
# United Kingdom<ref>{{#invoke:Cite web||date=1 April 2021|title=Information for Healthcare Professionals on COVID-19 Vaccine Moderna|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna/information-for-healthcare-professionals-on-covid-19-vaccine-moderna|access-date=6 April 2021|website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA)}}</ref><ref>{{#invoke:Cite web||date=19 February 2021|title=Summary of the Public Assessment Report for COVID-19 Vaccine Moderna|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna/summary-of-the-public-assessment-report-for-covid-19-vaccine-moderna|access-date=6 April 2021|website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA)}}</ref>
# United States<ref>{{Cite news|date=31 January 2022|title=Coronavirus (COVID-19) Update: FDA Takes Key Action by Approving Second COVID-19 Vaccine|work=[[Food and Drug Administration]]|url=https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-key-action-approving-second-covid-19-vaccine|access-date=31 January 2022|accessdate=6 July 2022|archivedate=31 January 2022|archiveurl=https://web.archive.org/web/20220131163702/https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-key-action-approving-second-covid-19-vaccine}}</ref>
{{-}}
;Emergency (<section begin="Moderna_EN" />104<section end="Moderna_EN" />)
<div style="margin-top: 0.3em; column-width: 15em;">
# Andorra<ref name="Andorra vaccines" />
# Argentina<ref>{{cite web|title=BOLETIN OFICIAL REPUBLICA ARGENTINA - MINISTERIO DE SALUD - Resolución 2711/2021|url=https://www.boletinoficial.gob.ar/detalleAviso/primera/250495|access-date=6 October 2021|website=www.boletinoficial.gob.ar}} {{Dead link|date=October 2026 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>
# Armenia<ref name="whotracker" />
# Bahrain<ref name="whotracker" />
# Bangladesh<ref>{{cite web |title=Moderna gets emergency use authorisation in Bangladesh|url=https://www.thedailystar.net/coronavirus-deadly-new-threat/news/moderna-gets-emergency-use-authorisation-bangladesh-2120677 |website=[[The Daily Star (Bangladesh)|The Daily Star]] |date=29 June 2021|access-date=30 June 2021}}</ref>
# Bhutan<ref name="whotracker"/>
# Botswana<ref>{{cite press release |title=Moderna Announces Agreement to Supply the Republic of Botswana with its COVID-19 Vaccine |url=https://www.businesswire.com/news/home/20210603005629/en/Moderna-Announces-Agreement-to-Supply-the-Republic-of-Botswana-with-its-COVID-19-Vaccine |publisher=Moderna|via=Business Wire |date=3 June 2021}}</ref>
# Bolivia<ref>{{cite web |url=https://www.swissinfo.ch/spa/coronavirus-bolivia_bolivia-recibe-1-9-millones-de-vacunas-moderna-donadas-por-espa%C3%B1a-y-alemania/47231766|title=Bolivia recibe 1,9 millones de vacunas Moderna donadas por España y Alemania}}</ref>
# Brazil<ref name="Agência Brasil"/>
# Brunei<ref name="whotracker"/>
# Cape Verde<ref name="whotracker"/>
# Chile<ref>{{Cite web |title=Instituto de Salud Pública de Chile |url=https://www.ispch.cl/noticia/el-isp-valida-el-uso-de-emergencia-de-la-vacuna-contra-covid-19-del-laboratorio-moderna/#:~:text=La%20s%C3%A9ptima%20vacuna%20aprobada%20en,s%C3%A9ptima%20vacuna%20contra%20COVID-19. |access-date=2022-05-21 |website=www.ispch.cl}}</ref>
# Colombia<ref>{{cite web |url=https://www.elespectador.com/salud/colombia-autoriza-el-uso-de-la-vacuna-de-moderna-para-el-coronavirus/ |title=Colombia autoriza el uso de la vacuna de Moderna para el coronavirus|first=El|last=Espectador|date=25 June 2021|website=El Espectador}}</ref>
# Congo-Brazzaville<ref name="cdctracker"/>
# Congo-Kinshasa<ref name="DRC"/>
# Egypt<ref>{{cite web |title=StackPath|url=https://dailynewsegypt.com/2021/10/31/egypt-receives-784280-doses-of-modernas-covid-19-vaccine/ |access-date=5 November 2021|website=dailynewsegypt}}</ref>
# El Salvador<ref name="whotracker"/>
# Fiji<ref name="whotracker"/>
# Ghana<ref>{{cite web|title=Farmacovigilancia de vacunas para COVID-19 - Moderna|url=https://covid-19pharmacovigilance.paho.org/|access-date=24 September 2021|website=Farmacovigilancia de vacunas para COVID-19|accessdate=6 October 2021|archivedate=6 October 2021|archiveurl=https://web.archive.org/web/20211006044523/https://covid-19pharmacovigilance.paho.org/}}</ref>
# Guatemala<ref name="auto3" />
# Honduras<ref>{{cite web |title=Honduras a la zaga de la vacunación en Centroamérica |url=https://proceso.hn/honduras-a-la-zaga-en-vacunacion-en-ca/ |website=Proceso Digital |language=es |date=10 April 2021}}</ref>
# India<ref>{{cite news |last1=Kaul |first1=Rhythma |title=Moderna's Covid vaccine approved for use in India |url=https://www.hindustantimes.com/india-news/modernas-covid-vaccine-approved-for-use-in-india-101624990937539.html |work=Hindustan Times |date=29 June 2021 }}</ref>
# Indonesia<ref>{{cite news |author= Friski Riana |editor= Laila Afifa|title=BPOM Issues Emergency Use Authorization for Moderna Vaccine |url=https://en.tempo.co/read/1478877/bpom-issues-emergency-use-authorization-for-moderna-vaccine |work=Tempo.co |date=2 July 2021 }}</ref>
# Israel<ref name="israelmoderna">{{cite web|title=Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel|url=https://investors.modernatx.com/news-releases/news-release-details/israeli-ministry-health-authorizes-covid-19-vaccine-moderna-use|publisher=modernatx.com|access-date=4 January 2021|date=4 January 2021|accessdate=7 July 2021|archivedate=17 February 2021|archiveurl=https://web.archive.org/web/20210217215148/https://investors.modernatx.com/news-releases/news-release-details/israeli-ministry-health-authorizes-covid-19-vaccine-moderna-use}}</ref>
# Japan<ref name="jp" /><ref>{{cite press release | title=Takeda Announces Approval of Moderna's COVID-19 Vaccine in Japan | publisher=Takeda | via=Business Wire | date=21 May 2021 | url=https://www.businesswire.com/news/home/20210520006154/en/Takeda-Announces-Approval-of-Moderna%E2%80%99s-COVID-19-Vaccine-in-Japan | access-date=2 July 2021}}</ref>
# Jordan<ref name="whotracker"/>
# Kenya<ref name=":10">{{Cite news|title=Kenya approves Moderna Sinopharm vaccines amid fourth wave|url=https://www.bloomberg.com/news/articles/2021-08-19/kenya-approves-moderna-sinopharm-vaccines-amid-fourth-wave|access-date=28 August 2021|newspaper=Bloomberg.com|date = 19 August 2021}}</ref>
# Kuwait<ref>{{cite web |title=COVID-19: Kuwait unlikely to import Sputnik V |url=https://gulfnews.com/world/gulf/kuwait/covid-19-kuwait-unlikely-to-import-sputnik-v-1.78388637 |website=gulfnews.com |access-date=21 April 2021 }}</ref>
# Kyrgyzstan<ref name="whotracker"/>
# Libya<ref name="cdctracker"/>
# Malawi<ref name="auto7"/>
# Malaysia<ref>{{cite web |author1=New Straits Times |title=DCA grants conditional approval for Moderna vaccine |url=https://www.nst.com.my/news/nation/2021/08/715318/dca-grants-conditional-approval-moderna-vaccine |date=8 August 2021}}</ref>
# Maldives<ref>{{cite web |author1=Maldives Food and Drug Agency |title=Approval to use of COVID-19 vaccine Moderna dispersion for injection |url=http://health.gov.mv/Uploads/Downloads//Informations/Informations(382).pdf |date=6 June 2021 |accessdate=7 July 2021 |archivedate=6 September 2021 |archiveurl=https://web.archive.org/web/20210906115734/http://health.gov.mv/Uploads/Downloads//Informations/Informations(382).pdf }}</ref>
# Marshall Islands{{efn|name=CFA}}
# Mexico<ref>{{cite web |title=Comité de Moléculas Nuevas y Subcomité emiten opinión favorable para vacuna Moderna|url=https://www.gob.mx/cofepris/articulos/comite-de-moleculas-nuevas-y-subcomite-emiten-opinion-favorable-para-vacuna-moderna |website=www.gob.mx/cofepris |language=es}}</ref><ref>{{cite web |title=COFEPRIS emite autorización para uso de emergencia a vacuna Moderna|url=https://www.gob.mx/cofepris/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-a-vacuna-moderna |website=www.gob.mx/cofepris |language=es}}</ref>
# Micronesia{{efn|name=CFA}}
# Moldova<ref name="msmps.gov.md">{{cite web |title=Membrii NITAG au venit cu recomandări privind utilizarea vaccinurilor împotriva COVID-19 în Republica Moldova |url=https://msmps.gov.md/comunicare/comunicate/membrii-nitag-au-venit-cu-recomandari-privind-utilizarea-vaccinurilor-impotriva-covid-19-in-republica-moldova/ |website=Ministerul Sănătății, Muncii și Protecţiei Sociale |language=ro |date=3 March 2021 |accessdate=7 July 2021 |archivedate=19 May 2021 |archiveurl=https://web.archive.org/web/20210519224416/https://msmps.gov.md/comunicare/comunicate/membrii-nitag-au-venit-cu-recomandari-privind-utilizarea-vaccinurilor-impotriva-covid-19-in-republica-moldova/ }}</ref>
# Mongolia<ref name="news.mn" />
# Nepal<ref>{{cite web|title=Nepal receives 1,965,600 doses of Moderna vaccine from COVAX|url=https://kathmandupost.com/health/2021/12/12/nepal-receives-1-965-600-doses-of-moderna-vaccine-from-covax|access-date=28 December 2021|website=kathmandupost.com}}</ref>
# Nigeria<ref>{{#invoke:Cite web||date=15 July 2021|title=NAFDAC approves emergency use of three additional Covid-19 vaccines for Nigeria|url=https://editor.guardian.ng/news/nafdac-approves-emergency-use-of-three-additional-covid-19-vaccines-for-nigeria/|access-date=21 July 2021|website=The Guardian Nigeria News - Nigeria and World News}}</ref>
# Pakistan<ref name="whotracker"/>
# Palau{{efn|name=CFA}}
# Palestine<ref name="cdctracker">{{cite web |title=COVID Data Tracker |url=https://covid.cdc.gov/covid-data-tracker/#global-vaccinations |website=U.S. [[Centers for Disease Control and Prevention]] (CDC) |date=28 March 2020 |archiveurl=https://web.archive.org/web/20210125031037/https://covid.cdc.gov/covid-data-tracker/#global-vaccinations |archivedate=25 January 2021 |accessdate=7 July 2021}}</ref>
# Paraguay<ref name="whotracker"/>
# Peru<ref>{{cite web|date=17 September 2021|title=Gobierno suscribió acuerdo con Moderna por 20 millones de dosis contra la COVID-19|url=https://rpp.pe/peru/actualidad/gobierno-suscribio-acuerdo-con-moderna-por-20-millones-de-vacunas-contra-la-covid-19-noticia-1358438?ref=rpp|access-date=4 October 2021|website=[[RPP Noticias]]}}</ref>
# Philippines<ref>{{cite news |author1=Galvez, Daphne |title=Moderna COVID-19 vaccine gets emergency use authorization |url=https://newsinfo.inquirer.net/1427462/moderna-covid-19-vaccine-gets-emergency-use-authorization |publisher=Philippine Daily Inquirer |date=5 May 2021}}</ref>
# Qatar<ref name="Aljazeera">{{#invoke:Cite web||title=Qatar approves emergency use of Moderna's COVID-19 vaccine|url=https://www.aljazeera.com/news/2021/2/10/qatar-approves-emergency-use-for-modernas-covid-19-vaccine|website=Al Jazeera|access-date=31 March 2021}}</ref>
# Rwanda<ref name="cdctracker" />
# Saudi Arabia<ref name="gulfnews.com">{{#invoke:Cite web||title=AstraZeneca and Moderna vaccines to be administered in Saudi Arabia|url=https://gulfnews.com/world/gulf/saudi/astrazeneca-and-moderna-vaccines-to-be-administered-in-saudi-arabia-1.76573439|access-date=19 January 2021|website=Gulf News}}</ref>
# Serbia<ref>{{cite web|title=Moderna arrived to Serbia|url=https://europa.rs/moderna-arrived-to-serbia/?lang=en}}</ref>
# Singapore<ref>{{cite news|date=3 February 2021|title=Singapore becomes first in Asia to approve Moderna's COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-singapore/singapore-becomes-first-in-asia-to-approve-modernas-covid-19-vaccine-idUSKBN2A30ZM|access-date=3 February 2021|publisher=Reuters}}</ref>
# South Korea<ref>{{Cite news |last1=Kim |first1=Han-joo |date=21 May 2021|title=Moderna COVID-19 vaccine gets final nod in S. Korea |url=https://en.yna.co.kr/view/AEN20210521005500320|access-date=21 May 2021|work=Yonhap News Agency}}</ref>
# Sri Lanka<ref name="whotracker"/>
# Taiwan<ref>{{#invoke:Cite web||date=5 May 2021|title=莫德納疫苗獲緊急授權 自費AZ疫苗供應不間斷|url=https://www.cna.com.tw/news/firstnews/202105050200.aspx|website=Central News Agency}}</ref>
# Tajikistan<ref>{{#invoke:Cite web||date=26 July 2021|title=1.5 million doses of Moderna Vaccines arrive in Tajikistan|url=https://www.unicef.org/tajikistan/press-releases/15-million-doses-moderna-vaccines-arrive-tajikistan|access-date=4 August 2021|website=[[UNICEF]]}}</ref>
# Thailand<ref>{{cite news | title = Thai FDA approves Moderna vaccine | date = 13 May 2021 | url = https://www.bangkokpost.com/thailand/general/2115195/thai-fda-approves-moderna-vaccine | work = Bangkok Post }}</ref>
# Tunisia<ref name="whotracker"/>
# Uganda<ref name="whotracker"/>
# Ukraine<ref>{{#invoke:Cite web||date=19 July 2021|title=U.S. Donates 2 Million Coronavirus Vaccine Doses To Ukraine|url=https://www.rferl.org/a/us-vaccine-ukraine-covid/31365604.html|access-date=4 August 2021|website=[[RadioFreeEurope]]}}</ref>
# United Arab Emirates<ref>{{cite news | title = Coronavirus latest: Moderna vaccine approved for emergency use by UAE | date = 4 July 2021 | url = https://www.thenationalnews.com/coronavirus/2021/07/03/coronavirus-latest-updates-uae-cases-vaccine-covid-test/ | work = The National }}</ref>
# Uzbekistan<ref>{{#invoke:Cite web||date=30 July 2021|title=U.S. Government Provides 3 Million of the Moderna COVID-19 Vaccine to Uzbekistan|url=https://uz.usembassy.gov/u-s-government-provides-3-million-doses-of-the-moderna-covid-19-vaccine-to-uzbekistan/|access-date=4 August 2021|website=}}</ref>
# Vietnam<ref>{{Cite news|date=29 June 2021|title=Bộ Y tế phê duyệt có điều kiện vaccine COVID-19 Moderna|work=[[Vietnam Television]]|url=https://vtv.vn/suc-khoe/bo-y-te-phe-duyet-co-dieu-kien-vaccine-covid-19-moderna-20210629110122178.htm}}</ref><ref>{{Cite news|date=29 June 2021|title=Bộ Y tế phê duyệt có điều kiện vaccine COVID-19 Moderna|work=Vietnam Government Portal|url=http://baochinhphu.vn/Hoat-dong-Bo-nganh/Bo-Y-te-phe-duyet-co-dieu-kien-vaccine-COVID19-Moderna/436244.vgp}}</ref>
'''{{nowrap|[[European Medicines Agency|EMA]] countries}}'''<ref name="COVID-19 Vaccine Moderna EPAR">{{cite web|title=Spikevax (previously COVID-19 Vaccine Moderna) EPAR|url=https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-moderna|website=[[European Medicines Agency]] (EMA)}}</ref><ref name="EU Marketing authorisation" /><ref>{{cite web | title=Spikevax | website=Union Register of medicinal products | url=https://ec.europa.eu/health/documents/community-register/html/h1507.htm | access-date=26 November 2021}}</ref>
# Austria
# Belgium
# Bulgaria
# Croatia
# Cyprus
# Czech Republic
# Denmark
# Estonia
# Finland
# France
# Germany
# Greece
# Hungary
# Iceland
# Ireland
# Italy
# Latvia
# Liechtenstein
# Lithuania
# Luxembourg
# Malta
# Netherlands
# Norway
# Poland
# Portugal
# Romania
# Slovakia
# Slovenia
# Spain
# Sweden
'''{{nowrap|[[Caribbean Public Health Agency|CARPHA]] countries}}'''<ref name="carpha-pfizer"/><ref name="COVID-19 Vaccine Information"/>
# Antigua and Barbuda
# Bahamas
# Barbados
# Belize
# Dominica
# Grenada
# Guyana
# Haiti
# Jamaica
# Saint Kitts and Nevis
# Saint Lucia
# Saint Vincent and the Grenadines
# Suriname
# Trinidad and Tobago
<!-- not counted --><br />
'''Non-country entities'''
* American Samoa<ref name="whotracker"/>
* Anguilla{{efn|name=carphance}}
* Aruba{{efn|name=carphance}}
* Bermuda{{efn|name=carphance}}
* British Virgin Islands{{efn|name=carphance}}
* Caribbean Netherlands{{efn|name=carphance}}
* Cayman Islands{{efn|name=carphance}}
* Curaçao{{efn|name=carphance}}
* Faroe Islands<ref name="cdctracker"/>
* Greenland<ref name="cdctracker"/>
* Guadeloupe<ref name="whotracker"/>
* Guam<ref name="whotracker"/>
* Guernsey<ref name="cdctracker"/>
* Isle of Man<ref name="whotracker"/>
* Jersey<ref name="cdctracker"/>
* Montserrat{{efn|name=carphance}}
* Northern Mariana Islands<ref name="whotracker"/>
* Puerto Rico<ref name="whotracker"/>
* Sint Maarten{{efn|name=carphance}}
* Turks and Caicos Islands{{efn|name=carphance}}
* Wallis and Futuna<ref name="whotracker"/>
* ''[[World Health Organization]]''<ref>{{cite news |title=WHO lists anti-COVID Moderna vaccine for emergency use |url=https://newsinfo.inquirer.net/1425841/who-lists-anti-covid-moderna-vaccine-for-emergency-use |work=Agence France-Presse |publisher=Philippine Daily Inquirer |date=1 May 2021}}</ref><ref>{{cite web | title=WHO Recommendation COVID-19 mRNA Vaccine (nucleoside modified) | website=[[World Health Organization]] (WHO) | date=30 April 2021 | url=https://extranet.who.int/pqweb/vaccines/covid-19-mrna-vaccine-nucleoside-modified | access-date=8 May 2021 | accessdate=7 July 2021 | archivedate=7 May 2021 | archiveurl=https://web.archive.org/web/20210507220946/https://extranet.who.int/pqweb/vaccines/covid-19-mrna-vaccine-nucleoside-modified }}</ref>
;Travel-only
* Hong Kong<ref name="HK"/>
* New Zealand<ref name="auto9"/>
* Turkey<ref name="visasturkey.com"/>
</div>
== Sinopharm BIBP ==
<section begin="bibpauthmap"/>
{{infobox|image={{Graph:Map|scale=65|defaultValue=gainsboro
|AD=limegreen|AE=blueviolet|AF=dodgerblue|AG=dodgerblue|AL=limegreen|AM=dodgerblue|AO=dodgerblue|AR=dodgerblue|AT=turquoise|AU=turquoise|AZ=limegreen
|BA=dodgerblue|BB=dodgerblue|BD=dodgerblue|BF=dodgerblue|BG=turquoise|BH=blueviolet|BI=dodgerblue|BJ=limegreen|BN=dodgerblue|BO=dodgerblue|BR=dodgerblue|BS=limegreen|BT=dodgerblue|BW=limegreen|BY=dodgerblue|BZ=dodgerblue
|CA=turquoise|CD=limegreen|CF=limegreen|CG=dodgerblue|CH=turquoise|CI=dodgerblue|CL=limegreen|CM=dodgerblue|CN=blueviolet|CO=limegreen|CR=limegreen|CU=dodgerblue|CV=dodgerblue|CY=turquoise
|DJ=dodgerblue|DM=dodgerblue|DO=dodgerblue|DZ=dodgerblue
|EC=limegreen|EE=turquoise|EG=dodgerblue|ES=turquoise|ET=dodgerblue
|FI=turquoise|FJ=limegreen|FM=limegreen
|GA=dodgerblue|GB=turquoise|GD=limegreen|GE=dodgerblue|GH=limegreen|GM=dodgerblue|GN=dodgerblue|GQ=dodgerblue|GR=turquoise|GT=limegreen|GW=dodgerblue|GY=dodgerblue
|HN=limegreen|HR=turquoise|HT=limegreen|HU=dodgerblue
|ID=dodgerblue|IE=turquoise|IN=limegreen|IQ=dodgerblue|IR=dodgerblue|IS=turquoise
|JM=dodgerblue|JO=dodgerblue
|KE=dodgerblue|KG=dodgerblue|KH=dodgerblue|KI=dodgerblue|KM=dodgerblue|KN=limegreen|KP=dodgerblue|KR=limegreen|KZ=dodgerblue
|LA=dodgerblue|LB=dodgerblue|LC=limegreen|LI=turquoise|LK=dodgerblue|LR=limegreen|LS=dodgerblue|LV=turquoise|LY=dodgerblue
|MA=dodgerblue|MC=limegreen|MD=dodgerblue|ME=dodgerblue|MG=dodgerblue|MH=limegreen|MK=dodgerblue|ML=limegreen|MM=dodgerblue|MN=dodgerblue|MO=blueviolet|MR=dodgerblue|MU=dodgerblue|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=dodgerblue
|NA=dodgerblue|NE=dodgerblue|NG=dodgerblue|NI=dodgerblue|NL=turquoise|NP=dodgerblue|NR=limegreen|NZ=limegreen
|OM=limegreen
|PA=limegreen|PE=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PS=dodgerblue|PY=dodgerblue
|QA=turquoise
|RS=dodgerblue|RW=dodgerblue
|SA=turquoise|SB=dodgerblue|SC=blueviolet|SD=dodgerblue|SE=turquoise|SG=dodgerblue|SI=turquoise|SK=turquoise|SL=dodgerblue|SN=dodgerblue|SO=dodgerblue|SR=dodgerblue|SS=dodgerblue|ST=limegreen|SV=dodgerblue|SY=dodgerblue|SZ=limegreen
|TD=dodgerblue|TG=limegreen|TH=dodgerblue|TJ=limegreen|TL=limegreen|TM=dodgerblue|TN=dodgerblue|TO=limegreen|TR=turquoise|TT=dodgerblue|TV=limegreen|TZ=dodgerblue
|UA=limegreen|UG=limegreen|US=turquoise|UY=limegreen|UZ=limegreen
|VC=limegreen|VE=dodgerblue|VN=dodgerblue|VU=dodgerblue
|WS=limegreen
|XK=limegreen
|YE=limegreen
|ZA=limegreen|ZM=dodgerblue|ZW=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|limegreen|Eligible [[COVAX]] recipient}}
}}
<section end="bibpauthmap"/>
The [[Sinopharm BIBP COVID-19 vaccine]] is an [[inactivated vaccine|inactivated virus vaccine]] produced by the [[China National Pharmaceutical Group]] (Sinopharm) and its Beijing Institute of Biological Products.<ref name="ChiCTR20000347802">{{cite journal|last1=Chen|first1=Wei|last2=Al Kaabi|first2=Nawal|date=18 July 2020|title=A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells)|url=http://www.chictr.org.cn/showprojen.aspx?proj=56651|journal=Chinese Clinical Trial Registry|access-date=15 August 2020|name-list-style=vanc}} {{Webarchive|url=https://web.archive.org/web/20201011084800/http://www.chictr.org.cn/showprojen.aspx?proj=56651%2F |date=11 October 2020 }} {{Cite web |title=Archive copy |url=http://www.chictr.org.cn/showprojen.aspx?proj=56651%2F |accessdate=28 September 2023 |archivedate=11 October 2020 |archiveurl=https://web.archive.org/web/20201011084800/http://www.chictr.org.cn/showprojen.aspx?proj=56651%2F }}</ref><ref name=":02">{{cite journal|display-authors=6|vauthors=Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z, Huang W, Xu W, Huang B, Wang H, Wang W, Zhang W, Li N, Xie Z, Ding L, You W, Zhao Y, Yang X, Liu Y, Wang Q, Huang L, Yang Y, Xu G, Luo B, Wang W, Liu P, Guo W, Yang X|date=October 2020|title=Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial|journal=The Lancet. Infectious Diseases|volume=21|issue=1|pages=39–51|doi=10.1016/s1473-3099(20)30831-8|pmc=7561304|pmid=33069281}}</ref>
;Full (<section begin="Sinopharm BIBP_FN"/>4<section end="Sinopharm BIBP_FN"/>)
# Bahrain<ref>{{#invoke:cite web||title=Bahrain approves China's Sinopharm coronavirus vaccine |url=https://www.arabianbusiness.com/healthcare/455832-bahrain-approves-chinas-sinopharm-coronavirus-vaccine |website=Arabian Business Industries |date=13 December 2020}}</ref>
# China<ref>{{#invoke:cite news||last1=Kuo |first1=Lily |title=China approves Sinopharm coronavirus vaccine, the country's first for general use |url=https://www.washingtonpost.com/world/asia_pacific/coronavirus-vaccine-china-sinopharm/2020/12/30/1cc4be9e-4a62-11eb-97b6-4eb9f72ff46b_story.html |work=The Washington Post| name-list-style=vanc}}</ref>
# Seychelles<ref>{{#invoke:Cite web||title=President Ramkalawan and First Lady receives second dose SinoPharm Vaccine|url=http://www.statehouse.gov.sc/news/5090/president-ramkalawan-and-first-lady-receives-second-dose-sinopharm-vaccine|access-date=5 February 2021|website=statehouse.gov.sc}}</ref>
# United Arab Emirates<ref name="nyt-uae-wee-dec-12-2020">{{#invoke:cite news||last1=Wee |first1=Sui-Lee |title=Chinese Covid-19 Vaccine Gets Key Push, but Doubts Swirl |url=https://www.nytimes.com/2020/12/09/business/china-coronavirus-vaccine-united-arab-emirates.html |access-date=12 December 2020 |work=[[The New York Times]] |date=9 December 2020| name-list-style=vanc}}</ref><ref>{{#invoke:Cite web||title=Coronavirus: UAE authorises emergency use of vaccine for frontline workers|url=https://www.thenationalnews.com/uae/health/coronavirus-uae-authorises-emergency-use-of-vaccine-for-frontline-workers-1.1077680|access-date=24 November 2020|website=The National|date=14 September 2020}}</ref>
{{-}}
;Emergency (<section begin="Sinopharm BIBP_EN" />106<section end="Sinopharm BIBP_EN" />)
<div style="margin-top: 0.3em; column-width: 15em;">
# Afghanistan<ref>{{#invoke:Cite web||title=China 'to provide 400,000 COVID vaccine doses' to Afghanistan|url=https://www.aljazeera.com/news/2021/3/1/china-to-provide-400000-covid-vaccine-doses-to-afghanistan|access-date=22 March 2021|publisher=Al Jazeera}}</ref>
# Algeria<ref>{{#invoke:Cite web||last=Presse|first=AFP-Agence France|title=Algeria Receives 200,000 Coronavirus Jabs From China|url=https://www.barrons.com/news/algeria-receives-200-000-coronavirus-jabs-from-china-01614270916|access-date=22 March 2021|website=Barrons}}</ref>
# Angola<ref>{{#invoke:Cite web||date=25 March 2021|title=Angola recebeu doação chinesa de 200 mil doses de vacinas Sinopharm|url=https://www.noticiasaominuto.com/mundo/1718180/angola-recebeu-doacao-chinesa-de-200-mil-doses-de-vacinas-sinopharm|access-date=14 April 2021|website=Notícias ao Minuto|language=pt}}</ref>
# Argentina<ref>{{#invoke:cite news||last1=Biannchi|first1=Walter|date=21 February 2021|title=Argentina approves Sinopharm COVID-19 vaccine for emergency use|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-argentina-vaccine-idUSKBN2AL0P9|access-date=23 February 2021}}</ref>
# Armenia<ref name="whotracker"/>
# Bangladesh<ref>{{#invoke:cite news||date=29 April 2021|title=Bangladesh approves emergency use of China's Sinopharm vaccine amid supply squeeze|publisher=[[bdnews24.com]]|url=https://bdnews24.com/bangladesh/2021/04/29/bangladesh-approves-emergency-use-of-chinas-sinopharm-vaccine-amid-supply-squeeze|access-date=29 April 2021}}</ref>
# Belarus<ref>{{#invoke:Cite web||date=15 March 2021|title=Belarus begins COVID-19 vaccinations with Chinese shots|url=https://eng.belta.by/society/view/belarus-begins-covid-19-vaccinations-with-chinese-shots-138222-2021/|access-date=16 March 2021|publisher=Belta}}</ref>
# Bhutan<ref>{{#invoke:Cite web||title=Bhutan receives 500,000 doses of COVID-19 vaccines through COVAX|url=https://www.unicef.org/rosa/press-releases/bhutan-receives-500000-doses-covid-19-vaccines-through-covax|access-date=15 July 2021|website=www.unicef.org}}</ref>
# Bolivia<ref>{{#invoke:Cite web||title=Bolivia begins inoculation with Sinopharm jabs |url=https://www.thestar.com.my/aseanplus/aseanplus-news/2021/02/26/bolivia-begins-inoculation-with-sinopharm-jabs|access-date=28 February 2021|website=The Star|location=Malaysia}}</ref>
# Bosnia and Herzegovina<ref>{{cite web|url=https://www.sarajevotimes.com/finalized-contract-for-the-procurement-of-half-a-million-doses-of-sinopharm-vaccine/|title=Finalized Contract for the Procurement of half a Million Doses of Sinopharm Vaccine|date=2 July 2021}}</ref>
# Brazil<ref name="Agência Brasil">{{#invoke:cite news||title=Covid-19: aumenta para sete o número de vacinas autorizadas no Brasil |url=https://agenciabrasil.ebc.com.br/radioagencia-nacional/saude/audio/2021-05/aumenta-para-sete-o-numero-de-vacinas-autorizadas-no-brasil |work=Agência Brasil |date=7 May 2021 |language=pt-br}}</ref>
# Brunei<ref>{{#invoke:Cite web||title=Vaccine donation from China arrives |url=https://www.thestar.com.my/aseanplus/aseanplus-news/2021/02/12/vaccine-donation-from-china-arrives|access-date=22 March 2021|website=The Star|location=Malaysia}}</ref>
# Burkina Faso<ref name="whotracker"/>
# Burundi<ref name="whotracker"/>
# Cambodia<ref>{{#invoke:Cite web||last1=Rinith|first1=Taing|date=4 February 2021|title=Health Ministry grants Emergency Use Authorization to China's Sinopharm vaccine|url=https://www.khmertimeskh.com/50810677/health-ministry-grants-emergency-use-authorization-to-chinas-sinopharm-vaccine/|access-date=4 February 2021|work=Khmer Times|name-list-style=vanc}}</ref>
# Cameroon<ref name="cdctracker"/>
# Cape Verde<ref name="whotracker"/>
# Chad<ref>{{#invoke:Cite web||last=AfricaNews|date=6 June 2021|title=Chadians line up for Sinopharm as COVID-19 vaccination campaign begins|url=https://www.africanews.com/2021/06/06/chadians-line-up-for-sinopharm-as-covid-19-vaccination-campaign-begins/|access-date=6 June 2021|website=Africanews}}</ref>
# Comoros<ref name="cdctracker"/>
# Congo-Brazzaville<ref name="cdctracker"/>
# Cuba<ref>{{cite web|date=28 August 2021|title=Cuba aplicará vacuna china Sinopharm junto a inoculaciones de desarrollo local|url=https://es.euronews.com/2021/08/28/salud-coronavirus-cuba-china|access-date=29 August 2021|website=euronews|language=es}}</ref>
# Djibouti<ref name="cdctracker"/>
# Dominican Republic<ref>{{#invoke:cite web||title=Ministro de Salud recibe su primera dosis de la vacuna Sinovac; asegura que el biológico es confiable |url=https://www.msp.gob.do/web/?p=11563 |website=Ministerio de Salud Pública |language=es |date=3 May 2021}}</ref>
# Egypt<ref>{{#invoke:Cite web||title=Egypt licenses China's Sinopharm COVID-19 vaccine for emergency use: health minister – Xinhua |url=http://xinhuanet.com/english/2021-01/03/c_139637781.htm|publisher=Xinhuanet}}</ref>
# El Salvador<ref name="whotracker"/>
# Equatorial Guinea<ref>{{#invoke:Cite web||title=StackPath|url=https://dailynewsegypt.com/2021/02/17/equatorial-guinea-president-receives-1st-dose-of-chinese-covid-19-vaccine/|access-date=22 March 2021|website=dailynewsegypt}}</ref>
# Ethiopia<ref>{{#invoke:Cite news||date=29 March 2021|title=Ethiopia to get 300,000 doses of Sinopharm COVID-19 shot, health minister says|publisher=Reuters|url=https://www.reuters.com/article/uk-healthcare-coronavirus-ethiopia-idUSKBN2BL1TE|access-date=14 April 2021}}</ref>
# Gabon<ref>{{#invoke:Cite web||date=12 March 2021|title=Gabon receives 100,000 doses of Sinopharm's vaccine from China|url=https://gabon24.ga/en/news/gabon-receives-100000-doses-of-sinopharms-vaccine-from-china/5155/|access-date=15 March 2021|publisher=Gabon 24}}</ref>
# Gambia<ref name="whotracker"/>
# Georgia<ref>{{#invoke:Cite web||date=4 May 2021|title=Georgia Starts COVID-19 Vaccination with Sinopharm|url=https://civil.ge/archives/417469|access-date=9 May 2021|website=Civil.ge}}</ref>
# Guinea-Bissau<ref name="cdctracker"/>
# Guinea<ref name="whotracker"/>
# Hungary<ref>{{#invoke:Cite web||title=Hungary signs deal for Chinese Sinopharm's COVID-19 vaccine, first in EU|url=https://nationalpost.com/pmn/health-pmn/hungary-signs-deal-for-chinese-sinopharms-covid-19-vaccine-first-in-eu|website=National Post}}</ref><ref name="WashPost Hungary" />
# Indonesia<ref>{{#invoke:Cite web||title=Indonesia approves Sinopharm COVID-19 vaccine for emergency use|url=https://english.kontan.co.id/news/indonesia-approves-sinopharm-covid-19-vaccine-for-emergency-use|website=Kontan|date=30 April 2021|access-date=30 April 2021}}</ref>
# Iran<ref>{{#invoke:Cite web||date=22 February 2021|title=Iran Launches Phase Two of Mass Inoculation Campaign|url=https://financialtribune.com/articles/national/107614/iran-launches-phase-two-of-mass-inoculation-campaign|access-date=23 February 2021|website=Financial Tribune}}</ref>
# Iraq<ref name="bignewsnetwork.com" />
# Ivory Coast<ref name="whotracker"/>
# Jordan<ref>{{#invoke:Cite web||title=First batch of Chinese Sinopharm vaccine arrives in Jordan|url=https://en.royanews.tv/news/24716/2021-01-10|access-date=9 January 2021|publisher=Roya News}}</ref>
# Kazakhstan<ref>{{#invoke:Cite web||last=Satubaldina|first=Assel|date=30 April 2021|title=Three Vaccines to Become Available to Kazakh Citizens|url=https://astanatimes.com/2021/04/three-vaccines-to-become-available-to-kazakh-citizens/|access-date=1 May 2021|website=The Astana Times}}</ref>
# Kenya<ref name=":10" />
# Kiribati<ref name="whotracker"/>
# Kyrgyzstan<ref>{{#invoke:Cite web||last=Kharizov|first=Ruslan|date=19 March 2021|title=150,000 doses of Sinopharm coronavirus vaccine delivered to Kyrgyzstan|url=https://24.kg/english/187138_150000_doses_of_Sinopharm_coronavirus_vaccine_delivered_to_Kyrgyzstan/|access-date=22 March 2021|website=24.kg}}</ref>
# Laos<ref name="auto1" />
# Lebanon<ref>{{#invoke:Cite web||last1=Crean|first1=Rosabel|title=China donates 50,000 doses of Sinopharm vaccine to Lebanon|url=http://www.dailystar.com.lb/News/Lebanon-News/2021/Mar-01/517953-china-donates-50000-doses-of-sinopharm-vaccine-to-lebanon.ashx|access-date=2 March 2021|work=[[The Daily Star (Bangladesh)|The Daily Star]]}}</ref>
# Lesotho<ref name="whotracker"/>
# Libya<ref>{{#invoke:Cite web||date=2 August 2021|title=Libya gets 2 million Sinopharm doses with more expected|url=https://www.africanews.com/2021/08/02/libya-gets-2-million-sinopharm-doses-with-more-expected/|access-date=5 August 2021|website=[[Africanews]]}}</ref>
# Madagascar<ref name="whotracker"/>
# Malawi<ref name=":11">{{Cite news|last1=Zimmer|first1=Carl|last2=Corum|first2=Jonathan|last3=Wee|first3=Sui-Lee|date=10 June 2020|title=Coronavirus Vaccine Tracker|work=The New York Times|url=https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html|access-date=29 August 2021|issn=0362-4331}}</ref>
# Malaysia<ref>{{#invoke:Cite news||last=Latiff|first=Rozanna|date=16 July 2021|title=Malaysia approves China's Sinopharm vaccine for emergency use|work=Reuters|url=https://www.reuters.com/article/health-coronavirus-malaysia-vaccine-idUSL4N2OS18D|access-date=16 July 2021}}</ref>
# Maldives<ref>{{#invoke:Cite web||last1=Rasheed|first1=Aishath Hanaan Hussain|title=MFDA approves Pfizer, Sinopharm Covid-19 vaccines for emergency use|url=https://raajje.mv/96801|access-date=16 March 2021|publisher=raajje.mv}}</ref>
# Mauritania<ref>{{#invoke:Cite web||title=Mauritania begins COVID-19 vaccination campaign|url=https://www.aa.com.tr/en/africa/mauritania-begins-covid-19-vaccination-campaign/2189322|access-date=29 March 2021|website=aa.com.tr}}</ref>
# Mauritius<ref name="cdctracker"/>
# Mexico<ref>{{cite web |title= Comité de Moléculas Nuevas emite opiniones favorables por unanimidad sobre remdesivir y vacuna Sinopharm \|url=https://www.gob.mx/cofepris/es/articulos/comite-de-moleculas-nuevas-emite-opiniones-favorables-por-unanimidad-sobre-remdesivir-y-vacuna-sinopharm |website=www.gob.mx/cofepris |language=es}}</ref><ref>{{cite web |title= Cofepris emite autorización para uso de emergencia a vacuna Sinopharm |url=https://www.gob.mx/cofepris/es/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-a-vacuna-sinopharm |website=www.gob.mx/cofepris |language=es}}</ref>
# Moldova<ref>{{#invoke:Cite web||last=Cristina|date=19 March 2021|title=O mie de studenți și medici-rezidenți din cadrul USMF vor fi imunizați anti-COVID cu vaccinul BBIBP-CorV, produs de către Sinopharm Beijing Institute of Biological Products|url=https://www.zdg.md/stiri/stiri-sociale/o-mie-de-studenti-si-medici-rezidenti-din-cadrul-usmf-vor-fi-imunizati-anti-covid-cu-vaccinul-bbibp-corv-produs-de-catre-sinopharm-beijing-institute-of-biological-products/|access-date=19 March 2021|website=Ziarul de Gardă|language=ro-RO}}</ref>
# Mongolia<ref>{{#invoke:Cite web||title=Deputy PM and City Governor get the first dose of Sinopharm vaccine|url=https://www.montsame.mn/en/read/256205|access-date=15 March 2021|publisher=Montsame}}</ref>
# Montenegro<ref>{{#invoke:Cite web||title=Montenegro receives 30,000 doses of China's COVID-19 vaccine|url=http://seenews.com/news/montenegro-receives-30000-doses-of-chinas-covid-19-vaccine-733151|access-date=22 March 2021|website=seenews}}</ref>
# Morocco<ref>{{#invoke:Cite web||title=Covid-19: Morocco authorizes use of the Sinopharm vaccine|url=https://en.yabiladi.com/articles/details/104807/covid-19-morocco-authorizes-sinopharm-vaccine.html|website=yabiladi}}</ref>
# Mozambique<ref>{{#invoke:cite news||date=6 March 2021|title=Mozambique expects to vaccinate 16 million against coronavirus by 2022|url=https://www.reuters.com/article/health-coronavirus-mozambique/mozambique-expects-to-vaccinate-16-million-against-coronavirus-by-2022-idUSL5N2L35GH|access-date=7 March 2021|publisher=Reuters}}</ref>
# Myanmar<ref>{{#invoke:Cite web||title=Myanmar to use China-donated Sinopharm Covid vaccine|url=https://elevenmyanmar.com/news/myanmar-to-use-china-donated-sinopharm-covid-vaccine|access-date=20 June 2021|website=Eleven Media Group Co., Ltd}}</ref>
# Namibia<ref>{{#invoke:Cite web||last=Namibian|first=The|title=Khomas, Erongo first to get vaccinated|url=https://www.namibian.com.na/index.php?page=read&id=99946|access-date=17 March 2021|website=The Namibian}}</ref>
# Nepal<ref>{{#invoke:Cite web||last1=Poudel|first1=Arjun|title=China's Shinopharm vaccine gets emergency use authorisation in Nepal|url=https://kathmandupost.com/health/2021/02/17/china-s-shinopharm-vaccine-gets-emergency-use-authorisation-in-nepal|access-date=19 February 2021|work=Kathmandu Post}}</ref>
# Nicaragua<ref>{{cite web|url=https://www.bbc.com/news/world-asia-59633388 |title=Nicaragua receives China vaccines after cutting ties with Taiwan |date= |publisher=[[BBC News]] |access-date=2022-03-04}}</ref>
# Niger<ref>{{#invoke:Cite web||title=China donates 400,000 doses of Sinopharm COVID-19 vaccine to Niger|url=https://www.channelnewsasia.com/news/world/china-donates-400-000-doses-of-sinopharm-covid-19-vaccine-to-14461352|access-date=1 April 2021|website=CNA}}</ref>
# Nigeria<ref>{{cite web|date=24 August 2021|title=Nigeria approves Sinopharm COVID vaccine, expects 7.7 mln doses|url=https://www.reuters.com/world/africa/nigeria-approves-sinopharm-covid-vaccine-expects-77-mln-doses-2021-08-24/|access-date=28 August 2021|website=Reuters}}</ref>
# North Korea<ref>{{#invoke:Cite news||last1=Son|first1=Hyemin|last2=Ji|first2=Jeongeun |last3=Lee|first3=Myungchul|title=North Korea Has Been Importing Chinese COVID-19 Vaccines Since Early May |url=https://www.rfa.org/english/news/korea/vax-06152021112903.html |work=[[Radio Free Asia]] |date=15 June 2021}}</ref>
# North Macedonia<ref>{{#invoke:Cite web||last=|first=|title=North Macedonia looks to Chinese vaccine to revive program|url=https://abcnews.go.com/Health/wireStory/north-macedonia-chinese-vaccine-revive-program-77418628|access-date=1 May 2021|website=ABC News}}</ref>
# Pakistan<ref>{{#invoke:Cite news||last1=Shahzad|first1=Asif|date=19 January 2021|title=Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use|url=https://www.reuters.com/article/health-coronavirus-pakistan-sinopharm/pakistan-approves-chinese-sinopharm-covid-19-vaccine-for-emergency-use-idUSKBN29O049|publisher=Reuters|name-list-style=vanc}}</ref>
# Palestine<ref>{{#invoke:Cite web||last=|first=|title=What we know about China's Sinopharm COVID vaccine|url=https://www.thefinancialexpress.com.bd/national/what-we-know-about-chinas-sinopharm-covid-vaccine-1619625832|access-date=1 May 2021|website=The Financial Express}}</ref>
# Papua New Guinea<ref>{{#invoke:Cite web||date=7 May 2021|title=Chinese vaccine to be gazetted|url=https://postcourier.com.pg/chinese-vaccine-to-be-gazetted/|access-date=21 May 2021|website=Post Courier}}</ref>
# Paraguay<ref name="whotracker"/>
# Peru<ref>{{#invoke:Cite news||date=27 January 2021|title=Peru grants 'exceptional' approval for Sinopharm COVID-19 vaccine – government sources|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-peru/peru-grants-exceptional-approval-for-sinopharm-covid-19-vaccine-government-sources-idUSKBN29W2TL}}</ref>
# Philippines<ref>{{#invoke:Cite news||author1=Aguilar, Krissy|title=PH approves Sinopharm COVID-19 vaccine for emergency use|url=https://newsinfo.inquirer.net/1442960/ph-approves-sinopharm-covid-19-vaccine-for-emergency-use|publisher=Philippine Daily Inquirer|date=7 June 2021}}</ref>
# Rwanda<ref>{{cite web|date=12 August 2021|title=Rwanda to acquire Sinopharm vaccines next week|url=https://www.newtimes.co.rw/news/rwanda-acquire-sinopharm-vaccines-next-week|access-date=28 August 2021|website=The New Times {{!}} Rwanda}}</ref>
# Senegal<ref>{{#invoke:Cite web||last1=Asala|first1=Kizzi|title=Senegal Kicks Off COVID-19 Vaccination Campaign with China's Sinopharm|url=https://www.africanews.com/2021/02/18/senegal-kicks-off-covid-19-vaccination-campaign-with-china-s-sinopharm/|access-date=23 February 2021|publisher=Africanews}}</ref>
# Serbia<ref>{{#invoke:Cite web||title=Serbia Becomes First European Nation To Use China's Sinopharm Vaccine|url=https://www.rferl.org/a/serbia-covid-vaccine-china-sinopharm/31053091.html|website=RadioFreeEurope/RadioLiberty}}</ref>
# Sierra Leone<ref>{{#invoke:Cite web||last1=Thomas|first1=Abdul Rashid|date=15 March 2021|title=Sierra Leone's President Bio leads the way in taking COVID-19 Vaccine|url=https://www.thesierraleonetelegraph.com/sierra-leones-president-bio-leads-the-way-in-taking-covid-19-vaccine/|access-date=16 March 2021|work=Sierra Leone Telegraph}}</ref>
# Singapore<ref>{{#invoke:Cite web||title=11 Singapore private healthcare providers allowed to bring in Sinopharm COVID-19 vaccine|url=https://www.channelnewsasia.com/news/singapore/sinopharm-covid-19-hsa-special-access-route-vaccine-sinovac-15337454|access-date=30 July 2021|website=CNA}}</ref>
# Solomon Islands<ref>{{#invoke:Cite web||title=Health Ministry Prepares for Sinopharm Roll Out - Solomon Times Online|url=https://www.solomontimes.com/news/health-ministry-prepares-for-sinopharm-roll-out/10856|access-date=21 May 2021|website=SolomonTimes}}</ref>
# Somalia<ref>{{#invoke:Cite web||last=|date=15 April 2021|title=Somalia rolls out Sinopharm vaccines to boost fight against COVID-19|url=https://newsghana.com.gh/somalia-rolls-out-sinopharm-vaccines-to-boost-fight-against-covid-19/|access-date=18 April 2021|website=News Ghana}}</ref>
# South Sudan<ref>{{cite web|date=27 August 2021|title=South Sudan to receive 100,000 doses of Sinopharm vaccines from China|url=https://jubaecho.com/2021/08/27/south-sudan-to-receive-100000-doses-of-sinopharm-vaccines-from-china/|access-date=29 August 2021|website=Juba echo|archive-date=29 August 2021|archive-url=https://web.archive.org/web/20210829043217/https://jubaecho.com/2021/08/27/south-sudan-to-receive-100000-doses-of-sinopharm-vaccines-from-china/|url-status=dead|accessdate=6 October 2021|archivedate=29 August 2021|archiveurl=https://web.archive.org/web/20210829043217/https://jubaecho.com/2021/08/27/south-sudan-to-receive-100000-doses-of-sinopharm-vaccines-from-china/}}</ref>
# Sri Lanka<ref>{{#invoke:Cite web||date=19 March 2021|title=NMRA approves sinopharm vaccine for emergency use|url=https://colombogazette.com/2021/03/19/nmra-approves-sinopharm-vaccine-for-emergency-use/|access-date=29 March 2021|website=Colombo Gazette}}</ref>
# Sudan<ref>{{#invoke:Cite web||title=China To Provide Sudan With 250,000 Doses Of Sinopharm Vaccine On Friday – Ambassador|url=https://www.urdupoint.com/en/world/china-to-provide-sudan-with-250000-doses-of-1203394.html|access-date=14 April 2021|website=UrduPoint}}</ref><ref>{{#invoke:Cite web||title=StackPath|url=https://dailynewsegypt.com/2021/03/28/china-donated-sinopharm-covid-19-vaccines-arrive-in-sudan/|access-date=14 April 2021|website=dailynewsegypt}}</ref>
# Syria<ref name="whotracker"/>
# Tanzania<ref name="whotracker"/>
# Thailand<ref>{{#invoke:cite news|| title = FDA approves use of Sinopharm vaccine | date = 28 May 2021 | url = https://www.bangkokpost.com/thailand/general/2123307/fda-approves-use-of-sinopharm-vaccine | work = [[Bangkok Post]]}}</ref>
# Tunisia<ref>{{#invoke:Cite web||title=China's Sinopharm COVID-19 vaccine approved for marketing in Tunisia - Xinhua | English.news.cn|url=http://www.xinhuanet.com/english/africa/2021-07/13/c_1310057298.htm|access-date=21 July 2021|website=xinhuanet}}</ref>
# Turkmenistan<ref>{{#invoke:Cite web||title=В Туркменистане от COVID бесплатно прививают китайской вакциной, российский "Спутник" можно купить|url=https://rus.azathabar.com/a/31190974.html|access-date=9 May 2021|website=Радио Азатлык|language=ru}}</ref>
# Vanuatu<ref>{{#invoke:Cite web||title=PM to receive Sinopharm jab today|url=https://dailypost.vu/news/pm-to-receive-sinopharm-jab-today/article_353ada2c-cd65-11eb-96db-9308a7cd2ac1.html|access-date=15 June 2021|website=Vanuatu Daily Post}}</ref>
# Venezuela<ref>{{#invoke:cite news||last1=Sequera|first1=Vivian|date=1 March 2021|title=Venezuela approves use of China's Sinopharm coronavirus vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-venezuela-vaccine-idUSKCN2AT3T2|access-date=2 March 2021}}</ref>
# Vietnam<ref>{{#invoke:Cite web||date=4 June 2021|title=Vietnam approves China's Sinopharm vaccine for use against COVID-19|url=https://www.reuters.com/business/healthcare-pharmaceuticals/vietnam-approves-chinas-sinopharm-vaccine-use-against-covid-19-media-2021-06-04/|access-date=4 June 2021|website=Reuters}}</ref>
# Zambia<ref>{{#invoke:Cite web||last=Sachiti|first=Roselyne|title=Zambia to get Sinopharm COVID-19 vaccines|url=https://www.herald.co.zw/zambia-to-get-sinopharm-covid-19-vaccines/|access-date=21 May 2021|website=The Herald}}</ref>
# Zimbabwe<ref>{{#invoke:Cite web||last1=Mutsaka|first1=Farai|date=18 February 2021|title=Zimbabwe starts administering China's Sinopharm vaccines|url=https://www.thestar.com/news/world/africa/2021/02/18/zimbabwe-starts-administering-chinas-sinopharm-vaccines.html|access-date=20 February 2021|work=Toronto Star}}</ref>
'''{{nowrap|[[Caribbean Public Health Agency|CARPHA]] countries}}'''<ref>https://www.carpha.org/Portals/0/Documents/COVID-19%20Vaccine%20Updates/CARPHA%20COVID-19%20Vaccine%20Update%20045%20November%2022%202021.pdf {{Bare URL PDF|date=March 2022}}</ref>
# Antigua and Barbuda
# Bahamas
# Barbados
# Belize
# Dominica
# Grenada
# Guyana
# Haiti
# Jamaica
# Saint Kitts and Nevis
# Saint Lucia
# Saint Vincent and the Grenadines
# Suriname
# Trinidad and Tobago
<br />'''[[List of ISO 3166-1 codes|Non-country entities]]'''<!-- not counted -->
* Anguilla{{efn|name=carphance}}
* Aruba{{efn|name=carphance}}
* British Virgin Islands{{efn|name=carphance}}
* Bermuda{{efn|name=carphance}}
* Caribbean Netherlands{{efn|name=carphance}}
* Cayman Islands{{efn|name=carphance}}
* Curaçao{{efn|name=carphance}}
* Macau<ref>{{#invoke:Cite web||date=7 February 2021|title=Macau receives first batch of COVID-19 vaccines|url=https://www.asgam.com/index.php/2021/02/08/macau-receives-first-batch-of-covid-19-vaccines/|access-date=24 February 2021|website=IAG}}</ref>
* Montserrat{{efn|name=carphance}}
* Sint Maarten{{efn|name=carphance}}
* Turks and Caicos Islands{{efn|name=carphance}}
* ''[[World Health Organization]]''<ref>{{cite press release | title=WHO lists additional COVID-19 vaccine for emergency use and issues interim policy recommendations | publisher=[[World Health Organization]] (WHO) | date=7 May 2021 | url=https://www.who.int/news/item/07-05-2021-who-lists-additional-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations | access-date=7 May 2021}}</ref><ref name=WHOEUA>{{cite news | last=Taylor | first=Adam | title=WHO grants emergency use authorization for Chinese-made Sinopharm coronavirus vaccine | newspaper=[[The Washington Post]] | date=7 May 2021 | url=https://www.washingtonpost.com/world/2021/05/07/who-sinopharm-emergency-use/ | access-date=7 May 2021}}</ref>
</div>
;Travel-only
{{div col|colwidth=18em}}
* Andorra<ref name="auto24">{{cite web|url=https://visitandorra.com/en/covid-19-in-andorra/faq-if-you-re-spending-a-few-days-in-andorra/|title=FAQ|website=Andorra Tourism|accessdate=2021-12-25|archivedate=2021-12-27|archiveurl=https://web.archive.org/web/20211227065841/https://visitandorra.com/en/covid-19-in-andorra/faq-if-you-re-spending-a-few-days-in-andorra/}}</ref>
* Australia<ref name="AU recognized">{{cite web | title=International COVID-19 vaccines recognised by Australia | website=Therapeutic Goods Administration (TGA) | url=https://www.tga.gov.au/international-covid-19-vaccines-recognised-australia | access-date=26 November 2021 | accessdate=25 December 2021 | archivedate=7 February 2022 | archiveurl=https://web.archive.org/web/20220207080016/https://www.tga.gov.au/international-covid-19-vaccines-recognised-australia }}</ref><ref name="tga-covaxin-bibp">{{cite press release |date=1 November 2021 |title=TGA recognises two more COVID-19 vaccines not registered in Australia but used widely internationally |url=https://www.tga.gov.au/media-release/tga-recognises-two-more-covid-19-vaccines-not-registered-australia-used-widely-internationally |publisher=Therapeutic Goods Administration |access-date=11 November 2021}}</ref>
* Austria<ref name="auto10">{{cite web|url=https://www.austria.info/en/service-and-facts/coronavirus-information/entry-regulations|title=Coronavirus: Entry Regulations to Austria|website=www.austria.info}}</ref> (only for entry)
* Bulgaria<ref>https://www.mh.government.bg/media/filer_public/2021/08/30/order_01-733_en_final.pdf {{Webarchive|url=https://web.archive.org/web/20211123001345/https://www.mh.government.bg/media/filer_public/2021/08/30/order_01-733_en_final.pdf |date=2021-11-23 }} {{Bare URL PDF|date=March 2022}}</ref>
* Canada<ref name="auto31">{{cite web|url=https://travel.gc.ca/travel-covid/travel-restrictions/covid-vaccinated-travellers-entering-canada|title=COVID-19 vaccinated travellers entering Canada - Travel restrictions in Canada|first=Global Affairs|last=Canada|date=8 April 2021|website=travel.gc.ca}}</ref>
* Chile<ref>{{cite web|url=https://www.chile.travel/en/traveltochileplan/|title=Travel to Chile Plan|first=Mi|last=Bajón}}</ref>
* Costa Rica<ref name="auto41">{{cite web|url=https://www.visitcostarica.com/es/costa-rica/planning-your-trip/entry-requirements|title=Requisitos de entrada|date=8 June 2016|website=Visit Costa Rica|accessdate=25 December 2021|archivedate=25 December 2021|archiveurl=https://web.archive.org/web/20211225175407/https://www.visitcostarica.com/es/costa-rica/planning-your-trip/entry-requirements}}</ref>
* Croatia<ref name="auto19">{{cite web|url=https://mup.gov.hr/uzg-covid/english/286212|title=English|website=mup.gov.hr}}</ref>
* Cyprus<ref name="auto15">{{cite web |url=https://cyprusflightpass.gov.cy/en/vaccinated-passengers |title=Vaccinated Passengers |publisher=Cyprus Flight Pass |date= |access-date=2022-03-04 |accessdate=2021-12-25 |archivedate=2022-03-06 |archiveurl=https://web.archive.org/web/20220306213314/https://cyprusflightpass.gov.cy/en/vaccinated-passengers }}</ref>
* Czech Republic<ref>{{cite web|author=Čeština |url=https://koronavirus.mzcr.cz/en/recognition-of-vaccination-certificates-from-other-countries/ |title=Recognition of vaccination certificates from other countries – Aktuální informace o COVID-19 |publisher=Koronavirus.mzcr.cz |date=2021-04-21 |access-date=2022-03-04}}</ref> (only for Hungarian citizens and EU nationals vaccinated in Hungary)
* Estonia<ref name="auto26">{{cite web|url=https://kkk.kriis.ee/en/faq/covid-19-vaccination/vaccines#q10069311|title=Questions and answers on coronavirus, related decisions and changes: Vaccines|website=kkk.kriis.ee|accessdate=2021-12-25|archivedate=2021-12-25|archiveurl=https://web.archive.org/web/20211225084747/https://kkk.kriis.ee/en/faq/covid-19-vaccination/vaccines#q10069311}}</ref> (only if approved in a person's country of origin)
* Finland<ref name="auto37">{{cite web|title=Vaccine series accepted in Finland - Infectious diseases and vaccinations - THL|url=https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/travel-and-the-coronavirus-pandemic/which-vaccines-are-accepted-at-the-points-of-entry-into-the-country-|access-date=16 November 2021|website=Finnish Institute for Health and Welfare (THL), Finland|accessdate=25 December 2021|archivedate=16 November 2021|archiveurl=https://web.archive.org/web/20211116182910/https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/travel-and-the-coronavirus-pandemic/which-vaccines-are-accepted-at-the-points-of-entry-into-the-country-}}</ref>
* Greece<ref name="auto27">{{cite web|url=https://news.gtp.gr/2021/08/11/greece-accepting-most-covid-19-vaccines-for-travel/|title=Greece Accepting Most Covid-19 Vaccines for Travel|date=11 August 2021|website=GTP Headlines|accessdate=25 December 2021|archivedate=8 December 2021|archiveurl=https://web.archive.org/web/20211208101400/https://news.gtp.gr/2021/08/11/greece-accepting-most-covid-19-vaccines-for-travel/}}</ref>
* Grenada<ref name="auto8">{{cite web |url=https://covid19.gov.gd/vaccinated-travellers/ |title=Vaccinated Travellers – Ministry Of Health – Government of Grenada |publisher=Covid19.gov.gd |date=2020-11-06 |access-date=2022-03-04 |accessdate=2021-12-25 |archivedate=2022-03-18 |archiveurl=https://web.archive.org/web/20220318190925/https://covid19.gov.gd/vaccinated-travellers/ }}</ref>
* Hong Kong<ref name="HK"/>
* Iceland<ref name="auto18">{{cite web|url=https://www.landlaeknir.is/um-embaettid/greinar/grein/item44162/certificate-of-vaccination-against-covid-19-accepted-at-the-border|title=Certificates of vaccination accepted at the border in Iceland for exemption of border measures due to COVID-19|website=www.landlaeknir.is|accessdate=2021-12-25|archivedate=2021-11-05|archiveurl=https://web.archive.org/web/20211105184914/https://www.landlaeknir.is/um-embaettid/greinar/grein/item44162/certificate-of-vaccination-against-covid-19-accepted-at-the-border}}</ref>
* Ireland<ref name="auto11">{{cite web|url=https://www.gov.ie/en/publication/77952-government-advice-on-international-travel/|title=Government advice on international travel|website=www.gov.ie|accessdate=2021-12-25|archivedate=2021-11-16|archiveurl=https://web.archive.org/web/20211116193913/https://www.gov.ie/en/publication/77952-government-advice-on-international-travel/}}</ref>
* Latvia<ref>{{cite web |url=https://www.spkc.gov.lv/lv/valstu-saslimstibas-raditaji-ar-covid-19-0 |title=Valstu saraksti |language=lv |publisher=SPKC |date= |access-date=2022-03-04}}</ref>
* Liechtenstein<ref name="auto28">{{cite web|url=https://tourismus.li/en/our-country/about-liechtenstein/current-information-on-covid-19-in-the-principality-of-liechtenstein/|title=Current information on COVID-19 in the Principality of Liechtenstein|website=tourismus.li|accessdate=2021-12-25|archivedate=2021-12-27|archiveurl=https://web.archive.org/web/20211227065825/https://tourismus.li/en/our-country/about-liechtenstein/current-information-on-covid-19-in-the-principality-of-liechtenstein/}}</ref>
* New Zealand<ref name="auto9">{{cite web|url=https://covid19.govt.nz/international-travel/travel-to-new-zealand/vaccination-requirements-for-travel-to-new-zealand/|title=Vaccination requirements for travel to New Zealand|website=Unite against COVID-19|accessdate=2022-07-06|archivedate=2022-07-04|archiveurl=https://web.archive.org/web/20220704215455/https://covid19.govt.nz/international-travel/travel-to-new-zealand/vaccination-requirements-for-travel-to-new-zealand/}}</ref>
* Oman<ref name="auto36">https://presspage-production-content.s3.amazonaws.com/uploads/2571/travelguideen-ar3.pdf?10000 {{Webarchive|url=https://web.archive.org/web/20211019030610/https://presspage-production-content.s3.amazonaws.com/uploads/2571/travelguideen-ar3.pdf?10000 |date=2021-10-19 }} {{Bare URL inline|date=March 2022}}</ref>
* Panama<ref name="auto35">{{cite web|url=https://es.tourismpanama.com/planea-tus-vacaciones/avisos/|title=Protocolos COVID-19|website=tourismpanama}}</ref>
* Portugal<ref name="visitmadeira1">{{cite web|url=https://www.visitmadeira.pt/en-gb/useful-info/corona-virus-(covid-19)/information-to-visitors-(covid-19)|title=Information COVID 19|accessdate=2021-12-25|archivedate=2021-12-27|archiveurl=https://web.archive.org/web/20211227070024/https://www.visitmadeira.pt/en-gb/useful-info/corona-virus-(covid-19)/information-to-visitors-(covid-19)}}</ref> (only in Madeira)
* Qatar<ref>{{#invoke:Cite news||author1=Arslan|title=Qatar gives conditional approval for Sinopharm Vaccine|url=https://covid19.moph.gov.qa/EN/travel-and-return-policy/Pages/default.asp|publisher=qaziarslantariq|date=1 August 2021}}</ref>
* Saudi Arabia (for short visits, [[Hajj]] and [[Umrah]] only)<ref>{{cite web |url=https://covid19.cdc.gov.sa/update-vaccinated-individuals-for-the-purpose-of-coming-to-the-kingdom-december-2021/# |title=Update vaccinated individuals (for the purpose of coming to the kingdom) December 2021 - Public Health Authority |publisher=Covid19.cdc.gov.sa |date= |access-date=2022-03-04 |archiveurl=https://web.archive.org/web/20220314194251/https://covid19.cdc.gov.sa/update-vaccinated-individuals-for-the-purpose-of-coming-to-the-kingdom-december-2021/ |archivedate=2022-03-14 |accessdate=2021-12-25 }}</ref>
* Slovakia<ref name="auto29">{{cite web|url=https://www.mic.iom.sk/en/news/637-covid-19-measures.html|title=COVID-19: official measures and important information (updated continually) - IOM Migration information center|website=www.mic.iom.sk|accessdate=2021-12-25|archivedate=2021-12-25|archiveurl=https://web.archive.org/web/20211225104008/https://www.mic.iom.sk/en/news/637-covid-19-measures.html}}</ref>
* Slovenia<ref name="auto30">{{cite web|url=https://www.gov.si/en/topics/coronavirus-disease-covid-19/border-crossing/|title=Border Crossing | GOV.SI|website=Portal GOV.SI}}</ref>
* South Korea<ref name="auto42">https://www.koreanair.com/kr/en/travel-update/covid19/travel-restriction/korea {{Webarchive|url=https://web.archive.org/web/20210730154938/https://www.koreanair.com/kr/en/travel-update/covid19/travel-restriction/korea |date=2021-07-30 }} {{Bare URL inline|date=March 2022}}</ref>
* Spain<ref name="auto40">{{cite web|title=Certificado Covid Digital De La Ue Y Otros Certificados|url=https://www.mscbs.gob.es/profesionales/saludPublica/sanidadExterior/CHS/Pdf/FAQs_CERTIFICADO_DIGITAL_COVID-19-UE_y_OTROS_CERTIFICADOS_ES_071021_v6.pdf|accessdate=2021-12-25|archivedate=2021-11-30|archiveurl=https://web.archive.org/web/20211130032702/https://www.mscbs.gob.es/profesionales/saludPublica/sanidadExterior/CHS/Pdf/FAQs_CERTIFICADO_DIGITAL_COVID-19-UE_y_OTROS_CERTIFICADOS_ES_071021_v6.pdf}}</ref>
* St. Kitts and Nevis<ref name="auto33">{{cite web|url=https://covid19.gov.kn/travel-protocols/|title=Travel Protocols – GOVERNMENT OF ST. KITTS AND NEVIS|archiveurl=https://web.archive.org/web/20211118225103/https://covid19.gov.kn/travel-protocols/|archivedate=2021-11-18|accessdate=2021-12-25}}</ref>
* St. Lucia<ref name="auto17">{{cite web|url=https://www.stlucia.org/en/covid-19/faqs/|title=NEW-FAQs|website=Saint Lucia Tourism Authority|accessdate=2021-12-25|archivedate=2022-12-08|archiveurl=https://web.archive.org/web/20221208103421/https://www.stlucia.org/en/covid-19/faqs/}}</ref>
* St. Vincent and the Grenadines<ref name="auto21">http://health.gov.vc/health/images/PDF/SVG_Health_Services_Subcommittee_Protocol_for_Fully_Vaccinated_Travelers_to_SVG_10112021.pdf {{Bare URL PDF|date=March 2022}}</ref>
* Sweden<ref name="auto38">{{cite web|title=Certificate requirements for foreign nationals travelling to Sweden - The Public Health Agency of Sweden|url=https://www.folkhalsomyndigheten.se/the-public-health-agency-of-sweden/communicable-disease-control/covid-19/if-you-are-planning-to-travel/negative-covid-19-test-required-for-entry-into-sweden/|access-date=16 November 2021|website=www.folkhalsomyndigheten.se|accessdate=25 December 2021|archivedate=16 November 2021|archiveurl=https://web.archive.org/web/20211116182910/https://www.folkhalsomyndigheten.se/the-public-health-agency-of-sweden/communicable-disease-control/covid-19/if-you-are-planning-to-travel/negative-covid-19-test-required-for-entry-into-sweden/}}</ref>
* Switzerland<ref name="auto39">{{cite web|url=https://www.bag.admin.ch/bag/en/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/empfehlungen-fuer-reisende/quarantaene-einreisende.html|title=Coronavirus: Entering Switzerland|first=Federal Office of Public Health|last=FOPH|website=www.bag.admin.ch|accessdate=2021-12-25|archivedate=2020-07-24|archiveurl=https://web.archive.org/web/20200724080307/https://www.bag.admin.ch/bag/en/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/empfehlungen-fuer-reisende/quarantaene-einreisende.html}}</ref>
* The Netherlands<ref name="auto25">{{cite web|url=https://www.government.nl/topics/coronavirus-covid-19/visiting-the-netherlands-from-abroad/requirements-for-proof-of-vaccination|title=Travelling to the Netherlands with proof of vaccination - Coronavirus COVID-19 - Government.nl|first=Ministerie van Algemene|last=Zaken|date=12 November 2021|website=www.government.nl}}</ref>
* Turkey<ref name="auto12">{{cite web|url=https://www.visasturkey.com/vaccinations-for-turkey/|title=Vaccinations for Turkey: Do I need an Approved COVID Vaccine?|date=10 April 2019|accessdate=25 December 2021|archivedate=16 November 2021|archiveurl=https://web.archive.org/web/20211116191928/https://www.visasturkey.com/vaccinations-for-turkey/}}</ref>
* Ukraine<ref name="auto22">{{cite web|url=https://visitukraine.today/|title=Visit Ukraine - Information and Rules|website=Visit Ukraine}}</ref>
* United Kingdom<ref name="auto34">{{cite web|url=https://www.gov.uk/government/news/travel-updatenew-guidance-for-people-vaccinated-under-who-emergency-use-listing-and-under-18s|title=Travel update: new guidance for people vaccinated under WHO Emergency Use Listing and under 18s|website=GOV.UK}}</ref>
* United States<ref name="auto16">{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/travelers/proof-of-vaccination.html|title=COVID-19 and Your Health|date=11 February 2020|website=U.S. [[Centers for Disease Control and Prevention]] (CDC)}}</ref>
* Uruguay<ref name="auto14">{{cite web|url=https://www.gub.uy/ministerio-salud-publica/comunicacion/publicaciones/requisitos-para-ingreso-uruguay-personas-nacionales-extranjeras|title=Requisitos para el ingreso a Uruguay de personas nacionales o extranjeras|website=Ministerio de Salud Pública}}</ref> (only if approved in a person's country of origin)
{{div col end}}
{{-}}
== Sputnik V ==
<section begin="sputnikauthmap" />
{{infobox
| image = {{Graph:Map|scale=65|defaultValue=gainsboro
|AE=dodgerblue|AG=dodgerblue|AM=dodgerblue|AO=dodgerblue|AR=dodgerblue|AU=turquoise|AZ=dodgerblue
|BA=dodgerblue|BD=dodgerblue|BH=dodgerblue|BO=dodgerblue|BR=dodgerblue|BY=dodgerblue
|CG=dodgerblue|CI=dodgerblue|CL=dodgerblue|CM=dodgerblue|CY=turquoise
|DJ=dodgerblue|DZ=dodgerblue
|EE=turquoise|EC=dodgerblue|EG=dodgerblue
|GA=dodgerblue|GH=dodgerblue|GM=dodgerblue|GN=dodgerblue|GR=turquoise|GT=dodgerblue|GY=dodgerblue
|HK=turquoise|HN=dodgerblue|HU=dodgerblue
|ID=dodgerblue|IL=turquoise|IN=dodgerblue|IQ=dodgerblue|IR=dodgerblue
|JO=dodgerblue
|KE=dodgerblue|KG=dodgerblue|KH=dodgerblue|KZ=dodgerblue
|LA=dodgerblue|LB=dodgerblue|LK=dodgerblue|LY=dodgerblue
|MA=dodgerblue|MD=dodgerblue|ME=dodgerblue|MK=dodgerblue|ML=dodgerblue|MM=dodgerblue|MN=dodgerblue|MU=dodgerblue|MV=dodgerblue|MX=dodgerblue|MY=turquoise
|NA=dodgerblue|NG=dodgerblue|NI=dodgerblue|NP=dodgerblue
|OM=dodgerblue|NZ=turquoise
|PA=dodgerblue|PE=dodgerblue|PH=dodgerblue|PK=dodgerblue|PS=dodgerblue|PY=dodgerblue
|RS=dodgerblue|RU=blueviolet|RW=dodgerblue
|SA=turquoise|SC=dodgerblue|SI=turquoise|SK=darkorange|SM=dodgerblue|SY=dodgerblue
|TH=turquoise|TJ=dodgerblue|TM=blueviolet|TN=dodgerblue|TR=dodgerblue
|UZ=blueviolet
|VC=dodgerblue|VE=dodgerblue|VN=dodgerblue
|ZA=red|ZW=dodgerblue
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|darkorange|Authorization expired}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|red|Rejected}}
}}
<section end="sputnikauthmap" />
The [[Sputnik V COVID-19 vaccine]] is a [[viral vector vaccine]]<ref name="NCT04436471">{{cite journal|date=17 June 2020|title=An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04436471|access-date=5 March 2021|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04436471}}</ref> produced by the Russian [[Gamaleya Research Institute of Epidemiology and Microbiology]].
;Full (<section begin="Sputnik V_FN" />3<section end="Sputnik V_FN" />)
# Russia<ref name="burki">{{cite journal|vauthors=Burki TK|date=November 2020|title=The Russian vaccine for COVID-19|journal=The Lancet. Respiratory Medicine|volume=8|issue=11|pages=e85–e86|doi=10.1016/S2213-2600(20)30402-1|pmc=7837053|pmid=32896274|doi-access=free|title-link=doi}}</ref><ref>{{Cite news|date=4 February 2022|title=Sputnik V vaccine granted full permanent approval in Russia|work=[[PR Newswire]]|url=https://www.prnewswire.com/in/news-releases/sputnik-v-vaccine-granted-full-permanent-approval-in-russia-879907727.html|access-date=8 February 2022}}</ref>
# Turkmenistan<ref>{{cite news|date=18 January 2021|title=Turkmenistan is the first in Central Asia to have registered 'Sputnik V' vaccine|work=Orient|url=https://orient.tm/en/turkmenistan-is-the-first-in-central-asia-to-have-registered-sputnik-v-vaccine/|accessdate=7 July 2021|archivedate=27 January 2021|archiveurl=https://web.archive.org/web/20210127203020/https://orient.tm/en/turkmenistan-is-the-first-in-central-asia-to-have-registered-sputnik-v-vaccine/}}</ref><ref>{{cite news|date=22 January 2021|title=Session of the Cabinet of Ministers of Turkmenistan |work=Turkmenistan today |url=https://tdh.gov.tm/en/post/25815/objectives-of-increasing-national-health-system%E2%80%99s-potential-discussed}}</ref>
# Uzbekistan<ref>{{cite news|date=17 February 2021|title=Uzbekistan Certifies Russia's Sputnik Vaccine For Mass Use|publisher=Agence France-Presse (Barron's)|url=https://www.barrons.com/news/uzbekistan-certifies-russia-s-sputnik-vaccine-for-mass-use-01613559912}}</ref>
{{-}}
;Emergency (<section begin="Sputnik V_EN" />76<section end="Sputnik V_EN" />)
<div style="margin-top: 0.3em; column-width: 15em;">
# Albania<ref name=":0" />
# Algeria<ref>{{cite news|date=10 January 2021|title=Covid19: National Pharmaceuticals Agency registers Sputnik V vaccine|work=Algeria Press service|url=https://www.aps.dz/en/health-science-technology/37478-covid19-national-pharmaceuticals-agency-registers-sputnik-v-vaccine}}</ref>
# Angola<ref name="Reuters idUSR4N2K301A" />
# Antigua and Barbuda<ref>{{cite press release|title=Antigua and Barbuda authorizes Sputnik V|url=https://sputnikvaccine.com/newsroom/pressreleases/antigua-and-barbuda-authorizes-sputnik-v/|website=sputnikvaccine.com|date=26 March 2021}}</ref>
# Argentina<ref>{{cite press release|title=Argentina has registered the Sputnik V vaccine based on Russian clinical trial data|url=https://sputnikvaccine.com/newsroom/pressreleases/argentina-has-registered-the-sputnik-v-vaccine-based-on-russian-clinical-trial-data-/|access-date=1 January 2021|publisher=Gamaleya Center}}</ref>
# Armenia<ref>{{cite news|date=1 February 2021|title=Armenia approves Russia's Sputnik V coronavirus vaccine -Russia's RDIF|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-russia-vaccine-armeni/armenia-approves-russias-sputnik-v-coronavirus-vaccine-russias-rdif-idUSR4N2J304T|access-date=1 February 2021}}</ref>
# Azerbaijan<ref>{{cite news|date=12 March 2021|title=Azerbaijan approves Russia's Sputnik V vaccine for use against COVID-19 -Azeri health ministry|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-russia-azerbaijan/azerbaijan-approves-russias-sputnik-v-vaccine-for-use-against-covid-19-azeri-health-ministry-idUSR4N2IW02L}}</ref><ref>{{#invoke:Cite web||title=Russian Direct Investment Fund|url=https://rdif.ru/Eng_fullNews/6524/|access-date=1 April 2021|website=rdif.ru}}</ref>
# Bahrain<ref>{{cite news|date=10 February 2021|title=Bahrain authorises Sputnik V COVID-19 vaccine for emergency use – Bahrain TV|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-bahrain-vaccine-int-idUSKBN2AA1GW|access-date=19 February 2021}}</ref>
# Bangladesh<ref>{{cite news|date=27 April 2021|title=Bangladesh approves Russia's Sputnik V Covid-19 vaccine for emergency use|publisher=[[Dhaka Tribune]]|url=https://www.dhakatribune.com/bangladesh/2021/04/27/bangladesh-approves-russia-s-sputnik-v-vaccine-for-emergency-use|access-date=27 April 2021}}</ref>
# Belarus<ref>{{cite news|date=21 December 2020|title=Belarus registers Sputnik V vaccine, in first outside Russia – RDIF|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-belarus/belarus-registers-sputnik-v-vaccine-in-first-outside-russia-rdif-idINKBN28V0ZG|access-date=22 December 2020}}</ref>
# Bolivia<ref>{{cite news|title=Ministerio de Salud de Bolivia – Bolivia y Rusia firman contrato para adquirir 5,2 millones de dosis de la vacuna Sputnik-V contra la COVID-19|work=minsalud.gob.bo|url=https://www.minsalud.gob.bo/5114-bolivia-y-rusia-firman-contrato-para-adquirir-5-2-millones-de-dosis-de-la-vacuna-sputnik-v-contra-el-covid-19|access-date=1 January 2021}}</ref>
# Bosnia and Herzegovina<ref name="Tass 20210205">{{#invoke:Cite web||date=5 February 2021|title=Sputnik V vaccine registered in Bosnia and Herzegovina's Republika Srpska|url=https://tass.com/world/1253307|access-date=8 February 2021|agency=TASS}}</ref>
# Brazil<ref name="g1.globo.com">{{cite news |title=Anvisa aprova, com restrições, a importação excepcional de doses da Covaxin e Sputnik V |trans-title=Anvisa approves import of doses of Covaxin and Sputnik V, with restrictions |url=https://g1.globo.com/bemestar/vacina/noticia/2021/06/04/anvisa-covaxin-sputnik-v.ghtml |access-date=4 June 2021 |work=G1 |agency=Globo |date=4 June 2021 |language=Portuguese}}</ref> ''(restricted)''
# Cambodia<ref name="auto20">{{cite web|title=Russian Direct Investment Fund|url=https://rdif.ru/Eng_fullNews/7138/|access-date=5 November 2021|website=rdif.ru|archive-date=5 November 2021|archive-url=https://web.archive.org/web/20211105013012/https://rdif.ru/Eng_fullNews/7138/|url-status=dead}}</ref>
# Cameroon<ref>{{cite news|date=19 March 2021|title=Cameroon approves Russia's Sputnik V coronavirus vaccine for use – RDIF|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-vaccine-russia-camero-idUSR4N2HG02H}}</ref>
# Chile<ref>{{#invoke:Cite web||title=Instituto de Salud Pública de Chile|url=https://www.ispch.cl/noticia/isp-aprueba-uso-de-emergencia-e-importacion-de-la-vacuna-sputnik-v/|access-date=21 July 2021}}</ref>
# Congo-Brazzaville<ref name="Reuters idUSR4N2K301A" />
# Djibouti<ref name="Reuters idUSR4N2K301A">{{cite news |title=Angola, Congo Republic and Djibouti approve Russia's Sputnik V vaccine |url=https://www.reuters.com/article/health-coronavirus-russia-vaccine-angola-idUSR4N2K301A |publisher=Reuters |date=3 March 2021 }}</ref>
# Ecuador<ref>{{cite news|title=Arcsa autoriza el ingreso al Ecuador de vacuna Sputnik V|work=www.controlsanitario.gob.ec|url=https://www.controlsanitario.gob.ec/arcsa-autoriza-el-ingreso-al-ecuador-de-vacuna-sputnik-v/|date=14 May 2021|access-date=15 May 2021}}</ref>
# Egypt<ref name="Gulf News">{{cite news|title=COVID-19: Egypt authorises Sputnik V, AstraZeneca virus jabs|work=Gulf News|url=https://gulfnews.com/world/mena/covid-19-egypt-authorises-sputnik-v-astrazeneca-virus-jabs-1.1614189861208|access-date=24 February 2021}}</ref>
# Gabon<ref>{{cite press release|title=Sputnik V authorised in Gabon|url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-v-authorized-in-gabon/|access-date=17 February 2021|publisher=Gamaleya Center}}</ref>
# Gambia<ref>{{cite web|title=Farmacovigilancia de vacunas para COVID-19 - Gamaleya Sputnik V; Sputnik Light|url=https://covid-19pharmacovigilance.paho.org/|access-date=9 October 2021|website=Farmacovigilancia de vacunas para COVID-19|accessdate=6 October 2021|archivedate=6 October 2021|archiveurl=https://web.archive.org/web/20211006044523/https://covid-19pharmacovigilance.paho.org/}}</ref>
# Ghana<ref>{{cite news|date=20 February 2021|title=Ghana approves Russia's Sputnik V vaccine for emergency use – RDIF|agency=[[Reuters]]|url=https://news.trust.org/item/20210220072758-kzlw8/|accessdate=7 July 2021|archivedate=19 March 2021|archiveurl=https://web.archive.org/web/20210319084048/https://news.trust.org/item/20210220072758-kzlw8/}}</ref>
# Guatemala<ref>{{#invoke:Cite web||title=Guatemala authorizes Sputnik V|url=https://www.pharmiweb.com/press-release/2021-02-26/guatemala-authorizes-sputnik-v|access-date=1 April 2021|website=PharmiWeb}}</ref>
# Guinea<ref>{{cite news|date=31 December 2020|title=Guinea Begins Administering Russia's Sputnik V Covid-19 Vaccine|work=Africa news|url=https://www.africanews.com/2020/12/31/guinea-begins-administering-russia-s-sputnik-v-covid-19-vaccine/}}</ref>
# Guyana<ref>{{cite news|date=3 March 2021|title=Russia's Sputnik V vaccine expands its reach in Latin America|publisher=CNN|url=https://edition.cnn.com/2021/03/03/americas/sputnik-latin-america-spreads-intl-latam/index.html}}</ref>
# Honduras<ref>{{cite news|date=25 February 2021|title=Honduras approves use of Sputnik V vaccine against COVID-19|publisher=Xinhuanet|url=http://www.xinhuanet.com/english/2021-02/25/c_139764745.htm|accessdate=7 July 2021|archivedate=10 March 2021|archiveurl=https://web.archive.org/web/20210310013921/http://www.xinhuanet.com/english/2021-02/25/c_139764745.htm}}</ref>
# Hungary<ref>{{cite news |title=Hungarian drug regulator approves Sputnik V vaccine: website |url=https://www.themoscowtimes.com/2021/02/07/hungary-approves-russias-sputnik-v-vaccine-a72853 |work=The Moscow Times |date=7 February 2021 }}</ref><ref name="Tass 20210205" /><ref name="WashPost Hungary">{{cite news | last=Spike | first=Justin | title=Hungary approves 2 more vaccines from outside EU amid spike |agency=Associated Press |website=ABC News | date=22 March 2021 | url=https://abcnews.go.com/Health/wireStory/hungary-approves-vaccines-eu-amid-spike-76604743 | access-date=14 July 2021 |name-list-style=vanc}}</ref>
# India<ref>{{cite news |title=India approves Russia's 'Sputnik V' COVID-19 vaccine: Economic Times |url=https://www.reuters.com/article/health-coronavirus-india-vaccine/india-approves-russias-sputnik-v-covid-19-vaccine-economic-times-idUSKBN2BZ11Y |publisher=Reuters |date=12 April 2021 }}</ref>
# Indonesia<ref>{{cite web|last=|first=|date=25 August 2021|title=BPOM Terbitkan Izin Darurat Vaksin Rusia Sputnik-V|url=https://www.cnnindonesia.com/nasional/20210825111626-20-685041/bpom-terbitkan-izin-darurat-vaksin-rusia-sputnik-v|access-date=25 August 2021|website=CNN Indonesia|language=id-ID}}</ref>
# Iran<ref>{{cite news|date=26 January 2021|title=Iran approves Russian coronavirus vaccine Sputnik V|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-russia-iran/iran-approves-russian-coronavirus-vaccine-sputnik-v-for-use-idUSKBN29V1A8}}</ref>
# Iraq<ref>{{cite press release|title=Sputnik V authorized in Iraq|url=https://www.pharmiweb.com/press-release/2021-03-05/sputnik-v-authorized-in-iraq|publisher=PharmiWeb.com|date=4 March 2021}}</ref>
# Ivory Coast<ref name="whotracker" />
# Jordan<ref>{{cite press release|title=Jordan approves Russia's Sputnik V vaccine for use against COVID-19|url=https://www.reuters.com/article/health-coronavirus-russia-jordan-vaccine/jordan-approves-russias-sputnik-v-vaccine-for-use-against-covid-19-idUSL1N2L8241|publisher=Reuters|date=10 March 2021}}</ref>
# Kazakhstan<ref>{{#invoke:Cite web||date=1 February 2021|title=Kazakhstan begins mass vaccination by Russian Sputnik V|url=https://www.neweurope.eu/article/kazakhstan-has-began-mass-vaccination-by-russian-sputnik-v/|access-date=19 February 2021}}</ref>
# Kenya<ref>{{cite news|date=10 March 2021|title=Morocco, Kenya approve Russian coronavirus vaccine for use – RDIF|url=https://www.reuters.com/article/uk-health-coronavirus-vaccine-russia-ken-idUSKBN2B2130|access-date=12 March 2021}}</ref>
# Kyrgyzstan<ref>{{cite press release|title=Sputnik V registered in Kyrgyzstan|url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-v-registered-in-kyrgyzstan/|website=Gamaleya Center|date=23 February 2021}}</ref>
# Laos<ref name="auto1">{{#invoke:Cite web||title=Laos declares Covid-19 vaccinations safe, more to be inoculated next week |url=https://www.thestar.com.my/aseanplus/aseanplus-news/2021/01/06/laos-declares-covid-19-vaccinations-safe-more-to-be-inoculated-next-week|access-date=19 February 2021|website=The Star|location=Malaysia}}</ref>
# Lebanon<ref>{{cite news|date=5 February 2021|title=Lebanon authorises emergency use of Russia's Sputnik V vaccine|agency=[[Reuters]]|url=https://news.trust.org/item/20210205151526-w0bv2/|accessdate=7 July 2021|archivedate=19 March 2021|archiveurl=https://web.archive.org/web/20210319084134/https://news.trust.org/item/20210205151526-w0bv2/}}</ref>
# Libya<ref name="auto4" /><ref name="auto5" />
# Maldives<ref>{{cite news|title=Maldives approves Russia's Sputnik V COVID-19 vaccine|url=https://www.reuters.com/article/health-coronavirus-vaccine-russia-maldiv/maldives-approves-russias-sputnik-v-covid-19-vaccine-idUSR4N2MN00D|website=reuters.com|date=13 May 2021|access-date=13 May 2021}}</ref>
# Mali<ref>{{cite news|date=30 March 2021|title=Mali approves Russia's Sputnik V vaccine – Russian sovereign wealth fund|publisher=Reuters|url=https://www.reuters.com/article/uk-health-coronavirus-russia-mali-vaccin/mali-approves-russias-sputnik-v-vaccine-russian-sovereign-wealth-fund-idUSKBN2BM0Y5}}</ref>
# Mauritius<ref>{{cite news|date=22 March 2021|title=Mauritius approves Russia's Sputnik V coronavirus vaccine – Russian RDIF fund|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-vaccine-russia-maurit/mauritius-approves-russias-sputnik-v-coronavirus-vaccine-russian-rdif-fund-idUSR4N2KP01G}}</ref>
# Mexico<ref>{{cite news|date=3 February 2021|title=Mexico, Germany warm to Russia's Sputnik V virus vaccine|work=The Jakarta Post|url=https://www.thejakartapost.com/news/2021/02/03/mexico-germany-warm-to-russias-sputnik-v-virus-vaccine-.html}}</ref>
# Moldova<ref name=":2" />
# Mongolia<ref>{{cite news|date=9 February 2021|title=Mongolia Approves Russia's Sputnik V Coronavirus Vaccine – RDIF|publisher=Urdu Point|url=https://www.urdupoint.com/en/world/mongolia-approves-russias-sputnik-v-coronavi-1163730.html}}</ref>
# Montenegro<ref>{{cite news|date=12 February 2021|title=Montenegro and St. Vincent approve Russia's Sputnik V vaccine – RDIF|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-russia-vaccine-mon/montenegro-and-st-vincent-approve-russias-sputnik-v-vaccine-rdif-idUSKBN2AC0QZ}}</ref>
# Morocco<ref>{{cite news|date=11 March 2021|title=Morocco orders one million doses of Russia's Sputnik V vaccine|publisher=Yabiladi|url=https://en.yabiladi.com/articles/details/107075/morocco-orders-million-doses-russia-s.html}}</ref>
# Myanmar<ref>{{#invoke:Cite web||title=Myanmar registers Russia's Sputnik V COVID-19 vaccine|url=https://tass.com/world/1253415|access-date=19 February 2021|publisher=Tass}}</ref>
# Namibia<ref>{{#invoke:Cite web||title=Russian Direct Investment Fund|url=https://rdif.ru/Eng_fullNews/6520/|access-date=1 April 2021|website=rdif.ru}}</ref>
# Nepal<ref>{{Cite news|author=Reuters Staff|date=20 April 2021|title=Nepal approves Russia's Sputnik V COVID-19 vaccine|work=[[Reuters]]|url=https://www.reuters.com/article/health-coronavirus-nepal-idINL4N2MD3KU|access-date=23 April 2021}}</ref>
# Nicaragua<ref>{{cite news|date=3 February 2021|title=Nicaragua approves Russian COVID-19 vaccine|work=Associated Press|url=https://apnews.com/article/nicaragua-europe-russia-health-coronavirus-pandemic-82f9744bcf62d1689683c56455ecf15a |access-date=2 June 2021}}</ref>
# Nigeria<ref>{{cite news |title=Sputnik V vaccine approved in Nigeria |url=https://rdif.ru/fullNews/6937/ |access-date=18 July 2021 |work=Russian Direct Investment Fund |date=15 July 2021 |archive-date=18 July 2021 |archive-url=https://web.archive.org/web/20210718122835/https://rdif.ru/fullNews/6937/ |url-status=dead }}</ref>
# North Macedonia<ref>{{#invoke:Cite web||date=7 March 2021|title=NRussia's Sputnik V COVID 19 vaccine registered in North Macedonia|url=https://tass.com/coronavirus-outbreak-in-china/1263509|publisher=[[TASS]]}}</ref>
# Oman<ref name="oman-coronavac-sputnik"/>
# Pakistan<ref>{{cite news|date=24 January 2021|title=Govt okays Russian vaccine for 'emergency use'|work=Dawn|url=https://www.dawn.com/news/1603273}}</ref>
# Palestine<ref>{{cite news|date=11 January 2021|title=Palestine has become the first country in the Middle East to register Sputnik V vaccine|work=RFID|url=https://rdif.ru/Eng_fullNews/6279/|archiveurl=https://web.archive.org/web/20210205141702/https://rdif.ru/Eng_fullNews/6279/|archivedate=5 February 2021|accessdate=22 March 2021}}</ref>
# Panama<ref>{{cite news |title=Panama approves use of Russian vaccine |url=https://www.newsroompanama.com/news/panama-approves-use-of-russian-vaccine |access-date=2 April 2021 |work=Newsroom Panama |date=1 April 2021}}</ref>
# Paraguay<ref>{{cite news|date=15 January 2021|title=Paraguay approves Russia's Sputnik V vaccine: RDIF|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-russia-vaccine-paragu/paraguay-approves-russias-sputnik-v-vaccine-rdif-idUSR4N2J303Y|access-date=15 January 2021}}</ref>
# Peru<ref>{{#invoke:Cite web||date=20 July 2021|title=Perú anuncia acuerdo para compra de 20 millones de dosis de la vacuna Sputnik V|url=https://elperuano.pe/noticia/125005-gobierno-firma-contrato-para-compra-de-20-millones-de-dosis-de-la-vacuna-sputnik-v|access-date=5 August 2021|website=[[El Peruano]]}}</ref>
# Philippines<ref>{{cite web |url=https://cnnphilippines.com/news/2021/3/19/Russia-Gamaleya-emergency-use-PH.html |title=Russia's Sputnik V approved for emergency use in PH |date=19 March 2021 |website=[[CNN Philippines]] |access-date=19 March 2021 |accessdate=7 July 2021 |archivedate=19 March 2021 |archiveurl=https://web.archive.org/web/20210319023615/https://cnnphilippines.com/news/2021/3/19/Russia-Gamaleya-emergency-use-PH.html }}</ref>
# Rwanda<ref name="whotracker"/>
# Saint Vincent and the Grenadines<ref name="auto2">{{#invoke:Cite web||date=11 February 2021|title=Public Health (Emergency Authorisation of COVID-19 Vaccine) Rules, 2021|url=https://www.gov.vc/images/pdf_documents/SRO-Public_Health_Emergency_Authorisation_of_Covid-19_Vaccine.pdf|access-date=12 February 2021|website=Government of Saint Vincent and the Grenadines}}</ref>
# San Marino<ref>{{cite news|date=20 February 2021|title=San Marino buys the Sputnik vaccine: "First doses already in the next few days"|work=Unioneonline|url=https://www.unionesarda.it/en/articolo/news/mondo/2021/02/19/san-marino-acquista-il-vaccino-sputnik-prime-dosi-gia-nei-prossim-137-1117575.html|accessdate=7 July 2021|archivedate=19 March 2021|archiveurl=https://web.archive.org/web/20210319083816/https://www.unionesarda.it/en/articolo/news/mondo/2021/02/19/san-marino-acquista-il-vaccino-sputnik-prime-dosi-gia-nei-prossim-137-1117575.html}}</ref><ref>{{cite news|date=12 April 2021|title=San Marino reopens thanks to Sputnik covid vaccine from Russia |work=Wanted in Rome|url=https://www.wantedinrome.com/news/san-marino-reopens-thanks-to-sputnik-covid-vaccine-from-russia.html}}</ref>
# Serbia<ref>{{cite news|date=31 December 2020|title=Agencija odobrila uvoz ruske vakcine Sputnjik V u Srbiju|language=sr-RS|work=N1|url=https://rs.n1info.com/vesti/agencija-odobrila-uvoz-ruske-vakcine-sputnjik-v-u-srbiju/}}</ref>
# Seychelles<ref>{{cite news|date=19 March 2021|title=Sputnik V vaccine approved in Seychelles|agency=[[TASS]]|url=https://tass.com/world/1268131}}</ref>
# Sri Lanka<ref>{{cite news|date=4 March 2021|title=Sri Lanka approves Russia's Sputnik V vaccine|work=The Hindu|url=https://www.thehindu.com/news/international/sri-lanka-approves-russias-sputnik-v-vaccine/article33987742.ece}}</ref>
# Syria<ref>{{cite news|date=22 February 2021|title=Syria authorizes use of Sputnik-V|publisher=Roya|url=https://en.royanews.tv/news/25728/2021-02-22|accessdate=2021-07-07|archivedate=2021-03-03|archiveurl=https://web.archive.org/web/20210303142243/https://en.royanews.tv/news/25728/2021-02-22}}</ref>
# Tajikistan<ref name="whotracker"/>
#Tanzania<ref>{{Cite news|last=Mohammed|first=Omar|date=2021-06-17|title=Tanzania poised to join COVAX vaccine-sharing facility - WHO|language=en|work=Reuters|url=https://www.reuters.com/world/africa/tanzania-submit-request-join-covax-vaccine-sharing-facility-2021-06-17/|access-date=2022-01-13}}</ref>
# Tunisia<ref>{{cite press release|title=Sputnik V vaccine authorized in Tunisia|url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-v-vaccine-authorized-in-tunisia/|access-date=30 January 2021|publisher=Gamaleya Center}}</ref>
# Turkey (limited use)<ref>{{Cite news|author=Merve Aydogan|date=30 April 2021|title=Turkey OKs emergency use of Sputnik-V vaccine|work=[[Anadolu Agency]]|url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkey-oks-emergency-use-of-sputnik-v-vaccine/2225824}}</ref><ref>{{Cite news|title=Erdogan unimpressed by Putin's COVID-19 antibodies, Sputnik V vaccine booster offer|url=https://english.alarabiya.net/coronavirus/2021/09/29/Erdogan-unimpressed-by-Putin-s-COVID-19-antibodies-Sputnik-V-vaccine-booster-offer|date=29 September 2021|access-date=11 January 2022|publisher=[[Al Arabiya English]]}}</ref>
# United Arab Emirates<ref>{{cite news|date=21 January 2021|title=UAE approves Russia's Sputnik vaccine for emergency use|work=Khaleej Times|url=https://www.khaleejtimes.com/coronavirus-pandemic/uae-approves-russias-sputnik-vaccine-for-emergency-use|access-date=21 January 2021}}</ref>
# Venezuela<ref>{{cite news|date=29 December 2020|title=Venezuela firma contrato para la adquisición de la vacuna rusa Sputnik V|language=es|publisher=Reuters|url=https://www.reuters.com/article/salud-coronavirus-venezuela-rusia-idLTAKBN2931X2}}</ref>
# Vietnam<ref name="vnexpress.net">{{cite news|title=Vietnam approves Russia Covid-19 vaccine for emergency use|publisher=[[VnExpress]]|url=https://vnexpress.net/news/news/vietnam-approves-russia-covid-19-vaccine-for-emergency-use-4240528.html|access-date=2 April 2021}}</ref>
# Zimbabwe<ref name="news24.com-zimbabwe-ssv">{{cite news|date=9 March 2021|title=Covid-19: Zimbabwe authorises Sputnik V, Sinovac vaccines for emergency use|publisher=news24.com|url=https://www.news24.com/news24/africa/news/covid-19-zimbabwe-authorises-sputnik-v-sinovac-vaccines-for-emergency-use-20210309}}</ref>
<br />'''[[List of ISO 3166-1 codes|Non-country entities]]'''
* Abkhazia<ref>{{#invoke:Cite web||url=https://civil.ge/archives/417592|title = Russia's COVID Vaccine Delivered to Tskhinvali Region, Abkhazia|date = 4 May 2021}}</ref>
* South Ossetia<ref>{{#invoke:Cite web||url=https://tass.com/world/1285695|title=First batch of Sputnik V vaccine delivered to South Ossetia}}</ref>
</div>
<br />
<div style="margin-top: 0.3em; column-width: 15em;">
;Expired
* Slovakia<ref>{{Cite news|date=1 March 2021|title=Povolenie na terapeutické použitie neregistrovaného lieku|url=https://www.health.gov.sk/Zdroje?/Sources/kategorizacia/doku_kl/ziad_lieky/sputnik.pdf|access-date=8 July 2021}}</ref><ref>{{cite web|date=14 April 2021|title=Zmätky s vakcínami pokračujú. Aký Sputnik máme v skladoch?|url=https://spravy.pravda.sk/domace/clanok/584380-zmatky-s-vakcinami-pokracuju-aky-sputnik-mame-v-skladoch/|access-date=8 July 2021|website=Pravda.sk|language=sk-SK}}</ref>
;Rejected
* South Africa<ref name="SAHPRA Oct 21">{{cite book |title=Update on the SAHPRA review of the Sputnik V vaccine |date=18 October 2021 |publisher=South African Health Products Regulatory Agency |url=https://www.sahpra.org.za/news-and-updates/update-on-the-sahpra-review-of-the-sputnik-v-vaccine/ |access-date=20 April 2022}}</ref><ref>{{cite web|last=AfricaNews|date=20 October 2021|title=South Africa rejects Russian-made coronavirus vaccine Sputnik V|url=https://www.africanews.com/2021/10/20/south-africa-rejects-russian-made-coronavirus-vaccine-sputnik-v/|access-date=22 October 2021|website=Africanews|accessdate=25 December 2021|archivedate=10 December 2021|archiveurl=https://web.archive.org/web/20211210175107/https://www.africanews.com/2021/10/20/south-africa-rejects-russian-made-coronavirus-vaccine-sputnik-v/}}</ref>
;Travel-only
* Australia<ref>{{cite web|title=Vaccines we recognise for the purpose of travel to Australia|url=https://www.tga.gov.au/international-covid-19-vaccines-recognised-australia|access-date=17 January 2022|website=Therapeutic Goods Administration|accessdate=25 December 2021|archivedate=7 February 2022|archiveurl=https://web.archive.org/web/20220207080016/https://www.tga.gov.au/international-covid-19-vaccines-recognised-australia}}</ref>
* Cyprus<ref>{{cite web|title=Vaccinated/Recovered Passengers|url=https://cyprusflightpass.gov.cy/en/vaccinated-passengers|accessdate=2021-12-25|archivedate=2022-03-06|archiveurl=https://web.archive.org/web/20220306213314/https://cyprusflightpass.gov.cy/en/vaccinated-passengers}}</ref>
* Estonia<ref>{{cite web|title=Questions and answers on coronavirus, related decisions and changes: Vaccines|url=https://kkk.kriis.ee/en/faq/covid-19-vaccination/vaccines#q10069311|access-date=24 November 2021|website=kkk.kriis.ee|accessdate=25 December 2021|archivedate=25 December 2021|archiveurl=https://web.archive.org/web/20211225084747/https://kkk.kriis.ee/en/faq/covid-19-vaccination/vaccines#q10069311}}</ref>
* Greece<ref>{{cite web|date=11 August 2021|title=Greece Accepting Most Covid-19 Vaccines for Travel|url=https://news.gtp.gr/2021/08/11/greece-accepting-most-covid-19-vaccines-for-travel/|access-date=20 November 2021|website=GTP Headlines|accessdate=25 December 2021|archivedate=8 December 2021|archiveurl=https://web.archive.org/web/20211208101400/https://news.gtp.gr/2021/08/11/greece-accepting-most-covid-19-vaccines-for-travel/}}</ref>
* Hong Kong<ref name="HK"/>
* Israel<ref>{{cite web|title=Entry to Israel - Non-Israeli Citizens: Air Travel|url=https://corona.health.gov.il/en/directives/air-travel-covid19-green/?tab=by-air|access-date=24 November 2021|website=Corona Traffic Light Model (Ramzor) Website}}</ref>
* Malaysia<ref name="MY">{{cite web|title=Travellers must have MySejahtera to enter Malaysia|url=https://themalaysianreserve.com/2022/03/25/travellers-must-have-mysejahtera-to-enter-malaysia/amp/|date=25 March 2022|publisher=The Malaysian Reserve|access-date=25 March 2022|website=themalaysianreserve.com}}</ref>
* New Zealand<ref name="auto9"/>
* Saudi Arabia<ref>{{cite web |title=Saudi Arabia has joined more than 100 countries accepting visitors vaccinated with Sputnik V following extensive work between Ministry of Health of Saudi Arabia and RDIF, supported by the Ministry of Investments of Saudi Arabia |url=https://sputnikvaccine.com/newsroom/pressreleases/saudi-arabia-has-joined-more-than-100-countries-accepting-visitors-vaccinated-with-sputnik-v/ |access-date=10 December 2021 |date=5 December 2021}}</ref>
* Slovenia<ref>{{cite web|title=Border Crossing {{!}} GOV.SI|url=https://www.gov.si/en/topics/coronavirus-disease-covid-19/border-crossing/|access-date=24 November 2021|website=Portal GOV.SI}}</ref>
* St. Lucia<ref>{{cite web|title=NEW-FAQs|url=https://www.stlucia.org/en/covid-19/faqs/|access-date=24 November 2021|website=Saint Lucia Tourism Authority|accessdate=25 December 2021|archivedate=8 December 2022|archiveurl=https://web.archive.org/web/20221208103421/https://www.stlucia.org/en/covid-19/faqs/}}</ref>
* Thailand<ref>{{cite web|title=THAILAND'S ENTRY REGULATIONS|url=https://thaiembassy.at/en/coe.html|access-date=20 December 2021|website=Royal Thai Embassy in Vienna}}</ref>
</div>
== CoronaVac ==
<section begin="coronavacauthmap"/>
{{infobox
| image = {{Graph:Map|scale=65|defaultValue=gainsboro
|AD=turqoise|AE=turqoise|AF=limegreen|AG=dodgerblue|AL=dodgerblue|AM=dodgerblue|AO=dodgerblue|AR=dodgerblue|AT=turquoise|AU=turquoise|AZ=limegreen
|BA=dodgerblue|BB=dodgerblue|BD=dodgerblue|BF=dodgerblue|BH=limegreen|BI=dodgerblue|BJ=limegreen|BN=dodgerblue|BO=dodgerblue|BR=dodgerblue|BS=limegreen|BT=dodgerblue|BW=dodgerblue|BZ=dodgerblue
|CA=turquoise|CD=limegreen|CF=limegreen|CG=dodgerblue|CH=turquoise|CI=dodgerblue|CL=dodgerblue|CM=dodgerblue|CN=blueviolet|CO=dodgerblue|CR=limegreen|CU=dodgerblue|CV=dodgerblue|CY=turquoise
|DJ=dodgerblue|DM=dodgerblue|DO=dodgerblue|DZ=dodgerblue
|EC=dodgerblue|EE=turquoise|EG=dodgerblue|ES=turquoise|ET=dodgerblue
|FI=turquoise|FJ=limegreen|FM=limegreen
|GA=dodgerblue|GB=turquoise|GD=limegreen|GE=dodgerblue|GH=limegreen|GM=dodgerblue|GN=dodgerblue|GQ=dodgerblue|GR=turquoise|GT=limegreen|GW=dodgerblue|GY=dodgerblue
|HN=limegreen|HR=turquoise|HT=limegreen|HU=dodgerblue
|ID=dodgerblue|IE=turquoise|IN=limegreen|IQ=dodgerblue|IR=limegreen|IS=turquoise
|JM=limegreen|JO=dodgerblue
|KE=dodgerblue|KG=dodgerblue|KH=dodgerblue|KI=dodgerblue|KM=dodgerblue|KN=limegreen|KP=limegreen|KR=turquoise|KW=dodgerblue|KZ=dodgerblue
|LA=dodgerblue|LB=dodgerblue|LC=limegreen|LI=turquoise|LK=dodgerblue|LR=limegreen|LS=dodgerblue|LY=dodgerblue
|MA=dodgerblue|MC=limegreen|MD=dodgerblue|ME=dodgerblue|MG=dodgerblue|MH=limegreen|MK=dodgerblue|ML=limegreen|MM=dodgerblue|MN=dodgerblue|MO=blueviolet|MR=dodgerblue|MU=dodgerblue|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=dodgerblue
|NA=dodgerblue|NE=dodgerblue|NG=dodgerblue|NI=limegreen|NL=turquoise|NO=turqoise|NP=dodgerblue|NR=limegreen|NZ=turquoise
|OM=dodgerblue
|PA=dodgerblue|PE=limegreen|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PS=dodgerblue|PT=turquoise|PW=turquoise|PY=dodgerblue
|QA=dodgerblue
|RS=limegreen|RW=dodgerblue
|SA=dodgerblue|SB=dodgerblue|SC=blueviolet|SD=dodgerblue|SE=turquoise|SG=dodgerblue|SI=turquoise|SK=turquoise|SL=dodgerblue|SN=dodgerblue|SO=dodgerblue|SR=dodgerblue|SS=limegreen|ST=limegreen|SV=dodgerblue|SY=dodgerblue|SZ=limegreen
|TD=dodgerblue|TG=limegreen|TH=dodgerblue|TJ=limegreen|TL=limegreen|TM=dodgerblue|TN=dodgerblue|TO=limegreen|TR=dodgerblue|TT=dodgerblue|TV=limegreen|TZ=dodgerblue
|UA=dodgerblue|UG=limegreen|US=turquoise|UY=dodgerblue|UZ=dodgerblue
|VC=limegreen|VE=dodgerblue|VU=dodgerblue
|WS=limegreen
|XK=limegreen
|YE=dodgerblue|VN=turquoise|
|ZA=dodgerblue|ZM=dodgerblue|ZW=dodgerblue
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|limegreen|Eligible [[COVAX]] recipient}}
}}
<section end="coronavacauthmap"/>
The [[CoronaVac]] COVID-19 vaccine is an [[inactivated vaccine|inactivated virus vaccine]]<ref name="NCT043835742">{{#invoke:Cite web||date=12 May 2020|title=Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection (COVID-19) (Renqiu)|url=https://clinicaltrials.gov/ct2/show/NCT04383574|url-status=live|archive-url=https://web.archive.org/web/20201011084809/https://clinicaltrials.gov/ct2/show/NCT04383574/|archive-date=11 October 2020|access-date=14 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04383574}}</ref> produced by the Chinese company [[Sinovac Biotech]].<ref name="NCT043835742"/><ref name="NCname= nct04456595=2">{{#invoke:Cite web||date=2 July 2020|title=Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)|url=https://clinicaltrials.gov/ct2/show/NCT04456595|url-status=live|archive-url=https://web.archive.org/web/20201011084811/https://clinicaltrials.gov/ct2/show/NCT04456595/|archive-date=11 October 2020|access-date=3 August 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04456595}}</ref><ref name=":12">{{cite journal|last1=PT. Bio Farma|date=10 August 2020|title=A Phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-COV-2 inactivated vaccine in healthy adults aged 18–59 years in Indonesia|url=https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX|journal=Registri Penyakit Indonesia|access-date=15 August 2020}} {{Webarchive|url=https://web.archive.org/web/20201011084814/https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX%2F |date=11 October 2020 }} {{Cite web |title=Archive copy |url=https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX%2F |accessdate=8 May 2025 |archivedate=11 October 2020 |archiveurl=https://web.archive.org/web/20201011084814/https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX%2F }}</ref>
;Full (<section begin="CoronaVac_FN"/>1<section end="CoronaVac_FN"/>)
# China<ref name="CoronaVacCN"/>
{{-}}
;Emergency (<section begin="CoronaVac_EN"/>71<section end="CoronaVac_EN"/>)
<div style="margin-top: 0.3em; column-width: 15em;">
# Albania<ref name=":0">{{#invoke:Cite web||last=Semini|first=Llazar|title=Albania starts mass COVID vaccinations before tourist season|url=https://abcnews.go.com/Business/wireStory/albania-starts-mass-covid-vaccinations-tourist-season-76733128|access-date=29 March 2021|website=ABC News}}</ref>
# Algeria<ref name="whotracker"/>
# Argentina<ref name="TrackVax"/>
# Armenia<ref>{{#invoke:Cite web||title=В Армению отправлена китайская вакцина от COVID-19|url=https://ru.armradio.am/2021/04/30/%d0%b2-%d0%b0%d1%80%d0%bc%d0%b5%d0%bd%d0%b8%d1%8e-%d0%be%d1%82%d0%bf%d1%80%d0%b0%d0%b2%d0%bb%d0%b5%d0%bd%d0%b0-%d0%ba%d0%b8%d1%82%d0%b0%d0%b9%d1%81%d0%ba%d0%b0%d1%8f-%d0%b2%d0%b0%d0%ba%d1%86%d0%b8/|access-date=9 May 2021|website=Общественное Радио Армении|language=ru-RU}}</ref>
# Azerbaijan<ref>{{#invoke:Cite web||last1=Aliyev|first1=Jeyhun|title=Azerbaijan kicks off COVID-19 vaccination|url=https://www.aa.com.tr/en/world/azerbaijan-kicks-off-covid-19-vaccination/2114591|access-date=7 February 2021|publisher=Anadolu Agency|name-list-style=vanc}}</ref>
# Bangladesh<ref>{{#invoke:Cite web||title=Bangladesh approves Sinovac Covid-19 vaccine for emergency use|date=6 June 2021|url=https://www.dhakatribune.com/bangladesh/2021/06/06/sinovac-covid-19-vaccine-approved-for-emergency-use|access-date=6 June 2021|publisher=[[Dhaka Tribune]]|name-list-style=vanc}}</ref>
# Benin<ref>{{#invoke:Cite web||last=Ayosso|first=Akpédjé|date=29 March 2021|title=Deux ministres vaccinés contre Covid-19|url=https://www.24haubenin.info/?Deux-ministres-vaccines-contre-Covid-19|access-date=7 April 2021|website=24haubenin.info|language=fr}}</ref>
# Bolivia<ref>{{#invoke:Cite web||title=Bolívia autoriza uso de vacinas Sputnik V e CoronaVac contra covid-19|url=https://noticias.uol.com.br/internacional/ultimas-noticias/2021/01/06/bolivia-autoriza-uso-de-vacinas-sputnik-v-e-coronavac-contra-covid-19.htm|access-date=6 January 2021|website=noticias.uol.com.br|language=pt-br}}</ref>
# Bosnia and Herzegovina<ref>{{#invoke:Cite web||last=Agency|first=Anadolu|date=28 March 2021|title=Turkey sends Chinese COVID-19 vaccines to Bosnia-Herzegovina|url=https://www.dailysabah.com/politics/diplomacy/turkey-sends-chinese-covid-19-vaccines-to-bosnia-herzegovina|access-date=14 April 2021|website=Daily Sabah}}</ref>
# Botswana<ref>{{#invoke:Cite web||title=Botswana Could Be First African Country to Vaccinate Entire Adult Population |url=https://www.voanews.com/covid-19-pandemic/botswana-could-be-first-african-country-vaccinate-entire-adult-population|access-date=21 May 2021|website=Voice of America}}</ref>
# Brazil<ref name="Covid-Vaccine">{{cite news|last1=McGeever|first1=Jamie|last2=Fonseca|first2=Pedro|date=17 January 2021|title=Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-brazil-idUSKBN29M0M3|access-date=17 January 2021|name-list-style=vanc}}</ref>
# Cambodia<ref>{{#invoke:Cite web||last1=Chanritheara|first1=Torn|title=Cambodia Approves AstraZeneca and Sinovac Vaccines for COVID-19 Emergency Use|url=https://cambodianess.com/article/cambodia-approves-astrazeneca-and-sinovac-vaccines-for-covid-19-emergency-use|access-date=12 February 2021|publisher=Cambodianess}}</ref>
# Chile<ref>{{#invoke:Cite web||date=20 January 2021|title=Chile aprueba el uso de emergencia de la vacuna china de Sinovac contra covid-19|url=https://www.france24.com/es/minuto-a-minuto/20210120-chile-aprueba-el-uso-de-emergencia-de-la-vacuna-china-de-sinovac-contra-covid-19|access-date=30 January 2021|publisher=France 24}}</ref>
# Colombia<ref>{{#invoke:Cite web||last1=Aliyev|first1=Jeyhun|title=Colombia approves emergency use of CoronaVac vaccine|url=https://www.aa.com.tr/en/americas/colombia-approves-emergency-use-of-coronavac-vaccine/2134570|access-date=7 February 2021|publisher=Anadolu Agency|name-list-style=vanc}}</ref>
# Djibouti<ref>{{#invoke:Cite web||title=Djibouti Ministry of Health|url=https://twitter.com/minsantedj/status/1372948366137696270|access-date=30 March 2021|website=Twitter}}</ref>
# Dominica<ref name="NYT vaccine tracker"/>
# Dominican Republic<ref>{{#invoke:Cite web||title=Anticovid vaccines run out as Dominican Republic awaits arrival of more doses|url=https://dominicantoday.com/dr/covid-19/2021/03/08/anticovid-vaccines-run-out-as-dominican-republic-awaits-arrival-of-more-doses/|access-date=10 March 2021|publisher=DominicanToday}}</ref>
# East Timor<ref>{{#invoke:Cite web||last=Martins|first=Filomeno|title=Government to launch Chinese Sinovac vaccine next week {{!}} TATOLI Agência Noticiosa de Timor-Leste|url=http://www.tatoli.tl/en/2021/06/11/government-to-launch-chinese-sinovac-vaccine-next-week/|access-date=15 June 2021}}</ref>
# Ecuador<ref>{{#invoke:Cite web||title=Ecuador signs agreement with Sinovac for 2 million COVID-19 vaccine: minister|url=https://nationalpost.com/pmn/health-pmn/ecuador-signs-agreement-with-sinovac-for-2-million-covid-19-vaccine-minister|access-date=26 February 2021|work=National Post}}</ref>
# Egypt<ref>{{#invoke:Cite web||title=Egypt approves Sinovac COVID-19 vaccine for emergency use|url=https://gulfnews.com/world/mena/egypt-approves-sinovac-covid-19-vaccine-for-emergency-use-1.1619472925063|access-date=27 April 2021|website=gulfnews}}</ref>
# El Salvador<ref>{{#invoke:Cite web||title=Llegan a El Salvador un millón de dosis de la vacuna china CoronaVac contra el covid-19 de la farmacéutica Sinovac|url=https://www.laprensagrafica.com/elsalvador/Llegan-a-El-Salvador-un-millon-de-dosis-de-la-vacuna-china-contra-el-covid-19-de-la-farmaceutica-Sinovac-20210328-0004.html|access-date=29 March 2021|website=Noticias de El Salvador – La Prensa Gráfica {{!}} Informate con la verdad|language=es-ES}}</ref>
# Equatorial Guinea<ref name="whotracker"/>
# Fiji<ref>{{#invoke:Cite web||title=China to donate Sinovac Vaccine to Fiji|url=https://www.fbcnews.com.fj/news/china-to-donate-sinovac-vaccine-to-fiji/|access-date=22 March 2021|website=Fiji Broadcasting Corporation}}</ref>
# Gabon<ref name="NYT vaccine tracker"/>
# Georgia<ref>{{#invoke:Cite web||title=Covid-19 vaccination with Sinovac to start on May 24 in Georgia|url=https://agenda.ge/en/news/2021/1336|access-date=21 May 2021|website=Agenda.ge}}</ref>
# Guinea<ref>{{#invoke:Cite web||title=Guinea receives purchase of 300,000 Sinovac COVID-19 vaccines|url=https://www.channelnewsasia.com/news/world/guinea-receives-purchase-of-300-000-sinovac-covid-19-vaccines-14649970|access-date=3 June 2021|website=CNA}}</ref>
# Guyana<ref name="NYT vaccine tracker"/>
# Hungary<ref name="whotracker"/>
# Indonesia<ref name="StraitsTimes20210111">{{cite news|last=Soeriaatmadja|first=Wahyudi|date=11 January 2021|title=Indonesia grants emergency use approval to Sinovac's vaccine, local trials show 65% efficacy|work=[[The Straits Times]]|url=https://www.straitstimes.com/asia/se-asia/indonesia-grants-emergency-use-approval-to-sinovac-vaccine-local-trials-show-65|access-date=11 January 2021|name-list-style=vanc}}</ref><ref name="Tempo">{{cite news|date=11 January 2021|title=BPOM Grants Emergency Use Authorization for Sinovac Vaccine|work=[[Tempo (Indonesian magazine)|Tempo]]|url=https://en.tempo.co/read/1422220/bpom-grants-emergency-use-authorization-for-sinovac-vaccine|access-date=11 January 2021}}</ref>
# Kazakhstan<ref>{{#invoke:Cite web||title=В Казахстан доставили первую партию китайской вакцины CoronaVac {{!}} Kazakhstan Today|url=https://www.kt.kz/rus/covid-19/v_kazahstan_dostavili_pervuyu_partiyu_kitayskoy_vaktsiny_1377916469.html|access-date=7 June 2021|website=www.kt.kz|language=ru}}</ref>
# Laos<ref name="CoronaVacCN">{{cite news|last1=Liu|first1=Roxanne|date=6 February 2021|title=China approves Sinovac Biotech COVID-19 vaccine for general public use|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-sinovac/china-approves-sinovac-biotech-covid-19-vaccine-for-general-public-use-idUSKBN2A60AY|access-date=7 February 2021|name-list-style=vanc}}</ref>
# Libya<ref>{{#invoke:Cite web||last=|date=9 May 2021|title=Libya begins administrating China's Sinovac vaccine in Tripoli|url=https://www.libyanexpress.com/libya-begins-administrating-chinas-sinovac-vaccine-in-tripoli/|access-date=21 May 2021|website=Libyan Express}}</ref>
# Malawi<ref name=":11" />
# Malaysia<ref>{{cite news|date=2 March 2021|title=Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use|publisher=Reuters|url=https://www.reuters.com/business/healthcare-pharmaceuticals/malaysia-approves-sinovac-astrazeneca-covid-19-vaccines-use-2021-03-02/ |access-date=21 November 2021}}</ref>
# Maldives<ref name="whotracker"/>
# Mexico<ref name="AD5 mexico">{{cite news|last1=Barrera|first1=Adriana|date=11 February 2021|title=Mexico approves China's CanSino and Sinovac COVID-19 vaccines|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-mexico-cansino/update-2-mexico-approves-chinas-cansino-and-sinovac-covid-19-vaccines-idUSL1N2KG0NO|access-date=11 February 2021}}</ref>
# Moldova<ref>{{Cite news|last=Tanas|first=Alexander|date=9 April 2021|title=Moldova to buy 400,000 doses of Sinovac COVID-19 vaccine|work=Reuters|url=https://www.reuters.com/article/health-coronavirus-moldova-sinovac-idUKL8N2M24JT|access-date=9 May 2021}}</ref>
# Morocco<ref name="NYT vaccine tracker"/>
# Myanmar<ref>{{#invoke:Cite web||last=Fishbein|first=Emily|title=Ethnic groups step in as Myanmar's COVID response falls apart|url=https://www.aljazeera.com/news/2021/5/10/ethnic-groups-step-in-as-myanmars-covid-response-falls-apart|access-date=23 July 2021|website=Al Jazeera}}</ref>
# Nepal<ref>{{#invoke:Cite web||title=Nepal gives emergency use approval to China's Sinovac Covid-19 vaccine|url=https://kathmandupost.com/health/2021/06/04/nepal-gives-emergency-use-approval-to-china-s-sinovac-covid-19-vaccine|access-date=7 June 2021|website=kathmandupost}}</ref>
# North Macedonia<ref>{{#invoke:Cite web||last=Testorides|first=Konstantin|date=27 June 2021|title=North Macedonia gets 500,000 doses of Sinovac vaccines|url=https://apnews.com/article/coronavirus-vaccine-coronavirus-pandemic-health-government-and-politics-business-1827f4b8b524449d72dd43e62a97ac63|access-date=28 June 2021|publisher=Associated Press}}</ref>
# Oman<ref name="oman-coronavac-sputnik">{{#invoke:Cite web||title=COVID-19: Oman approves use of Sinovac and Sputnik vaccines|url=https://gulfnews.com/world/gulf/oman/covid-19-oman-approves-use-of-sinovac-and-sputnik-vaccines-1.80173049|access-date=25 June 2021|website=gulfnews}}</ref>
# Pakistan<ref>{{#invoke:Cite web||title=DRAP allows emergency authorisation to fifth Covid-19 vaccine|url=https://www.thenews.com.pk/print/817278-drap-allows-emergency-authorisation-to-fifth-covid-19-vaccine|access-date=10 April 2021|website=The News International}}</ref>
# Palestine<ref name="whotracker"/>
# Panama<ref>{{cite news|date=9 April 2021|title=Panama approves emergency use of Chinese vaccine against COVID-19|publisher=Xinhuanet|url=http://www.xinhuanet.com/english/2021-04/10/c_139870805.htm|access-date=9 April 2021|accessdate=7 July 2021|archivedate=10 April 2021|archiveurl=https://web.archive.org/web/20210410031413/http://www.xinhuanet.com/english/2021-04/10/c_139870805.htm}}</ref>
# Paraguay<ref>{{#invoke:Cite web||title=CoronaVac, vacuna de alta eficacia|url=https://www.mspbs.gov.py/portal/22762/coronavac-vacuna-de-alta-eficacia.html|website=Ministerio de Salud Publica Y Bienestar Social (Paraguay)}}</ref>
# Philippines<ref>{{cite news|date=22 February 2021|title=Philippines approves Sinovac's COVID-19 vaccine for emergency use|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-philippines-vaccine/philippines-approves-sinovacs-covid-19-vaccine-for-emergency-use-idUSL4N2KL0UK}}</ref>
# Rwanda<ref name="whotracker"/>
# Saint Vincent and the Grenadines<ref name="NYT vaccine tracker"/>
# Saudi Arabia<ref>{{Cite news|date=24 August 2021|title=MoH: Six COVID-19 vaccines approved in Saudi Arabia|work=[[Saudi Gazette]]|url=https://saudigazette.com.sa/article/610193|access-date=25 December 2021}}</ref>
# Singapore<ref>{{cite web|author=Matthew Mohan|date=23 October 2021|title=Sinovac COVID-19 vaccine to be included in Singapore's national vaccination programme|url=https://www.channelnewsasia.com/singapore/sinovac-covid-19-vaccine-national-vaccination-programme-three-dose-singapore-2263787|access-date=23 October 2021|website=CNA}}</ref>
# Somalia<ref name="cdctracker"/>
# South Africa<ref>{{cite news|date=3 July 2021|title=SAHPRA authorises the CoronaVac vaccine with conditions|publisher=SAHPRA|url=https://www.sahpra.org.za/press-releases/sahpra-authorises-the-coronavac-vaccine-with-conditions/}}</ref>
# Sri Lanka<ref>{{#invoke:Cite web||title=Sri Lanka approves China's Sinovac COVID-19 vaccine for emergency use|url=http://www.colombopage.com/archive_21A/Jul17_1626497465CH.php|access-date=18 July 2021|website=ColomboPage}}</ref>
# Sudan<ref name="cdctracker"/>
# Syria<ref name="whotracker"/>
# Tajikistan<ref>{{#invoke:Cite web||title=Китайской вакциной в Таджикистане первоначально будут прививать людей старше 60 лет {{!}} Новости Таджикистана ASIA-Plus|url=https://asiaplustj.info/ru/news/tajikistan/society/20210621/kitaiskoi-vaktsinoi-v-tadzhikistane-pervonachalno-budut-privivat-lyudei-starshe-60-let|access-date=13 July 2021|website=asiaplustj.info}}</ref>
# Tanzania<ref>{{#invoke:Cite web||last=|first=|date=13 July 2021|title=Vaccine-Holdout Tanzania Begins Inoculations With Sinovac Doses - BNN Bloomberg|url=https://www.bnnbloomberg.ca/vaccine-holdout-tanzania-begins-inoculations-with-sinovac-doses-1.1628276|access-date=13 July 2021|website=Bloomberg}}</ref>
# Thailand<ref>{{cite news|last1=Thepgumpanat|first1=Panarat|date=22 February 2021|title=Thailand allows emergency use of Sinovac's COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-thailand/thailand-allows-emergency-use-of-sinovacs-covid-19-vaccine-idUSKBN2AM1BX|access-date=23 February 2021}}</ref>
# Togo<ref>{{#invoke:Cite web||last=|title=Le CoronaVac pour les étudiants du public|url=https://www.republicoftogo.com/Toutes-les-rubriques/Education/Le-CoronaVac-pour-les-etudiants-du-public|access-date=23 May 2021|website=République Togolaise|language=fr}}</ref>
# Trinidad and Tobago<ref name="newsday.co.tt">{{cite web|date=8 November 2021|title=Health Ministry: Covaxin vaccine approved use in Trinidad and Tobago|url=https://newsday.co.tt/2021/11/08/health-ministry-covaxin-vaccine-approved-use-in-trinidad-and-tobago/|access-date=30 November 2021|website=Trinidad and Tobago Newsday|archiveurl=https://web.archive.org/web/20211224084701/https://newsday.co.tt/2021/11/08/health-ministry-covaxin-vaccine-approved-use-in-trinidad-and-tobago/|archivedate=24 December 2021|accessdate=25 December 2021}}</ref>
# Tunisia<ref>{{#invoke:Cite web||date=5 March 2021|title=Tunisia approva vaccino cinese Sinovac|url=https://www.ansa.it/sito/notizie/mondo/dalla_cina/2021/03/05/covid-tunisia-approva-vaccino-cinese-sinovac_9ba5fbb3-4ee9-48de-9327-c37a3931f5d1.html|access-date=7 March 2021|publisher=Agenzia Nazionale Stampa Associata (in Italian)|language=it}}</ref>
# Turkey<ref>{{cite news|date=14 January 2021|title=Turkey grants emergency authorization to Sinovac's CoronaVac|url=https://www.reuters.com/article/us-health-coronavirus-turkey-vaccine-idUSKBN29I29F|access-date=9 January 2022|publisher=Reuters}}</ref>
# Turkmenistan<ref>{{#invoke:Cite web||last=turkmenportal|title=В Туркменистан поступила крупная партия китайской вакцины "CoronaVac" |url=https://turkmenportal.com/blog/36504/v-turkmenistan-postupila-krupnaya-partiya-kitaiskoi-vakciny-coronavac|access-date=7 June 2021|website=Туркменистан, интернет портал о культурной, деловой и развлекательной жизни в Туркменистане|language=ru}}</ref>
# Uganda<ref name="whotracker"/>
# Ukraine<ref>{{cite news|last1=Zinets|first1=Natalia|date=9 March 2021|title=Ukraine approves China's Sinovac COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-ukraine-vaccine-idUSKBN2B11H6|access-date=10 March 2021|publisher=Reuters}}</ref>
# Uruguay<ref name="CoronaVacCN" />
# Uzbekistan<ref>{{#invoke:Cite web||title=Uzbekistan plans to obtain Sinovac coronavirus vaccine|url=https://akipress.com/news:658218:Uzbekistan_plans_to_obtain_Sinovac_coronavirus_vaccine/|access-date=21 May 2021|website=akipress}}</ref>
# Venezuela<ref>{{#invoke:Cite web||date=30 June 2021|title=COVID-19 Information|url=https://ve.usembassy.gov/covid-19-information/|access-date=23 August 2021|website=U.S. Embassy in Venezuela}}</ref>
# Yemen<ref name="whotracker"/>
# Zimbabwe<ref name="news24.com-zimbabwe-ssv" />
<!-- not counted -->
<br />'''[[List of ISO 3166-1 codes|Non-country entities]]'''
* Hong Kong<ref>{{#invoke:Cite web||date=18 February 2021|title=Use of Sinovac vaccine authorised|url=https://www.news.gov.hk/eng/2021/02/20210218/20210218_111857_034.html|access-date=19 February 2021|publisher=Government of Hong Kong}}</ref>
* Northern Cyprus<ref name=":4" />
* ''[[World Health Organization]]''<ref>{{cite news |last=Nebehay |first=Stephanie |title=WHO approves Sinovac COVID vaccine, the second Chinese-made dose listed |url=https://www.reuters.com/article/us-health-coronavirus-who-sinovac/who-approves-sinovac-covid-vaccine-the-second-chinese-made-dose-listed-idUSKCN2DD3V5 |access-date=1 June 2021 |work=Reuters |date=1 June 2021 |location=Geneva}}</ref><ref name="WHO recommendation">{{cite web | title=WHO recommendation Sinovac COVID-19 vaccine (Vero Cell [Inactivated]) – CoronaVac | website=[[World Health Organization]] (WHO) | date=1 May 2021 | url=https://extranet.who.int/pqweb/vaccines/who-recommendation-sinovac-covid-19-vaccine-vero-cell-inactivated-coronavac | access-date=1 June 2021 | accessdate=7 July 2021 | archivedate=2 June 2021 | archiveurl=https://web.archive.org/web/20210602213345/https://extranet.who.int/pqweb/vaccines/who-recommendation-sinovac-covid-19-vaccine-vero-cell-inactivated-coronavac }}</ref><ref name="WHO PR 20210601">{{cite press release | title=WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations | website=[[World Health Organization]] (WHO) | url=https://www.who.int/news/item/01-06-2021-who-validates-sinovac-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations | access-date=1 June 2021}}</ref>
</div>
;Travel-only
{{div col|colwidth=18em}}
* Andorra<ref name="auto24"/>
* Australia<ref name="AU recognized" /><ref>{{cite news|date=1 October 2021|title=Australia set to restart international travel in November, Scott Morrison says|work=[[The Guardian]]|url=https://www.theguardian.com/australia-news/2021/oct/01/australia-set-to-restart-international-travel-in-november-scott-morrison-says|access-date=21 November 2021}}</ref>
* Austria<ref name="auto10"/> (only for entry)
* Canada<ref name="auto31"/>
* Costa Rica<ref name="auto41"/>
* Croatia<ref name="auto19"/>
* Cyprus<ref name="auto15"/>
* Estonia<ref name="auto26"/> (only if approved in a person's country of origin)
* Finland<ref name="auto37"/>
* Greece<ref name="auto27"/>
* Grenada<ref name="auto8"/>
* Iceland<ref name="auto18"/>
* Ireland<ref name="auto11"/>
* Liechtenstein<ref name="auto28"/>
* Norway<ref>{{cite web|url=https://www.helsenorge.no/en/coronavirus/international-travels/#who-can-travel-to-norway|title=CInternational travels to Norway|date=23 March 2020}}</ref>
* New Zealand<ref name="auto9"/>
* Norway<ref name="police1">{{cite web|url=http://www.police.hu/en/content/information-on-general-rules-of-border-crossing|title=INFORMATION ON GENERAL RULES OF BORDER CROSSING – National Police Headquarters of Hungary}}</ref>
* Palau<ref name="palaugov.pw">{{cite web|url=https://www.palaugov.pw/travel/|title=COVID-19 Pandemic Entry Requirements – PalauGov.pw}}</ref>
* Panama<ref name="auto35"/>
* Portugal<ref name="visitmadeira1"/> (only in Madeira)
* Slovakia<ref name="auto29"/>
* Slovenia<ref name="auto30"/>
* South Korea<ref name="auto42"/>
* Spain<ref name="auto40"/>
* St. Kitts and Nevis<ref name="auto33"/>
* St. Lucia<ref name="auto17"/>
* St. Vincent and the Grenadines<ref name="auto21"/>
* Sweden<ref name="auto38"/>
* Switzerland<ref name="auto39"/>
* The Netherlands<ref name="auto25"/>
* Ukraine<ref name="auto22"/>
* United Arab Emirates<ref name="mohap.gov.ae">{{cite web|url=https://www.mohap.gov.ae/en/services/travelers-vaccination|title=Travelers Vaccinations - Ministry of Health and Prevention - UAE|website=www.mohap.gov.ae|accessdate=2021-12-25|archivedate=2021-11-22|archiveurl=https://web.archive.org/web/20211122031706/https://www.mohap.gov.ae/en/services/travelers-vaccination}}</ref>
* United Kingdom<ref name="auto34"/>
* United States<ref name="auto16"/>
* Vietnam<ref>{{cite news|date=21 October 2021|title=Việt Nam temporarily approves COVID-19 vaccine certificates by 72 countries, territories: Foreign ministry|work=[[Việt Nam News]]|url=https://vietnamnews.vn/politics-laws/1063197/viet-nam-temporarily-approves-covid-19-vaccine-certificates-by-72-countries-territories-foreign-ministry.html|access-date=8 January 2022}}</ref>
{{div col end}}
{{clear}}
{{-}}
== Novavax ==
<section begin="NVXauthmap"/>
{{infobox
| image = {{Graph:Map|scale=65|defaultValue=gainsboro
|AF=limegreen|AG=limegreen|AL=limegreen|AM=limegreen|AO=limegreen|AR=limegreen|AT=dodgerblue|AU=blueviolet|AZ=limegreen
|BA=limegreen|BB=limegreen|BD=dodgerblue|BE=dodgerblue|BF=limegreen|BG=dodgerblue|BJ=limegreen|BN=limegreen|BO=limegreen|BR=limegreen|BS=limegreen|BT=limegreen|BZ=limegreen
|CA=blueviolet|CD=limegreen|CG=limegreen|CH=dodgerblue|CI=limegreen|CL=limegreen|CM=limegreen|CO=limegreen|CR=limegreen|CV=limegreen|CY=dodgerblue|CZ=dodgerblue
|DE=dodgerblue|DK=dodgerblue|DJ=limegreen|DM=limegreen|DO=limegreen|DZ=limegreen
|EC=limegreen|EE=dodgerblue|EG=limegreen|ES=dodgerblue
|FI=dodgerblue|FJ=limegreen|FM=limegreen|FR=dodgerblue
|GD=limegreen|GE=limegreen|GH=limegreen|GM=limegreen|GN=limegreen|GR=dodgerblue
|HN=limegreen|HR=dodgerblue|HT=limegreen|HU=dodgerblue
|ID=dodgerblue|IE=dodgerblue|IQ=limegreen|IS=dodgerblue|IT=dodgerblue
|JM=limegreen|JO=limegreen|JP=blueviolet
|KE=limegreen|KH=limegreen|KI=limegreen|KM=limegreen|KN=limegreen|KP=limegreen|KR=blueviolet|
|LA=limegreen|LB=limegreen|LC=limegreen|LR=limegreen|LS=limegreen|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=limegreen
|MA=limegreen|MC=limegreen|MD=limegreen|ME=limegreen|MH=limegreen|MK=limegreen|ML=limegreen|MR=limegreen|MT=dodgerblue|MU=limegreen|MV=limegreen|MW=limegreen|MY=limegreen|MZ=limegreen
|NA=limegreen|NE=limegreen|NG=limegreen|NL=dodgerblue|NO=dodgerblue|NR=limegreen|NZ=dodgerblue
|PA=turquoise|PE=limegreen|PG=limegreen|PH=dodgerblue|PK=limegreen|PL=dodgerblue|PT=dodgerblue
|QA=limegreen
|RO=dodgerblue|RS=limegreen|RW=limegreen
|SB=limegreen|SD=limegreen|SE=dodgerblue|SG=dodgerblue|SI=dodgerblue|SK=dodgerblue|SL=limegreen|SN=limegreen|SO=limegreen|SR=limegreen|SS=limegreen|ST=limegreen|SV=limegreen|SY=limegreen|SZ=limegreen
|TD=limegreen|TG=limegreen|TH=dodgerblue|TJ=limegreen|TL=limegreen|TN=limegreen|TO=limegreen
|TR=turquoise|TV=limegreen
|UA=limegreen|UG=limegreen|GB=dodgerblue|UY=limegreen|UZ=limegreen
|VC=limegreen|VU=limegreen
|WS=limegreen|XK=limegreen|YE=limegreen|ZA=limegreen|ZM=limegreen|IN=dodgerblue
|US=turquoise|AE=turquoise|SA=limegreen|ET=limegreen|CF=limegreen|KG=limegreen
|BW=limegreen|ZW=limegreen|MX=limegreen|PY=limegreen|VE=limegreen|IR=limegreen|NI=limegreen|GY=limegreen|MM=limegreen|VN=limegreen|MG=limegreen|LK=limegreen|GT=limegreen
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|limegreen|Eligible [[COVAX]] recipient}}
}}
<section end="NVXauthmap"/>
The [[Novavax COVID-19 vaccine]], codenamed NVX-CoV2373, is a subunit COVID-19 vaccine candidate developed by [[Novavax]] and the [[Coalition for Epidemic Preparedness Innovations]], that is undergoing trials in India under the brand name Covovax. It requires two doses and is stable at 2 to 8 °C (36 to 46 °F) refrigerated temperatures.
NVX-CoV2373 has been described as both a [[Protein subunit|protein]] [[subunit vaccine]] and a [[virus-like particle#Vaccines|virus-like particle vaccine]], though the producers call it a "recombinant nanoparticle vaccine".
;Full (<section begin="Novavax_FN"/>4<section end="Novavax_FN"/>)
# Australia<ref>{{cite web|title=TGA provisionally approves Novavax (Biocelect Pty Ltd's) COVID-19 vaccine NUVAXOVID|url=https://www.tga.gov.au/media-release/tga-provisionally-approves-novavax-biocelect-pty-ltds-covid-19-vaccine-nuvaxovid|access-date=20 January 2022|website=Therapeutic Goods Administration|date=20 January 2022|accessdate=6 July 2022|archivedate=28 January 2022|archiveurl=https://web.archive.org/web/20220128170700/https://www.tga.gov.au/media-release/tga-provisionally-approves-novavax-biocelect-pty-ltds-covid-19-vaccine-nuvaxovid}}</ref>
# Canada<ref>{{Cite news|last=Reuters|date=2022-02-17|title=Canada approves Novavax's COVID-19 vaccine for adults|language=en|work=Reuters|url=https://www.reuters.com/business/healthcare-pharmaceuticals/canada-approves-novavaxs-covid-19-vaccine-2022-02-17/|access-date=2022-02-17}}</ref>
# Japan<ref>{{Cite news|date=2022-04-19|title=Japan approves Novavax as 4th COVID vaccine amid new surge|language=en|work=ABC News|url=https://abcnews.go.com/Health/wireStory/japan-approves-novavax-covid-19-vaccine-84159564|access-date=2022-04-21}}</ref>
# South Korea<ref>{{Cite news|date=2022-01-12|title=South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine|language=en|work=Novavax, Inc.|url=https://ir.novavax.com/2022-01-12-South-Korea-Ministry-of-Food-and-Drug-Safety-Approves-Novavax-COVID-19-Vaccine|access-date=2022-01-22}}</ref>
{{-}}
<div style="margin-top: 0.3em; column-width: 15em;">
;Emergency (<section begin="Novavax_EN"/>40<section end="Novavax_EN"/>)
# Bangladesh<ref>{{cite news |title=Novavax Reports First Quarter 2022 Financial Results and Operational Highlights |url=https://finance.yahoo.com/news/novavax-reports-first-quarter-2022-200200347.html |work=Novavax, Inc. |date=9 May 2022}}</ref>
# India<ref name="vacxine2">{{cite news |last1=Achom |first1=Debasish |title=India Clears 2 New Vaccines And Merck's Covid Pill |url=https://www.ndtv.com/india-news/coronavirus-2-more-vaccines-covovax-and-corbevax-and-anti-viral-drug-molnupiravir-cleared-in-india-2675170 |work=NDTV.com |date=28 December 2021}}</ref>
# Indonesia<ref>{{Cite news|last1=O'donnell|first1=Carl|last2=Nadeem|first2=Dania|date=1 November 2021|title=Novavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says|work=Reuters|url=https://www.reuters.com/business/healthcare-pharmaceuticals/novavax-covid-19-vaccine-receives-emergency-use-authorization-indonesia-2021-11-01/|access-date=1 November 2021}}</ref>
# New Zealand<ref>{{cite news|last1=The Associated Press Staff|date=3 February 2022|title=Novavax's COVID-19 shot receives provisional approval in New Zealand|agency=Associated Press|url=https://www.ctvnews.ca/world/novavax-s-covid-19-shot-receives-provisional-approval-in-new-zealand-1.5767524|access-date=4 February 2022|accessdate=6 July 2022|archivedate=21 March 2022|archiveurl=https://web.archive.org/web/20220321110739/https://www.ctvnews.ca/world/novavax-s-covid-19-shot-receives-provisional-approval-in-new-zealand-1.5767524}}</ref>
# Philippines<ref>{{cite news |title=Philippines approves emergency use of Novavax's COVID-19 vaccine |url=https://www.reuters.com/business/healthcare-pharmaceuticals/philippines-approves-emergency-use-novavaxs-covid-19-vaccine-2021-11-17/ |access-date=17 November 2021 |publisher=Reuters |date=17 November 2021}}</ref>
# Singapore<ref>{{cite web|author=Clara Chong|date=14 February 2022|title=Novavax Covid-19 vaccine approved for those aged 18 and above in Singapore|url=https://www.straitstimes.com/singapore/novavax-covid-19-vaccine-approved-for-those-aged-18-and-above-to-arrive-in-the-next-few-months|access-date=14 February 2022|website=[[The Straits Times]]|language=en}}</ref>
# Switzerland<ref>{{cite news |title=Swissmedic grants temporary authorisation for the Nuvaxovid COVID-19 vaccine from Novavax |url=https://www.swissmedic.ch/swissmedic/en/home/news/coronavirus-covid-19/zl-nuvaxovid-novovax.html |work=Swissmedic |date=13 April 2022}}</ref>
# Thailand<ref>{{cite web|title=Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand|url=https://finance.yahoo.com/news/novavax-serum-institute-india-receive-130000777.html|access-date=2022-04-11|website=[[Yahoo! Finance]]|language=en}}</ref>
# Taiwan<ref>{{Cite web |last=News |first=Taiwan |date=2022-06-19 |title=Novavax cleared for use by Taiwan FDA {{!}} Taiwan News {{!}} 2022-06-19 11:45:00 |url=https://www.taiwannews.com.tw/en/news/4574660 |access-date=2022-06-24 |website=Taiwan News}}</ref>
# United Kingdom<ref>{{cite web|title=Novavax COVID-19 vaccine Nuvaxovid approved by MHRA|url=https://www.gov.uk/government/news/novavax-covid-19-vaccine-nuvaxovid-approved-by-mhra|access-date=2022-02-03|website=GOV.UK|language=en}}</ref>
'''{{nowrap|[[European Medicines Agency|EMA]] countries}}'''<ref>{{cite web|date=20 December 2021|title=EMA recommends Nuvaxovid for authorisation in the EU|url=https://www.ema.europa.eu/en/news/ema-recommends-nuvaxovid-authorisation-eu|publisher=European Medicines Agency}}</ref>
# Austria
# Belgium
# Bulgaria
# Croatia
# Cyprus
# Czech Republic
# Denmark
# Estonia
# Finland
# France
# Germany
# Greece
# Hungary
# Iceland
# Ireland
# Italy
# Latvia
# Liechtenstein
# Lithuania
# Luxembourg
# Malta
# Netherlands
# Norway
# Poland
# Portugal
# Romania
# Slovakia
# Slovenia
# Spain
# Sweden
<!-- not counted -->
<br />'''[[List of ISO 3166-1 codes|Non-country entities]]'''
* ''[[World Health Organization]]''<ref name="WHO PR 20211217">{{cite press release | title=WHO lists 9th COVID-19 vaccine for emergency use with aim to increase access to vaccination in lower-income countries | website=[[World Health Organization]] (WHO) | url=https://www.who.int/news/item/17-12-2021-who-lists-9th-covid-19-vaccine-for-emergency-use-with-aim-to-increase-access-to-vaccination-in-lower-income-countries | access-date=17 December 2021}}</ref><ref>{{cite news |title=WHO issues emergency use listing to Novavax-Serum Institute's COVID-19 vaccine |url=https://www.reuters.com/business/healthcare-pharmaceuticals/who-issues-emergency-use-listing-novavax-serum-institutes-covid-19-vaccine-2021-12-17/ |work=Reuters |date=17 December 2021 }}</ref>
;Travel-only
* Hong Kong<ref name="HK"/>
* Palau<ref name="palaugov.pw"/>
* Panama<ref name="auto35"/>
* St. Kitts and Nevis<ref name="auto33"/>
* St. Lucia<ref name="auto17"/>
* St. Vincent and the Grenadines<ref name="auto21"/>
* Switzerland<ref name="auto39"/>
* Turkey<ref name="auto12"/>
* United Arab Emirates<ref name="mohap.gov.ae"/>
* United States<ref name="auto16"/>
{{clear}}
</div>
== VLA2001 ==
[[Valneva COVID-19 vaccine|VLA2001]] is an inactivated vaccine developed by [[Valneva SE]] and Dynavax Technologies.
;Full (<section begin="VLA2001_FN" />31<section end="VLA2001_FN" />)
# United Kingdom<ref>|url= https://www.bbc.co.uk/news/health-61104594</ref>
'''{{nowrap|[[European Medicines Agency|EMA]] countries}}'''<ref name="Valneva EPAR">{{cite web |date=20 June 2022 |title=COVID-19 Vaccine (inactivated, adjuvanted) Valneva EPAR |url=https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-inactivated-adjuvanted-valneva |url-status=live |archive-url=https://web.archive.org/web/20220628005530/https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-inactivated-adjuvanted-valneva |archive-date=28 June 2022 |access-date=28 June 2022 |website=[[European Medicines Agency]] (EMA)}}</ref>
# Austria
# Belgium
# Bulgaria
# Croatia
# Cyprus
# Czech Republic
# Denmark
# Estonia
# Finland
# France
# Germany
# Greece
# Hungary
# Iceland
# Ireland
# Italy
# Latvia
# Liechtenstein
# Lithuania
# Luxembourg
# Malta
# Netherlands
# Norway
# Poland
# Portugal
# Romania
# Slovakia
# Slovenia
# Spain
# Sweden
;Emergency (<section begin="VLA2001_EN" />2<section end="VLA2001_EN" />)
# Bahrain<ref>|url=https://www.bbc.co.uk/news/health-61104594</ref>
# United Arab Emirates<ref>{{Cite web |date=2022-05-17 |title=Valneva receives EUA from UAE for its inactivated COVID-19 vaccine |url=https://www.expresspharma.in/valneva-receives-eua-from-uae-for-its-inactivated-covid-19-vaccine/ |access-date=2022-06-20 |website=Express Pharma |language=en-US}}</ref>
;Travel-only
* Malaysia<ref name="MY" />
* New Zealand<ref name="auto9" />
* Turkey<ref name="visasturkey.com" />
== Sputnik Light ==
<section begin="sputniklightauthmap"/>
{{infobox|image={{Graph:Map|scale=65|defaultValue=gainsboro
|AO=dodgerblue|AE=dodgerblue|AR=dodgerblue
|BH=dodgerblue|BJ=dodgerblue|BY=dodgerblue
|CG=dodgerblue
|EG=dodgerblue
|IR=dodgerblue
|IN=dodgerblue
|KG=dodgerblue|KH=dodgerblue|KZ=dodgerblue
|LA=dodgerblue
|MN=dodgerblue|MU=dodgerblue|MY=turquoise
|NI=dodgerblue|NZ=turquoise
|PH=dodgerblue|PS=dodgerblue
|RU=dodgerblue
|SM=dodgerblue|SY=dodgerblue
|TM=dodgerblue|TN=dodgerblue|TR=turquoise|TZ=dodgerblue
|VC=dodgerblue|VE=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
<section end="sputniklightauthmap"/>
[[Sputnik Light]] is a [[viral vector vaccine]],<ref name="Ryumin">{{cite news|last=Ryumin|first=Alexander|date=20 February 2021|title=Russia registers its third COVID-19 vaccine CoviVac|publisher=[[TASS]]|location=Moscow|url=https://tass.com/society/1258859|access-date=6 March 2021}}</ref> produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology. It consists of the first dose of the [[Sputnik V COVID-19 vaccine|Sputnik V vaccine]], which is based on the Ad26 vector.<ref>{{cite press release |date=6 May 2021 |title=Single dose vaccine, Sputnik Light, authorized for use in Russia |url=https://rdif.ru/Eng_fullNews/6763/ |publisher=Russian Direct Investment Fund |access-date=11 May 2021}}</ref>
;Full (<section begin="Sputnik Light_FN"/>0<section end="Sputnik Light_FN"/>)
;Emergency (<section begin="Sputnik Light_EN"/>28<section end="Sputnik Light_EN"/>)
<div style="margin-top: 0.3em; column-width: 15em;">
# Angola<ref>{{cite news |title=Sputnik Light Vaccine Approved For Use In Angola |url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-light-vaccine-approved-for-use-in-angola/ |access-date=13 May 2021 |publisher=Sputnik V vaccine |date=12 May 2021}}</ref>
# Argentina<ref>{{cite web|title=BOLETIN OFICIAL REPUBLICA ARGENTINA - MINISTERIO DE SALUD - Resolución 3451/2021|url=https://www.boletinoficial.gob.ar/detalleAviso/primera/253978|access-date=7 December 2021|website=www.boletinoficial.gob.ar}} {{Dead link|date=October 2026 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>
# Armenia<ref>{{cite web|title=Armenia approves Russian one-dose Sputnik Light vaccine|url=https://en.armradio.am/2021/09/06/armenia-approves-russian-one-dose-sputnik-light-vaccine/|access-date=8 December 2021|website=Public Radio of Armenia}}</ref>
# Bahrain<ref>{{cite news|date=11 May 2021|title=Bahrain authorizes emergency use of one-shot Sputnik-Light COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/world/middle-east/bahrain-authorizes-emergency-use-one-shot-sputnik-light-covid-19-vaccine-2021-05-11/|access-date=12 May 2021}}</ref>
# Belarus<ref>{{cite news |title=Belarus registers Russia's Sputnik Light vaccine for use |url=https://www.reuters.com/business/healthcare-pharmaceuticals/belarus-registers-russias-sputnik-light-vaccine-use-2021-06-03/ |access-date=4 June 2021 |date=3 June 2021}}</ref>
# Benin<ref>{{Cite news|date=14 January 2022|title=Sputnik Light vaccine authorized in Benin, says Russian Direct Investment Fund|work=[[TASS]]|url=https://tass.com/world/1388289|access-date=7 February 2022}}</ref>
# Cambodia<ref name="auto20"/>
# Congo-Brazzaville<ref>{{cite web |title=Single-dose Sputnik Light vaccine approved for use in the Republic of the Congo |url=https://rdif.ru/Eng_fullNews/6878/ |publisher=Russian Direct Investment Fund |website=rdif.ru |date=7 June 2021 |access-date=7 June 2021 |archive-date=7 June 2021 |archive-url=https://web.archive.org/web/20210607175016/https://rdif.ru/Eng_fullNews/6878/ |url-status=dead }}</ref>
# Egypt<ref>{{cite web|title=The single-component Sputnik Light vaccine authorized in Egypt|url=https://sputnikvaccine.com/newsroom/pressreleases/the-single-component-sputnik-light-vaccine-authorized-in-egypt/|access-date=1 October 2021|website=sputnikvaccine}}</ref>
# Iran<ref name="TrackVax"/>
# India<ref>{{cite web|title=Sputnik Light: DCGI nod to emergency use of single-dose Covid vaccine|url=https://www.livemint.com/news/india/sputnik-light-dcgi-nod-to-emergency-use-of-single-dose-covid-vaccine-11644160096963.html|website=Livemint|date=2 February 2022}}</ref>
# Kazakhstan<ref>{{cite news |title=Kazakhstan approves Russia's single-dose Sputnik Light vaccine |url=https://www.reuters.com/world/asia-pacific/kazakhstan-approves-russias-single-dose-sputnik-light-vaccine-rdif-2021-07-15/ |access-date=15 July 2021 |work=Reuters |date=15 July 2021 |location=Moscow}}</ref>
# Kyrgyzstan<ref>{{#invoke:Cite web||title=Single-dose Sputnik Light vaccine registered in Kyrgyzstan|url=https://sputnikvaccine.com/newsroom/pressreleases/single-dose-sputnik-light-vaccine-registered-in-kyrgyzstan/|access-date=25 June 2021|website=sputnikvaccine}}</ref>
# Laos<ref name="whotracker"/>
# Mauritius<ref>{{cite news |title=Russia's Sputnik Light vaccine approved for use in Mauritius |url=https://www.reuters.com/business/healthcare-pharmaceuticals/russias-sputnik-light-vaccine-approved-use-mauritius-rdif-2021-06-02/ |access-date=4 June 2021 |work=Reuters |date=2 June 2021}}</ref>
# Mongolia<ref>{{cite press release |title=Single-dose Sputnik Light vaccine registered in Mongolia |url=https://rdif.ru/Eng_fullNews/6907/ |location=Moscow |publisher=Russian Direct Investment Fund |access-date=25 June 2021 |date=11 June 2021 |archive-date=29 June 2021 |archive-url=https://web.archive.org/web/20210629205823/https://rdif.ru/Eng_fullNews/6907/ |url-status=dead }}</ref>
# Nicaragua<ref>{{cite news |title=Single-dose Sputnik Light vaccine approved for use in Nicaragua |url=https://rdif.ru/Eng_fullNews/6846/ |publisher=Russian Direct Investment Fund |date=20 May 2021 |access-date=1 June 2021 |archive-date=3 June 2021 |archive-url=https://web.archive.org/web/20210603092124/https://rdif.ru/Eng_fullNews/6846/ |url-status=dead }}</ref>
# Palestine<ref>{{cite news |title=Russia's Sputnik Light vaccine approved for use in Palestinian territories |url=https://www.reuters.com/article/health-coronavirus-russia-israel-palesti-idUSR4N2NB01F |access-date=4 June 2021 |work=Reuters |date=31 May 2021}}</ref>
# Philippines<ref>{{cite news|title=Philippines approves emergency use of Russia's Sputnik Light vaccine|url=https://www.reuters.com/world/asia-pacific/philippines-approves-emergency-use-russias-sputnik-light-vaccine-2021-08-23/ |access-date=23 August 2021 |work=Reuters |date=23 August 2021}}</ref>
# Russia<ref>{{cite news |title=Russia Approves Single-Dose Sputnik Light Covid Vaccine For Use |url=https://www.ndtv.com/world-news/russia-approves-single-dose-sputnik-light-covid-19-vaccine-for-use-2436470 |publisher=NDTV Coronavirus |date=6 May 2021}}</ref>
# Saint Vincent and the Grenadines<ref name="whotracker"/>
# San Marino<ref>{{cite web|title=Russian Direct Investment Fund|url=https://rdif.ru/Eng_fullNews/7171/|access-date=30 November 2021|website=rdif.ru|archive-date=30 November 2021|archive-url=https://web.archive.org/web/20211130200937/https://rdif.ru/Eng_fullNews/7171/|url-status=dead}}</ref>
# Syria<ref>{{cite news |title=Batch of Russia's Sputnik Light vaccine delivered to Syria |url=https://tass.com/world/1317383 |access-date=31 July 2021 |work=TASS |date=24 July 2021 |location=Damascus}}</ref>
# Tanzania<ref name="TrackVax"/>
# Tunisia<ref name="TrackVax"/>
# Turkmenistan<ref name="TrackVax"/><ref>[https://turkmenportal.com/blog/42752/turkmenistan-zaregistriroval-oblegchennyi-variant-rossiiskoi-vakciny-sputnik-v Туркменистан зарегистрировал облегченный вариант российской вакцины «Спутник V»]</ref>
# United Arab Emirates<ref>{{cite web|date=6 October 2021|title=UAE authorises Sputnik Light COVID-19 vaccine -Russia's RDIF|url=https://www.reuters.com/world/middle-east/uae-authorises-sputnik-light-covid-19-vaccine-russias-rdif-2021-10-06/|access-date=23 October 2021|website=[[Reuters]]}}</ref>
# Venezuela<ref>{{cite press release|title=Single-dose Sputnik Light vaccine approved for use in Venezuela |url=https://sputnikvaccine.com/newsroom/pressreleases/single-dose-sputnik-light-vaccine-approved-for-use-in-venezuela/|access-date=15 May 2021|publisher=Gamaleya Center}}</ref>
<br />'''Non-country entities'''
* Abkhazia<ref>{{Cite news|date=28 October 2021|title=In Abkhazia, 3,638 People Were Covid-19 Vaccination With Satellite Light|url=https://minzdrav.apsny.land/novosti/item/801-v-abkhazii-privivku-ot-covid-19-sputnikom-lajt-sdelali-3638-chelovek|accessdate=25 December 2021|archivedate=6 December 2021|archiveurl=https://web.archive.org/web/20211206233003/https://minzdrav.apsny.land/novosti/item/801-v-abkhazii-privivku-ot-covid-19-sputnikom-lajt-sdelali-3638-chelovek}}</ref>
* Donbass Region (unofficially)<ref>{{cite web |url=https://warsawinstitute.org/moscow-plays-donbas-part-ukraine-conflict/ |title=Moscow Plays Up Donbas As Part Of The Ukraine Conflict |publisher=Warsaw Institute |date=2021-07-30 |access-date=2022-03-04 |accessdate=2022-07-06 |archivedate=2021-08-04 |archiveurl=https://web.archive.org/web/20210804163629/https://warsawinstitute.org/moscow-plays-donbas-part-ukraine-conflict/ }}</ref>
</div>
;Travel-only
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9"/>
* Turkey<ref name="visasturkey.com"/>
{{clear}}
== Covaxin ==
<section begin="covaxinauthmap"/>
{{infobox
| image = {{Graph:Map|scale=65|defaultValue=gainsboro
|AF=limegreen|AG=limegreen|AL=limegreen|AM=limegreen|AO=limegreen|AR=limegreen|AZ=limegreen|AU=turquoise
|BA=limegreen|BB=limegreen|BD=limegreen|BF=limegreen|BH=dodgerblue|BJ=limegreen|BN=limegreen|BO=limegreen|BR=limegreen|BS=limegreen|BT=limegreen|BW=dodgerblue|BZ=limegreen
|CD=limegreen|CF=dodgerblue|CG=limegreen|CI=limegreen|CL=limegreen|CM=limegreen|CO=limegreen|CR=limegreen|CV=limegreen
|DJ=limegreen|DM=limegreen|DO=limegreen|DZ=limegreen
|EC=limegreen|EE=turquoise|EG=limegreen|ET=dodgerblue|
|FJ=limegreen|FM=limegreen|FI=turquoise
|GD=limegreen|GB=turquoise|GE=limegreen|GH=limegreen|GM=limegreen|GN=limegreen|GR=turquoise|GT=dodgerblue|GY=dodgerblue
|HK=dodgerblue|HN=limegreen|HT=limegreen
|ID=limegreen|IN=blueviolet|IQ=limegreen|IR=dodgerblue|IS=turquoise
|JM=limegreen|JO=limegreen
|KE=limegreen|KG=turquoise|KH=limegreen|KI=limegreen|KM=dodgerblue|KN=limegreen|KP=limegreen|KR=limegreen|
|LA=limegreen|LB=limegreen|LC=limegreen|LK=turquoise|LR=limegreen|LS=limegreen|LY=limegreen
|MA=limegreen|MC=limegreen|MD=limegreen|ME=limegreen|MH=limegreen|MK=limegreen|ML=limegreen|MM=dodgerblue|MN=turquoise|MR=limegreen|MU=dodgerblue|MV=limegreen|MW=limegreen|MX=dodgerblue|MY=dodgerblue|MZ=limegreen
|NA=limegreen|NE=limegreen|NG=limegreen|NI=dodgerblue|NP=dodgerblue|NR=limegreen|NZ=turquoise
|OM=turquoise
|PA=limegreen|PE=limegreen|PG=limegreen|PH=dodgerblue|PK=limegreen|PS=turquoise|PY=dodgerblue
|QA=limegreen
|RS=limegreen|RW=limegreen
|SA=turquoise|SB=limegreen|SD=limegreen|SG=turquoise|SL=limegreen|SN=limegreen|SO=limegreen|SR=limegreen|SS=limegreen|ST=limegreen|SV=limegreen|SY=limegreen|SZ=limegreen
|TD=limegreen|TG=limegreen|TH=turquoise|TJ=limegreen|TL=limegreen|TN=limegreen|TO=limegreen|TT=dodgerblue|TV=limegreen
|UA=limegreen|UG=limegreen|US=turquoise|UY=limegreen|UZ=limegreen|CH=turquoise|TR=turquoise|
|VC=limegreen|VE=dodgerblue|VN=dodgerblue|VU=limegreen
|WS=limegreen
|XK=limegreen
|YE=limegreen
|ZA=limegreen|ZM=limegreen|ZW=dodgerblue
|AD=turquoise|AT=turquoise|CA=turquoise|HR=turquoise|CY=turquoise|IE=turquoise|LI=turquoise|NL=turquoise|SI=turquoise|SK=turquoise|ES=turquoise|SE=turquoise
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|limegreen|Eligible [[COVAX]] recipient}}
}}
<section end="covaxinauthmap"/>
[[Covaxin]] is an [[inactivated vaccine|inactivated virus vaccine]] produced by the Indian company [[Bharat Biotech]] in collaboration with the [[Indian Council of Medical Research]]–[[National Institute of Virology]].
;Full (<section begin="Covaxin_EN"/>1<section end="Covaxin_EN"/>)
# India<ref name=":1"/>
;Emergency (<section begin="Covaxin_EN"/>19<section end="Covaxin_EN"/>)
<div style="margin-top: 0.3em; column-width: 18em;">
# Bahrain<ref>{{Cite news|date=11 November 2021|title=Bahrain authorizes COVAXIN for emergency use|work=[[Bahrain News Agency]]|url=https://www.bna.bh/en/BahrainauthorizesCOVAXINforemergencyuse.aspx?cms=q8FmFJgiscL2fwIzON1%2bDvdCpVGdtuusfPwcuTv4D1k%3d|access-date=29 January 2022|accessdate=6 July 2022|archivedate=29 September 2022|archiveurl=https://web.archive.org/web/20220929020808/https://www.bna.bh/en/BahrainauthorizesCOVAXINforemergencyuse.aspx?cms=q8FmFJgiscL2fwIzON1%2BDvdCpVGdtuusfPwcuTv4D1k%3D}}</ref>
# Botswana<ref name="cov-200421">{{#invoke:Cite web||url=https://timesofindia.indiatimes.com/india/covid-19-bharat-biotech-ramps-up-covaxin-capacity-to-700-million-doses-per-annum/articleshow/82162467.cms|title=Covid-19: Bharat Biotech ramps up Covaxin capacity to 700 million doses per annum | India News |website=The Times of India}}</ref>
# Central African Republic<ref name="cdctracker"/>
# Comoros<ref name="cdctracker"/>
# Ethiopia<ref name="whotracker" />
# Guatemala<ref name="cov-200421"/> (not used)<ref name="auto23">{{cite web|url=https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp|title=COVID-19 vaccine doses administered in the Americas|website=ais.paho.org}}</ref>
# Guyana<ref name="cov-200421"/> (not used)<ref name="auto23"/>
# Iran<ref>{{cite news |title=Iran issues permit for emergency use for three other COVID-19 vaccines: Official |url=https://en.irna.ir/news/84233593/Iran-issues-permit-for-emergency-use-for-three-other-COVID-19 |work=IRNA English |date=17 February 2021 }}</ref>
# Malaysia<ref>{{cite web|url=
https://www.nst.com.my/news/nation/2022/02/770394/covaxin-given-conditional-approval-under-emergency-use-protocols|title=Covaxin given conditional approval under emergency use protocols|website=nst.com.my|publisher=[[New Straits Times]]|date=10 February 2021|access-date=10 February 2022}}</ref>
# Mauritius<ref name="auto32">{{cite web|last=Livemint|date=1 November 2021|title=5 more countries recognise India's Covid vaccination certificate. Details here|url=https://www.livemint.com/news/india/five-more-countries-recognise-india-s-covid-vaccination-certificate-details-here-11635766929707.html|access-date=1 November 2021|website=mint}}</ref>
# Mexico<ref>{{#invoke:Cite web||url=https://www.excelsior.com.mx/nacional/mexico-autoriza-covaxin-vacuna-de-emergencia-india/1441874|title=México autoriza Covaxin, la vacuna india contra covid-19|publisher=Excelsior|date=6 April 2021}}</ref> (not used)<ref name="auto23"/>
# Myanmar<ref>{{cite news |title=Myanmar sees over 130,000 Covid-19 recoveries, just over 7,000 still in hospital |url=https://elevenmyanmar.com/news/myanmar-sees-over-130000-covid-19-recoveries-just-over-7000-still-in-hospital |work=[[Eleven Media Group]] |date=19 February 2021}}</ref>
# Nepal<ref>{{cite news|last=Sharma|first=Gopal|date=19 March 2021|title=Nepal becomes third country to give emergency nod to Indian vaccine COVAXIN|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-nepal-india-idUSKBN2BB1KN|access-date=19 March 2021}}</ref>
# Nicaragua<ref name="cov-200421"/> (not used)<ref name="auto23"/>
# Paraguay<ref name="covaxin-py">{{#invoke:Cite web||url=https://www.hindustantimes.com/india-news/covid19-india-provides-100-000-doses-of-covaxin-vaccine-to-paraguay-101617057324587.html|title=India provides 100,000 doses of Covaxin vaccine to Paraguay|work=Hindustan Times|date=30 March 2021}}</ref><ref>{{cite tweet|number=1376615865068752896|user=MaritoAbdo|title=Acaban de llegar 100.000 dosis de vacunas contra el Covid-19, provenientes de la India. La prioridad es avanzar hacia la inmunización de todo el personal de blanco y luego la población de riesgo. Gracias a la República de la India por el apoyo.|date=30 March 2021}}</ref>
# Philippines<ref>{{cite news |title=Philippine FDA issues full EUA to Bharat Biotech's Covaxin |url=https://mb.com.ph/2021/06/23/philippine-fda-issues-full-eua-to-bharat-biotechs-covaxin/ |publisher=Manila Bulletin |date=23 June 2021}}</ref><ref>{{cite news |title=FDA grants full emergency use authorization for Covaxin |url=https://cnnphilippines.com/news/2021/6/25/COVAXIN-EUA-Philippines.html |publisher=CNN Philippines |date=25 June 2021 |accessdate=7 July 2021 |archivedate=3 July 2021 |archiveurl=https://web.archive.org/web/20210703070449/https://cnnphilippines.com/news/2021/6/25/COVAXIN-EUA-Philippines.html }}</ref>
# Trinidad and Tobago<ref name="newsday.co.tt"/>
# Venezuela<ref name="cov-200421"/> (not used)<ref name="auto23"/>
# Vietnam<ref name="hk-vn-covaxin">{{cite news |title=Covid-19: Hong Kong, Vietnam latest to approve Covaxin for emergency use |url=https://www.hindustantimes.com/india-news/covid19-hong-kong-vietnam-latest-to-approve-covaxin-for-emergency-use-101636530349366.html |work=Hindustan Times |date=10 November 2021 }}</ref>
# Zimbabwe<ref>{{#invoke:Cite web||date=4 March 2021|title=Zimbabwe approves Covaxin, first in Africa to okay India-made Covid-19 vaccine|url=https://www.hindustantimes.com/world-news/zimbabwe-approves-covaxin-first-in-africa-to-okay-india-made-covid-19-vaccine-101614859597880.html|access-date=3 July 2021|website=Hindustan Times}}</ref>
<!-- not counted -->
<br />'''[[List of ISO 3166-1 codes|Non-country entities]]'''
* ''[[World Health Organization]]''<ref>{{cite news |title=India's first homegrown COVID-19 shot wins WHO emergency use listing |url=https://www.reuters.com/world/india/whos-advisory-group-recommends-emergency-listing-indias-first-homegrown-covid-19-2021-11-03/ |work=Reuters |date=3 November 2021 }}</ref><ref name="WHO PR 20211103">{{cite press release | title=WHO issues emergency use listing for eighth COVID-19 vaccine | website=[[World Health Organization]] (WHO) | url=https://www.who.int/news/item/03-11-2021-who-issues-emergency-use-listing-for-eighth-covid-19-vaccine | access-date=3 November 2021}}</ref>
</div>
;Travel-only
{{div col|colwidth=18em}}
* Andorra<ref name="auto24"/>
* Australia<ref name="AU recognized" /><ref name="tga-covaxin-bibp"/>
* Austria<ref name="auto10"/> (only for entry)
* Canada<ref name="auto31"/>
* Costa Rica<ref name="auto41"/>
* Croatia<ref name="auto19"/>
* Cyprus<ref name="auto15"/>
* Estonia<ref name="auto26"/> (only if approved in a person's country of origin)
* Finland<ref name="auto37"/>
* Greece<ref name="auto27"/>
* Grenada<ref name="auto8"/>
* Hong Kong<ref name="HK"/>
* Iceland<ref name="auto18"/>
* Ireland<ref name="auto11"/>
* Kyrgyzstan<ref name="auto32"/>
* Liechtenstein<ref name="auto28"/>
* Mongolia<ref name="auto32"/>
* New Zealand<ref name="auto9"/>
* Norway<ref name="police1"/>
* Oman<ref name="auto36"/>
* Palestine<ref name="auto32"/>
* Palau<ref name="palaugov.pw"/>
* Panama<ref name="auto35"/>
* Portugal<ref name="visitmadeira1"/> (only in Madeira)
* Saudi Arabia<ref>{{cite web |url=https://keralakaumudi.com/en/news/mobile/news.php?id=701543&u= |title=Relief for expatriates: Saudi Arabia approves four more vaccines, including Covaxin |date=6 December 2021 |publisher=[[Kerala Kaumudi]]}}</ref>
* Singapore<ref name="channelnewsasia.com"/>
* Slovakia<ref name="auto29"/>
* Slovenia<ref name="auto30"/>
* South Korea<ref name="auto42"/>
* Spain<ref name="auto40"/>
* Sri Lanka<ref>{{cite news |title=Sri Lanka green light for Covaxin: Opens quarantine free for fully jabbed Indian tourists |url=https://m.timesofindia.com/business/international-business/sri-lanka-green-light-for-covaxin-opens-quarantine-free-for-fully-jabbed-indian-tourists/articleshow/85594554.cms |newspaper=[[The Times of India]] |date=24 August 2021}}</ref>
* St. Kitts and Nevis<ref name="auto33"/>
* St. Lucia<ref name="auto17"/>
* St. Vincent and the Grenadines<ref name="auto21"/>
* Sweden<ref name="auto38"/>
* Switzerland<ref name="auto39"/>
* Thailand<ref name="ThailandPass">{{cite web |title=Thailand Pass FAQs |url=https://consular.mfa.go.th/th/content/thailand-pass-faqs-2 |website=Department of Consular Affairs |access-date=11 January 2022 |accessdate=6 July 2022 |archivedate=30 June 2022 |archiveurl=https://web.archive.org/web/20220630074407/https://consular.mfa.go.th/th/content/thailand-pass-faqs-2 }}</ref>
* The Netherlands<ref name="auto25"/>
* Turkey<ref name="auto12"/>
* Ukraine<ref name="auto22"/>
* United Kingdom<ref name="auto34"/>
* United States<ref name="auto16"/>
{{div col end}}
{{clear}}
== Convidecia ==
<section begin="convideciaauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|AR=dodgerblue
|CL=dodgerblue
|CN=blueviolet
|EC=dodgerblue
|HK=turquoise
|HU=dodgerblue
|ID=dodgerblue
|MD=dodgerblue
|MX=dodgerblue
|MY=dodgerblue
|NZ=turquoise
|PK=dodgerblue
|TR=turquoise
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
<section end="convideciaauthmap"/>
[[Ad5-nCoV|Convidecia]] is a [[viral vector vaccine]]<ref name="zhu7-20">{{cite journal|display-authors=6|vauthors=Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ, Wu SP, Wang Z, Wu XH, Xu JJ, Zhang Z, Jia SY, Wang BS, Hu Y, Liu JJ, Zhang J, Qian XA, Li Q, Pan HX, Jiang HD, Deng P, Gou JB, Wang XW, Wang XH, Chen W|date=August 2020|title=Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial|journal=Lancet|volume=396|issue=10249|pages=479–88|doi=10.1016/s0140-6736(20)31605-6|pmc=7836858|pmid=32702299|doi-access=free|title-link=doi}}</ref> produced by the Chinese company [[CanSino Biologics]] and the Beijing Institute of Biotechnology of the [[Academy of Military Medical Sciences]].
;Full (<section begin="Convidecia_FN"/>1<section end="Convidecia_FN"/>)
# China<ref>{{cite news |title=China approves two more domestic COVID-19 vaccines for public use |url=https://www.reuters.com/article/us-health-coronavirus-china-vaccine-idUSKBN2AP1MW |access-date=16 March 2021 |publisher=Reuters |date=25 February 2021}}</ref>
;Emergency (<section begin="Convidecia_EN"/>9<section end="Convidecia_EN"/>)
# Argentina<ref>{{#invoke:Cite web||date=11 June 2021|title=Argentina issues emergency approval to China's single-dose Cansino COVID-19 vaccine|url=https://www.reuters.com/world/americas/argentina-issues-emergency-approval-chinas-single-dose-cansino-covid-19-vaccine-2021-06-11/|access-date=11 June 2021|website=Reuters}}</ref>
# Chile<ref name=":7">{{#invoke:Cite web||title=ISP Approves Emergency Use And Importation Of Cansino Vaccine To Fight COVID-19|url=https://www.ispch.cl/noticia/isp-aprueba-uso-de-emergencia-e-importacion-de-la-vacuna-covid-19-de-laboratorio-cansino/|access-date=8 April 2021|website=Institute of Public Health of Chile}}</ref>
# Ecuador<ref>{{#invoke:Cite web||date=15 June 2021|title=Ecuador authorizes use of China's CanSino vaccine against COVID-19|url=https://www.reuters.com/world/americas/ecuador-authorizes-use-chinas-cansino-vaccine-against-covid-19-2021-06-15/|access-date=16 June 2021|website=Reuters}}</ref>
# Hungary<ref>{{cite web | title=China's CanSino Biologics COVID-19 vaccine receives emergency use approval in Hungary | publisher=MSN | date=22 March 2021 | url=https://www.msn.com/en-xl/europe/top-stories/china-s-cansino-biologics-covid-19-vaccine-receives-emergency-use-approval-in-hungary/ar-BB1eOIEV | access-date=22 March 2021}}</ref><ref name="WashPost Hungary" />
# Indonesia<ref name="auto6"/>
# Malaysia<ref>{{#invoke:Cite web||title=Govt approves Pfizer jabs for 12-year-olds and above, CanSino and Johnson & Johnson vaccines get conditional registration, says Health DG|url=https://www.thestar.com.my/news/nation/2021/06/15/govt-approves-pfizer-jabs-for-12-year-olds-and-above-conditional-approval-for-cansino-and-johnson--johnson-vaccines-says-health-dg|access-date=15 June 2021|website=The Star}}</ref>
# Mexico<ref name="AD5 mexico"/>
# Moldova<ref name="msmps.gov.md"/>
# Pakistan<ref>{{cite news | last1=Shahzad |first1=Asif |title=Pakistan approves Chinese CanSinoBIO COVID vaccine for emergency use |url=https://www.reuters.com/article/us-health-coronavirus-pakistan-vaccine/pakistan-approves-chinese-cansinobio-covid-vaccine-for-emergency-use-idUSKBN2AC1FG |publisher=Reuters |access-date=12 February 2021 |date=12 February 2021}}</ref>
<!-- not counted --><br />'''[[List of ISO 3166-1 codes|Non-country entities]]'''
* ''[[World Health Organization]]''
;Travel-only
* Hong Kong<ref name="HK"/>
* New Zealand<ref name="auto9"/>
* Turkey<ref name="visasturkey.com"/>
{{clear}}
== Sinopharm WIBP ==
<section begin="wibpauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|AE=dodgerblue
|CN=blueviolet
|HK=turquoise
|MK=dodgerblue
|MY=turquoise
|NZ=turquoise
|PE=dodgerblue
|PH=dodgerblue
|TR=turquoise
|VE=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
<section end="wibpauthmap"/>
The [[Sinopharm WIBP COVID-19 vaccine]] is an [[inactivated vaccine|inactivated virus vaccine]] produced by the [[China National Pharmaceutical Group]] (Sinopharm) and its [[Wuhan Institute of Biological Products]].
;Full (<section begin="Sinopharm-WIBP_FN"/>1<section end="Sinopharm-WIBP_FN"/>)
# China<ref>{{Cite news|last=Wee|first=Sui-Lee|date=25 February 2021|title=China approves two more Covid-19 vaccines.|work=The New York Times|url=https://www.nytimes.com/live/2021/02/25/world/covid-19-coronavirus|access-date=1 April 2021}}</ref>
;Emergency (<section begin="Sinopharm-WIBP_EN"/>5<section end="Sinopharm-WIBP_EN"/>)
# North Macedonia<ref name="whotracker"/>
# Peru<ref name="whotracker"/>
# Philippines<ref>{{cite news |author1=De Vera, Analou |title=FDA grants EUA to COVID-19 vaccine Sinopharm manufactured by Wuhan affiliate |url=https://mb.com.ph/2021/08/25/fda-grants-eua-to-covid-19-vaccine-sinopharm-manufactured-by-wuhan-affiliate/ |publisher=Manila Bulletin |date=25 August 2021}}</ref>
# United Arab Emirates<ref name="NYT vaccine tracker" />
# Venezuela<ref name="whotracker"/>
;Travel-only
* Hong Kong<ref name="HK"/>
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9"/>
* Turkey<ref name="visasturkey.com"/>
{{clear}}
== Abdala ==
<section begin="abdalaauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|CU=dodgerblue
|GY=turquoise
|KH=turquoise
|LC=turquoise
|MX=dodgerblue
|MY=turquoise
|NI=dodgerblue
|NZ=turquoise
|TR=turquoise
|UY=turquoise
|VC=turquoise
|VE=dodgerblue
|VN=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
<section end="abdalaauthmap"/>
[[Abdala (vaccine)|Abdala]] is a [[subunit vaccine]] developed by the [[Center for Genetic Engineering and Biotechnology]] in [[Cuba]].
;Full (<section begin="Abdala_FN"/>0<section end="Abdala_FN"/>)
;Emergency (<section begin="Abdala_EN"/>6<section end="Abdala_EN"/>)
# Cuba<ref name="Cubarollout">{{Cite news|date=9 July 2021|title=COVID: Cuba approves emergency use of own Abdala vaccine|work=Deutsche Welle|url=https://www.dw.com/en/covid-cuba-approves-emergency-use-of-own-abdala-vaccine/a-58222105|access-date=9 July 2021}}</ref><ref>{{#invoke:Cite web||title=Aprueba el CECMED el Autorizo de Uso de Emergencia del candidato vacunal cubano ABDALA {{!}} CECMED|url=https://www.cecmed.cu/noticias/aprueba-cecmed-autorizo-uso-emergencia-candidato-vacunal-cubano-abdala|access-date=9 July 2021|website=www.cecmed.cu|language=es}}</ref>
# Mexico<ref>{{cite web|date=29 December 2021|title=Cofepris emite autorización para uso de emergencia de vacuna Abdala|url=https://www.gob.mx/cofepris/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-de-vacuna-abdala|access-date=29 December 2021|website=www.gob.mx/cofepris|language=es}}</ref>
# Nicaragua<ref>{{cite news|title=Nicaragua authorises two COVID-19 vaccines from Cuba, Cuban firm says|url=https://www.reuters.com/business/healthcare-pharmaceuticals/nicaragua-authorises-two-covid-19-vaccines-cuba-cuban-firm-says-2021-10-02/ |access-date= 4 October 2021|publisher=Reuters |date=2 October 2021}}</ref>
# St. Vincent and the Grenadines<ref>{{cite web|title=Vincentians have access to Cuban Abdala vaccine {{!}} Loop Caribbean News|url=https://caribbean.loopnews.com/content/vincentians-have-access-cuban-abdala-vaccine|access-date=28 December 2021|website=Loop News|accessdate=6 July 2022|archivedate=25 April 2022|archiveurl=https://web.archive.org/web/20220425033824/https://caribbean.loopnews.com/content/vincentians-have-access-cuban-abdala-vaccine}}</ref><ref>{{Cite news|date=28 December 2021|title=St Vincent, The Grenadines to use Cuba's Abdala vaccine|work=Political Lore|url=https://www.politicallore.com/st-vincent-the-grenadines-to-use-cubas-abdala-vaccine/27626|access-date=13 January 2022|accessdate=6 July 2022|archivedate=12 August 2022|archiveurl=https://web.archive.org/web/20220812182942/https://www.politicallore.com/st-vincent-the-grenadines-to-use-cubas-abdala-vaccine/27626}}</ref>
# Venezuela<ref>{{cite news |title=Venezuela receives first shipment of Cuban coronavirus vaccine |url=https://www.reuters.com/world/americas/venezuela-receives-first-shipment-cuban-coronavirus-vaccine-2021-06-24/ |access-date=3 July 2021 |publisher=Reuters |date=25 June 2021}}</ref>
# Vietnam<ref name="NYT vaccine tracker"/>
;Travel-only
* Cambodia<ref>{{cite web|url=https://www.khmertimeskh.com/50971131/list-of-covid-19-vaccines-recognised-by-cambodia-for-quarantine-free-international-entry/|title = List of COVID-19 vaccines recognised by Cambodia for quarantine free international entry - Khmer Times|date = 15 November 2021}}</ref>
* Colombia<ref>{{cite web|title=Conozca las 20 vacunas aceptadas para el ingreso de viajeros a Colombia|url=https://www.cali.gov.co/publicaciones/165988/conozca-las-20-vacunas-aceptadas-para-el-ingreso-de-viajeros-a-colombia/|access-date=15 December 2021|website=www.cali.gov.co|language=es}}</ref>
* Guyana<ref name=":9">{{cite web |date=November 2021 |title=Requirements for Port Entry into Guyana |url=https://www.health.gov.gy/images/travel_requirement.pdf#page=2 |access-date=2 March 2022 |website=www.health.gov.gy/index.php/component/k2/item/304-travel-guidelines |language=en }}{{Dead link|date=December 2024 |bot=InternetArchiveBot |fix-attempted=yes }}</ref><ref name=":14">{{cite web |date=19 January 2022 |title=Travel Restrictions Entering Guyana from Cuba |url=https://airheart.com/travel-bans/from/cuba/to/guyana |access-date=2 March 2022 |website=airheart.com/travel-bans |language=en |accessdate=6 July 2022 |archivedate=2 March 2022 |archiveurl=https://web.archive.org/web/20220302141904/https://airheart.com/travel-bans/from/cuba/to/guyana }}</ref>
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9"/>
* St. Lucia<ref name="auto17"/>
* Turkey<ref name="visasturkey.com"/>
* Uruguay<ref name="auto14"/> (only if accepted in the country of the person's origin)
{{clear}}
== EpiVacCorona ==
<section begin="epivac-coronaauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|TM=blueviolet|TR=turquoise
|RU=dodgerblue
|BY=dodgerblue
|NZ=turquoise
|KH=dodgerblue
|VE=dodgerblue
|MY=turquoise
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
<section end="epivac-coronaauthmap"/>
[[EpiVacCorona]] is a [[peptide vaccine]] produced by the Russian [[State Research Center of Virology and Biotechnology VECTOR]]<wbr />.<ref name="NCT045275753">{{#invoke:Cite web||date=22 September 2020|title=Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19 (EpiVacCorona)|url=https://clinicaltrials.gov/ct2/show/NCT04527575|access-date=16 November 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04368988}}</ref>
;Full (<section begin="EpiVacCorona_FN"/>1<section end="EpiVacCorona_FN"/>)
# Turkmenistan<ref>{{cite news |title= Turkmenistan registers vaccines for the prevention of infectious diseases |url=https://tdh.gov.tm/en/post/25911/turkmenistan-registers-vaccines-prevention-infectious-diseases |work=Turkmenistan Today |date=29 January 2021 }}</ref><ref>{{cite news |title=Russian vaccine "EpiVacCorona" was registered in Turkmenistan |url=https://www.en24news.com/e/2021/01/russian-vaccine-epivaccorona-was-registered-in-turkmenistan.html |work=EN24 |date=29 January 2021 |accessdate=7 July 2021 |archivedate=19 March 2021 |archiveurl=https://web.archive.org/web/20210319140314/https://www.en24news.com/error }}</ref>
;Emergency (<section begin="EpiVacCorona_EN"/>4<section end="EpiVacCorona_EN"/>)
# Belarus<ref>{{#invoke:Cite web||date=3 February 2021|title=Belarus receives Russia's EpiVacCorona vaccine|url=https://eng.belta.by/society/view/belarus-receives-russias-epivaccorona-vaccine-137131-2021/|access-date=5 April 2021|website=Belta}}</ref>
# Cambodia<ref name="TrackVax"/>
# Russia<ref>{{cite web | title = О регистрации вакцины ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора "ЭпиВакКорона" | website = Rospotrebnadzor | url = https://www.rospotrebnadzor.ru/region/rss/rss.php?ELEMENT_ID=15660 | date = 14 October 2020 | language = ru | accessdate = 7 July 2021 | archivedate = 1 November 2020 | archiveurl = https://web.archive.org/web/20201101010437/https://www.rospotrebnadzor.ru/region/rss/rss.php?ELEMENT_ID=15660 }}</ref><ref>{{cite web | title = Russia's EpiVacCorona vaccine post-registration trials started | publisher=The Pharma Letter |url = https://www.thepharmaletter.com/article/russia-s-epivaccorona-vaccine-post-registration-trials-started |date=18 November 2020 }}</ref>
# Venezuela<ref name="TrackVax"/>
;Travel-only
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9"/>
* Turkey<ref name="visasturkey.com"/>
{{clear}}
== Zifivax ==
<section begin="rbd-dimerauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|CN=dodgerblue
|HK=turquoise
|ID=dodgerblue
|MY=turquoise
|NZ=turquoise
|PK=dodgerblue
|TR=turquoise
|UZ=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
<section end="rbd-dimerauthmap"/>
[[ZF2001|Zifivax]] is a [[subunit vaccine]] produced by the Chinese company [[Anhui Zhifei Longcom Biopharmaceutical]].<ref name="london2">{{#invoke:Cite web||date=1 March 2021|title=COVID-19 vaccine development pipeline (Refresh URL to update)|url=https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/|access-date=10 March 2021|publisher=Vaccine Centre, London School of Hygiene and Tropical Medicine}}</ref>
;Full (<section begin="Zifivax_FN"/>0<section end="Zifivax_FN"/>)
;Emergency (<section begin="Zifivax_EN"/>5<section end="Zifivax_EN"/>)
# China<ref>{{cite news|last=Liu|first=Roxanne|date=15 March 2021|title=China IMCAS's COVID-19 vaccine obtained emergency use approval in China|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-china-vaccine-idUSL4N2LD3BZ|access-date=15 March 2021}}</ref>
# Colombia<ref>{{Cite web |last=de 2022 |first=26 de Enero |title=Invima recomienda el uso de emergencia de Zifivax, otra vacuna anticovid producida en China |url=https://www.infobae.com/america/colombia/2022/01/27/invima-recomienda-el-uso-de-emergencia-de-zifivax-otra-vacuna-anticovid-producida-en-china/ |access-date=2022-06-24 |website=infobae |language=es-ES}}</ref>
# Indonesia<ref>{{cite web|date=7 October 2021|title=BPOM Setujui Penggunaan Dalam Kedaruratan Vaksin Zifivax|url=https://republika.co.id/berita/nasional/umum/r0ljxq436/bpom-setujui-penggunaan-dalam-kedaruratan-vaksin-zifivax|access-date=7 October 2021|work=Republika.co.id|language=id}}</ref>
# Pakistan<ref>{{cite web|title=Pakistan gears up for China's "ZF-2001 vaccine"--China Economic Net|url=http://en.ce.cn/Insight/202111/08/t20211108_37068436.shtml|access-date=30 November 2021|website=en.ce.cn}}</ref>
# Uzbekistan<ref>{{cite news | last1=Mamatkulov |first1=Mukhammadsharif |title=Uzbekistan approves Chinese-developed COVID-19 vaccine |url=https://www.reuters.com/article/uzbekistan-china-coronavirus-vaccine/uzbekistan-approves-chinese-developed-covid-19-vaccine-idUSS0N2IK00P |publisher=Reuters |access-date=2 March 2021 |date=1 March 2021}}</ref>
;Travel-only
* Hong Kong<ref name="HK"/>
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9"/>
* Turkey<ref name="visasturkey.com"/>
{{clear}}
== Soberana 02 ==
<section begin="soberana2authmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|CU=dodgerblue
|GY=turquoise
|HU=turquoise
|IR=dodgerblue
|MY=turquoise
|NI=dodgerblue|NZ=turquoise
|TR=turquoise
|VE=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
<section end="soberana2authmap"/>
[[Soberana 02]], is a [[conjugate vaccine]] developed by the [[Finlay Institute]] in [[Cuba]].<ref name="finlayIran">{{cite web |title=Autorizo de emergencia SOBERANA 02 en Irán |url=https://www.finlay.edu.cu/blog/autorizo-de-emergencia-soberana-02-en-iran/ |website=finlay.edu.cu |publisher=Instituto Finlay de Vacunas |access-date=6 July 2021 |date=1 July 2021}}</ref>
;Full (<section begin="Soberana 02_FN"/>0<section end="Soberana 02_FN"/>)
;Emergency (<section begin="Soberana 02_EN"/>4<section end="Soberana 02_EN"/>)
# Cuba<ref>{{cite news |title=Cuba grants emergency approval to second homegrown COVID-19 vaccine |url=https://www.gmanetwork.com/news/scitech/science/800262/cuba-grants-emergency-approval-to-second-homegrown-covid-19-vaccine/story/ |publisher=GMA News |date=21 August 2021}}</ref>
# Iran<ref name="finlayIran"/>
# Nicaragua<ref>{{cite news |title=Nicaragua authorises two COVID-19 vaccines from Cuba, Cuban firm says|url=https://www.reuters.com/business/healthcare-pharmaceuticals/nicaragua-authorises-two-covid-19-vaccines-cuba-cuban-firm-says-2021-10-02/|publisher=Reuters |date =2 October 2021}}</ref>
# Venezuela<ref name="TrackVax"/>
;Travel-only
* Guyana<ref name=":9" /><ref name=":14" />
* Hungary<ref name="hungarytoday.hu">{{cite web|date=16 December 2021|title=Iran and Hungary to Mutually Honour Immunity Certificates|url=https://hungarytoday.hu/hungary-iran-immunity-certificate-szijjarto/|access-date=19 December 2021|website=Hungary Today}}</ref>
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9" />
* Turkey<ref name="visasturkey.com"/>
== CoviVac ==
<section begin="covivacauthmap" />
{{infobox
| image = {{Graph:Map|scale=50|defaultValue=gainsboro
|BY=dodgerblue
|KH=dodgerblue
|MY=turquoise
|NZ=turquoise
|RU=dodgerblue
|TR=turquoise
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
<section end="covivacauthmap" />
[[CoviVac (Russia COVID-19 vaccine)|CoviVac]] is an [[inactivated vaccine|inactivated virus vaccine]]<ref name="Ryumin" /> produced by the Chumakov Centre at the [[Russian Academy of Sciences]].<ref>{{#invoke:Cite web||date=18 January 2021|title=Briefing with Deputy Prime Minister Tatyana Golikova, Health Minister Mikhail Murashko and Head of Rospotrebnadzor Anna Popova|url=http://government.ru/en/news/41342/|access-date=20 February 2021|publisher=Government of Russia}}</ref>
;Full (<section begin="CoviVac_FN" />0<section end="CoviVac_FN" />)
;Emergency (<section begin="CoviVac_EN" />3<section end="CoviVac_EN" />)
# Belarus<ref>{{#invoke:Cite web||date=16 December 2021|title=Минздрав выдал разрешение на ввоз и применение вакцины КовиВак|url=http://minzdrav.gov.by/ru/novoe-na-sayte/minzdrav-vydal-razreshenie-na-vvoz-i-primenenie-vaktsiny-kovivak/|publisher=Ministry of Health of the Republic of Belarus|language=RU}}</ref>
# Cambodia<ref name="TrackVax" />
# Russia<ref>{{cite news |date=20 February 2021 |title=Russia approves its third COVID-19 vaccine, CoviVac |publisher=Reuters |url=https://www.reuters.com/article/us-health-coronavirus-russia-vaccine/russia-approves-its-third-covid-19-vaccine-covivac-idUKKBN2AK07H}}</ref>
; Travel-only
* Malaysia<ref name="MY" />
* New Zealand<ref name="auto9" />
* Turkey<ref name="visasturkey.com" />
== QazCovid-in ==
<section begin="qazcovid-inauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|KZ=dodgerblue
|KG=dodgerblue
|MY=turquoise
|NZ=turquoise
|TR=turquoise
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
<section end="qazcovid-inauthmap"/>
[[QazCovid-in]], also known as QazVac, is an [[inactivated vaccine|inactivated virus vaccine]] developed by the Research Institute for Biological Safety Problems in Kazakhstan.<ref name="qazvac">{{cite web |title=A new vaccine on the scene: Kazakhstan begins rollout of homegrown QazVac |date=26 April 2021 |url=https://fortune.com/2021/04/26/new-covid-19-vaccine-kazakhstan-qazvac/ |website=Fortune}}</ref>
;Full (<section begin="QazCovid-in_FN"/>0<section end="QazCovid-in_FN"/>)
;Emergency (<section begin="QazCovid-in_EN"/>2<section end="QazCovid-in_EN"/>)
# Kazakhstan<ref name="qazvac"/>
# Kyrgyzstan<ref>{{cite news | title=Vaccination against COVID-19: QazVac registered in Kyrgyzstan
|url=https://24.kg/english/204508_Vaccination_against_COVID-19_QazVac_registered_in_Kyrgyzstan/ |publisher=24.kg |date=19 August 2021 }}</ref><ref>{{cite news | title=Kyrgyzstan to start using Kazakh-made QazVac after expert review|url=https://www.eureporter.co/world/kazakhstan/2021/08/19/kyrgyzstan-to-start-using-kazakh-made-qazvac-after-expert-review/ |publisher=Eureporter |date=19 August 2021 }}</ref><ref>{{cite news |title=The Covid-19 Vaccine Qazvac Is Firstly Registrated Abroad |url=https://www.biosafety.kz/en/uncategorized/%d0%b2%d0%b0%d0%ba%d1%86%d0%b8%d0%bd%d0%b0-qazvac-%d0%bf%d1%80%d0%be%d1%82%d0%b8%d0%b2-covid-19-%d0%bf%d0%be%d0%bb%d1%83%d1%87%d0%b8%d0%bb%d0%b0-%d0%bf%d0%b5%d1%80%d0%b2%d1%83%d1%8e-%d1%80%d0%b5%d0%b3/ |publisher=Biosafety.kz |date=18 August 2021 |accessdate=6 October 2021 |archivedate=18 April 2022 |archiveurl=https://web.archive.org/web/20220418235422/https://www.biosafety.kz/en/uncategorized/%d0%b2%d0%b0%d0%ba%d1%86%d0%b8%d0%bd%d0%b0-qazvac-%d0%bf%d1%80%d0%be%d1%82%d0%b8%d0%b2-covid-19-%d0%bf%d0%be%d0%bb%d1%83%d1%87%d0%b8%d0%bb%d0%b0-%d0%bf%d0%b5%d1%80%d0%b2%d1%83%d1%8e-%d1%80%d0%b5%d0%b3/ }}</ref>
;Travel-only
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9"/>
* Turkey<ref name="visasturkey.com"/>
{{-}}
== Minhai ==
<section begin="Minhaiauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|CN=dodgerblue
|ID=dodgerblue
|MY=turquoise
|NZ=turquoise
|TR=turquoise
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
<section end="Minhaiauthmap"/>[[Minhai COVID-19 vaccine]], is an [[inactivated vaccine|inactivated virus vaccine]] developed by Minhai Biotechnology Co. and [[Shenzhen Kangtai Biological Products]] Co. Ltd. in China.<ref name="MinhaiEUA">{{Cite news|author=Reuters Staff|date=14 May 2021|title=Kangtai Biological's COVID-19 vaccine gets emergency use approval in China|work=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-kangtai-idUSKBN2CV1F6|access-date=20 May 2021}}</ref>
;Full (<section begin="Minhai_FN"/>0<section end="Minhai_FN"/>)
;Emergency (<section begin="Minhai_EN"/>2<section end="Minhai_EN"/>)
# China<ref name="MinhaiEUA"/>
# Indonesia<ref>{{cite web|last=Co.,Ltd|first=Shenzhen Kangtai Biological Products|title=BioKangtai's adenovirus vector COVID-19 vaccine obtained EUA in Indonesia|url=https://www.prnewswire.com/news-releases/biokangtais-adenovirus-vector-covid-19-vaccine-obtained-eua-in-indonesia-301415162.html|access-date=30 November 2021|website=PR Newswire}}</ref>
;Travel-only
* Hong Kong<ref name="HK"/>
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9"/>
* Turkey<ref name="visasturkey.com"/>
== Medigen ==
<section begin="medigenauthmap" />
{{infobox
| image = {{Graph:Map|scale=50|defaultValue=gainsboro
|BZ=turquoise
|ID=turquoise
|MY=turquoise
|NZ=turquoise
|PW=turquoise
|PY=dodgerblue
|SOMALILAND=dodgerblue
|TH=turquoise
|TR=turquoise
|TW=dodgerblue
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
<section end="medigenauthmap" />
[[MVC COVID-19 vaccine|MVC-COV1901]], is a [[Protein subunit|protein subunit vaccine]] developed by [[Taiwan]]'s Medigen Vaccine Biologics and Dynavax Technologies.<ref name="MVCTW">{{cite web |date=19 July 2021 |title=Taiwan approves Medigen's COVID-19 vaccine candidate |url=https://www.reuters.com/world/asia-pacific/taiwan-approves-production-medigens-covid-19-vaccine-candidate-2021-07-19/ |access-date=19 July 2021 |publisher=Reuters}}</ref>
;Full (<section begin="Medigen_FN" />0<section end="Medigen_FN" />)
;Emergency (<section begin="Medigen_EN" />2<section end="Medigen_EN" />)
# Taiwan<ref name="MVCTW" />
# Paraguay<ref>{{cite news |date=2022-02-14 |title=Paraguay aprueba vacuna taiwanesa Medigen para uso de emergencia |agency=Diario HOY |url=https://www.hoy.com.py/nacionales/paraguay-aprueba-vacuna-taiwanesa-medigen-para-uso-de-emergencia}}</ref>
;Non-country entities
* Somaliland<ref>{{cite web |date=28 December 2021 |title=Taiwan to donate domestic COVID-19 vaccines to Somaliland |url=https://focustaiwan.tw/politics/202112280007 |access-date=7 January 2022 |website=Focus Taiwan}}</ref>
;Travel-only
* Belize<ref>{{cite web |date=30 November 2021 |title=MOHW Approves Entry for Persons with the Taiwanese Medigen Jab |url=https://lovefm.com/mohw-approves-entry-for-persons-with-the-taiwanese-medigen-jab/ |access-date=8 January 2022 |website=Love FM News |accessdate=6 July 2022 |archivedate=7 January 2022 |archiveurl=https://web.archive.org/web/20220107161153/https://lovefm.com/mohw-approves-entry-for-persons-with-the-taiwanese-medigen-jab/ }}</ref>
* Indonesia<ref>{{cite web |date=16 November 2021 |title=Negara yang mengakui vaksin Medigen menjadi 4 negara |url=https://news.pts.org.tw/article/554169 |access-date=8 January 2022 |website=PTS news}}</ref>
* Malaysia<ref name="MY" />
* New Zealand<ref name="auto9" />
* Palau<ref>{{cite web |title=COVID-19 Pandemic Entry Requirements – PalauGov.pw |url=https://www.palaugov.pw/travel/ |access-date=24 December 2021}}</ref>
* Thailand<ref name="ThailandPass" />
* Turkey<ref name="visasturkey.com" />
== Corbevax ==
[[Corbevax]] is a [[Protein subunit|protein]] [[subunit vaccine]] developed by Texas Children's Hospital at the [[Baylor College of Medicine]] in [[Houston, Texas]], and licensed to Indian biopharmaceutical firm [[Biological E. Limited]] (BioE) for development and production.<ref name="vacxine2" /><ref>{{cite news |last=Raghavan |first=Prabha |name-list-style=vanc |date=10 June 2021 |title=Explained: How is Biological E's Corbevax different? |website=The Indian Express |url=https://indianexpress.com/article/explained/corbevax-vaccine-biological-e-india-7344928/ |access-date=29 December 2021}}</ref>
;Full (<section begin="Corbevax_FN" />0<section end="Corbevax_FN" />)
;Emergency (<section begin="Corbevax_EN" />2<section end="Corbevax_EN" />)
# India<ref name="vacxine2" />
# Botswana<ref>{{Cite news |date=2022-03-28 |title=Botswana Approves Corbevax Covid Vaccine, Plans Local Output |language=en |work=Bloomberg.com |url=https://www.bloomberg.com/news/articles/2022-03-28/botswana-approves-corbevax-covid-vaccine-plans-local-output |access-date=2022-06-29}}</ref>
;Travel-only
* Malaysia<ref name="MY" />
* New Zealand<ref name="auto9" />
* Turkey<ref name="visasturkey.com" />
== COVIran Barekat ==
<!-- <section begin="coviranauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|HU=turquoise
|IR=dodgerblue
|MY=turquoise
|NZ=turquoise
|TR=turquoise
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
<section end="coviranauthmap"/> -->
[[COVIran Barekat]], is an [[inactivated vaccine|inactivated virus vaccine]] developed by Shifa Pharmed Industrial Co. in Iran.<ref name="ShifaEUA">{{#invoke:Cite web||date=14 June 2021|title=Iran issues license on its coronavirus vaccine|url=https://en.trend.az/iran/society/3439812.html|access-date=14 June 2021|website=Trend.Az}}</ref>
;Full (<section begin="COVIran Barakat_FN"/>0<section end="COVIran Barakat_FN"/>)
;Emergency (<section begin="COVIran Barekat_EN"/>1<section end="COVIran Barekat_EN"/>)
# Iran<ref name="ShifaEUA"/>
;Travel-only
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9"/>
* Hungary<ref name="ReferenceB">{{cite web|date=16 December 2021|title=Iran and Hungary to Mutually Honour Immunity Certificates|url=https://hungarytoday.hu/hungary-iran-immunity-certificate-szijjarto/|access-date=18 December 2021|website=Hungary Today}}</ref>
*Turkey<ref>{{cite web|date=10 April 2019|title=Vaccinations for Turkey: Do I need an Approved COVID Vaccine?|url=https://www.visasturkey.com/vaccinations-for-turkey/|access-date=26 December 2021|website=Turkey Visa|accessdate=25 December 2021|archivedate=16 November 2021|archiveurl=https://web.archive.org/web/20211116191928/https://www.visasturkey.com/vaccinations-for-turkey/}}</ref>
== Chinese Academy of Medical Sciences ==
<!-- <section begin="Chinese Academy of Medical Sciences authmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|CN=dodgerblue
|HK=turquoise
|NZ=turquoise
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
<section end="Chinese Academy of Medical Sciences authmap"/> -->
[[Chinese Academy of Medical Sciences COVID-19 vaccine]], is an [[inactivated vaccine|inactivated virus vaccine]] developed by [[Peking Union Medical College|Chinese Academy of Medical Sciences]].<ref name="IMBCAMSEUA">{{cite news |last1=Liu |first1=Roxanne |last2=Woo |first2=Ryan |title=China builds new plant for IMBCAMS COVID-19 vaccine -state media |url=https://www.reuters.com/world/asia-pacific/china-builds-new-plant-imbcams-covid-19-vaccine-state-media-2021-06-09/ |access-date=15 June 2021 |work=Reuters |date=9 June 2021}}</ref>
;Full (<section begin="Chinese Academy of Medical Sciences_FN"/>0<section end="Chinese Academy of Medical Sciences_FN"/>)
;Emergency (<section begin="Chinese Academy of Medical Sciences_EN"/>1<section end="Chinese Academy of Medical Sciences_EN"/>)
# China<ref name="IMBCAMSEUA"/>
;Travel-only
* Hong Kong<ref name="HK"/>
* New Zealand<ref name="auto9"/>
* Turkey<ref name="visasturkey.com"/>
*
== ZyCoV-D ==
[[ZyCoV-D]], is a [[DNA vaccine|DNA plasmid]] based [[COVID-19 vaccine]] developed by the Indian pharmaceutical company [[Cadila Healthcare]] with support from the [[Department of Biotechnology|Biotechnology Industry Research Assistance Council]].<ref name="zycov-d">{{cite news |title=India gives emergency approval for world's first COVID-19 DNA vaccine |url=https://www.reuters.com/business/healthcare-pharmaceuticals/india-approves-zydus-cadilas-covid-19-vaccine-emergency-use-2021-08-20/ |work=Reuters |date=20 August 2021 }}</ref>
;Full (<section begin="ZyCoV-D_FN"/>0<section end="ZyCoV-D_FN"/>)
;Emergency (<section begin="ZyCoV-D_EN"/>1<section end="ZyCoV-D_EN"/>)
# India<ref name="zycov-d"/>
;Travel-only
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9"/>
* Turkey<ref name="visasturkey.com"/>
== FAKHRAVAC ==
<!--<section begin="fakhravacauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|IR=dodgerblue
|NZ=turquoise
|HU=turquoise
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
}}
<section end="fakhravacauthmap"/> -->
[[FAKHRAVAC]] (or MIVAC), is an [[inactivated vaccine|inactivated virus vaccine]] developed in Iran by the [[Organization of Defensive Innovation and Research]], an organization of [[Ministry of Defence and Armed Forces Logistics (Iran)|Iran's Ministry of Defense]].<ref name="FakhraVacEUA">{{cite web|date=9 September 2021|title=Iran Authorizes Emergency Use of Third Homegrown Vaccine - Defense news|url=https://www.tasnimnews.com/en/news/2021/09/09/2568712/iran-authorizes-emergency-use-of-third-homegrown-vaccine|url-status=live|archive-url=https://web.archive.org/web/20210909123956/https://www.tasnimnews.com/en/news/2021/09/09/2568712/iran-authorizes-emergency-use-of-third-homegrown-vaccine|archive-date=9 September 2021|access-date=9 September 2021|website=Tasnim News Agency}}</ref>
;Full (<section begin="FAKHRAVAC_FN"/>0<section end="FAKHRAVAC_FN"/>)
;Emergency (<section begin="FAKHRAVAC_EN"/>1<section end="FAKHRAVAC_EN"/>)
# Iran<ref name="FakhraVacEUA"/>
;Travel-only
* Hungary<ref name="ReferenceB"/>
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9"/>
* Turkey<ref name="visasturkey.com"/>
== COVAX-19 ==
<!-- <section begin="COVAX19authmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|IR=dodgerblue
|MY=turquoise
|NZ=turquoise
|HU=turquoise
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
}}
<section end="COVAX19authmap"/> -->
[[COVAX-19]], also known as SpikoGen, is a [[subunit vaccine|protein subunit vaccine]] jointly developed by Australian-based company Vaxine and Iran-based company [[Cinnagen|CinnaGen]].<ref name="COVAX19EUA">{{cite news |title=Iran issues emergency permit for new local Covid-19 vaccine |url=https://en.mehrnews.com/news/179432/Iran-issues-emergency-permit-for-new-local-Covid-19-vaccine |access-date=12 October 2021 |publisher=[[Mehr News Agency]] |date= 6 October 2021}}</ref>
;Full (<section begin="COVAX-19_FN"/>0<section end="COVAX-19_FN"/>)
;Emergency (<section begin="COVAX-19_EN"/>1<section end="COVAX-19_EN"/>)
# Iran<ref name="COVAX19EUA"/>
;Travel-only
* Hungary<ref name="hungarytoday.hu"/>
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9"/>
* Turkey<ref name="visasturkey.com"/>
== Razi Cov Pars ==
<!-- <section begin="RaziCovParsauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|IR=dodgerblue
|NZ=turquoise
|HU=turquoise
|MY=turquoise
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
}}
<section end="RaziCovParsauthmap"/> -->
[[Razi Cov Pars]] is a [[subunit vaccine|protein subunit vaccine]] developed by [[Razi Vaccine and Serum Research Institute]].<ref name="Razieua">{{cite web|date=1 November 2021|title=Two homegrown vaccines receive emergency use license|url=https://www.tehrantimes.com/news/466570/Two-homegrown-vaccines-receive-emergency-use-license|access-date=27 November 2021|website=Tehran Times}}</ref>
;Full (<section begin="Razi Cov Pars_FN"/>0<section end="Razi Cov Pars_FN"/>)
;Emergency (<section begin="Razi Cov Pars_EN"/>1<section end="Razi Cov Pars_EN"/>)
# Iran<ref name="Razieua"/>
;Travel-only
* Hungary<ref name="ReferenceB"/>
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9"/>
* Turkey<ref name="visasturkey.com"/>
== Turkovac ==
<!--<section begin="turkovacsauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|TR=dodgerblue
|NZ=turquoise
|MY=turquoise
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
}}
<section end="turkovacauthmap"/>-->
[[Turkovac]] is an [[inactivated vaccine]] developed by [[Ministry of Health (Turkey)|Health Institutes of Turkey]] and [[Erciyes University]].<ref name="Turkoeua">{{cite news |last1=Aliyev |first1=Jeyhun |last2=Nur Duz |first2=Zehra |title=Turkey's domestic COVID-19 vaccine Turkovac approved for emergency use |url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkeys-domestic-covid-19-vaccine-turkovac-approved-for-emergency-use/2454638 |access-date=26 December 2021 |agency=Anadolu Agency |date=22 December 2021}}</ref>
;Full (<section begin="TurkoVac_FN"/>0<section end="TurkoVac_FN"/>)
;Emergency (<section begin="TurkoVac_EN"/>1<section end="TurkoVac_EN"/>)
# Turkey<ref name="Turkoeua"/>
;Travel-only
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9"/>
== Sinopharm CNBG ==
[[Sinopharm CNBG COVID-19 vaccine]] is a [[Recombinant vaccine|recombinant]] [[Protein subunit|protein]] [[subunit vaccine]] developed by China National Biotec Group (CNBG), a subsidiary of [[Sinopharm (company)|Sinopharm]].<ref name="CNBG">{{Cite news|date=27 December 2021|title=Emergency use of Sinopharm's new CNBG protein vaccine approved in UAE|work=[[Gulf News]]|url=https://gulfnews.com/uae/emergency-use-of-sinopharms-new-cnbg-protein-vaccine-approved-in-uae-1.84628476|access-date=27 December 2021}}</ref>
;Full (<section begin="CNBG_FN"/>0<section end="CNBG_FN"/>)
;Emergency (<section begin="CNBG_EN"/>1<section end="CNBG_EN"/>)
# United Arab Emirates<ref name="CNBG" />
;Travel-only
* Malaysia<ref name="MY"/>
* Turkey<ref name="visasturkey.com"/>
== Soberana Plus ==
[[Soberana Plus]] is a single-dose of [[conjugate vaccine]] developed by the [[Finlay Institute]] in [[Cuba]].<ref name="CubBoost">{{cite news | vauthors = Dönmez BB |title=Cuba grants emergency use to 2 virus vaccines |url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/cuba-grants-emergency-use-to-2-virus-vaccines/2341850 |access-date=23 September 2021 |agency=Anadolu Agency |date=21 August 2021}}</ref>
;Full (<section begin="Soberana Plus_FN"/>0<section end="Soberana Plus_FN"/>)
;Emergency (<section begin="Soberana Plus_EN"/>1<section end="Soberana Plus_EN"/>)
# Cuba<ref name="CubBoost"/>
;Travel-only
* Guyana<ref name=":9" /><ref name=":14" />
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9"/>
* Turkey<ref name="visasturkey.com"/>
== CoVLP ==
[[CoVLP]] is a [[Virus-like particle|Virus-Like Particle]] vaccine grown in an Australian weed, [[Nicotiana benthamiana]]. It is marketed under the name [https://medicago.com/en/press-release/covifenz/ Covifenz] {{Webarchive|url=https://web.archive.org/web/20220224161443/https://medicago.com/en/press-release/covifenz/ |date=2022-02-24 }}.
;Full (<section begin="CoVLP_FN" />1<section end="CoVLP_FN" />)
# Canada
;Emergency (<section begin="CoVLP_EN" />0<section end="CoVLP_EN" />)
;Travel-only
* Malaysia<ref name="MY"/>
* New Zealand<ref name="auto9"/>
* Turkey<ref name="visasturkey.com"/>
== Noora ==
[[Noora (vaccine)|Noora]] is a protein-based vaccine developed by the [[Baqiyatallah University of Medical Sciences]].
;Full (<section begin="Noora_FN" />0<section end="Noora_FN" />)
;Emergency (<section begin="Noora_EN" />1<section end="Noora_EN" />)
# Iran<ref>{{Cite news |date=1 March 2022 |title="Noora" vaccine receives emergency use license |work=[[Tehran Times]] |url=https://www.tehrantimes.com/news/470601/Noora-vaccine-receives-emergency-use-license |access-date=2 March 2022}}</ref>
;Travel-only
* Malaysia<ref name="MY"/>
* Turkey<ref name="visasturkey.com"/>
== SKYCovione ==
[[SKYCovione]] is a protein subunit vaccine developed by [[SK Group|SK Bioscience]].
;Full (<section begin="SKYCovione_FN" />0<section end="SKYCovione_FN" />)
;Emergency (<section begin="SKYCovione_EN" />1<section end="SKYCovione_EN" />)
# South Korea<ref>{{Cite news |last=Kim |first=Tong-Hyung |date=29 June 2022 |title=South Korea approves first homemade COVID-19 vaccine |work=[[Associated Press]] |url=https://apnews.com/article/covid-health-pandemics-public-db128bb38e561e45f477035b0e0f7524 |access-date=29 June 2022}}</ref>
== Тэмдэглэл ==
{{reflist|group=lower-alpha}}
== Зүүлтэ ==
{{reflist}}
{{COVID-19 pandemic}}
{{Vaccines}}
[[Категори:COVID-19-дэ эсэргүү вакцина| ]]
[[Категори:Медицинскэ шэнжэлэлгэ]]
a84rkl47wt7h7ipdwkbd0e6m15g07ut
Йорубанууд
0
13199
75166
70187
2026-11-19T23:53:13Z
InternetArchiveBot
12366
Rescuing 1 sources and tagging 0 as dead. #IABot (v2.0.9.7)
75166
wikitext
text/x-wiki
{{Инфобокс этническэ бүлэг
| group = Йоруба<br />{{small|'' Ìran Yorùbá, Ọmọ Odùduwà, Ọmọ Ilẹ̀ Káàárọ̀-oòjíire''}}
| total = {{circa|41,768,010}}{{efn|Population figures not inclusive of pre-20th century diasporic communities who trace full or partial Yoruba heritage}}
| image = [[File:The Yoruba Cultural Group Children of Fasta International School - Photo Session.jpg|300px]]
| caption = Олоной үмэнэ хэмжээндэ оролсожо буй Йорубанууд
| region1 = {{nbsp}}[[File:Oduduwa Flag.jpg|21px]] [[Йорубаланд]]
| pop1 = > 35,000,000
| region2 = {{NGR}}
| pop2 = 37,500,000
| ref2 = <ref>{{cite web |title=Ethnologue, languages of the World - Yoruba 39,500,000. As L1; 37,500,000 - c.2015|website=Ethnologue.com (July 2019)|url=https://www.ethnologue.com/language/YOR|archive-url=https://web.archive.org/web/20190725014951/https://www.ethnologue.com/language/YOR|language=en|access-date=October 29, 2021|archive-date=25 July 2019}}</ref> (2015)
| region3 = {{BEN}}
| pop3 = 1,600,000
| ref3 = <ref>{{cite web |title=Beninese Culture - Yoruba 12.3%|website=Beninembassy.us|url=https://beninembassy.us/culture-beninoise|language=en|access-date=October 29, 2021}}</ref>
| region4 = {{GHA}}
| pop4 = 546,000
| ref4 = <ref>{{cite web |title=Yoruba and Ife in Ghana|website=Joshua Project|url=https://joshuaproject.net/people_groups/16057/GH|language=en|access-date=November 13, 2019}}</ref>
| langs = [[Йоруба хэлэн|Йоруба]] ба [[Йорубоид хэлэнүүд]] <br>Бусад: [[Англи хэлэн|Англи]] гү, али [[Франци хэлэн|Франци]]<br>
[[Португал хэлэн|Португал]], [[Испани хэлэн|Испани]]
| region5 = {{TOG}}
| pop5 = 351,000
| ref5 = <ref>{{cite web |title=Yoruba groups of Togo (The Ife, The Northern Nago and The Yoruba) |url=https://joshuaproject.net/clusters/320/ |language=en |access-date=September 4, 2020}}</ref><ref>{{cite web |title=Togo RGPH-04 Population and Housing Census (Ethnicity) |website=INSEED Togo |url=https://inseed.tg/statistiques-demographiques/ |language=fr |access-date=September 4, 2020}}</ref>
| region6 = {{USA}}
| pop6 = 196,000
| ref6 = <ref>{{cite web |title=Yoruba in USA |website=Joshua Project |url=https://joshuaproject.net/people_groups/16057/US |language=en |access-date=November 13, 2019}}</ref>
| region7 = {{CIV}}
| pop7 = 124,000
| ref7 = <ref>{{cite web |title=Yoruba in Cote d'Ivoire |website=Joshua Project |url=https://joshuaproject.net/people_groups/16057/IV |language=en |access-date=November 13, 2019}}</ref>
| region8 = {{UK}}
| pop8 = 102,000
| ref8 = <ref>{{cite web |title=Yoruba in United Kingdom |website=Joshua Project |url=https://joshuaproject.net/people_groups/16057/UK |language=en |access-date=November 13, 2019}}</ref>
| region9 = {{NIG}}
| pop9 = 78,000
| ref9 = <ref>{{cite web |title=Yoruba in Niger |website=Joshua Project |url=https://joshuaproject.net/people_groups/16057/NG |language=en |access-date=November 13, 2019}}</ref>
| region10 = {{BUR}}
| pop10 = 74,000
| ref10 = <ref>{{cite web |title=Yoruba in Burkina Faso |website=Joshua Project |url=https://joshuaproject.net/people_groups/16057/UV |language=en |access-date=November 13, 2019}}</ref>
| region11 = {{EQG}}
| pop11 = 64,000
| ref11 = <ref>{{cite web |title=Yoruba in Equatorial Guinea |website=Joshua Project |url=https://joshuaproject.net/people_groups/16057/EK |language=en |access-date=November 13, 2019}}</ref>
| region12 = {{ITA}}
| pop12 = 57,000
| ref12 = <ref>{{cite web |title=Yoruba in Italy |website=Joshua Project |url=https://joshuaproject.net/people_groups/16057/IT |language=en |access-date=November 13, 2019}}</ref>
| region13 = {{LBR}}
| pop13 = 24,000
| ref13 = <ref>{{cite web |title=Yoruba in Liberia |website=Joshua Project |url=https://joshuaproject.net/people_groups/16057/LI |language=en |access-date=November 13, 2019}}</ref>
| region14 = {{CAN}}
| pop14 = 16,210
| ref14 = <ref>{{cite web |title=2015 Canadian Population census, Language spoken at home |url=https://www12.statcan.gc.ca/census-recensement/2016/dp-pd/dt-td/Rp-eng.cfm?TABID=2&Lang=E&APATH=3&DETAIL=0&DIM=0&FL=A&FREE=0&GC=0&GID=1235625&GK=0&GRP=1&PID=110212&PRID=10&PTYPE=109445&S=0&SHOWALL=0&SUB=0&Temporal=2016&THEME=118&VID=0&VNAMEE=&VNAMEF=&D1=0&D2=0&D3=0&D4=0&D5=0&D6=0
|access-date=September 3, 2021}}</ref>
| region15 = {{GAM}}
| pop15 = 12,000
| ref15 = <ref>{{cite web |title=Yoruba in Gambia |website=Joshua Project |url=https://joshuaproject.net/people_groups/16057/GA |language=en |access-date=November 13, 2019}}</ref>
| region16 = {{IRL}}
| pop16 = 10,100
| ref16 = <ref>{{cite web |url=http://www.cso.ie/en/media/csoie/census/documents/census2011profile6/Profile_6_Migration_and_Diversity_entire_doc.pdf |title=Profile 6 - Migration and Diversity |date=October 2012 |publisher=[[Central Statistics Office (Ireland)|Central Statistics Office]] |access-date=4 September 2021}}</ref>
| region17 = {{SLE}}
| pop17 = 6,400
| ref17 = <ref>{{cite web |title=Yoruba in Sierra Leone |website=Joshua Project |url=https://joshuaproject.net/people_groups/16057/SL |language=en |access-date=November 13, 2019}}</ref>
| region18 = {{GRE}}
| pop18 = 5,300
| ref18 = <ref>{{cite web |title=Yoruba in Greece |website=Joshua Project |url=https://joshuaproject.net/people_groups/16057/GR |language=en |access-date=November 13, 2019}}</ref>
| region19 = {{AUS}}
| pop19 = 2,000
| ref19 = <ref>{{cite web |title=Yoruba in Australia |website=Joshua Project|url=https://joshuaproject.net/people_groups/16057/AS|language=en|access-date=November 13, 2019}}</ref>
| religions = [[Христосой шажан|Христос]]{{·}}[[Лалын шажан|Лалын]]{{·}}[[Йоруба шажан]]</br><ref>https://academic.oup.com/view-large/35408497</ref><ref name="Research note: Exploring survey dat">{{cite journal |last1=Nolte |first1=Insa |last2=Jones |first2=Rebecca |last3=Taiyari |first3=Khadijeh |last4=Occhiali |first4=Giovanni |title=Research note: Exploring survey data for historical and anthropological research: Muslim–Christian relations in south-west Nigeria |journal=African Affairs |date=July 2016 |volume=115 |issue=460 |pages=541–561 |doi=10.1093/afraf/adw035 |doi-access=free }}</ref><ref>{{cite web |url=https://www.grin.com/document/353192|title=GRIN - Identity conflicts among Yoruba Muslim groups in selected states of Nigeria|website=grin.com}}</ref>
| related-c =
<div style="text-align: center;">[[Йорубоид хэлэнүүд|(Йорубоид)]] {{nbsp}}[[Окунууд (Сьерра-Леоне)|Аку]]{{·}}[[Игала]]{{·}}[[Итсекири]]{{·}}[[Нагос]]{{·}}[[Табом арад|Табом]]</div>
<div style="text-align: center;">[[Гбе хэлэнүүд|(Гбе)]] {{nbsp}}[[Ажа хүнүүд|Ажа]]{{·}}[[Эве арад|Эве]]{{·}}[[Фон арад|Фон]]{{·}}[[Маһи арад|Маһи]]{{·}}[[Огу арад|Огу]]</div>
<div style="text-align: center;">[[Ква хэлэнүүд|(Ква)]] {{nbsp}}[[Адель хэлэн|Адель]]{{·}}[[Акебу хэлэн|Акебу]]{{·}}[[Ании хэлэн|Ании]]{{·}}[[Га арад|Га]]{{·}}[[Кпосо арад|Кпосо]]</div>
<div style="text-align: center;">[[Нупоид хэлэнүүд|(Нупоид)]] {{nbsp}}[[Игбира арад|Игбира]]{{·}}[[Гбари арад|Гбари]]{{·}}[[Нупе арад|Нупе]]</div>
<div style="text-align: center;">[[Эдоид хэлэнүүд|(Эдоид)]] {{nbsp}}[[Афемай арад|Афемай]]{{·}}[[Бини арад|Бини]]{{·}}[[Ишан арад|Ишан]]{{·}}[[Исоко арад|Исоко]]{{·}}[[Урхобо арад|Урхобо]]<ref>{{cite web|url=http://www.raceandhistory.com/historicalviews/edoofbenin.htm|title=Raceandhistory.com - Nigeria: The Edo of Benin|website=raceandhistory.com|archiveurl=https://web.archive.org/web/20250710154313/http://www.raceandhistory.com/historicalviews/edoofbenin.htm|archivedate=2025-07-10|accessdate=2025-06-20}}</ref><ref>{{cite journal |url=https://www.jstor.org/stable/179535 |jstor=179535 |title=The Itsekiri in the Nineteenth Century; an Outline Social History |last1=Lloyd |first1=P. C. |journal=The Journal of African History |year=1963 |volume=4 |issue=2 |pages=207–231 |doi=10.1017/S0021853700004035}}</ref></div>
<div style="text-align: center;">[[Гур хэлэнүүд|(Гур)]] {{nbsp}}[[Барба арад|Барба]]{{·}}[[Лоссо арад|Лоссо]]<ref>{{Cite journal |last=Oyèláràn |first=Ọlásopé O. |date=May 2018 |title=Oríta Borgu: the Yorùbá and the Bààtonu down the ages|journal=Africa |language=en |volume=88 |issue=2 |pages=238–266 |doi=10.1017/S0001972017000900 |s2cid=150028429 |issn=0001-9720 |doi-access=free}}</ref></div>
<div style="text-align: center;">[[Африкын диаспора|(Диаспора)]] {{nbsp}}[[Африкын Америкашууд#Генетикэ|Африкын Америкашууд]]{{·}}[[Афро-Бразилшууд|Афро-</br>Бразилшууд]]{{·}}[[Афро-Кариб хүнүүд#Хэлэнүүд|Афро-Кариб хүнүүд]].<ref name="Montinaro2014">{{cite journal |author1=Francesco Montinaro |author2=George B.J. Busby |author3=Vincenzo L. Pascali |author4=Simon Myers |author5=Garrett Hellenthal |author6=Cristian Capelli |title=Unravelling the hidden ancestry of American admixed populations|journal=Nature Communications |date=March 24, 2015 |doi=10.1038/ncomms7596 |volume=6 |page=6596 |pmid=25803618 |pmc=4374169 |bibcode=2015NatCo...6.6596M }}</ref><ref>{{cite book |last=Falola |first=Toyin |title=Encyclopedia of the Yoruba |publisher=Indiana University Press |location=Bloomington |year=2016 |isbn=9780253021441 |pages=95–96}}</ref><ref>{{cite web |url=https://escholarship.org/content/qt17c6d1sb/qt17c6d1sb.pdf |title=The Vitality of Yoruba Culture in the Americas |date=2020}}</ref></div>
| native_name =
| native_name_lang =
| related_groups =
}}
'''Йорубанууд''' - Африкын аймаг юм.
[[File:Anna Hinderer building.jpg|thumb|right|Йоруба аймагын архитектураын үльгэр (XIX зуун).]]
== Зүүлтэ ==
{{зүүлтэ}}
[[Категори:Арадууд]]
g4rbvbe5kzn0lyelzf2yei6lqk5616d
Хэрэглэгшые хэлэлсэхэ:Mark Ekimov
3
15016
75162
2026-11-19T17:47:38Z
S.Marchenko
18041
S.Marchenko ондоо тээшэнь шэлжүүлэгдээ хуудаһан [[Хэрэглэгшые хэлэлсэхэ:Mark Ekimov]]-һаа [[Хэрэглэгшые хэлэлсэхэ:Чёрный дрозд]] руу: Автоматическое переименование страницы при переименовании участника «[[Special:CentralAuth/Mark Ekimov|Mark Ekimov]]» в «[[Special:CentralAuth/Чёрный дрозд|Чёрный дрозд]]»
75162
wikitext
text/x-wiki
#перенаправление [[Хэрэглэгшые хэлэлсэхэ:Чёрный дрозд]]
73k7xskwieeqjuzjybin64zphg46ncq